previous
show
erythropoietin
epo
attenu
morpholog
sign
spinal
cord
ischemiareperfus
ir
injuri
swine
without
howev
improv
neurolog
function
clinic
use
epo
caution
recent
due
seriou
safeti
concern
aris
increas
mortal
acut
stroke
patient
treat
epo
simultan
receiv
system
thrombolysi
carbamyl
epo
cepo
epo
deriv
without
erythropoiet
activ
devoid
epo
side
eff
ect
appar
well
maintain
cytoprotect
qualiti
therefor
test
hypothesi
whether
cepo
may
equal
effi
cient
epo
reduc
morpholog
well
function
aortic
occlusioninduc
spinal
cord
ir
injuri
method
random
blind
trial
pig
receiv
either
vehicl
control
n
epo
cepo
respect
n
iukg
minut
fi
rst
hour
reperfus
anim
underw
minut
thorac
aortic
balloon
occlus
cathet
place
immedi
downstream
subclavia
upstream
aortic
trifurc
spinal
cord
function
assess
motor
evok
potenti
mep
percentag
amplitud
aortic
occlus
lower
limb
refl
exe
assess
subject
strength
respons
period
hour
reperfus
tissu
damag
evalu
use
nissl
stain
result
epotr
cepotr
anim
present
attenu
spinal
cord
injuri
nissl
stain
median
quartil
percentag
damag
neuron
thorac
segment
control
cepo
epo
p
vs
control
group
lumbar
segment
control
cepo
epo
p
vs
control
group
howev
cepo
treatment
associ
recoveri
mep
amplitud
preocclus
valu
compar
control
group
p
lower
limb
refl
ex
respons
compar
restor
stronger
treatment
group
p
vs
control
conclus
clinic
relev
porcin
model
mimick
aortic
crossclamp
vascular
surgeri
repair
thorac
aortic
aneurysm
cepo
protect
spinal
cord
function
integr
eff
ectiv
epo
appli
equipot
dose
acknowledg
support
deutsch
forschung
gemeinschaft
sche
figur
abstract
phenylbutyr
reduc
unfold
protein
respons
introduct
awak
spontan
breath
mice
inhal
hydrogen
sulfi
de
h
induc
hibernationlik
metabol
state
characteris
reduc
energi
expenditur
hypothermia
protect
otherwis
lethal
hypoxia
hemorrhag
result
impair
cellular
energi
metabol
therefor
investig
metabol
eff
ect
inhal
h
model
resuscit
murin
septic
shock
method
sixteen
hour
induct
sepsi
cecal
ligat
punctur
clp
sham
oper
anesthet
mechan
ventil
mice
receiv
ppm
h
vehicl
hour
bodi
temperatur
respect
observ
period
hyperdynam
hemodynam
maintain
colloid
resuscit
noradrenalin
infus
endogen
glucos
product
calcul
blood
isotop
enrich
deriv
rate
appear
stabl
nonradioact
label
glucos
continu
isotop
infus
wholebodi
glucos
oxid
rate
deriv
total
co
product
rate
mix
expiratori
co
co
isotop
ratio
infus
rate
steadi
state
achiev
result
endogen
glucos
product
aff
ect
hypothermia
signifi
cantli
higher
septic
anim
compar
correspond
sham
oper
group
like
due
ongo
noradrenalin
infus
contrast
despit
catecholamin
infus
higher
glucos
releas
whole
bodi
glucos
oxid
signifi
cantli
reduc
normotherm
septic
anim
hypothermia
h
shift
substrat
toward
preferenti
glucos
utilis
eff
ect
disappear
septic
mice
conclus
h
inhal
alon
infl
uenc
glucos
metabol
temperatur
maintain
normotherm
level
anesthetis
mechan
ventil
mice
h
srelat
shift
energi
metabo
lism
toward
preferenti
carbohydr
oxid
present
hypothermia
blunt
sepsi
possibl
result
ongo
catecholamin
treatment
introduct
unfold
protein
respons
upr
mediat
apoptosi
play
pivot
role
ischemiareperfus
injuri
sodium
pba
report
act
chemic
chaperon
inhibit
uprmedi
apoptosi
trigger
ischemia
variou
organ
heart
therefor
investig
whether
pba
reduc
uprmedi
apoptosi
protect
myocardi
ischemiareperfus
injuri
mice
method
mice
subject
minut
lad
ischemia
follow
reperfus
pba
mgkg
pb
control
administr
intraperiton
ischemia
apoptosi
infarct
size
tissu
protein
level
uprmedi
apoptosisassoci
protein
evalu
tunel
ttc
stain
western
blot
analys
respect
hour
ischemia
n
group
echocardiographi
perform
week
ischemia
surviv
ratio
observ
n
group
result
compar
pb
pba
reduc
apoptot
cell
vs
p
infarct
size
vs
p
ischemiareperfus
increas
mice
pb
pba
attenu
increas
p
p
pba
inhibit
deterior
cardiac
paramet
includ
lvedd
mm
vs
mm
p
lvesd
mm
vs
mm
p
fs
vs
p
mice
pba
surviv
anim
pb
die
conclus
pba
maintain
cardiac
function
improv
surviv
ratio
myocardi
ischemiareperfus
reduc
uprmedi
apoptosi
mice
refer
introduct
awak
spontan
breath
mice
inhal
hydrogen
sulfi
de
h
induc
hibernationlik
metabol
state
characteris
reduc
energi
expenditur
hypothermia
protect
otherwis
lethal
hypoxia
hemorrhag
contrast
author
report
inhibit
endogen
h
synthesi
attenu
posthemorrhag
organ
dysfunct
data
origin
howev
unresuscit
model
use
pretreat
design
therefor
investig
timedepend
eff
ect
intraven
h
clinic
relev
longterm
model
porcin
hemorrhag
resuscit
method
surgic
instrument
pig
subject
hour
hemorrhag
shock
induc
remov
calcul
blood
volum
thereaft
addit
remov
retransfus
blood
boli
need
maintain
map
mmhg
anim
randomli
receiv
vehicl
control
n
intraven
h
donor
na
start
hour
hemorrhag
pretreat
n
begin
blood
remov
earli
posttreat
n
begin
resuscit
late
posttreat
n
group
na
infus
continu
fi
rst
hour
reperfus
resuscit
compris
retransfus
shed
blood
colloid
volum
expans
noradrenalin
titrat
keep
map
preshock
level
system
renal
liver
perfus
exchang
organ
function
assess
end
hemorrhag
well
hour
resuscit
result
surviv
control
vs
pretreat
earli
posttreat
late
posttreat
group
respect
signifi
cantli
improv
treatment
group
noradrenalin
infus
rate
requir
maintain
hemodynam
target
signifi
cantli
reduc
earli
posttreat
group
coincid
progress
drop
core
temperatur
attenu
kidney
dysfunct
blood
creatinin
level
creatinin
clearanc
anim
conclus
na
applic
improv
surviv
regardless
drug
time
less
benefi
cial
eff
ect
pretreat
organ
function
may
due
higher
total
amount
drug
infus
possibl
suggest
toxic
dose
translat
previou
anim
studi
human
icu
clinic
trial
frequent
produc
neg
result
anim
studi
high
baselin
mortal
employ
standardis
manag
sepsi
usual
provid
icu
aim
studi
develop
larg
anim
model
septic
shock
receiv
standardis
intens
care
manag
thu
replic
manag
septic
shock
human
method
eleven
marino
ewe
weight
kg
hemiazyg
vein
ligat
anaesthetis
radiolog
guid
cathet
insert
iliac
renal
hepat
vein
coronari
sinu
pulmonari
carotid
arteri
tracheostomi
tube
insert
anim
mechan
ventil
support
sling
six
sheep
administ
intraven
e
coli
atcc
x
orgskg
hour
septic
sheep
fi
receiv
placebo
nonsept
sheep
hour
anim
monitor
receiv
sedat
midazolam
ketamin
ventil
fl
uid
inotrop
accord
protocol
primari
endpoint
noradrenalin
na
dose
maintain
mean
arteri
pressur
map
mmhg
secondari
endpoint
includ
haemodynam
variabl
respiratori
hepat
renal
function
haematolog
acidbas
statu
global
hindlimb
renal
hepat
coronari
oxygen
extract
ratio
oer
result
sheep
success
instrument
monitor
support
hour
septic
sheep
requir
na
mean
dose
vs
p
develop
higher
cardiac
index
lm
vs
p
lower
svri
dynesm
vs
p
hour
septic
sheep
renal
impair
creatinin
mmoll
vs
p
urea
mmoll
vs
p
metabol
acidosi
ph
vs
p
lactat
mmoll
vs
p
pco
vs
p
coagulopathi
inr
vs
p
fi
brinogen
gl
vs
p
preserv
respiratori
hepat
function
global
oer
lower
septic
sheep
vs
p
coronari
oer
vs
p
oer
chang
sepsi
kidney
vs
p
liver
vs
p
hindlimb
vs
p
conclus
develop
larg
anim
model
septic
shock
receiv
intens
care
support
standardis
manag
model
replic
much
pathophysiolog
manag
occur
human
septic
shock
allow
larg
rang
physiolog
paramet
assess
investig
new
therapi
sepsi
introduct
sepsisinduc
lymphocyt
apoptosi
play
fundament
role
pathophysiolog
sepsi
recent
anim
model
sepsi
identifi
ed
anomali
extrins
apoptot
pathway
key
patholog
occurr
sepsi
specifi
calli
apoptosi
marker
caspas
fadd
shown
signifi
cant
anim
model
infect
investig
mrna
transcript
marker
human
model
sever
sepsi
hypothes
icu
mortal
sever
sepsi
associ
distinct
gene
express
extrins
apoptosi
marker
method
prospect
observ
studi
patient
sever
sepsi
perform
mononuclear
cell
isol
patient
sever
sepsi
total
rna
extract
sampl
day
admiss
day
fadd
caspas
mrna
quantifi
ed
quantit
realtim
polymeras
chain
reaction
qrtpcr
standard
demograph
outcom
data
record
betweengroup
comparison
perform
wilcoxon
rank
sum
test
valu
state
median
interquartil
rang
result
sixteen
patient
die
icu
caspas
mrna
copi
number
signifi
cantli
increas
day
survivor
group
x
x
x
compar
death
icu
group
x
x
x
p
fadd
caspas
mrna
copi
number
signifi
cantli
diff
erent
patient
die
discharg
icu
either
day
day
admiss
conclus
caspas
may
import
regul
apoptot
mechan
human
late
sepsi
proapoptot
mechan
may
role
resolut
sever
sepsi
conclus
individu
variabl
occur
faecal
zymosan
periton
model
shown
heterogen
clinic
respons
local
immun
cell
number
dose
similar
anim
cellular
immun
respons
model
consist
current
understand
infectioninduc
infl
ammat
neutrophil
macrophag
rose
proport
worsen
clinic
sever
signifi
canc
cell
fs
model
requir
evalu
introduct
lymphocyt
crucial
immun
cell
analys
tcell
subset
phenotyp
test
singl
cell
level
abil
produc
key
cytokin
earli
human
sepsi
method
whole
blood
collect
septic
patient
icu
admiss
peripher
blood
mononuclear
cell
pbmc
isol
tcell
subset
analys
studi
cytokin
product
pmbc
cultur
presenc
pmaionomycin
ngml
supplement
rpmi
hour
intracellular
cytokin
stain
cell
use
fl
ow
cytometri
number
cytokin
produc
cell
compar
agesexmatch
healthi
human
volunt
data
express
mean
sem
result
patient
year
old
six
male
apach
eight
survivor
nine
volunt
found
rel
increas
frequenc
treg
cell
proport
cell
remain
unchang
septic
patient
pmaionomycin
lead
maxim
tcell
stimul
test
abil
individu
cell
subset
produc
cytokin
septic
patient
display
reduct
vs
p
tendenc
higher
number
vs
p
produc
cell
proport
cell
increas
vs
p
howev
overal
tcell
popul
reduc
vs
follow
ex
vivo
activ
patient
number
stain
cell
unchang
figur
conclus
result
confi
rm
rel
increas
treg
skew
toward
lineag
cell
highli
activ
cell
appear
suscept
activationinduc
cell
death
introduct
current
understood
agent
modul
host
respons
sepsi
fail
act
refrain
overexagger
immun
respons
wherea
immunoparalysi
take
place
time
administr
eff
ect
immunoparalysi
monocyt
sepsi
assess
introduct
nitric
oxid
play
central
role
pathogenesi
sepsi
recent
demonstr
endotheli
no
eno
contribut
endogen
noproduct
modul
infl
ammat
associ
preserv
cardiac
function
result
prolong
surviv
eno
compar
wildtyp
wt
mice
role
neuron
no
nno
septic
cardiomyopathi
remain
unclear
studi
aim
elucid
infl
uenc
nno
presenceabs
eno
cardiac
function
surviv
clinic
relev
model
sepsi
method
inhibit
nno
achiev
via
continu
applic
select
nnosinhibitor
vinyllnio
vlnio
mgkg
bwhour
use
osmot
mini
pump
wt
eno
mice
render
septic
cecum
ligat
punctur
clp
hour
heart
function
analyz
use
pressurevolum
cathet
place
left
ventricl
catecholamin
respons
norepinephrin
appli
bwminut
intraperiton
noxlevel
plasma
measur
use
highpressur
perform
liquid
chromatographi
result
inhibit
nno
via
vlnio
applic
result
signifi
cantli
reduc
nitrat
plasma
level
prolong
surviv
wt
clp
vlnio
critic
care
volum
suppl
http
hour
vs
wt
clp
hour
howev
cardiac
function
norepinephrin
respons
improv
compar
untreat
septic
wt
contrast
wt
applic
vlnio
eno
infl
uenc
plasma
nitrat
level
cardiac
function
surviv
signifi
cantli
impair
compar
untreat
septic
eno
impair
cardiac
function
accompani
decreas
surviv
time
eno
clp
vlnio
hour
vs
eno
clp
hour
conclus
pharmacolog
inhibit
nno
result
signifi
cant
reduct
plasma
nitrat
level
prolong
surviv
compar
untreat
septic
wt
despit
unimprov
septic
cardiomyopathi
contrast
signifi
cant
surviv
benefi
septic
eno
compar
septic
wt
abrog
pharmacolog
nno
inhibit
furthermor
latter
develop
sever
septic
cardiomyopathi
whether
eno
act
modul
nno
set
remain
clarifi
ed
studi
introduct
high
mobil
group
box
hmgb
releas
activ
monocytesmacrophag
sepsi
level
correl
mortal
patient
antihmgb
antibodi
prevent
endotoxininduc
death
anim
model
mark
contrast
fi
nding
report
cytoprotect
eff
ect
hmgb
protect
liver
ischemiareperfus
ir
hmgbtransgen
mice
resist
myocardi
infarct
despit
report
littl
known
role
mechan
hmgb
aim
evalu
hmgb
rat
heart
pulmonari
renal
cell
cultur
method
isol
heart
receiv
hmgbvehicl
minut
ischemia
minut
reperfus
separ
studi
rat
render
septic
caecal
ligat
punctur
clp
prior
ir
left
ventricular
lv
function
measur
latex
lv
balloon
infarct
size
measur
ttc
stain
human
cell
cultur
studi
alveolar
cell
renal
tubular
cell
treat
hmgbvehicl
incub
normoxia
hypoxia
fluorimetr
activ
use
measur
apoptosi
cytochrom
c
measur
elisa
cell
mtt
assay
use
test
viabil
result
hmgb
prior
cardiac
ir
preserv
develop
lvp
minut
reperfus
compar
control
mmhg
vs
mmhg
p
infarct
size
express
v
weight
sem
reduc
vs
p
n
heart
clp
rat
reduc
baselin
dlvp
mmhg
vs
p
infarct
size
ir
signifi
cantli
reduc
p
vs
p
cell
hmgb
inhibit
apoptosi
reduc
activ
vs
au
p
associ
reduc
cytochrom
c
releas
vs
pgml
p
use
mtt
assay
hmgb
protect
hypoxiainduc
cell
death
vs
control
viabil
vs
p
conclus
hmgb
sepsi
similarli
precondit
heart
ir
injuri
hmgb
antiapoptot
eff
ect
protect
hypox
renal
alveolar
cell
injuri
conclud
hmgb
potent
antiischem
eff
ect
multipl
organ
may
function
innat
cytoprotect
mediat
sepsi
purpos
studi
evalu
btype
natriuret
peptid
bnp
predictor
septic
complic
icu
mortal
patient
new
onset
fever
fi
rst
day
hospit
icu
method
thirtyon
icu
patient
male
femal
new
onset
fever
leukocytosi
within
fi
rst
day
icu
admiss
prospect
includ
studi
exclus
criteria
heart
renal
failur
chronic
obstruct
pulmonari
diseas
head
trauma
serial
plasma
sampl
taken
day
onset
fever
bnp
level
measur
bnp
valu
correl
sever
score
acut
physiolog
chronic
health
evalu
apach
ii
sequenti
organ
failur
assess
sofa
progress
septic
shock
fi
nal
outcom
result
accord
clinic
laboratori
fi
nding
within
fi
rst
day
hospit
patient
includ
studi
divid
three
group
group
system
infl
ammatori
respons
syndrom
sir
seven
patient
group
b
sepsi
patient
group
c
septic
shock
patient
bnp
valu
day
signifi
cantli
associ
sofa
max
valu
p
bnp
valu
day
signifi
cantli
associ
icu
mortal
p
optim
cutoff
bnp
valu
diff
erenti
nonsurvivor
survivor
estim
pgml
sensit
specifi
citi
group
b
patient
bnp
valu
day
signifi
cantli
higher
patient
fi
nalli
progress
septic
shock
p
optim
cutoff
bnp
valu
identifi
patient
estim
pgml
sensit
specifi
citi
conclus
icu
patient
new
onset
fever
fi
rst
day
icu
hospit
bnp
valu
day
seem
good
predictor
icu
mortal
patient
sepsi
cutoff
bnp
valu
pgml
day
could
predictor
progress
septic
shock
due
small
number
patient
includ
studi
studi
need
confi
rm
fi
nding
introduct
highaffi
niti
receptor
igg
upregul
infl
ammatori
cytokin
neutrophil
upregul
link
pmn
activ
sir
sepsi
aim
verifi
correl
method
enrol
icu
critic
patient
three
group
creat
sir
sir
sepsi
evalu
xmean
valu
among
three
group
shown
figur
use
test
check
correl
upris
diff
erent
group
verifi
ed
correl
figur
wbc
ne
patient
age
use
r
result
found
higher
level
sepsi
compar
sir
p
sir
p
high
posit
linear
correl
sofa
score
r
introduct
incid
sepsi
report
around
european
icu
mortal
rate
depend
sever
organ
failur
four
organ
involv
multipl
organ
failur
mof
due
microcirculatori
dysfunct
microthrombosi
result
coagul
disord
includ
platelet
activ
earli
diagnosi
identifi
microcirculatori
dysfunct
mof
becam
clinic
evid
diagnosi
sepsi
commonli
base
clinic
criteria
pathogen
identifi
cation
use
marker
like
procalcitonin
pct
creactiv
protein
pcr
associ
infect
aim
studi
evalu
whether
routin
measur
immatur
platelet
fraction
ipf
consid
precoci
marker
platelet
product
associ
sepsi
sever
andor
whether
could
use
predict
marker
sepsi
method
enrol
consecut
patient
admit
icu
divid
two
group
septic
n
septic
n
sever
sepsi
evalu
exclus
criterion
platelet
count
blood
count
coagul
pcr
pct
ipf
collect
everi
day
ipf
valu
septic
septic
patient
diff
er
p
correl
found
ipf
valu
sever
septic
condit
sepsi
sepsi
sever
sepsi
septic
shock
p
consid
subject
sepsi
icu
admiss
found
patient
develop
sepsi
recoveri
ipf
valu
higher
patient
develop
sepsi
tabl
conclus
result
ipf
consid
marker
sepsi
convers
could
use
predict
index
sepsi
identifi
patient
develop
sepsi
introduct
role
matrix
metalloproteinas
mmp
tissu
inhibitor
matrix
metalloproteinas
timp
sepsi
remain
unclear
introduct
serum
creactiv
protein
crp
synthes
respons
infl
ammatori
statu
elev
crp
level
associ
increas
risk
multiorgan
failur
icu
patient
preoper
elev
serum
crp
prognost
indic
gastric
colorect
surgeri
aim
studi
determin
serum
crp
prognost
variabl
patient
undergo
esophagectomi
gastric
tube
reconstruct
contrast
icu
admit
patient
method
data
collect
retrospect
total
patient
admit
icu
follow
elect
surgeri
octob
decemb
patient
includ
underw
esophagectomi
gastric
tube
reconstruct
liver
transplant
hemihepatectomi
neuroand
abdomin
aneurysm
surgeri
postop
serum
marker
measur
relat
cours
postop
serum
crp
develop
complic
prognosi
patient
investig
result
postop
serum
crp
signifi
cantli
higher
patient
undergo
esophagectomi
gastric
tube
reconstruct
compar
patient
higher
serum
crp
level
correl
occurr
complic
heterogen
icu
popul
especi
esophagectomi
patient
within
group
serum
crp
level
signifi
cantli
higher
patient
postop
pneumonia
associ
increas
mortal
conclus
postop
serum
crp
level
easili
monitor
icu
order
identifi
patient
risk
develop
postop
complic
especi
esophagectomi
patient
occurr
postop
complic
associ
reduc
surviv
introduct
examin
whether
safe
shorten
period
antibiot
administr
septic
patient
procalcitonin
pct
measur
compar
pct
measur
method
particip
septic
patient
includ
hospit
icu
februari
novemb
administ
antibiot
day
stop
antibiot
icu
stay
treat
patient
februari
june
without
pct
measur
group
hand
treat
patient
juli
novemb
refer
serum
pct
level
group
b
group
b
sepsi
secondari
hydronephrosi
graph
clearli
show
rise
procalcitonin
pct
earli
onset
sepsi
fall
antibiot
treatment
antibiot
discontinu
pct
level
fell
peak
valu
day
exampl
right
laparoscop
cholecystectomi
complic
bile
periton
good
respons
antibiot
initi
pct
start
rise
day
prompt
us
chang
antibiot
serial
pct
use
assess
respons
treatment
introduct
bloodstream
infect
lifethreaten
condit
high
mortal
rate
especi
intens
care
neutropen
patient
standard
diagnost
base
blood
cultur
bc
howev
limit
bc
includ
rel
low
sensit
long
timetoresult
identifi
cation
pathogen
gener
day
ground
data
multicentr
studi
use
univers
rrna
gene
pcr
assay
molecular
diagnosi
discuss
rapid
sensit
tool
detect
identifi
cation
pathogen
support
bc
new
commerci
pcr
test
direct
detect
bacteria
whole
blood
compar
bc
term
sensit
specifi
citi
predict
valu
time
posit
ttp
bacteri
infect
bloodstream
critic
ill
patient
method
test
molzym
bremen
compris
extract
rrna
gene
pcr
detect
bacteri
dna
whole
blood
sampl
bacteria
posit
sampl
identifi
ed
sequenc
analysi
amplicon
prospect
multicentr
studi
blood
sampl
patient
system
infl
ammatori
respons
syndrom
sir
sepsi
neutropen
fever
includ
result
compar
bc
diagnost
sensit
specifi
citi
pcrsequenc
respect
posit
rate
pcrsequenc
higher
bc
pcr
sequencingposit
bcneg
patient
receiv
antibiot
pcr
result
judg
true
possibl
bacteraemia
use
routin
test
workfl
ow
time
posit
pcr
test
averag
decreas
hour
anaerobefastidi
infect
hour
yeast
infect
modest
diff
erenc
circul
concentr
coagulationfi
brinolysi
marker
ed
present
day
fi
rst
day
p
day
p
valu
anova
model
adjust
sex
race
comorbid
smoke
statu
tobit
model
use
censor
data
p
day
p
valu
mix
eff
ect
model
adjust
sex
race
comorbid
smoke
statu
tobmit
model
use
censor
data
introduct
prompt
initi
appropri
antibiot
therapi
improv
outcom
critic
ill
patient
tertiarylevel
icu
evalu
appropri
adher
antibiot
guidelin
base
local
bacteri
epidemiolog
cdcdefi
ned
hospitalassoci
infect
method
conduct
prospect
observ
studi
april
octob
consecut
icu
admiss
patient
satisfi
ed
investigatoradjud
classifi
cation
icuacquir
infect
accord
cdc
criteria
assess
patient
characterist
includ
sever
ill
admiss
icu
length
stay
lo
appropri
initi
antibiot
choic
judg
vitro
sensit
result
appropri
current
guidelin
result
present
mean
sd
median
appropri
result
studi
period
antibiot
start
patient
sepsi
secondari
icuacquir
infect
medic
patient
form
studi
cohort
whilst
patient
gener
surgic
remain
post
cardiothorac
surgeri
age
admiss
apach
ii
score
studi
cohort
year
median
lo
icu
mortal
cohort
day
common
cdc
report
diagnosi
clinic
microbiolog
confi
rmed
pneumonia
n
follow
intraabdomin
infect
ssigit
n
urinari
tract
infect
suti
n
cultur
posit
rate
appropri
icu
antibiot
guidelin
summaris
tabl
monotherapi
use
episod
median
length
antibiot
treatment
posit
cultur
day
day
cultur
neg
episod
sepsi
episod
neg
cultur
antibiot
stop
within
day
episod
introduct
secondari
periton
frequent
form
periton
character
high
diseas
burden
high
mortal
rate
choic
adequ
antibiot
independ
factor
surviv
aim
studi
compar
treatment
secondari
periton
tigecyclin
tg
standard
regimen
sr
econom
standpoint
method
ethic
committe
approv
studi
perform
prospect
nonintervent
cohort
trial
medic
center
germani
patient
could
includ
suff
ere
sever
secondari
periton
treat
icu
patient
pregnanc
age
year
milder
form
diseas
apach
ii
score
elig
order
compar
treatment
tg
sr
follow
data
document
demograph
data
diseas
sever
score
caus
microorgan
laboratori
paramet
length
stay
lo
patient
analys
accord
initi
antibiot
choic
except
periop
prophylaxi
order
balanc
diff
erenc
comorbid
sever
diseas
matchedpair
analysi
perform
base
logist
regress
analysi
result
total
patient
enrol
sr
logist
regress
analysi
match
gender
age
year
apach
ii
score
non
exist
liver
cirrhosi
arteri
sclerosi
coronari
heart
diseas
match
pair
built
compar
sr
group
tg
group
tendenc
higher
creatinin
urea
glucos
level
higher
number
comorbid
vs
ns
higher
number
pathogen
isol
initi
surgeri
vs
ns
higher
number
discharg
tg
group
vs
sr
ns
patient
die
vs
sr
ns
consid
factor
trend
shorter
lo
patient
treat
tg
day
vs
day
day
vs
day
survivor
nonsurvivor
respect
ns
total
cost
icu
stay
signifi
cantli
lower
tg
group
vs
p
conclus
nonintervent
studi
tigecyclin
tend
use
patient
sever
comorbid
spite
trend
shorter
lo
treatment
cost
signifi
cantli
lower
make
tigecyclin
attract
treatment
also
pharmacoeconom
standpoint
introduct
purpos
studi
compar
eff
ectiv
colistin
monotherapi
colistin
combin
treatment
nosocomi
infect
multiresist
germ
method
retrospect
studi
includ
patient
realiz
year
januari
decemb
medic
icu
univers
hospit
ibn
rochd
casablanca
morocco
studi
includ
patient
suff
er
nosocomi
infect
multiresist
germ
site
concern
patient
divid
group
group
includ
patient
treat
colistin
group
includ
patient
treat
associ
colistinrifampicin
colistin
administ
intraven
andor
nebul
intrathec
way
accord
consid
infecti
site
main
criterion
judgment
rate
mortal
resuscit
unit
second
criteria
judgment
ventil
wean
introduct
vasoact
drug
superven
side
eff
ect
result
sixtythre
patient
judg
appropri
includ
mean
age
patient
year
apach
score
admiss
total
mortal
caus
infect
basic
characterist
two
group
similar
mortal
group
group
p
rate
introduct
vasoact
drug
group
versu
group
p
group
patient
develop
renal
failur
patient
group
p
rifampicin
patient
group
present
cytolysi
conclus
studi
suggest
colistin
repres
good
therapeut
altern
treatment
nosocomi
infect
multiresist
germ
howev
studi
without
limit
retrospect
studi
absenc
random
control
group
patient
studi
compar
eff
ect
renal
function
fl
ucloxacillin
vancomycin
antibiot
prophylaxi
elect
fi
rsttime
coronari
arteri
bypass
graft
cabg
surgeri
use
direct
biochem
marker
indirect
clinic
outcom
measur
recent
evid
suggest
vancomycin
may
nephrotox
patient
undergo
cardiac
surgeri
method
retrospect
observ
studi
patient
undergo
elect
fi
rsttime
cabg
perform
cover
period
patient
receiv
prophylact
antibiot
fl
ucloxacillin
g
preoper
three
g
dose
postop
patient
mrsaposit
mrsa
unknown
penicillin
allerg
receiv
altern
regimen
vancomycin
g
preoper
g
postop
exclus
criteria
preoper
creatinin
antibiot
prophylaxi
haemodynam
support
except
dopamin
result
patient
studi
period
met
studi
criteria
patient
receiv
fl
ucloxacillin
patient
receiv
vancomycin
signifi
cant
diff
erenc
two
group
sex
age
bmi
euroscor
diabet
statu
eject
fraction
preoper
creatinin
egfr
sodium
potassium
compar
chang
renal
function
preoper
postop
signifi
cant
group
diff
erenc
chang
creatinin
mmoll
van
median
iqr
flu
p
egfr
mlmin
van
flu
p
sodium
mmoll
van
flu
p
chang
potassium
diff
ere
signifi
cantli
mmoll
van
flu
p
clinic
outcom
measur
group
similar
patient
group
stay
itu
day
signifi
cant
diff
erenc
number
patient
stay
longer
day
van
flu
p
diff
erenc
hospit
length
stay
day
van
flu
p
conclus
elect
fi
rsttime
cabg
patient
signifi
cant
diff
erenc
chang
renal
function
given
vancomycin
antibiot
prophylaxi
given
fl
ucloxacillin
prophylaxi
assess
creatinin
egfr
sodium
level
indirect
clinic
outcom
measur
potassium
increas
vancomycin
group
clinic
signifi
canc
unclear
data
suggest
prophylact
vancomycin
impair
renal
function
rel
fl
ucloxacillin
introduct
antibiot
dose
recommend
usual
base
plasma
cerebr
spinal
fl
uid
pharmacokinet
pk
studi
howev
infect
mainli
occur
extracellular
tissu
fl
uid
ecf
correspond
unbound
ecf
antibiot
concentr
respons
antimicrobi
eff
ect
bloodbrain
barrier
cerebr
antibiot
distribut
thought
reduc
compar
tissu
without
physiolog
barrier
studi
aim
determin
meropenem
mpm
unbound
concentr
brain
compar
mpm
concentr
plasma
explor
cerebr
distribut
mpm
patient
acut
brain
injuri
method
local
ethic
approv
written
inform
consent
two
braininjur
patient
sedat
mechan
ventil
receiv
mpm
infect
monitor
cerebr
microdialysi
cma
membran
length
mm
membran
diamet
mm
molecular
cutoff
kda
cma
stockholm
sweden
enrol
pk
studi
succeed
g
meropenem
minut
brain
dialys
blood
sampl
collect
minut
probe
recoveri
evalu
individu
retrodialysi
mpm
assay
hplc
coupl
tandem
mass
spectrometri
lcmsm
result
two
patient
mpm
brain
auc
much
lower
plasma
auc
accordingli
brain
serum
auc
ratio
respect
patient
patient
mpm
concentr
versu
time
curv
brain
delay
timetopeak
minut
minut
present
smooth
peak
compar
correspond
curv
plasma
figur
mean
probe
recoveri
respect
conclus
mpm
brain
auc
much
lower
plasma
auc
two
patient
enrol
consist
pk
theori
presenc
tissu
effl
ux
transport
patient
need
better
understand
mpm
brain
distribut
characterist
aim
studi
explor
eff
ect
chang
antibiot
prophylaxi
protocol
microbi
fl
ora
sputum
method
retrospect
studi
patient
admit
day
icu
elect
cv
surgeri
june
june
group
compar
group
patient
juli
august
group
patient
receiv
singledos
prophylaxi
bypass
surgeri
day
prophylaxi
cardiac
prosthet
surgeri
group
receiv
cefuroxim
group
receiv
cefazolin
patient
receiv
select
digest
tract
decontamin
isol
pathogen
elect
sputum
cultur
patient
regist
compar
group
divid
pathogen
six
class
base
profi
le
intrins
antibiot
suscept
compar
data
group
analyz
pearson
test
result
one
hundr
fi
ftyeight
patient
posit
sputum
cultur
compar
total
amount
posit
cultur
signifi
cant
diff
erenc
colon
pathogen
microorgan
group
n
patient
group
n
patient
group
colon
pathogen
class
enterobacteriacea
pseudomona
aeruginosa
observ
compar
group
vs
p
nonsignifi
cant
diff
erenc
group
mainli
attribut
diff
erenc
colon
pseudomona
class
pathogen
diff
erenc
observ
diff
erenc
postop
wound
infect
note
group
conclus
prophylact
use
cefazolin
instead
cefuroxim
cv
surgeri
result
trend
toward
reduct
colon
respiratori
tract
intrins
microbi
fl
ora
patient
prolong
icu
stay
without
advers
eff
ect
incid
postop
wound
infect
refer
introduct
sought
studi
characterist
outcom
icu
patient
carbapenemresist
crkp
carbapenemsensit
cskp
k
pneumonia
infect
fiftyon
male
mean
apach
ii
score
median
durat
hospit
stay
infect
day
fortyeight
patient
bacteremia
urinari
tract
infect
pneumonia
seven
periton
seven
skin
soft
tissu
infect
fiftyeight
patient
previou
concurr
infect
respect
seventysix
patient
die
univari
analysi
show
prior
hospit
p
dialysi
p
histori
urolog
neoplasia
p
associ
develop
carbapenemresist
infect
independ
risk
factor
found
multivari
analysi
apach
ii
score
p
need
dialysi
p
shock
prior
infect
p
p
respect
respiratori
distress
prior
infect
p
p
respect
multiorgan
failur
prior
infect
p
p
respect
treatment
failur
p
acidosi
develop
infect
p
associ
death
univari
analysi
shock
infect
p
treatment
failur
p
independ
predictor
mortal
multivari
analysi
diff
erenc
mortal
found
patient
crkp
cskp
isol
conclus
infect
due
k
pneumonia
icu
associ
high
mortal
infect
treatment
hemodynam
support
patient
may
import
determin
clinic
cours
critic
ill
patient
infect
refer
introduct
multidrugresist
mdr
pathogen
constitut
emerg
threat
increas
incid
uncertain
outcom
hand
patient
undergo
open
heart
surgeri
repres
vulner
popul
method
evalu
incid
identifi
cation
mdr
pathogen
cardiac
surgeri
patient
period
examin
clinic
featur
patient
mdr
infect
elucid
impact
outcom
patient
consist
male
six
femal
least
one
mdr
pathogen
isol
gramposit
pathogen
certifi
ed
fi
patient
gramneg
patient
specifi
calli
four
patient
infect
vancomycinresist
enterococcu
vre
six
klebsiella
pneumonia
three
acinetobact
spp
one
vre
acinetobact
spp
four
acinetobact
k
pneumonia
low
output
syndrom
ci
common
patient
essenti
contribut
deterior
clinic
situat
depend
inotrop
support
prolong
mechan
ventil
day
acut
renal
failur
need
haemodilut
therefor
icu
hospit
stay
prolong
day
day
accordingli
pathogenesi
mdr
infect
provok
day
icu
stay
consequ
nine
patient
mdr
infect
die
critic
ill
patient
multipl
organ
dysfunct
syndrom
broadspectrum
antimicrobi
hospitalacquir
bloodstream
mdr
bacteremia
conclus
infect
mdr
pathogen
rare
constitut
notabl
prognost
marker
increas
mortal
cardiac
surgeri
worth
note
higher
mortal
rate
mainli
attribut
sever
comorbid
haemodynam
compromis
patient
manag
must
concentr
implement
eff
ectiv
prevent
strategi
introduct
prior
antimicrobi
therapi
one
import
factor
lead
acquisit
mdr
organ
formul
antibiot
polici
choic
empir
antibiot
select
help
know
associ
mdr
gramneg
organ
previou
exposur
particular
antibiot
method
prospect
observ
studi
januari
june
icu
tertiari
care
hospit
specimen
sent
day
start
antibiot
day
stop
date
includ
studi
analys
base
specimen
result
detect
mdr
gramneg
organ
observ
rel
risk
rr
antibiot
class
comput
respect
mdr
infect
rr
comput
ratio
risk
event
acquir
infect
occur
expos
group
vs
nonexpos
group
logist
regress
model
use
multipl
antibiot
appli
result
total
specimen
patient
met
criteria
specifi
ed
specimen
result
detect
mdr
bacteria
result
detect
nonmdr
bacteria
bacteria
detect
remain
specimen
total
case
mdr
acquisit
esbl
enterobacteriacea
mdr
acineto
mdr
pseudo
risk
isol
esbl
enterobacteriacea
highli
signifi
cant
prior
exposur
thirdgener
cephalosporin
rr
p
risk
isol
mdr
acinetobact
spp
highli
signifi
cant
exposur
piperacillintazobactam
rr
p
risk
isol
mdr
pseudomona
spp
signifi
cant
exposur
group
carbapenem
rr
p
group
carbapenem
aminoglycosid
found
signifi
cant
associ
individu
mdr
organ
conclus
previou
exposur
antibiot
lead
increas
acquisit
mdr
organ
signifi
cant
associ
isol
diff
erent
mdr
organ
previou
exposur
particular
class
antibiot
introduct
emerg
multidrugresist
acinetobact
baumanii
mdrab
pose
seriou
threat
patient
icu
product
leav
colistin
therapeut
option
outbreak
due
mdrab
persist
month
tradit
decontamin
method
fail
deal
level
colonis
contamin
eff
ectiv
tackl
recent
outbreak
mdrab
eff
ectiv
use
gaseou
ozon
knowledg
fi
rst
time
ozon
use
control
outbreak
mdrab
method
extern
compani
hydrozon
environment
ltd
hire
perform
fumig
icu
divid
three
decontamin
area
use
heavyduti
polythen
sheet
patient
turn
reloc
contamin
clean
area
area
seal
fumig
humid
level
within
rais
use
humidifi
er
ozon
ultra
pro
ghour
ozon
gener
ozon
destruct
capabl
oper
remot
deliv
ozon
target
concentr
ppm
minut
fan
use
achiev
even
dispers
safeti
reason
perimet
ozon
concentr
monitor
uv
photomet
kept
ppm
effi
caci
fumig
measur
environment
microbiolog
sampl
fumig
result
fumig
area
receiv
ozon
concentr
ppm
minut
ozon
detect
outsid
treatment
area
prior
fumig
environment
sampl
mdrabposit
follow
fumig
nine
sampl
posit
sampl
nontouch
area
exampl
ceil
door
frame
signifi
cant
dust
collect
without
daili
clean
consid
dust
may
imped
ozon
penetr
introduct
current
pandem
like
patient
admit
hospit
requir
respiratori
support
includ
mechan
ventil
patient
like
profound
system
infl
ammatori
respons
syndrom
sir
consequ
may
multiorgan
failur
mof
requir
renal
replac
therapi
rrt
haemofi
ltration
two
question
aris
dose
oseltamivir
tamifl
u
give
patient
shorten
durat
infect
modifi
dose
respons
alter
renal
drug
clearanc
requir
rrt
method
young
adult
femal
patient
infect
mof
given
oseltamivir
mg
bd
nasogastr
failur
respond
chang
risk
benefi
ratio
justifi
ed
doubl
dose
despit
uncertainti
overal
reduc
clearanc
enter
nutrit
absorpt
uncertain
thu
sampl
blood
ensur
adequ
oseltamivir
absorpt
activ
prodrug
inhibit
undertook
serial
sampl
blood
concentr
assay
determin
pharmacokinet
paramet
diffi
cult
scenario
blood
sampl
collect
plain
serum
tube
without
sodium
fl
uorid
sampl
spun
refriger
within
half
hour
batch
ship
bangkok
drug
concentr
measur
result
report
parent
oseltamivir
phosphat
op
activ
metabolit
oseltamivir
carboxyl
oc
op
level
low
ngml
oc
concentr
high
ngml
conclus
popul
normal
paramet
halflif
op
hour
oc
hour
singl
dose
mg
op
expect
achiev
op
level
ngml
oc
level
ngml
slightli
low
op
level
like
due
ex
vivo
hydrolysi
collect
tube
due
lack
esteras
inhibitor
high
oc
level
probabl
due
reduc
renal
elimin
despit
haemofi
ltration
concern
focus
possibl
viral
mutat
subsequ
shown
neg
poor
enter
absorptionactiv
found
mg
bd
produc
adequ
oc
level
treat
infect
introduct
invas
candidiasi
ic
associ
increas
morbid
mortal
critic
ill
patient
conjunct
diffi
culti
diagnosi
underscor
need
novel
treatment
strategi
base
identifi
cation
signifi
cant
risk
factor
ic
aim
studi
evalu
effi
caci
safeti
protocol
preemptiv
antimycot
treatment
method
random
prospect
control
trial
carri
gener
icu
year
implic
inclus
exclus
criteria
patient
submit
block
random
stratifi
ed
basi
initi
sap
ii
expand
score
develop
protocol
preemptiv
antimycot
treatment
review
current
literatur
combin
signifi
cant
risk
factor
ic
tree
major
clinic
criteria
persist
nonbacteri
sepsi
assum
algorithm
indic
start
preemptiv
therapi
accord
protocol
antimycot
therapi
start
day
inclus
treatment
group
proven
ic
control
group
initi
data
gather
demograph
characterist
patient
proven
risk
factor
icrel
mortal
malnutrit
nonalbican
colon
creatinin
clearanc
sever
infl
ammatori
respons
organ
dysfunct
dynam
sir
sofa
subsequ
candida
isol
ventilatorfre
day
length
icu
stay
outcom
eventu
advers
reaction
follow
result
total
patient
equal
group
enrol
statist
signifi
cant
diff
erenc
basal
characterist
patient
length
icu
stay
number
ventilatorfre
day
found
delta
sofa
score
signifi
cantli
lower
treatment
group
p
inhospit
mortal
treatment
group
vs
control
group
p
associ
preemptiv
therapi
rel
risk
ci
signifi
cant
diff
erenc
kaplanmey
estim
surviv
found
logrank
test
p
total
advers
reaction
observ
among
treat
patient
group
associ
higher
mortal
risk
conclus
implement
develop
protocol
reduc
degre
organ
dysfunct
sever
associ
signifi
cant
surviv
benefi
idsa
treatment
guidelin
candidiasi
favor
echinocandin
initi
treatment
candidemia
patient
sever
ill
prospect
random
studi
anidulafungin
result
improv
global
respons
gr
trend
toward
improv
surviv
compar
fl
uconazol
method
retrospect
analysi
patient
classifi
ed
sever
ill
studi
entri
treatment
initi
icu
group
apach
ii
score
group
presenc
sever
sepsi
group
within
group
anidulafungin
compar
fl
uconazol
gr
rate
end
intraven
therapi
mortal
result
group
n
gr
vs
ci
group
n
gr
vs
ci
group
n
gr
vs
ci
patient
mod
n
gr
vs
ci
anidulafungin
versu
fl
uconazol
respect
across
group
associ
anidulafungin
use
lower
day
mortal
suggest
patient
receiv
anidulafungin
vs
receiv
fl
uconazol
p
ns
see
figur
conclus
patient
sever
ill
anidulafungin
associ
greater
gr
fl
uconazol
signifi
cantli
apach
ii
score
mod
support
idsa
guidelin
introduct
direct
hemoperfus
use
polymyxin
bimmobil
fi
ber
column
dhppmx
toray
industri
inc
tokyo
japan
fi
rst
develop
sinc
use
treatment
septic
shock
method
total
patient
septic
shock
receiv
dhppmx
hour
retrospect
review
examin
improv
sepsisrel
factor
dhppmx
analyz
relationship
improv
increas
sbp
introduct
direct
hemoperfus
use
polymyxin
bimmobil
fi
ber
column
dhppmx
use
treatment
septic
shock
altern
method
acut
blood
purifi
cation
therapi
continu
venoven
hemodiafi
ltration
cvvhdf
report
eff
ectiv
clinic
treatment
critic
ill
patient
howev
optim
column
perform
cvvhdf
remain
controversi
hand
recent
one
lipid
mediat
endocannabinoid
narachidonoylethanolamin
aea
glycerol
report
blood
pressur
decreas
eff
ect
method
investig
polymethylmethacryl
pmma
membran
hemofi
lter
three
polyacrylonitril
pan
membran
hemofi
lter
use
patient
septic
shock
therefor
clinic
studi
use
cvvhdf
dhppmx
treat
patient
septic
shock
determin
optim
acut
blood
purifi
cation
therapi
subsequ
divid
patient
two
group
group
underw
cvvhdf
use
pmma
membran
hemofi
lter
undergo
dhppmx
n
group
b
underw
cvvhdf
use
pan
membran
hemofi
lter
undergo
dhppmx
n
addit
level
endocannabinoid
aea
measur
sever
score
improv
endocannabinoid
compar
two
group
result
endocannabinoid
aea
adsorb
pmma
column
aea
ngcolumn
pan
column
aea
ngcolumn
averag
acut
physiolog
chronic
health
evalu
apach
ii
score
averag
sepsisrel
organ
failur
assess
sofa
score
diff
er
signifi
cantli
two
group
group
show
better
outcom
compar
group
b
p
addit
group
show
signifi
cant
improv
blood
aea
level
day
p
conclus
studi
suggest
pmma
column
might
better
column
perform
cvvhdf
dhppmx
treatment
suggest
adsorpt
blood
purifi
cation
endocannabinoid
refer
introduct
diagnosi
treatment
acut
pneumonia
pn
problem
high
signifi
canc
modern
medicin
incid
complic
lethal
acut
pn
increas
candid
gene
great
import
cours
acut
diseas
complic
cytokin
xenobiot
detox
gene
investig
aim
investig
studi
genet
predisposit
acut
pn
method
result
associ
dna
polymorph
studi
patient
acut
communityacquir
pn
present
healthi
individu
form
control
group
genet
variabl
candid
loci
studi
reninangiotensin
ace
system
gene
chemokin
receptor
gene
four
gene
control
xenobiot
detoxifi
cation
multiplex
polymeras
chain
reaction
util
genotyp
insertiondelet
polymorph
loci
ace
nucleotid
pair
delet
nucleotid
pair
odd
ratio
index
use
describ
degre
associ
genotyp
diseas
statist
analysi
done
mean
fisher
exact
test
onlin
program
snpstat
http
bioinfoiconcologianet
result
increas
predisposit
pn
develop
regist
homozygot
delet
ace
locu
p
posit
genotyp
locu
p
homozygot
allel
gene
p
conclus
combin
posit
genotyp
locu
homozygot
allel
gene
p
incid
control
present
eff
ectiv
prognost
power
refer
associ
progress
airway
colon
ac
ventilatorassoci
tracheobronch
vat
vat
ventilatorassoci
pneumonia
vap
analyz
fulli
elucid
endeavor
studi
relationship
ac
develop
infect
vat
vap
lrt
icu
patient
method
retrospect
studi
consecut
icu
patient
ventil
hour
past
year
patient
age
gender
apach
ii
prior
ill
caus
admitt
length
stay
lo
time
mechan
ventil
mv
outcom
time
appear
ac
infect
lrt
regist
mod
cpi
measur
onset
infect
vatvap
day
mod
also
calcul
day
ac
appear
bronchial
secret
cultur
admiss
least
week
whenev
chang
amount
qualiti
bronchial
secret
clinic
infect
suspect
mannwhitney
test
use
statist
analysi
statist
signifi
canc
set
p
result
studi
patient
colon
develop
infect
vat
vap
colon
appear
day
icu
admiss
exclus
gramneg
microorgan
twentyfi
colon
patient
develop
infect
lrt
pathogen
vat
day
diagnos
vap
day
eight
vat
patient
four
develop
vap
day
none
colon
patient
die
colon
patient
develop
infect
elderli
p
sever
ill
p
time
infect
diagnosi
higher
temperatur
p
sever
leukocytosi
p
statist
signifi
cant
organ
dysfunct
p
appear
vap
caus
sever
organ
dysfunct
p
longer
mv
durat
p
longer
lo
p
infl
uenc
mortal
day
ac
detect
mod
vat
detect
mod
vap
appear
mod
cpi
vat
detect
vap
detect
day
day
iii
conclus
ac
result
lrt
infect
onethird
patient
major
lrt
infect
preced
ac
introduct
murin
model
infl
uenza
signifi
cant
weight
loss
occur
day
postinfect
sought
determin
whether
weight
loss
infl
uenza
could
alter
rehydr
whether
aff
ect
pulmonari
immun
respons
method
adult
balbc
mice
infect
infl
uenza
via
intranas
rout
random
intraperiton
rehydr
mlkg
compound
sodium
lactat
csl
normal
salin
ns
rehydr
nr
start
day
follow
infect
continu
day
n
day
mice
challeng
x
streptococcu
pneumonia
serotyp
two
cohort
mice
challeng
diff
erent
dose
infl
uenza
rehydr
day
investig
pulmonari
immun
respons
absenc
bacteria
mice
infect
n
infl
uenza
rehydr
daili
n
infl
uenza
rehydr
twice
daili
mlkg
csl
daili
weight
surviv
follow
secondari
bacteri
pneumonia
number
colonyform
unit
hour
bacteri
challeng
peripher
blood
lung
nasal
wash
cellular
lung
compart
measur
result
rehydr
aff
ect
weight
loss
follow
infl
uenza
infect
mice
g
infl
uenza
plu
nr
g
infl
uenza
plu
csl
g
infl
uenza
ns
g
repeat
experi
csl
daili
twice
daili
alter
weight
loss
compar
nr
p
surviv
cfu
count
follow
bacteri
pneumonia
diff
er
group
p
total
number
activ
statu
bronchoalveolar
lung
macrophagesmonocyt
lymphocyt
aff
ect
rehydr
follow
infl
uenza
infect
hour
follow
bacteri
pneumonia
p
p
vs
mice
conclus
rehydr
aff
ect
immun
pathophysiolog
murin
infl
uenza
infect
model
assum
result
extrapol
clinic
set
fi
nding
support
use
conserv
fl
uid
resuscit
strategi
patient
infl
uenza
refer
introduct
bacterem
pneumonia
associ
wors
outcom
includ
higher
mortal
attain
program
compar
telavancin
tlv
lipoglycopeptid
antibiot
vancomycin
van
treatment
nosocomi
pneumonia
np
due
gramposit
pathogen
includ
mrsa
subgroup
analysi
examin
baselin
characterist
clinic
outcom
bacterem
hap
case
method
attain
methodolog
ident
random
doubleblind
phase
studi
adult
patient
np
due
presum
confi
rmed
gramposit
pathogen
random
tlv
mg
kg
intraven
everi
hour
van
g
intraven
everi
hour
adjust
per
sitespecifi
c
guidelin
day
modifi
ed
alltreat
mat
popul
consist
patient
receiv
dose
studi
medic
respiratori
pathogen
recov
baselin
cultur
bacterem
np
defi
ned
identifi
cation
pneumoniacaus
pathogen
blood
pathogen
lung
blood
ident
suscept
profi
le
clinic
outcom
assess
testofcur
toc
day
end
studi
treatment
result
mat
patient
bacterem
np
n
includ
analysi
baselin
tlv
patient
van
patient
icu
tlv
van
ventilatorassoci
pneumonia
tlv
van
apach
ii
score
similar
group
mean
sd
tlv
van
aureu
common
pathogen
tlv
van
includ
mrsa
tlv
van
cure
rate
tlv
van
respect
diff
erenc
tlv
van
ci
onstudi
mortal
similar
treatment
group
incid
advers
event
ae
similar
group
except
nausea
tlv
van
vomit
tlv
van
proport
patient
discontinu
studi
medic
due
ae
similar
tlv
van
conclus
tlv
van
similar
cure
rate
subgroup
attain
patient
bacterem
np
safeti
profi
le
tlv
van
mostli
compar
patient
modifi
ed
alltreat
popul
mat
patient
baselin
respiratori
pathogen
receiv
dose
studi
medic
microbiolog
evalu
popul
protocol
adher
mat
patient
baselin
gramposit
pathogen
patient
mix
grampositivegramneg
infect
exclud
analysi
result
total
late
vap
case
analyz
baselin
characterist
includ
apach
ii
score
balanc
treatment
group
figur
least
one
advers
event
ae
report
mat
patient
tlv
van
group
respect
tlv
group
van
group
die
studi
conclus
exploratori
subgroup
analysi
numer
higher
cure
rate
observ
tlv
van
patient
late
vap
incid
report
ae
mortal
rate
similar
tlv
van
group
introduct
vap
rate
brazil
higher
relat
europ
usa
studi
object
examin
eff
ect
institut
healthcar
improv
ventil
bundl
plu
oral
decontamin
chlorhexidin
odc
incid
vap
icu
method
studi
conduct
medicalsurg
icu
criteria
nosocomi
pneumonia
cdc
strategi
implement
ihi
ventil
bundl
plu
odc
goal
icu
team
adhes
achiev
ninth
month
bundl
implement
year
followup
measur
includ
fi
strategi
prevent
ventilatorassoci
pneumonia
elev
head
bed
adequ
sedat
level
ramsay
dvtpe
prevent
peptic
ulcer
prophylaxi
oral
decontamin
chlorhexidin
februari
onward
icu
nurs
staff
ict
perform
daili
checklist
order
observ
fi
issu
accomplish
item
found
inadequ
promptli
correct
introduct
systemat
review
aim
evalu
evid
randomis
control
trial
rct
oral
chlorhexidin
prevent
nosocomi
pneumonia
intub
mechan
ventil
critic
ill
adult
use
oral
chlorhexidin
appeal
sinc
reduc
bacteri
aspir
orophayrnx
number
rct
recent
publish
topic
method
search
medlin
embas
cochran
librari
grey
literatur
regist
confer
proceed
refer
list
rct
compar
chlorhexidin
placebo
standard
care
prevent
pneumonia
critic
ill
outcom
episod
nosocomi
respiratori
tract
infect
rti
mortal
durat
mechan
ventil
mv
length
itu
stay
itu
lo
review
manag
nordic
cochran
centr
use
data
synthesi
eff
ect
estim
odd
ratio
dichotom
weight
mean
diff
erenc
continu
data
calcul
use
random
eff
ect
model
fourteen
studi
identifi
ed
three
involv
patient
undergo
cardiac
surgeri
patient
involv
patient
noncardiothorac
itu
patient
see
tabl
five
studi
includ
two
cardiac
studi
found
signifi
cant
reduct
episod
nosocomi
rti
chlorhexidinetr
group
versu
placebo
standard
care
pool
data
indic
signifi
cant
reduct
nosocomi
rti
treatment
group
among
patient
among
cardiac
noncardiac
subgroup
odd
ratio
ci
respect
howev
signifi
cant
diff
erenc
mortal
durat
mechan
ventil
itu
stay
demonstr
signifi
cant
heterogen
statist
detect
outcom
except
mortal
conclus
use
oral
chlorhexidin
associ
reduct
nosocomi
respiratori
tract
infect
intub
mechan
ventil
critic
ill
adult
shown
combin
select
digest
decontamin
topic
antibiot
sdd
decontamin
regimen
use
nasal
mupirocin
chlorhexidin
bodywash
mc
markedli
reduc
acquir
infect
ai
intub
patient
compar
sdd
alon
mc
alon
none
report
surveil
ai
icu
implement
multipl
site
decontamin
msd
routin
prevent
procedur
introduct
aim
studi
analyz
correl
antivir
therapi
effi
caci
neg
profi
le
rtpcr
made
pharyng
swab
subglott
aspir
bronchoalveolar
lavag
patient
aff
ect
ard
caus
infect
method
prospect
analysi
perform
patient
admit
icu
tertiari
referr
center
careggi
teach
hospit
florenc
itali
patient
underw
daili
rtpcr
monitor
pharyng
swab
subglott
aspir
bronchoalveolar
lavag
patient
treat
oral
administr
oseltamivir
mg
twice
daili
inhal
zanamivir
mg
twice
daili
sinc
icu
admiss
six
patient
treat
extracorpor
membran
oxygen
ecmo
due
critic
respiratori
condit
two
result
coinfect
legionella
pneumophila
result
shown
figur
rtpcr
pharyng
swab
icu
admiss
fail
demonstr
viral
infect
four
patient
wherea
rtpcr
bronchoalveolar
lavag
sensibl
similarli
time
cours
show
rtpcr
pharyng
swab
result
neg
averag
time
day
therapi
start
rtpcr
bronchoalveolar
lavag
continu
permit
infect
monitor
therapi
regimen
conduct
none
rtpcr
subglott
aspir
sampl
result
posit
patient
recov
discharg
aliv
icu
spontan
breath
conclus
experi
reliabl
method
diagnos
monitor
infect
rtpcr
bronchoalveolar
lavag
sinc
pharyng
swab
er
enough
sensibl
either
antivir
therapi
initi
antivir
therapi
manag
sampl
subglott
aspir
avoid
due
low
sensibl
bedsid
lung
ultrasound
abl
identifi
high
sensibl
sensit
pulmonari
patholog
pattern
wide
adopt
critic
ill
patient
daili
manag
feasibl
reliabl
method
identifi
cation
lung
patholog
pattern
caus
infl
uenza
infect
method
studi
took
place
icu
region
referr
center
ecmo
avail
respiratori
failur
careggi
teach
hospit
florenc
itali
eight
patient
admit
ard
septemb
octob
underw
daili
lu
examin
examin
standard
procedur
ad
hoc
order
achiev
complet
compar
report
everi
patient
patient
examin
supin
take
later
anterior
view
possibl
one
side
intercost
space
use
acoust
window
everi
singl
examin
fi
nding
report
icu
databas
result
pleural
thick
present
case
mostli
relat
littl
multipl
pleural
consolid
anyway
pleural
glide
present
time
even
visibl
decreas
movement
replac
lung
puls
presenc
import
lung
consolid
alveolar
interstiti
syndrom
ai
alway
present
whole
lung
rang
moder
sever
high
posit
base
posteriorli
white
lung
appear
everi
patient
lung
base
middl
fi
eld
posteriorli
far
consolid
concern
presenc
confi
rmed
patient
associ
satellit
multipl
subpleur
consolid
patient
basal
lung
alway
involv
follow
middl
apic
fi
eld
bronchogram
present
patient
bigger
consolid
aspect
aerial
one
patient
sever
consolid
turn
fl
uid
one
anecho
pleural
eff
usion
found
patient
case
pneumothorax
detect
conclus
group
patient
infect
show
diff
erent
lung
pattern
altogeth
frequent
seem
sever
basal
posterior
ai
multipl
subpleur
lung
consolid
multipl
parenchym
consolid
bronchogram
presenc
spare
area
seem
belong
lu
pattern
introduct
pneumocysti
pneumonia
pcp
hivneg
patient
frequent
present
fulmin
respiratori
failur
associ
high
mortal
rate
patient
requir
mechan
ventil
aim
studi
evalu
outcom
prognost
factor
patient
hivneg
pcp
requir
mechan
ventil
mv
method
retrospect
review
medic
record
collect
hivneg
patient
microbiolog
confi
rmed
pcp
requir
mv
icu
period
tertiari
care
teach
hospit
result
total
patient
identifi
ed
mean
age
year
mean
apach
ii
score
icu
admiss
mortal
inhospit
mortal
respect
survivor
nonsurvivor
signifi
cant
diff
erenc
baselin
characterist
apach
ii
score
pao
fio
ratio
absolut
neutrophil
count
icu
admiss
day
also
mortal
diff
erent
relat
presenc
barotrauma
applic
noninvas
ventil
time
suscept
antibiot
administr
chang
salvag
regimen
presenc
cytomegaloviru
coinfect
even
microbiolog
persist
followup
specimen
base
type
intens
previou
immunosuppress
therapi
classifi
ed
patient
three
subgroup
patient
receiv
lowdos
steroid
mainten
immunosuppress
agent
ls
repres
previous
stabl
organ
transplant
anoth
group
consist
patient
receiv
recent
intens
chemotherapi
ctx
group
refer
patient
receiv
high
dose
defi
ned
week
least
mgkg
dose
steroid
therapi
immunosuppress
agent
hs
signifi
cant
diff
erenc
outcom
observ
among
three
diff
erent
group
mortal
ls
ctx
hs
p
mortal
ls
ctx
hs
p
method
bsa
deriv
use
mostel
formula
metric
equival
simul
patient
rang
ft
ft
lb
lb
priori
defi
ned
normal
co
normal
ci
normal
sv
mlbeat
normal
si
algebra
analysi
use
determin
bsa
level
would
classifi
sv
co
abnorm
result
critic
bsa
threshold
present
tabl
exampl
sv
bsa
higher
second
decim
place
would
classifi
patient
low
si
conclus
patient
extrem
bsa
increasingli
encount
icu
especi
larger
bsa
relat
obes
provid
threshold
valu
extrem
bsa
classifi
high
sv
co
valu
low
index
valu
rang
consid
normal
si
ci
may
inappropri
patient
extrem
bsa
particularli
obes
caution
reli
sole
si
ci
assess
hemodynam
perform
instead
sv
co
along
physiolog
paramet
also
consid
make
therapeut
decis
introduct
remain
great
challeng
measur
system
blood
fl
ow
critic
ill
newborn
especi
transit
period
intracardiac
extracardiac
shunt
due
technic
restraint
size
limit
necess
rel
larg
amount
blood
withdrawn
possibl
indic
toxic
mani
method
cardiac
output
monitor
feasibl
henc
cardiac
output
gener
estim
indirect
paramet
system
blood
fl
ow
former
studi
assess
agreement
cardiac
output
use
ultrasound
dilut
method
udco
ultrasound
transit
timebas
measur
main
pulmonari
blood
fl
ow
juvenil
piglet
model
without
shunt
present
studi
analyz
infl
uenc
lefttoright
shunt
agreement
udco
ultrason
transit
time
pulmonari
blood
fl
ow
juvenil
lamb
model
method
prospect
experiment
anim
studi
approv
ethic
committe
anim
research
radboud
univers
nijmegen
place
shunt
left
pulmonari
arteri
descend
aorta
eight
randombr
newborn
lamb
kg
aortopulmonari
shunt
intermitt
open
close
cardiac
output
manipul
creat
hemorrhag
hypotens
ultrasound
dilut
cardiac
output
qudco
use
repeat
inject
mlkg
isoton
salin
bodi
temperatur
compar
pulmonari
blood
fl
ow
qmpa
invas
measur
perivascular
fl
ow
probe
around
main
pulmonari
arteri
figur
increas
nicom
sv
show
sensit
specifi
citi
predict
pulseco
chang
conclus
nicom
demonstr
moder
agreement
lidco
show
excel
agreement
pulseco
track
co
chang
follow
therapeut
intervent
introduct
arrhythmia
common
among
highrisk
surgic
icu
patient
pulseco
pressur
waveform
algorithm
use
lidcorapid
hemodynam
monitor
frequent
use
estim
cardiac
output
co
critic
ill
patient
cardiac
arrythmia
could
increas
variat
lithium
dilut
lidco
andor
pulseco
measur
setup
algorithm
calibr
compar
pulseco
co
estim
averag
second
known
co
normal
lidco
gener
calibr
factor
cf
studi
design
explor
eff
ect
arrythmia
accuraci
cf
gener
pulseco
monitor
method
hemodynam
data
fi
le
obtain
retro
spectiv
univers
hospit
medicalsurg
icu
file
separ
record
without
arrhythmia
defi
ned
heart
rate
variat
least
one
addit
cf
determin
monitor
setup
previou
studi
establish
coeffi
cient
variat
cv
singl
lidco
determin
pulseco
measur
combin
cv
refl
ect
eff
ect
calibr
estim
result
expect
precis
cf
data
analys
variat
cf
hrv
use
linear
regress
student
test
result
twentyeight
record
collect
analys
twentyon
record
contain
post
setup
calibr
event
occur
hrv
median
rang
occur
hrv
median
rang
averag
variat
cf
hrv
high
hrv
initi
valu
test
indic
diff
erenc
mean
variat
cf
p
median
correl
hrv
cf
variat
r
ninetyon
per
cent
observ
cf
variat
less
initi
cf
valu
conclus
cf
determin
signifi
cantli
aff
ect
hrv
valid
arteri
waveformbas
devic
measur
cardiac
output
co
without
need
invas
calibr
x
coe
x
mtt
respect
maximum
upslop
downslop
dilut
curv
one
hundr
thirtyseven
measur
done
inotrop
stimul
dobutamin
hypovolemia
bleed
hypervolemia
fl
uid
overload
induc
acut
lung
injuri
oleic
acid
introduct
need
recalibr
best
time
point
recalibr
matter
debat
sinc
introduct
picco
monitor
pulsion
germani
set
analyz
perform
puls
contour
pc
analysi
without
recalibr
period
method
studi
cardiac
index
ci
period
eight
nonop
patient
admit
icu
seven
ci
measur
median
number
everi
hour
thermodilut
td
perform
patient
triplic
pcderiv
data
record
continu
use
special
piccoplu
monitor
disabl
autorecalibr
featur
td
lead
automat
calibr
pc
analysi
calibr
perform
manual
start
analysi
patient
later
td
measur
record
eff
ect
cipc
addit
comparison
perform
use
flotracvigileo
system
edward
usa
need
manual
recalibr
instead
recalibr
everi
second
base
arteri
waveform
flotracvigileo
monitor
use
secondgener
devic
softwar
version
pressur
transduc
picco
flotrac
connect
seri
femor
arteri
cathet
introduct
cardiac
output
co
monitor
one
key
point
hemodynam
evalu
critic
ill
patient
use
variou
set
highrisk
surgeri
lack
evid
extens
use
invas
devic
hemodynam
monitor
good
impact
term
outcom
less
invas
system
propos
aim
compar
co
estim
vigileoflotrac
blood
fl
ow
thorac
aorta
measur
transoesophag
doppler
patient
undergo
open
abdomin
aortic
aneurysm
repair
aortic
crossclamp
aox
phase
measur
augment
index
ai
paramet
relat
vascular
stiff
ness
use
applan
tonometri
method
order
better
understand
eff
ect
aox
blood
pressur
wave
method
enrol
consecut
patient
men
age
year
undergo
elect
open
aaa
repair
asa
ii
iii
gener
anesthesia
radial
arteri
access
use
semiinvas
determin
blood
pressur
co
apco
vigileo
esophag
doppler
posit
clinic
stabil
applan
tonometri
measur
aortic
clamp
found
signifi
cant
p
increas
co
report
vigileoflotrac
system
postclamp
phase
compar
preclamp
basal
phase
blood
fl
ow
thorac
aorta
result
decreas
accord
theori
redistribut
fl
uid
splanchnic
venou
vasculatur
import
contribut
wave
refl
ection
aortic
puls
pressur
wave
aox
express
signifi
cant
increas
ai
vigileoflotrac
system
appear
overestim
co
aox
compar
measur
blood
fl
ow
thorac
aorta
result
could
infl
uenc
puls
pressur
wave
refl
ection
occur
clamp
highrisk
surgic
set
situat
rapid
chang
system
resist
vessel
could
similarli
misread
thu
suggest
necess
tailor
vigileo
algorithm
introduct
postop
hemodynam
optim
prove
reduc
morbid
highrisk
patient
nowaday
stroke
volum
index
svi
monitor
avail
diff
erent
less
invas
techniqu
shown
diff
erent
level
agreement
precis
pulmonari
arteri
cathet
aim
studi
evalu
agreement
precis
svi
obtain
calibr
lidco
ltd
cambridg
uk
uncalibr
puls
contour
analysi
devic
flotracvigileo
edward
lifesci
irvin
ca
usa
patient
undergo
postop
hemodynam
optim
method
patient
undergo
hemodynam
optim
protocol
care
accord
previou
publish
trial
reach
oxygen
deliveri
method
prospect
studi
respiratori
critic
care
univers
hospit
eleven
patient
spontan
breath
activ
consid
volum
expans
increas
stroke
volum
index
svi
volum
expans
defi
ned
respond
patient
measur
respons
bioreact
stroke
volum
plr
salin
infus
ml
minut
proport
chang
nicomsvi
induc
plr
correl
proport
chang
nicomsvi
induc
volum
expans
r
p
proport
chang
nicomcardiac
index
ci
induc
plr
also
correl
proport
chang
nicomci
induc
volum
expans
r
p
plrinduc
increas
stroke
volum
predict
increas
stroke
volum
volum
expans
sensit
specifi
citi
conclus
respons
nicomstrok
volum
plr
good
predictor
volum
respons
hemodynam
unstabl
patient
spontan
breath
activ
fl
uid
respons
assess
total
noninvas
bioreact
devic
introduct
transpulmonari
thermodilut
tptd
deriv
volumetr
paramet
global
enddiastol
volum
gedi
elwi
establish
hemodynam
cornerston
assess
preload
gedi
pulmonari
hydrat
normal
valu
gedi
creat
decad
ago
base
studi
preselect
patient
therefor
aim
prospect
studi
investig
correl
gedi
cardiac
index
ci
clinic
routin
method
period
routin
tptd
measur
consecut
patient
apach
ii
intern
icu
picco
cathet
prospect
document
analys
correl
spearman
multipl
regress
analysi
spss
result
includ
measur
ci
univari
correl
gedi
r
p
dp
max
r
p
heart
rate
r
p
cvp
r
p
correl
gedi
dp
max
heart
rate
ci
confi
rmed
multivari
analysi
p
three
variabl
chang
ci
deltaci
univari
correl
chang
gedi
r
dp
max
r
elwi
r
p
comparison
multivari
analysi
measur
deltaci
independ
associ
chang
gedi
p
dp
max
p
cvp
p
subgroup
analysi
measur
gedi
lower
normal
level
mlkgm
demonstr
independ
associ
ci
gedi
p
dp
max
p
elwi
p
cvp
similarli
deltaci
independ
associ
chang
gedi
dp
max
p
similar
result
found
measur
gedi
within
normal
rang
mlkg
signifi
cant
independ
correl
ci
gedi
p
dp
max
p
chang
ci
independ
correl
chang
gedi
p
dp
max
p
cvp
p
interestingli
even
measur
gedi
mlkgm
ci
independ
correl
gedi
p
dp
max
p
chang
ci
group
independ
associ
chang
dp
max
gedi
p
subgroup
measur
gedi
mlkgm
correl
paramet
ci
howev
chang
ci
independ
correl
chang
gedi
p
dp
max
p
conclus
gedi
dp
max
chang
independ
posit
correl
ci
chang
even
patient
increas
gedi
relationship
stroke
volum
variat
puls
pressur
variat
global
enddiastol
volum
patient
undergo
brain
surgeri
wolf
c
lumenta
l
p
friederich
introduct
monitor
intravascular
volum
patient
intracrani
patholog
often
mandatori
maintain
hemodynam
stabil
cyclic
chang
cardiac
stroke
volum
puls
pressur
induc
posit
pressur
ventil
well
target
valu
global
enddiastol
volum
index
gedvi
mlm
allow
volum
therapi
guidanc
relationship
stroke
volum
variat
svv
puls
pressur
variat
ppv
well
svv
ppv
valu
gedvi
establish
patient
intracrani
patholog
method
prospect
investig
correl
dynam
static
hemodynam
paramet
patient
undergo
brain
surgeri
studi
measur
perform
use
picco
technolog
statist
analysi
nonparametr
correl
analysi
hypothesi
test
appli
result
svv
correl
signifi
cantli
ppv
r
p
neither
svv
r
p
ppv
r
p
correl
gedvi
threshold
valu
svv
well
ppv
allow
discrimin
group
signifi
cantli
diff
erent
valu
stroke
volum
index
fail
discrimin
group
signifi
cantli
diff
erent
valu
gedvi
dichotom
patient
group
gedvi
mlm
mlm
result
group
signifi
cantli
diff
erent
valu
stroke
volum
index
well
fail
discrimin
group
signifi
cantli
diff
erent
valu
svv
ppv
conclus
static
gedvi
dynam
svv
ppv
paramet
cardiac
preload
may
refl
ect
diff
erent
properti
cardiovascular
system
combin
svv
ppv
gedvi
may
er
precis
inform
cardiovascular
system
either
paramet
alon
predict
valu
puls
pressur
variat
patient
ventil
low
vt
well
studi
valid
predictor
volum
respons
sever
studi
patient
ventil
vt
mlkg
one
studi
shown
predict
volum
respons
patient
ventil
low
vt
hypothes
lower
cutoff
valu
predict
volum
respons
patient
low
vt
method
thirtyseven
adult
patient
mechan
ventil
tidal
volum
mlkg
pbw
without
cardiac
arrhythmia
pulmonari
arteri
cathet
peripher
arteri
cathet
includ
increas
cardiac
index
thermodilut
output
fl
uid
challeng
crystalloid
ml
colloid
ml
consid
posit
respons
result
seventeen
patient
respond
roc
curv
show
best
cutoff
valu
roc
area
ci
sensit
specifi
citi
posit
likelihood
ratio
neg
twelv
patient
consist
heterogen
group
patient
liver
transplant
acut
pancreat
aortic
surgeri
among
septic
shock
patient
show
roc
area
sensit
specifi
citi
case
greater
greater
fl
uid
respons
better
predictor
cvp
paop
conclus
limit
valu
patient
ventil
low
vt
howev
may
help
identifi
septic
shock
patient
respond
fl
uid
challeng
alreadi
demonstr
mechan
ventil
patient
respiratori
chang
preeject
period
reliabl
dynam
index
predict
increas
cardiac
output
volum
infus
howev
anim
studi
kubitz
colleagu
show
preeject
period
sensit
chang
intravascular
volum
statu
method
studi
investig
infl
uenc
chang
intravascular
volum
statu
pig
ecg
arteri
pressur
cardiac
output
deriv
swanganz
cathet
record
measur
perform
normovolaem
condit
haemorrhag
ml
kg
follow
retransfus
mlkg
constant
tidal
volum
mlkg
respir
rate
earli
phase
sepsi
excess
fl
uid
administr
may
worsen
pulmonari
edema
prolong
mechan
ventil
accur
predict
fl
uid
respons
obviat
unnecessari
fl
uid
load
help
detect
patient
may
benefi
volum
expans
puls
pressur
variat
dpp
reliabl
predictor
fl
uid
respons
mechan
ventil
patient
tidal
volum
least
mlkg
aim
studi
evalu
predict
valu
dpp
fl
uid
respons
maneuv
chang
tidal
volum
mlkg
patient
ventil
mlkg
method
prospect
clinic
studi
patient
ventil
mlkg
resuscit
phase
sever
sepsi
septic
shock
fluid
challeng
indic
attend
physician
mlkg
hydroxyethyl
starch
complet
hemodynam
measur
includ
dpp
dpp
mlkg
obtain
baselin
tidal
volum
chang
mlkg
dpp
dpp
mlkg
measur
minut
ventilatori
set
return
mlkg
fl
uid
challeng
patient
whose
cardiac
output
co
increas
consid
fl
uid
respond
receiv
oper
characterist
roc
curv
analysi
use
evalu
predict
valu
dpp
patient
respond
co
increas
fl
uid
infus
fluid
respons
better
predict
dpp
mlkg
roc
curv
area
pulmonari
arteri
occlud
pressur
right
atrial
pressur
increas
tidal
volum
mlkg
improv
predict
roc
curv
area
dpp
mlkg
best
cutoff
valu
defi
ned
roc
curv
analysi
dpp
mlkg
dpp
mlkg
respect
conclus
maneuv
chang
tidal
volum
mlkg
patient
ventil
protect
ventilatori
strategi
better
predict
fl
uid
respons
use
fluid
respons
correctli
predict
patient
ventil
tidal
volum
mlkg
major
head
neck
surgeri
involv
reconstruct
free
fl
ap
oropharyng
cancer
complex
prolong
oper
appropri
fl
uid
manag
becom
diffi
cult
potenti
advers
eff
ect
fl
uid
mismanag
group
patient
includ
fl
ap
hypoperfus
relat
hypovolaemia
fl
ap
oedema
deterior
alveolararteri
gradient
relat
excess
fl
uid
administr
studi
look
ongo
standard
practic
determin
whether
use
cardiac
output
monitor
could
improv
fl
uid
manag
subset
patient
method
singleblind
prospect
observ
studi
conduct
consecut
adult
patient
undergo
major
head
neck
reconstruct
free
fl
ap
surgeri
patient
anaesthetis
individu
use
standardis
techniqu
volumecontrol
posit
pressur
ventil
initi
patient
patient
receiv
mainten
crystalloid
fl
uid
rate
mlkghour
addit
fl
uid
challeng
ml
crystalloid
bolus
given
minut
administ
discret
anaesthetist
priori
criterion
fl
uid
respons
defi
ned
increas
stroke
volum
sv
measur
lidcorapid
fl
uid
challeng
anaesthetist
blind
lidcorapid
data
observ
made
independ
investig
data
collect
heart
rate
hr
mean
arteri
pressur
map
central
venou
pressur
cvp
result
fortyseven
fl
uid
bolus
assess
median
age
patient
year
rang
year
median
weight
kg
rang
kg
ventilatori
setup
use
median
tidal
volum
mlkg
rang
ml
fifteen
fl
uid
challeng
posit
assess
chang
stroke
volum
compar
fl
uid
respond
nonrespond
diff
erenc
hr
bpm
vs
bpm
map
mmhg
vs
mmhg
cvp
mmhg
vs
mmhg
conclus
preliminari
report
suggest
fl
uid
challeng
given
theatr
eff
ectiv
increas
sv
potenti
twothird
fl
uid
challeng
may
detriment
seen
sv
monitor
continu
data
confi
rm
lidcorapid
may
use
guid
fl
uid
administr
order
optimis
sv
therebi
minim
risk
fl
uid
overload
introduct
patient
undergo
elect
abdomin
aortic
surgeri
eaa
risk
develop
complic
due
preoper
comorbid
surgic
trauma
blood
loss
infl
ammatori
injuri
individu
goaldirect
therapi
igdt
propos
improv
outcom
patient
undergo
highrisk
surgeri
aim
studi
investig
whether
igdt
target
stroke
volum
sv
oxygen
deliveri
perform
safe
eaa
method
sixtythre
eaa
patient
random
igdt
convent
therapi
system
use
sv
monitor
sv
optim
ml
fl
uid
challeng
intraop
fi
rst
hour
postop
optim
hour
postop
target
level
mlminm
infus
dobutamin
necessari
hemodynam
data
collect
baselin
preoper
aortic
crossclamp
end
surgeri
fi
rst
hour
postop
patient
monitor
fi
velead
ecg
dobutamin
infus
dosag
reduc
sign
ischemia
heart
rate
baselin
dobutamin
dosag
limit
maximum
mean
svi
level
higher
igdt
group
compar
control
group
p
higher
entir
intervent
period
p
mean
higher
p
higher
entir
intervent
period
igdt
group
p
mean
arteri
pressur
heart
rate
diff
er
signifi
cantli
p
p
diff
erenc
frequenc
postop
cardiac
complic
group
conclus
result
studi
demonstr
igdt
target
sv
perform
safe
patient
undergo
eaa
whether
intervent
benefi
cial
evalu
current
studi
introduct
studi
suggest
tissu
oxygen
sto
measur
thenar
muscl
sensit
track
acut
chang
hemodynam
due
reduct
central
blood
volum
aim
investig
feasibl
sto
measur
mouth
quantit
indic
compar
sto
measur
obtain
thenar
emin
chang
central
blood
volum
cbv
method
perform
headup
tilt
hut
test
healthi
volunt
experiment
model
reduc
cbv
sto
continu
measur
use
two
devic
inspectra
model
multipl
depth
optic
probe
place
thenar
emin
mm
probe
place
mouth
subject
place
electr
driven
tilt
tabl
footboard
minut
baselin
measur
supin
posit
tabl
tilt
return
supin
posit
minut
sto
read
analyz
lowest
stroke
volum
valu
result
subject
mean
age
six
male
toler
well
supin
headup
posit
cardiac
output
signifi
cantli
decreas
hut
posit
simultan
decreas
sto
observ
mouth
thenar
gener
result
hut
test
shown
tabl
introduct
hemodynam
optimis
base
fl
ow
variabl
allow
earli
detect
correct
possibl
occult
organ
hypoperfus
patient
undergo
major
surgeri
shoemak
describ
markedli
decreas
cardiac
index
ci
nonsurvivor
remain
signifi
cantli
valu
compar
survivor
surgeri
aim
studi
evalu
length
icu
stay
overal
inhospit
stay
postop
outcom
group
patient
undergo
major
urolog
surgeri
ci
maintain
within
normal
rang
intraop
period
method
patient
randomis
group
day
surgeryconvent
manag
group
decis
fl
uid
therapi
vasoact
support
base
intern
guidelin
preserv
normal
macrohemodynam
variabl
protocol
group
patient
protocol
group
receiv
oesophag
doppler
probe
ted
hemoson
arrow
intern
usa
start
gener
anaesthesia
hemodynam
optimis
fl
uid
manag
vasoact
drug
accord
ted
variabl
perform
keep
ci
lminutem
enrol
patient
control
group
n
protocol
group
n
highrisk
criteria
surgeri
fulfi
lled
patient
protocol
group
control
group
signifi
cant
diff
erenc
baselin
variabl
group
age
gender
length
surgic
procedur
estim
blood
loss
also
intraop
valu
map
cvp
protocol
group
observ
high
frequenc
ci
lminutem
induct
anesthesia
fast
recoveri
ci
introduct
fluid
therapi
icu
patient
serv
maintain
tissu
perfus
direct
increas
cardiac
stroke
volum
sv
increas
preload
fl
uid
respons
although
increas
evid
region
blood
fl
ow
predict
global
hemodynam
measur
relat
sv
paramet
peripher
perfus
clear
aim
studi
evalu
eff
ect
increas
preload
commonli
use
paramet
peripher
perfus
method
hemodynam
unstabl
patient
clinic
suspect
fl
uid
respons
underw
passiv
leg
rais
plr
test
consist
minut
rest
semirecumb
posit
follow
minut
plr
lower
limb
elev
trunk
supin
posit
sv
measur
continu
puls
contour
analysi
use
picco
pulsion
peripher
perfus
measur
continu
sidestream
dark
fi
eld
imag
sublingu
area
laser
doppler
fl
owmetri
ldf
fi
nger
result
sixteen
patient
age
year
apach
ii
sofa
includ
studi
patient
six
increas
sv
respons
plr
flow
indic
ldf
sublingual
microcirculatori
fl
ow
chang
howev
trend
increas
function
capillari
densiti
respond
see
figur
conclus
data
suggest
increas
sv
hemodynam
unstabl
patient
might
improv
peripher
perfus
howev
sublingu
area
patient
relat
system
circul
peripher
perfus
remain
investig
whether
optim
sv
actual
result
improv
tissu
perfus
among
patient
baselin
median
ci
divc
lminut
respect
volum
expans
signifi
cantli
increas
median
ci
lminutem
p
decreas
divc
p
median
divc
r
higher
nr
vs
p
fluid
therapi
decreas
divc
r
nr
r
p
nr
p
divc
show
similar
trend
group
septic
shock
ss
trauma
shock
ts
patient
fl
uid
therapi
divc
ss
ts
fl
uid
therapi
ss
ts
therapi
conclus
data
suggest
divc
sensit
index
fl
uid
respons
ness
septic
trauma
patient
shock
limit
patient
introduct
myocardi
depress
occur
patient
present
sepsi
critic
ill
patient
peak
fi
rst
deriv
aortic
pressur
aodpdt
max
deriv
fl
uidfi
lled
cathet
commonli
use
clinician
decad
assess
direct
chang
left
ventricular
lv
contractil
howev
paramet
remain
question
preload
sensit
aim
studi
test
whether
aodpdt
max
repres
accur
method
assess
lv
contractil
preload
independ
base
dynam
indic
achiev
method
lv
pressurevolum
data
obtain
conduct
cathet
invas
aortic
pressur
obtain
fl
uidfi
lled
cathet
continu
record
six
anaesthet
mechan
ventil
pig
stabil
period
endotoxin
infus
induc
septic
shock
fluid
administr
continu
control
preload
respons
hold
puls
pressur
variat
ppv
catecholamin
transient
administr
shock
aodpdt
max
compar
endsystol
elast
e
es
gold
standard
method
assess
lv
contractil
result
endotoxininduc
septic
shock
catecholamin
infus
lead
signifi
cant
variat
lv
contractil
best
correl
r
agreement
aodpdt
max
e
es
obtain
ppv
figur
conclus
aodpdt
max
minim
invas
accur
method
assess
lv
contractil
eff
ectiv
preload
independ
defi
ned
ppv
achiev
introduct
pressur
record
analyt
method
pram
puls
contour
method
need
calibr
sinc
estim
vivo
beat
beat
imped
cardiovascular
system
cardiac
cycl
effi
cienci
cce
novel
paramet
directli
relat
cardiovascular
imped
sinc
aortic
valv
contribut
imped
hypothes
aortic
valvuloplasti
perform
sever
aortic
stenosi
cardiovascular
imped
may
decreas
reduct
transvalvular
gradient
method
cath
lab
fi
consecut
patient
undergo
aortic
valv
plasti
sever
aortic
stenosi
monitor
mean
pram
procedur
systol
sap
diastol
mean
map
arteri
pressur
stroke
volum
sv
heart
rate
hr
cardiac
output
sv
x
hr
cce
dp
dt
max
continu
collect
afterward
analyz
stroke
work
sw
sv
x
map
minut
work
mw
sbp
x
co
also
measur
result
case
nomi
diagnos
laparotomi
mean
age
year
year
old
male
femal
ratio
one
patient
receiv
pump
coronari
arteri
bypass
surgeri
fi
underw
thorac
aortic
surgeri
hemodialysi
initi
one
six
patient
oper
continu
hemodiafi
ltration
initi
patient
postop
oper
highdos
catecholamin
necessari
fi
six
patient
long
period
sever
hypotens
four
six
patient
abdomin
pain
present
symptom
rest
two
patient
nonspecifi
c
present
ventil
sedat
patient
present
abdomin
distens
abdomin
xray
show
paralyt
ileu
featur
serum
valu
ast
ldh
ck
lactat
slightli
elev
patient
five
six
patient
die
septic
shock
multipl
organ
failur
mortal
rate
patient
nomi
potenti
risk
factor
contribut
occurr
nomi
sensit
marker
might
follow
continu
hemodiafi
ltration
hypotens
highdos
catecholamin
dehydr
abdomin
pain
paralyt
ileu
pattern
abdomin
xray
conclus
increas
nomi
incid
follow
cardiothorac
surgeri
might
relat
continu
hemodiafi
ltration
hypotens
dehydr
use
highdos
catecholamin
identifi
cation
patient
nomi
risk
prevent
hypovolem
hypotens
use
vasodil
may
help
reduc
incid
nomi
increas
preval
chf
elderli
aim
present
studi
investig
major
caus
comorbid
inhospit
mortal
patient
chf
method
retrospect
studi
perform
patient
male
femal
valid
primari
discharg
diagnosi
chf
hospit
januari
decemb
chines
pla
gener
hospit
beij
patient
divid
fi
group
base
number
etiolog
comorbid
one
fi
fi
compar
analysi
perform
explor
major
caus
comorbid
inhospit
mortal
patient
among
group
mean
sd
age
patient
year
onecomorbid
group
year
twocomorbid
group
year
threecomorbid
group
year
fourcomorbid
group
year
fi
vecomorbid
group
introduct
sildenafi
l
inhibitor
select
decreas
pulmonari
arteri
pressur
far
mechan
underli
sildenafi
l
eff
ect
pulmonari
vascular
remodel
potassium
channel
activ
pulmonari
arteri
smooth
muscl
cell
pasmc
clearli
address
pulmonari
hypertens
secondari
increas
pulmonari
blood
fl
ow
method
total
male
sd
rat
randomli
divid
sham
group
n
shunt
group
n
shunt
sildenafi
l
group
n
lefttoright
shunt
establish
perform
abdomin
aorta
inferior
vena
cava
fi
stula
shunt
group
shunt
sildenafi
l
group
rat
shunt
sildenafi
l
group
receiv
oral
sildenafi
l
mgkg
day
wherea
rat
sham
group
shunt
group
fed
normal
salin
volum
eleven
week
later
mean
pulmonari
arteri
pressur
mpap
measur
meanwhil
ratio
right
ventricular
mass
left
ventricular
plu
septal
mass
rv
lv
detect
marker
degre
right
ventricular
hypertrophi
rel
medial
thick
rmt
middl
small
pulmonari
muscular
arteri
calcul
sign
patholog
chang
pulmonari
vasculatur
voltageg
potassium
channel
mrna
express
pulmonari
vasculatur
detect
use
realtim
pcr
result
eleven
week
later
rat
shunt
group
develop
pulmonari
hypertens
evidenc
signifi
cantli
increas
mpap
rv
lv
well
higher
rmt
middl
small
pulmonari
muscular
arteri
p
addit
rat
shunt
group
decreas
mrna
express
pulmonari
vasculatur
p
rat
shunt
sildenafi
l
group
signifi
cantli
decreas
mpap
rv
lv
ratio
lower
rmt
well
p
wherea
level
mrna
express
signifi
cantli
upregul
p
furthermor
statist
signifi
cant
diff
erenc
mpap
rv
lv
ratio
rmt
middl
small
pulmonari
muscular
arteri
mrna
express
shunt
sildenafi
l
group
sham
group
p
ns
conclus
oral
sildenafi
l
attenu
pulmonari
vascular
remodel
upregul
mrna
express
rat
pulmonari
hypertens
secondari
lefttoright
shunt
method
eleven
anesthes
pig
instrument
measur
arteri
blood
pressur
central
venou
pressur
rv
pulmonari
pressur
ultrason
fl
owprob
transon
posit
main
pulmonari
arteri
obtain
pulmonari
fl
ow
distal
fl
owprob
balloonocclud
posit
facilit
gradual
constrict
pulmonari
arteri
obtain
stepwis
pressur
diff
erenc
increment
band
mmhg
measur
gradual
infl
ate
balloonocclud
minut
invas
hemodynam
data
regist
epicardi
echocardiographi
perform
obtain
tricuspid
fl
ow
veloc
isovolumetr
isovolumetr
relax
time
calcul
tei
index
one
heartbeat
echocardiograph
measur
synchron
fl
owprob
measur
obtain
eject
time
ratio
obtain
tissu
doppler
echocardiographi
later
tricuspid
annulu
echocardiograph
measur
perform
tripl
averag
eject
period
mean
pulmonari
acceler
cardiac
output
calcul
pulmonari
fl
ow
curv
deriv
ultrason
fl
owprob
resist
pulmonari
band
calcul
pressur
gradient
divid
cardiac
output
pathobiolog
persist
right
ventricular
rv
failur
observ
acut
increas
pulmonari
arteri
pressur
p
pa
remain
incomplet
understood
hypothes
sever
complic
might
relat
activ
apoptot
pathway
method
fourteen
anesthet
dog
randomis
transient
minut
pulmonari
arteri
constrict
sham
oper
follow
minut
later
hemodynam
measur
includ
eff
ectiv
arteri
elast
e
estim
rv
afterload
endsystol
elast
e
es
estim
rv
contractil
sampl
cardiac
tissu
assess
apoptosi
realtim
quantit
polymeras
chain
reaction
enzymelink
immunosorb
assay
immunohistochemistri
result
transient
increas
p
pa
persist
increas
e
mmhgml
decreas
e
es
mmhgml
e
es
e
cardiac
output
lminut
indic
rv
failur
compar
shamoper
group
left
ventricular
tissu
anim
persist
rv
failur
decreas
gene
express
rv
septal
chang
gene
express
bax
bak
increas
ratio
rv
septal
bclxl
rv
bclw
gene
express
decreas
compar
shamoper
group
activ
rv
caspas
rv
septal
caspas
diff
use
rv
septal
apoptosi
confi
rmed
tunel
stain
also
increas
rv
septal
protein
express
conclus
acut
afterloadinduc
persist
rv
failur
appear
relat
earli
activ
apoptot
pathway
myocardi
increas
current
approv
treatment
nicardipin
n
dihydralazin
drawback
sinc
hypertens
pe
associ
increas
sympathet
activ
urapidil
u
peripher
antagonist
potenti
bp
control
pe
control
comparison
u
n
avail
preliminari
random
control
trial
aim
compar
effi
caci
safeti
u
n
reduc
bp
sever
pe
method
irb
approv
sign
inform
consent
women
sever
pe
without
previou
antihypertens
treatment
random
u
n
group
therapeut
goal
achiev
mean
bp
mbp
mmhg
u
patient
fi
rst
receiv
u
mg
bolus
everi
minut
diastol
bp
drop
mmhg
follow
mghour
infus
adjust
need
n
group
patient
fi
rst
receiv
n
infus
reduct
mean
bp
follow
n
infus
adjust
need
noninvas
bp
assess
everi
minut
treatment
titrat
everi
minut
time
need
reach
therapeut
goal
regist
main
endpoint
achiev
bp
goal
hour
less
toler
assess
number
episod
hypotens
ho
defi
ned
mbp
mmhg
side
eff
ect
sever
ho
defi
ned
mbp
mmhg
two
episod
ho
consid
treatment
failur
led
exclus
assess
limit
safeti
amount
ocytoc
use
neonat
evalu
icu
paediatrician
discharg
icu
result
compar
use
analysi
varianc
side
eff
ect
compar
chisquar
test
result
one
u
patient
exclud
effi
caci
assess
due
protocol
violat
main
endpoint
reach
patient
minut
group
fi
rst
hour
need
treatment
adjust
median
valu
u
group
n
group
side
eff
ect
attribut
studi
treatment
observ
six
nine
case
n
group
one
nine
case
u
group
p
sever
side
eff
ect
neonat
side
eff
ect
conclus
diff
erenc
effi
caci
could
shown
preliminari
seri
treatment
easi
titrat
fewer
side
eff
ect
record
u
group
studi
need
order
compar
u
n
introduct
patient
frequent
refer
emerg
depart
hypertens
relat
disord
hypertens
crisi
diagnos
patient
urgent
treatment
necessari
howev
take
patient
satisfact
consider
emerg
physician
usual
discharg
patient
lower
blood
pressur
variou
medic
prospect
random
placebocontrol
studi
design
order
compar
eff
ect
captopril
furosemid
lorazepam
lower
blood
pressur
increas
patient
satisfact
method
one
hundr
patient
uncompl
hypertens
includ
studi
random
four
group
captopril
group
furosemid
group
lorazepam
group
placebo
group
blood
pressur
measur
baselin
minut
patient
satisfact
assess
visual
analog
scale
va
baselin
minut
result
captopril
mmhg
lorazepam
mmhg
furosemid
mmhg
found
similarli
eff
ectiv
lower
blood
pressur
compar
baselin
minut
three
drug
superior
placebo
mmhg
p
tabl
patient
satisfact
assess
va
captopril
mm
furosemid
mm
lorazepam
mm
statist
similar
three
drug
superior
placebo
mm
conclus
three
drug
use
subject
refer
emerg
depart
uncompl
hypertens
similarli
eff
ectiv
lower
blood
pressur
increas
patient
satisfact
introduct
hypertens
crise
hc
common
among
patient
admit
emerg
room
howev
data
lack
preval
critic
ill
admit
icu
aim
studi
assess
rate
hc
cohort
patient
admit
medicalsurg
icu
look
risk
factor
hc
assess
outcom
patient
hc
patient
divid
two
group
fi
rst
group
includ
patient
underw
electr
cardiovers
cve
group
n
discharg
sinu
rhythm
second
includ
patient
undergo
electr
cardiovers
discharg
chronic
atrial
fi
brillat
caf
group
n
group
mortal
antiarrhythm
drug
therapi
oral
anticoagul
regimen
monitor
fi
rst
group
followup
evalu
mainten
sinu
rhythm
number
dc
shock
requir
mainten
sinu
rhythm
patient
cve
group
also
collect
main
outcom
paramet
consid
mortal
result
patient
group
result
similar
demograph
clinic
paramet
patient
includ
cve
group
mainten
sinu
rhythm
achiev
one
dc
shock
two
dc
shock
three
dc
shock
case
mortal
rate
hour
day
wherea
patient
caf
group
mortal
rate
see
figur
conclus
pilot
studi
indic
improv
ventricular
perform
contribut
atrial
systol
might
improv
critic
ill
patient
outcom
consid
small
number
case
prospect
studi
base
preliminari
result
ongo
incid
acut
cardiogen
pulmonari
edema
acp
increas
one
lead
caus
morbid
mortal
societi
global
popul
european
countri
get
older
impact
arteri
stiff
ness
becom
import
pathophysiolog
acp
besid
coronari
vascular
diseas
valvular
diseas
aim
studi
evalu
whether
acut
modifi
cation
elast
arteri
distens
involv
pathogenesi
acp
method
six
consecut
patient
four
men
two
women
age
year
admit
icu
clinic
diagnosi
acp
patient
studi
transthorac
echocardiographi
tte
evalu
puls
wave
analysi
pwa
puls
wave
veloc
pwv
applan
tonometri
method
perform
admiss
clinic
stabil
patient
left
ventricular
systol
function
signifi
cantli
reduc
evalu
transthorac
echocardiographi
diastol
dysfunct
alway
demonstr
record
signifi
cant
p
decreas
blood
pressur
valu
clinic
stabil
estim
central
aortic
pressur
waveform
mathemat
transform
radial
tonometri
pressur
similarli
reduc
tonometr
paramet
augment
index
repres
contribut
wave
refl
ection
global
puls
pressur
wave
pwv
invers
correl
arteri
complianc
also
signifi
cantli
decreas
compar
valu
admiss
time
subendocardi
viabil
ratio
sevr
indirect
index
myocardi
perfus
rel
cardiac
workload
increas
treatment
vasodilat
conclus
data
confi
rm
determin
role
increas
arteri
stiff
ness
pathogenesi
acp
therapeut
strategi
abl
amelior
target
associ
clinic
improv
patient
applan
tonometri
could
interest
method
evalu
patient
icu
set
introduct
sever
studi
use
angiograph
echocardiograph
method
shown
septic
shock
ssh
sever
sepsi
se
cardiac
abnorm
often
document
seem
relev
prognost
signifi
canc
conclus
studi
reinforc
concept
chang
systol
diastol
function
common
septic
shock
sever
septic
patient
develop
chang
adapt
mechan
seem
correl
invers
acut
mortal
rate
icu
stay
introduct
advantag
pulsatil
perfus
pp
cardiopulmonari
bypass
cpb
term
clinic
outcom
remain
subject
debat
possibl
benefi
ts
gener
thought
occur
via
improv
microvascular
fl
ow
howev
current
support
human
clinic
data
therefor
use
realtim
human
microvascular
imag
test
hypothesi
pulsatil
perfus
would
enhanc
microvascular
perfus
method
use
sidestream
dark
fi
eld
imag
record
video
clip
human
microcircul
patient
undergo
routin
cpb
cardiac
surgeri
follow
administr
cardioplegia
cpb
continu
either
pulsatil
pp
n
nonpulsatil
np
mode
minut
microvascular
record
made
perfus
mode
switch
pp
np
vice
versa
ten
minut
later
second
seri
microvascular
video
record
obtain
global
hemodynam
laboratori
data
record
energi
equival
pressur
eep
puls
pressur
mean
sd
calcul
quantifi
pp
gener
surplu
energi
microvascular
analysi
perform
smaller
larger
microvessel
diamet
cutoff
assess
includ
perfus
vessel
densiti
pvd
mean
sd
confi
denc
interv
diff
erenc
np
pp
cid
microvascular
flow
index
mfi
mean
sd
interquartil
rang
result
pulsatil
perfus
result
higher
puls
pressur
vs
mmhg
p
cpb
circuit
eep
vs
mmhg
p
compar
np
map
similar
perfus
mode
vs
mmhg
p
small
larger
microvessel
found
diff
erenc
indic
microvascular
perfus
pp
np
small
microvessel
pvd
similar
pp
np
vs
cid
p
conclus
studi
complet
echocardiograph
assess
possibl
use
tte
patient
twothird
popul
echocardiograph
abnorm
previous
unknown
presenc
lv
asynergi
reduc
rv
systol
function
associ
wors
prognosi
detect
cardiac
abnorm
increas
predict
icu
mortal
base
logist
regress
introduct
btype
natriuret
peptid
bnp
ntermin
probnp
ntprobnp
routin
diagnost
monitor
marker
patient
heart
failur
lv
function
prognosi
patient
shown
refl
ect
bnp
ntprobnp
level
howev
patient
cardiogen
shock
myocardi
infarct
relationship
relev
marker
elucid
method
iabp
shock
trial
monocentr
randomis
prospect
clinic
trial
determin
role
therapeut
intraaort
balloon
pump
iabp
counterpuls
primari
percutan
translumin
coronari
angioplasti
pci
acut
myocardi
infarct
ami
complic
cardiogen
shock
cardiac
catheter
perform
patient
within
hour
onset
hemodynam
instabl
creatinin
hemodynam
paramet
surviv
determin
bnp
ntprobnp
level
measur
admiss
well
hour
afterward
result
bnp
level
detect
diff
erenc
treatment
regard
lvunload
iabp
pgml
vs
pgml
p
howev
signifi
cant
diff
erenc
group
treat
iabp
iabp
regard
ntprobnp
level
interestingli
ntprobnp
level
clearli
diff
erenti
survivor
nonsurvivor
pgml
vs
pgml
p
contrari
signifi
cant
diff
erenc
survivor
nonsurvivor
regard
bnp
level
ns
elev
level
ntprobnp
patient
cardiogen
shock
might
depend
impair
renal
function
might
refl
ect
addit
organ
dysfunct
creatinin
vs
creatinin
pgml
vs
pgml
p
conclus
myocardi
infarct
complic
cardiogen
shock
level
bnp
ntprobnp
provid
valuabl
addit
inform
bnp
seem
close
refl
ect
cardiac
statu
eff
ect
therapi
ntprobnp
seem
good
indic
prognosi
patient
cardiogen
shock
depend
organ
dysfunct
previous
shown
data
fusion
index
base
integr
vital
sign
continu
monitor
stepdown
unit
sdu
identifi
cardiorespiratori
instabl
often
preced
advers
event
show
correl
vital
sign
captur
data
fusion
index
base
probabilist
model
normal
chang
time
cardiorespiratori
instabl
method
observ
studi
carri
sdu
vital
sign
patient
continu
record
exist
standard
care
use
singlechannel
medic
emerg
team
met
activ
criteria
determin
individu
vital
sign
becam
abnorm
retrospect
evalu
continu
vital
sign
data
identifi
ed
met
criteria
exceed
nonartefactu
occas
one
hundr
eleven
indic
suffi
cient
cardiorespiratori
instabl
requir
met
call
critic
event
vitalsign
dynam
event
compar
data
stabl
period
use
order
statist
covari
analysi
found
probabl
distribut
extrem
median
data
paramet
interv
bivari
gaussian
distribut
best
fi
data
critic
event
abnorm
respiratori
rate
rr
heart
rate
hr
show
signifi
cant
diff
erenc
covari
compar
calcul
data
interv
stabl
patient
see
figur
covari
indic
ellips
orient
normal
condit
black
ellips
rr
correl
hr
critic
event
tachycardia
occur
littl
variat
rr
red
ellips
tachypnoea
occur
littl
variat
hr
blue
ellips
conclus
dynam
correl
exist
vital
sign
period
stabil
chang
signifi
cantli
period
abnorm
statist
approach
integr
vital
sign
captur
correl
sensit
cardiorespiratori
deterior
introduct
vivo
microdialysi
md
bedsid
sampl
method
permit
continu
analysi
patient
extracellular
tissu
chemistri
without
consum
blood
md
perform
implant
commerci
avail
cathet
mimic
blood
capillari
site
interest
method
total
men
mechan
ventil
septic
patient
median
age
year
studi
patient
met
accp
sccm
consensu
criteria
sepsi
upon
sepsi
onset
microdialysi
cathet
cma
cma
solna
sweden
insert
subcutan
adipos
tissu
upper
thigh
dialys
sampl
collect
microvi
analyz
immedi
glucos
pyruv
lactat
glycerol
use
mobil
cma
iscu
analyz
lactatepyruv
lp
ratio
automat
calcul
measur
perform
six
time
per
day
fi
rst
day
sepsi
onset
daili
mean
valu
md
measur
calcul
patient
result
sepsi
sever
studi
group
grade
follow
sepsi
n
sever
sepsi
n
septic
shock
n
apach
sofa
score
studi
entri
respect
overal
patient
die
yield
icu
mortal
rate
md
reveal
studi
entri
patient
septic
shock
higher
lactat
vs
p
higher
pyruv
vs
p
level
compar
septic
patient
without
shock
contrast
two
group
similar
valu
glucos
vs
p
glycerol
vs
p
lp
ratio
vs
p
septic
shock
correl
sofa
day
r
p
apach
ii
r
p
lactat
day
r
p
lactat
day
r
p
pyruv
day
r
p
pyruv
day
r
p
nonsurvivor
higher
glycerol
vs
p
studi
entri
day
vs
p
compar
survivor
nonsurvivor
also
higher
pyruv
level
day
vs
p
day
vs
p
logist
regress
analysi
show
apach
ii
p
glycerol
day
p
independ
predict
patient
outcom
conclus
md
seem
safe
promis
tool
grade
sepsi
sever
predict
earli
mortal
critic
ill
patient
musclespecifi
c
infl
ammatori
respons
strenuou
exercis
similar
observ
sepsi
use
mirror
sepsisspecifi
c
infl
ammatori
respons
nearinfrar
spectroscopi
nir
use
quantifi
sepsisinduc
metabol
alter
measur
variat
tissu
oxygen
satur
sto
vascular
occlus
test
vot
aim
investig
whether
nir
dynam
variabl
could
refl
ect
magnitud
infl
ammatori
process
follow
strenuou
exercis
marathon
runner
method
votnir
inspectra
model
measur
perform
fi
nish
line
day
marathon
runner
malesthre
femal
votderiv
nir
trace
analyz
sto
r
dec
sto
sto
upslop
r
inc
sto
blood
sampl
collect
measur
creactiv
protein
crp
procalcitonin
pct
white
blood
cell
wbc
creatin
kinas
ck
lactat
data
mean
sd
tabl
median
iqr
p
consid
statist
signifi
cant
result
nir
dynam
hemodynam
variabl
shown
tabl
r
dec
sto
signifi
cantli
increas
day
marathon
signifi
cant
increas
lactat
vs
wbc
x
vs
x
observ
complet
marathon
serum
crp
pct
ck
signifi
cantli
increas
day
marathon
vs
vs
vs
indic
musclespecifi
c
infl
ammatori
respons
result
muscl
damag
conclus
delay
increas
thenar
vo
associ
musclespecifi
c
infl
ammatori
respons
strenuou
exercis
result
muscl
damag
introduct
current
clinic
paramet
effi
cienci
resuscit
often
insuffi
cient
unabl
reliabl
assess
tissu
hypoxia
consider
interest
aim
direct
monitor
tissu
oxygen
tension
pto
howev
golden
standard
yet
found
anim
experiment
model
shown
interest
result
hypovolem
septic
shock
lead
interest
clinic
studi
purpos
review
evalu
current
valu
pto
monitor
anim
experiment
studi
variou
pathophysiolog
condit
method
electron
literatur
search
pubm
embas
databas
conduct
fi
nd
relev
articl
tissu
oxygen
hemorrhag
trauma
endotoxemia
initi
amount
articl
retriev
appli
inclus
exclus
criteria
critic
apprais
articl
rank
level
evid
result
screen
articl
articl
found
suitabl
answer
goal
ten
articl
discuss
tissu
oxygen
hemorrhag
model
nine
articl
model
endotoxemia
relev
articl
concern
pto
experiment
trauma
found
eight
articl
compar
splanchnic
pto
measur
relat
pto
measur
sever
peripher
site
like
subcutan
skelet
muscl
tissu
posit
correl
locat
found
seven
articl
decreas
peripher
central
tissu
oxygen
pressur
pto
found
hemorrhag
importantli
peripher
pto
chang
earlier
hemorrhag
hemodynam
paramet
contrast
one
articl
found
earlier
chang
hemodynam
paramet
peripher
pto
nine
articl
discuss
pto
model
septic
shock
two
studi
compar
peripher
pto
measur
splanchnic
pto
measur
site
decreas
pto
valu
endotoxemia
found
chang
chang
hemodynam
paramet
conclus
signifi
cant
relat
intestin
pto
peripher
pto
found
studi
experiment
model
hemorrhag
septic
shock
suggest
peripher
site
like
subcutan
tissu
skelet
muscl
tissu
reliabl
locat
measur
pto
cardiac
output
co
stroke
volum
sv
puls
pressur
variat
ppv
standard
hemodynam
paramet
continu
record
fluid
respons
defi
ned
increas
sv
ml
colloid
hea
infus
minut
sto
measur
vot
sphygmomanomet
infl
ate
mmhg
systol
pressur
kept
infl
ate
sto
decreas
perform
anaesthesia
induct
baselin
ppv
therefor
defi
ning
hypovolemia
fl
uid
challeng
result
baselin
patient
preload
depend
mean
ppv
none
requir
vasopressor
procedur
baselin
mean
sto
co
sv
lminut
ml
respect
hypovolemia
compar
baselin
diff
erenc
sto
p
sto
desatur
rate
minut
p
sto
recoveri
slope
lower
second
p
patient
respond
fl
uid
challeng
volum
expans
sv
vs
ml
p
co
vs
lminut
p
higher
signifi
cant
chang
sto
sto
desatur
rate
fluid
challeng
induc
increas
sto
recoveri
slope
p
figur
compar
baselin
conclus
whilst
redistribut
blood
fl
ow
may
occur
circulatori
failur
vasoconstrict
lesser
vital
organ
impair
microcircul
tissu
hypoperfus
indic
particular
import
hypovolemia
intravascular
volum
expans
associ
signifi
cant
modifi
cation
dynam
recoveri
slope
sto
futur
studi
need
better
clarifi
potenti
clinic
applic
introduct
although
advers
eff
ect
mechan
ventil
circul
intestin
organ
perfus
well
known
infl
uenc
assist
breath
versu
control
ventil
investig
hypothes
pressur
support
ventil
caus
less
decreas
gut
perfus
less
neutrophil
adhes
control
ventil
method
male
sd
rat
n
anesthet
tracheotom
anim
ventil
pressur
support
psv
pressur
control
pcv
mode
pcv
anim
paralyz
hour
ventil
intravit
microscopi
perform
endotoxin
mgkg
lipopolysaccharid
given
rat
anim
serv
control
critic
care
volum
suppl
http
result
diff
erenc
baselin
hemodynam
ga
exchang
anim
stabl
whole
observ
period
minim
chang
blood
pressur
oxygen
pcv
percentag
function
capillari
longitudin
mucos
layer
lower
psv
sepsi
decreas
pcv
major
decreas
psv
leukocyt
adhes
intestin
submocos
venul
exampl
venul
higher
pcv
psv
control
septic
anim
conclus
septic
rat
preserv
macrohemodynam
stabil
intestin
perfus
impair
lp
infus
pressurecontrol
ventil
signifi
cant
infl
uenc
microcircul
neutrophil
adhes
control
septic
anim
pressur
support
ventil
attenu
advers
eff
ect
compar
pcv
introduct
central
venou
oxygen
satur
scvo
shown
use
therapeut
target
septic
shock
highrisk
surgeri
central
venoustoarteri
carbon
dioxid
diff
erenc
pcvaco
propos
complementari
tool
goaldirect
therapi
gdt
septic
shock
test
hypothesi
scvo
pcvaco
could
use
complementari
tool
gdt
highrisk
surgeri
method
seventi
adult
patient
asa
iii
undergo
major
abdomin
surgeri
randomli
assign
mlkghour
rgdt
group
n
mlkghour
cgdt
group
n
crystalloid
addit
bolus
he
given
maintain
respiratori
variat
peak
aortic
fl
ow
veloc
group
scvo
cardiac
output
co
oxygen
deliveri
pcvaco
postop
complic
blindli
record
result
baselin
diff
erenc
hemodynam
variabl
scvo
vs
p
pcvaco
vs
p
total
volum
fl
uid
perfus
larger
cgdt
group
rgdt
group
p
two
group
show
diff
erenc
intraop
blood
loss
blood
transfus
mean
co
mean
valu
overal
postop
complic
increas
rgdt
group
p
especi
postop
sepsi
occur
often
p
minim
scvo
minscvo
higher
cgdt
group
vs
p
patient
complic
minscvo
signifi
cantli
reduc
vs
p
minscvo
independ
associ
sepsi
ci
p
intraop
mean
pcvaco
higher
rgdt
group
vs
mmhg
p
patient
develop
sepsi
pcvaco
higher
patient
vs
mmhg
p
patient
scvo
develop
sepsi
pcvaco
also
signifi
cantli
higher
p
area
roc
curv
ci
discrimin
patient
scvo
develop
sepsi
mmhg
best
threshold
valu
conclus
scvo
refl
ect
import
chang
oxygen
deliveri
relat
oxygen
need
periop
period
might
help
guid
gdt
better
alon
pcvaco
appear
use
tool
identifi
persist
hypoperfus
gdt
associ
scvo
marker
venou
fl
ow
adequaci
remov
total
co
produc
peripher
tissu
substitut
central
mix
venousarteri
pco
diff
erenc
accept
object
assess
relationship
sofa
score
variat
patient
sever
sepsi
septic
shock
lactat
sco
also
evalu
method
prospect
observ
studi
patient
sever
sepsi
septic
shock
admit
adult
tertiari
icu
manag
sepsi
carri
propos
surviv
sepsi
campaign
guidelin
earliest
simultan
measur
lactat
svco
obtain
clinic
indic
hour
sofa
score
determin
hour
calcul
conclus
patient
hyperlactatemia
begin
admiss
persist
increas
level
lactat
evolv
worsen
sofa
score
hour
svco
trend
unrel
sofa
score
hour
measur
cardiac
output
adequaci
tissu
need
essenti
hemodynam
evalu
recent
review
state
venoustoarteri
carbon
dioxid
diff
erenc
dpco
could
consid
marker
adequaci
venou
blood
fl
ow
remov
total
co
produc
peripher
tissu
sever
studi
alreadi
shown
dpco
cardiac
index
ci
invers
correl
critic
ill
patient
howev
dpco
infl
uenc
ci
also
factor
govern
co
product
co
elimin
aim
work
studi
behaviour
dpco
measur
central
venou
blood
evolut
earli
stage
septic
shock
method
fortysix
patient
septic
shock
prospect
includ
dpco
calcul
diff
erenc
arteri
pco
pco
central
venou
blood
valu
dpco
mmhg
consid
high
ci
measur
transpulmonari
thermodilut
scvo
serum
lactat
obtain
patient
separ
normal
dpco
group
high
dpco
group
result
compar
student
test
mannwhitney
test
p
chosen
signifi
canc
result
inclus
patient
high
dpco
patient
lower
ci
vs
lminm
p
lower
scvo
vs
p
patient
normal
dpco
diff
erenc
found
paco
pao
fio
level
group
suggest
similar
co
elimin
thirteen
patient
decreas
dpco
mmhg
mmhg
p
associ
increas
ci
lmin
p
convers
patient
increas
dpco
mmhg
mmhg
p
patient
ci
decreas
lminm
p
equal
neg
correl
establish
dpco
ci
r
p
chang
dpco
chang
ci
r
p
studi
lactat
level
similar
group
scvo
correl
ci
r
p
conclus
dpco
patient
septic
shock
seem
relat
princip
ci
dpco
might
marker
tissu
perfus
adequaci
patient
metabol
could
resuscit
target
manag
septic
shock
patient
introduct
high
lactat
lct
identifi
es
critic
ill
patient
predict
risk
mortal
guid
resuscit
low
central
venou
oxygen
satur
svo
associ
mortal
use
resuscit
target
chang
lct
svo
shown
relat
outcom
physiolog
plausibl
low
svo
high
lct
wors
versu
one
svo
lct
abnorm
normal
earli
chang
combin
may
also
determin
subsequ
chang
organ
perform
hypothesis
chang
combin
svo
lct
day
day
predict
chang
total
sofa
day
day
method
use
retrospect
cohort
methodolog
use
data
obtain
electron
clinic
inform
system
includ
patient
underw
lct
svo
measur
intern
jugular
subclavian
vein
fi
st
hour
icu
admiss
baselin
demograph
physiolog
daili
followup
physiolog
sofa
mortal
data
record
worst
admiss
valu
use
combin
svo
lct
four
group
sl
group
dichotomis
mean
svo
median
lct
nn
ln
nh
lh
variabl
individu
associ
p
chang
total
sofa
day
day
includ
multivari
linear
regress
model
chang
total
sofa
depend
variabl
use
forward
stepwis
inclus
variabl
adjust
p
remain
fi
nal
model
result
total
patient
includ
complet
data
chang
variabl
avail
patient
mean
sd
svo
median
iqr
lct
mean
sd
apach
ii
age
respect
male
mean
fall
sd
total
sofa
day
day
apach
ii
adj
p
day
sl
group
adj
p
sofa
adj
p
creactiv
protein
mgl
adj
p
independ
associ
chang
sl
group
associ
improv
organ
function
adj
p
conclus
apach
ii
sl
group
total
sofa
day
creactiv
protein
mgl
associ
worsen
organ
function
day
day
improv
combin
svo
lct
associ
chang
organ
perform
concept
altern
set
lactat
product
nowaday
challeng
comprehens
oxygen
deliveri
consumpt
recent
studi
shown
prognost
valu
oxygen
lactat
gradient
measur
central
venou
pulmonari
arteri
circul
data
repres
one
sampl
experiment
research
tri
build
conceptu
framework
relat
oxygen
lactat
dynam
diff
erent
hypox
state
method
sixteen
larg
white
pig
kg
seven
sham
studi
anesthesia
full
monitor
ekg
map
etco
continu
ga
analysi
doppler
portal
fl
ow
small
bowel
tonometri
liver
tpo
urin
output
abdomin
sepsi
induc
fecal
periton
conclus
preliminari
data
show
high
rate
oxygen
extract
rate
coronari
circul
suggest
appar
lactat
consumpt
heart
lactat
product
lung
experiment
sepsi
present
studi
clarifi
whether
metformin
increas
cellular
lactat
product
inhibit
mitochondri
function
tissu
liver
method
plateletrichplasma
prp
healthi
volunt
incub
hour
diff
erent
dose
metformin
plasma
lactat
concentr
measur
proport
normal
polar
vs
abnorm
depolar
platelet
mitochondria
assess
fl
ow
cytometri
stain
platelet
respiratori
chain
complex
activ
citrat
synthas
cs
activ
marker
mitochondri
content
measur
spectrophotometri
data
present
mean
sd
analysi
perform
oneway
anova
main
result
report
tabl
conclus
metformin
caus
hyperlactatemia
impair
platelet
mitochondri
function
introduct
patient
present
sever
acidosi
pointofcar
poc
lactat
mmoll
led
suspicion
mesenter
ischemia
potenti
need
laparotomi
howev
plasma
lactat
mmoll
ethylen
glycol
eg
ingest
subsequ
diagnos
therefor
wish
determin
discrep
lactat
occur
whether
lactat
gap
diff
erenc
lactat
measur
use
two
common
method
could
clinic
use
lactat
import
substrat
intermediari
metabol
allow
movement
carbon
reduc
power
cell
use
measur
end
organ
perfus
marker
tissu
hypoxia
critic
ill
well
establish
suggest
rise
serum
lactat
sensit
indic
poor
prognosi
group
wish
identifi
whether
case
patient
popul
method
retrospect
case
note
review
consecut
admiss
glasgow
royal
infi
rmari
icu
undertaken
period
serum
lactat
initi
blood
ga
analysi
follow
admiss
intens
care
retriev
clinic
inform
system
demograph
apach
ii
score
outcom
data
retriev
ward
watcher
system
icu
critic
care
volum
suppl
http
result
total
patient
includ
complet
data
calcul
day
day
paramet
avail
patient
respect
overal
mortal
mean
sd
age
apach
ii
score
respect
survivor
versu
nonsurvivor
signifi
cant
diff
erenc
baselin
sida
p
isida
side
lactat
base
excess
p
sig
p
increas
sida
p
side
p
decreas
isida
lactat
p
sig
p
predict
mortal
day
day
weakli
predict
mortal
per
unit
increas
p
ci
n
diff
erenc
surviv
group
p
conclus
studi
confi
rm
recent
data
suggest
baselin
diff
erenc
chang
day
relationship
strong
weak
ion
pco
refl
ect
sida
lactat
impact
mortal
diff
erent
eff
ect
observ
sig
impli
signifi
cant
unmeasur
acid
load
infl
uenc
mortal
bia
confound
may
aff
ect
fi
nding
therefor
confi
rmed
prospect
introduct
intub
mechan
ventil
impair
secret
clearanc
lead
lung
collaps
consolid
ventilatorassoci
pneumonia
howev
valid
diagnosi
secret
retent
intub
ventil
patient
vibrat
respons
imag
vri
commerci
develop
acoust
lung
imag
system
display
breath
sound
distribut
vri
abl
identifi
relationship
specifi
c
breath
sound
distribut
secret
retent
preliminari
studi
investig
chang
vri
measur
chest
physiotherapi
adult
intub
mechan
ventil
patient
method
intub
ventil
adult
patient
receiv
chest
physiotherapi
investig
lung
sound
amplitud
peak
inspir
measur
immedi
chest
physiotherapi
use
two
array
sensor
attach
patient
back
supin
posit
chest
physiotherapi
includ
combin
close
airway
suction
salin
lavag
postur
drainag
manual
techniqu
andor
lung
hyperinfl
ation
depend
upon
clinic
indic
mean
compar
wilcoxon
matchedpair
signedrank
test
result
total
patient
includ
studi
male
four
femal
age
patient
predominantli
ventil
continu
posit
airway
pressur
pressur
support
follow
physiotherapi
total
lung
sound
amplitud
peak
inspir
decreas
twofold
arbitrari
unit
au
signifi
cant
reduct
left
lung
p
furthermor
diff
erenc
sound
amplitud
right
left
lung
signifi
cantli
decreas
posttreat
compar
pretreat
p
conclus
computer
lung
sound
monitor
may
use
assess
secret
retent
eff
ectiv
secret
remov
mechan
ventil
patient
investig
howev
necessari
order
distinguish
secretionrel
eff
ect
chang
due
factor
airfl
ow
rate
pattern
introduct
posterior
auscult
mechan
ventil
patient
challeng
environment
icu
nois
make
detect
subtl
auscultatori
featur
diffi
cult
digit
pulmonari
acoust
monitor
recent
introduc
icu
explor
possibl
listen
sound
wave
record
vri
system
method
lung
sound
record
second
use
two
array
piezoelectr
contact
sensor
attach
patient
back
supin
posit
sound
fi
le
archiv
wav
format
offl
ine
analysi
three
physician
one
train
respiratori
therapist
blind
patient
clinic
statu
provid
fi
nding
listen
sound
wave
record
sensor
distribut
apex
base
six
lung
breath
sound
categor
normal
versu
abnorm
adventiti
lung
sound
character
wheez
rhonchi
crackl
find
compar
anterior
stethoscop
auscult
perform
time
record
one
physician
result
eighteen
critic
ill
mechan
ventil
patient
age
enrol
studi
chest
radiographi
cxr
fi
nding
includ
consolid
patient
agreement
among
least
three
clinician
normalabnorm
classifi
cation
furthermor
patient
assess
base
sound
wave
analysi
agreement
anterior
stethoscop
auscult
final
physician
perform
sound
wave
analysi
stethoscop
auscult
report
cracklesrhonchi
fi
patient
consolid
sound
wave
analysi
one
patient
auscult
conclus
level
interobserv
variabl
sound
wave
character
compar
level
usual
report
stethoscop
auscult
howev
patient
consolid
higher
number
cracklesrhonchi
report
posterior
sound
wave
analysi
anterior
stethoscop
auscult
discrep
may
either
due
anteriorposterior
orient
higher
sensit
offl
ine
sound
wave
analysi
introduct
knowledg
micromechan
properti
lung
parenchyma
essenti
understand
macroscop
lung
mechan
fi
rst
result
vivo
situ
measur
use
endomicroscop
devic
report
degre
local
lung
deform
depend
local
appli
pressur
shown
method
endoscop
system
includ
two
concentr
trocar
construct
appli
defi
ned
local
pressur
within
fi
eld
view
p
fov
endoscop
system
place
rib
mechan
ventil
rat
tip
place
pleura
p
fov
appli
circular
area
lung
surfac
led
local
deform
adjust
fl
ow
rate
fl
ush
fl
uid
outer
trocar
inner
trocar
p
fov
vari
result
local
deform
lung
parenchyma
optic
measur
estim
diamet
ceram
particl
fi
xed
pleura
purpos
deform
measur
diff
erent
level
airway
pressur
p
aw
p
fov
ramp
mbar
healthi
lung
figur
parenchyma
show
less
deform
caus
fl
uidic
pressur
compar
lavag
lung
figur
contrast
lavag
lung
deform
healthi
lung
less
higher
p
aw
present
conclus
micromechan
properti
lung
parenchyma
analyz
vivo
alveolar
level
healthi
lung
parenchyma
appear
stiff
er
less
deform
higher
p
aw
stronger
deform
less
depend
airway
pressur
lavag
lung
support
hypothesi
small
lung
complianc
lavag
lung
might
reason
stiff
lung
parenchyma
rather
region
collaps
refer
everi
step
studi
chang
frc
c
rs
pao
fio
ratio
perform
transthorac
echocardiographi
agil
hewlett
packard
evalu
integr
veloc
time
left
ventricular
outfl
ow
tract
lvot
vti
data
report
mean
sd
anova
use
compar
chang
time
result
tabl
present
main
result
studi
best
peep
set
cmh
level
decreas
frc
improv
c
rs
indic
start
derecruit
end
overdistent
introduct
electr
imped
tomographi
eit
promis
new
tool
bedsid
monitor
region
lung
ventil
sever
studi
focus
ventil
distribut
relationship
region
lung
volum
lower
caudal
lung
level
howev
inform
avail
higher
cranial
lung
level
method
eit
eit
evalu
kit
germani
measur
cranial
caudal
lung
level
patient
cardiothorac
surgeri
patient
fulli
sedat
mechan
ventil
peep
trial
perform
four
peep
level
cmh
center
graviti
index
decreas
lower
peep
level
caudal
cranial
lung
level
figur
right
wherea
tidal
volum
imped
variat
divid
tidal
volum
increas
cranial
lung
level
decreas
caudal
lung
level
stepwis
reduct
peep
figur
conclus
decrement
peep
step
ventil
distribut
shift
dorsal
ventral
direct
also
caudal
cranial
direct
introduct
electr
imped
tomographi
eit
promis
bedsid
tool
monitor
region
lung
ventil
mechan
ventil
purpos
studi
assess
region
lung
ventil
eit
pig
model
acidinduc
acut
lung
injuri
ali
pressurecontrol
pcv
volumecontrol
ventil
vcv
method
ten
anesthet
tracheotom
femal
pig
kg
random
two
group
mechan
ventil
pcv
pressur
adjust
achiev
maintain
mlkg
tidal
volum
n
vcv
mlkg
n
fio
ali
induc
group
intratrach
instil
mlkg
hydrochlor
acid
hcl
n
imped
chang
draeger
germani
record
belt
place
level
sixth
intercost
space
four
horizont
equallys
region
interest
roi
defi
ned
offl
ine
data
analysi
measur
perform
tbl
lung
injuri
tali
lung
tidal
volum
vt
pulmonari
static
complianc
c
stat
pulmonari
mean
arteri
pressur
mpap
peak
pressur
p
p
respiratori
rate
rr
pao
fio
ratio
also
record
statist
analysi
base
twoway
anova
follow
tukey
test
analysi
data
within
group
test
use
analysi
imped
chang
induc
ali
introduct
electr
imped
tomographi
eit
noninvas
bedsid
imag
tool
potenti
assess
region
lung
ventil
reliabl
purpos
studi
monitor
chang
lung
imped
pig
model
sever
shock
follow
fl
uid
resuscit
method
twelv
anesthet
mechan
ventil
mlkg
peep
cmh
supin
pig
submit
acut
hemorrhag
shock
infus
endotoxin
anim
alloc
posit
control
pc
n
treatment
group
lactat
ringer
achiev
maintain
puls
pressur
variat
mean
arteri
pressur
mmhg
ppv
n
ventilatori
hemodynam
paramet
record
baselin
hour
hemorrhag
shock
tshock
hourli
hour
belt
place
level
sixth
intercost
space
eit
measur
germani
offl
ine
analysi
base
four
horizont
region
interest
roi
ventrodors
lung
area
statist
analysi
base
twoway
anova
follow
tukey
test
p
tshock
hemodynam
compromis
statist
decreas
lung
complianc
c
stat
signifi
cant
increas
pulmonari
vascular
resist
index
mean
pulmonari
arteri
pressur
peak
pressur
p
peak
statist
diff
erenc
group
endpoint
hemodynam
stabil
achiev
ppv
group
minut
c
stat
continu
deterior
p
peak
continu
rise
group
compar
pc
ppv
group
signifi
cant
imped
increas
roi
increas
roi
also
statist
greater
tshock
within
group
statist
decreas
percentag
tidal
distribut
roi
increas
roi
ppv
group
relat
pc
group
also
note
conclus
despit
reestablish
hemodynam
adequaci
ppv
group
although
ventilatori
paramet
similar
group
time
resuscit
perform
studi
induc
signifi
cant
chang
tidal
imped
toward
nondepend
lung
region
impli
greater
lung
impair
treat
anim
introduct
bedsid
even
research
work
analysi
respiratori
system
mechan
limit
quasistat
condit
exclud
insight
happen
breath
new
glidingslic
method
help
look
breath
develop
slice
method
calcul
complianc
resist
subsequ
intratid
volum
rang
slice
pressurevolum
pv
loop
multipl
linear
regress
analysi
continu
way
allow
detect
intratid
complianc
resist
nonlinear
ongo
ventil
object
determin
whether
nonlinear
intratid
complianc
profi
le
hint
level
set
peep
tidal
volum
vt
make
lung
ventil
protect
method
piglet
atelectasi
induc
applic
neg
pressur
pv
relationship
ecg
signal
record
mechan
ventil
diff
erent
level
endexpiratori
pressur
peep
cmh
vt
mlkg
bw
use
glidingslic
method
intratid
complianc
profi
le
calcul
compar
convent
quasistat
complianc
result
contrast
quasistat
complianc
glidingslic
method
reveal
pronounc
intratid
nonlinear
complianc
profi
le
ongo
ventil
figur
low
level
peep
intratid
complianc
increas
low
volum
rang
remain
high
level
volum
deliv
fi
nalli
decreas
volum
mlkg
bw
higher
level
peep
intratid
complianc
decreas
onset
inspir
conclus
glidingslic
method
give
detail
insight
intratid
cours
complianc
uninterrupt
ventil
introduct
heartbeat
transfer
mechan
energi
lung
caus
fl
ow
pressur
disturb
appear
cardiogen
oscil
co
airway
open
adopt
new
approach
analyz
respiratori
system
mechan
consid
beat
heart
natur
intrathorac
mechan
oscil
transfer
mechan
energi
lung
travel
across
lung
parenchyma
co
therefor
convey
inform
mechan
condit
lung
parenchyma
cross
method
piglet
either
healthi
atelectat
lung
pressurevolum
relationship
ecg
signal
record
mechan
ventil
diff
erent
level
endexpiratori
pressur
peep
cmh
heartbeatrel
disturb
pv
loop
quantifi
ed
maxim
complianc
follow
rwave
ecg
signal
determin
glidingslic
method
atelectasi
assess
ct
intratid
pattern
heartbeatinduc
c
co
chang
peep
atelectasi
characterist
way
peep
tidal
volum
level
assum
lung
protect
c
co
high
littl
intratid
chang
compar
atelectasi
overdistens
signal
low
c
co
either
increas
atelectasi
decreas
overdistens
intratid
systol
pressur
variat
parallel
c
co
pattern
hint
neglig
impact
hemodynam
inspiratori
c
co
pattern
conclus
heartbeat
induc
fl
uctuat
pv
loop
consequ
peak
complianc
show
characterist
pattern
depend
presenc
atelectasi
overdistens
glidingslic
method
potenti
detect
intratid
nonlinear
without
requir
addit
technic
equip
make
use
ecg
signal
pressur
fl
ow
signal
alreadi
requir
control
ventil
introduct
set
optim
level
posit
endexpiratori
pressur
peep
icu
still
matter
debat
talmor
colleagu
use
transpulmonari
pressur
calcul
oesophag
balloon
set
peep
recent
random
control
studi
strategi
aim
prevent
alveolar
collaps
counterbalanc
gravit
forc
lung
equal
higher
peep
evalu
relat
ventil
distribut
measur
eit
transpulmonari
pressur
peep
trial
porcin
ali
method
eight
pig
kg
studi
peep
trial
induct
acut
lung
injuri
ali
oleic
acid
global
lung
paramet
region
complianc
oesophag
pressur
record
end
peep
step
region
complianc
calcul
divid
tidal
imped
variat
eit
evalu
kit
germani
appli
drive
pressur
result
transpulmonari
pressur
neg
cmh
peep
becam
posit
stepwis
increas
peep
cmh
cmh
peep
induct
ali
figur
optimum
region
complianc
diff
erent
ventral
nondepend
dorsal
depend
region
interest
roi
healthi
lung
optimum
peep
dorsal
roi
ventral
roi
wherea
ali
dorsal
roi
ventral
roi
conclus
eit
measur
caudal
lung
level
optim
eit
peep
depend
lung
exce
peep
requir
posit
transpulmonari
pressur
use
talmor
studi
wherea
nondepend
lung
optim
eit
peep
equal
ali
lower
ali
specul
probabl
infl
uenc
locat
eit
slice
cranial
caudal
direct
prospect
pilot
studi
eff
ect
neutrophil
elastas
pulmonari
vascular
permeabl
patient
pneumonia
tagami
introduct
case
pneumonia
may
lead
hypoxemia
acut
respiratori
failur
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
may
requir
intens
manag
neutrophil
elastas
thought
one
caus
aliard
rais
pulmonari
capillari
permeabl
lyse
pulmonari
connect
tissu
protein
produc
leukocyt
chemotact
factor
howev
causal
relationship
plasma
neutrophil
elastas
level
chang
pulmonari
capillari
permeabl
establish
patient
pneumonia
one
seriou
diseas
underli
aliard
therefor
object
studi
determin
whether
increas
plasma
neutrophil
elastas
relat
elev
pulmonari
capillari
permeabl
patient
pneumonia
method
patient
pneumonia
hospit
novemb
april
pao
room
air
need
mechan
ventil
prospect
enrol
studi
plasma
neutrophil
elastas
level
collect
via
blood
sampl
baselin
day
start
studi
enrol
patient
pao
fio
also
extravascular
lung
water
index
evlwi
pulmonari
vascular
permeabl
index
pvpi
monitor
use
picco
system
pulsion
munich
germani
requir
attend
physician
statist
analysi
perform
use
spearman
correl
coeffi
cient
r
p
assum
signifi
cant
result
fourteen
patient
enrol
studi
six
patient
evlwi
pvpi
measur
simultan
baselin
elastas
level
pvpi
show
strong
signifi
cant
correl
r
n
p
plot
data
six
patient
show
strong
correl
elastas
level
evlwi
r
n
p
pvpi
r
n
p
plasma
neutrophil
elastas
level
pvpi
measur
picco
strongli
correl
patient
pneumonia
suggest
rise
blood
level
elastas
may
elev
pvpi
result
introduct
acut
lung
injuri
ali
sever
subset
acut
respiratori
distress
syndrom
ard
major
caus
mortal
icu
mechan
ventil
support
therapi
necessari
sustain
life
mani
case
may
contribut
worsen
ali
term
ventilatorinduc
lung
injuri
vili
fibroprolifer
earli
respons
lung
injuri
inde
dysregul
repair
result
pulmonari
fi
brosi
may
heart
ventil
depend
ard
characteris
role
excess
lung
stretch
contribut
aberr
repair
mechan
would
assist
develop
strategi
hasten
recoveri
ard
method
male
spraguedawley
rat
anaesthet
orotrach
intub
subject
injuri
ventil
defi
ned
worsen
complianc
note
rat
recov
extub
level
ongo
injuryrepair
characteris
time
period
hour
day
system
oxygen
lung
complianc
wetdri
ratio
bal
total
protein
cytokin
cell
count
histolog
analysi
carri
time
point
result
demonstr
timecoursedepend
improv
complianc
oxygen
togeth
clearanc
neutro
philic
infi
ltration
hour
signifi
cantli
elev
bal
fl
uid
earli
post
injuri
although
total
lung
collagen
remain
similar
time
point
evid
earli
fi
broprolif
respons
present
form
transform
growth
activ
procollagen
iii
peptid
mrna
level
matrix
metalloproteinas
zymographi
demonstr
increas
level
matrikin
histolog
assess
injuri
reveal
increas
alveolar
tissu
fraction
includ
hour
post
injuri
myofi
broblast
present
muscl
actin
stain
section
signifi
cantli
increas
number
post
injuri
conclus
rat
model
repair
vili
demonstr
mechan
excess
lung
stretch
contribut
fi
broprolifer
ard
serv
improv
knowledg
aberr
lung
tissu
remodel
well
provid
use
paradigm
test
strategi
hasten
recoveri
ali
eff
ect
hemorrhag
shock
respiratori
system
mechan
rare
investig
publish
data
controversi
pulmonari
complianc
depend
part
intrapulmonari
blood
interstiti
fl
uid
volum
complianc
sever
reduc
small
modifi
cation
compon
may
import
eff
ect
present
analysi
explor
eff
ect
hemorrhag
shock
respiratori
system
mechan
oxygen
paramet
model
pig
ard
method
evalu
dynam
respiratori
system
complianc
c
rs
vt
inspiratori
airway
pressur
peep
domest
pig
anim
mechan
ventil
tidal
volum
vt
set
mlkg
respiratori
rate
bpm
peep
cmh
anim
separ
control
group
n
ard
group
n
ard
induc
lung
lavag
nacl
hemorrhag
total
blood
volum
remov
blood
infus
retransfus
phase
control
group
c
rs
mlcmh
chang
hemorrhag
retransfus
figur
ard
group
c
rs
decreas
lung
lavag
baselin
p
hemorrhag
c
rs
increas
p
compar
lavag
decreas
retransfus
p
group
pao
fio
mmhg
decreas
ard
baselin
p
increas
hemorrhag
p
chang
retransfus
p
shunt
fraction
decreas
hemorrhag
ard
group
lavag
p
chang
signifi
cantli
retransfus
p
conclus
acut
reduct
blood
volum
associ
increas
respiratori
system
complianc
oxygen
paramet
reduct
intrapulmonari
blood
interstiti
fl
uid
volum
thorac
cage
complianc
could
respons
eff
ect
introduct
trial
compar
higher
versu
lower
level
posit
endexpiratori
pressur
peep
adult
acut
lung
injuri
acut
respiratori
distress
syndrom
ard
underpow
detect
small
import
eff
ect
mortal
overal
subgroup
method
search
medlin
embas
cochran
central
regist
trial
randomli
assign
adult
acut
lung
injuri
ard
higher
versu
lower
level
peep
minim
diff
erenc
cmh
fi
rst
day
use
low
tidal
volum
ventil
compar
mortal
data
individu
patient
three
trial
analyz
use
uniform
outcom
defi
nition
test
prespecifi
ed
eff
ect
modifi
er
use
multivari
hierarch
regress
adjust
import
prognost
factor
cluster
eff
ect
result
overal
hospit
death
higher
peep
group
lower
peep
group
adjust
rel
risk
confi
denc
interv
ci
p
treatment
eff
ect
vari
presenc
absenc
ard
defi
ned
ratio
partial
pressur
oxygen
fraction
inspir
oxygen
concentr
equal
less
mmhg
interact
p
rel
risk
hospit
mortal
patient
without
ard
ci
p
ci
p
respect
patient
ard
like
achiev
unassist
breath
earlier
hazard
ratio
ci
p
wherea
hazard
ratio
time
unassist
breath
ci
p
patient
without
ard
baselin
rate
pneumothorax
use
neuromuscular
blocker
vasopressor
corticosteroid
similar
conclus
higher
level
peep
like
improv
surviv
patient
ard
patient
less
sever
acut
lung
injuri
introduct
experiment
clinic
studi
shown
benefi
cial
eff
ect
recruit
maneuv
rm
sustain
infl
ation
si
sigh
ventilatori
ga
exchang
paramet
studi
investig
eff
ect
diff
erent
rm
bacteri
transloc
lung
blood
method
thirtytwo
rat
anesthet
tracheotomi
perform
ventil
start
cmh
p
aw
cmh
peep
breathsminut
ie
pressurecontrol
ventil
pcv
mode
cannul
carotid
arteri
perform
baselin
blood
ga
sampl
taken
subsequ
ml
cfuml
pseudomona
aeruginosa
inocul
tracheotomi
tube
peep
increas
cmh
ventil
minut
random
rat
random
four
group
si
perform
cmh
peep
p
aw
second
four
time
hour
interv
si
perform
cmh
peep
p
aw
second
four
time
hour
interv
sigh
perform
four
time
hour
interv
cmh
p
aw
mh
peep
second
control
group
ventil
p
aw
cmh
peep
studi
period
multipl
pressur
pressur
perform
time
studi
group
equal
blood
cultur
taken
baselin
minut
random
rm
fi
rst
hour
last
blood
cultur
taken
minut
fourth
rm
rat
sacrifi
ced
intraarteri
sodium
thiopent
lung
extirp
left
lung
taken
measur
wet
weightdri
weight
ratio
wwdw
result
diff
erenc
baselin
ph
pao
paco
map
hr
among
group
pao
decreas
group
statist
signifi
cant
compar
baselin
valu
wwdw
ratio
found
higher
compar
diff
erenc
signifi
cant
amount
posit
blood
cultur
higher
earli
studi
period
conclus
sigh
recruit
maneuv
caus
high
probabl
bacteri
transloc
lung
bloodstream
introduct
alveolar
recruitmentderecruit
rd
seem
play
import
role
develop
vili
mani
clinician
base
determin
peep
set
mechan
ventil
ard
ali
patient
estim
alveolar
recruit
project
aim
establish
onlin
tool
provid
estim
rd
patient
bedsid
method
volumecontrol
ventil
piglet
ard
model
airway
pressur
p
aw
sispeci
instrument
germani
fl
ow
rate
q
f
g
gmbh
hechingen
germani
continu
record
hz
pressur
curv
show
high
nonlinear
suspect
recruit
eff
ect
inspir
relax
process
end
inspiratori
paus
base
obtain
data
paramet
linear
viscoelast
model
calcul
lse
fi
tting
process
paramet
c
repres
static
constant
complianc
lung
model
capabl
reproduc
nonlinear
eff
ect
inspir
improv
constant
complianc
c
replac
nonlinear
pressuredepend
complianc
describ
recruit
dilat
propos
hickl
result
sinc
nonlinear
model
far
variabl
paramet
optim
fi
tting
process
linear
model
approach
via
fi
tting
linear
model
fi
rst
help
therefor
estim
paramet
linear
model
fi
use
start
valu
fi
tting
nonlinear
model
focu
put
recruit
phenomena
new
nonlinear
model
use
estim
valu
r
r
c
linear
model
figur
left
possibl
reproduc
nonlinear
characterist
figur
conclus
use
new
model
possibl
fi
nonlinear
behavior
due
alveolar
recruit
separ
viscoelast
eff
ect
minim
error
cmh
imag
obtain
end
expir
inspir
global
region
quantit
ct
analys
step
peep
compar
result
analys
patient
show
mr
reduc
signifi
cantli
global
amount
nonaer
tissu
p
tidal
recruit
p
figur
depend
region
tidal
recruit
signifi
cantli
increas
peep
cmh
p
signifi
cantli
decreas
mr
p
high
peep
cmh
necessari
sustain
recruit
increas
peep
without
full
recruit
may
caus
lung
injuri
exacerb
sever
ard
popul
patient
acut
respiratori
distress
syndrom
ard
tidal
ventil
alway
inhomogen
atelectasi
depend
lung
overdistent
nondepend
lung
aim
studi
develop
fl
ow
pattern
simultan
produc
local
diff
erent
alveolar
pressur
order
recruit
collaps
alveoli
time
prevent
hyperinfl
ation
alreadi
open
alveoli
method
modifi
ed
horsfi
eld
model
canin
lung
predict
alveolar
pressur
diff
erenc
collaps
open
alveoli
morphometr
model
asymmetr
branch
airway
system
order
wherebi
order
correspond
trachea
branch
termin
viscoelast
tissu
unit
total
acini
whole
model
use
model
atelectasi
alveoli
simul
reduc
diamet
small
airway
order
origin
size
tissu
damp
factor
g
time
higher
collaps
alveoli
normal
alveoli
shunt
ga
compress
complianc
c
g
alveolu
time
smaller
diff
erent
percentag
atelectat
area
simul
flow
distribut
airway
input
imped
calcul
diff
erent
frequenc
hz
alveolar
pressur
diff
erenc
obtain
analyz
product
fl
ow
distribut
alveolar
input
imped
alveolar
pressur
p
alv
reduc
frequenc
increas
collaps
open
alveoli
compar
situat
hz
p
alv
reduc
hz
hand
p
alv
increas
percentag
atelectat
area
increas
frequenc
p
alv
increas
alveoli
collaps
compar
collaps
pressur
diff
erenc
collaps
open
alveoli
increas
frequenc
increas
hz
diff
erenc
hz
diff
erenc
rel
lower
valu
introduct
low
tidal
volum
vt
thought
protect
lung
avoid
overdistens
recent
shown
vt
may
also
infl
uenc
repeat
open
close
oc
goal
studi
determin
whether
decreas
vt
mlkg
eff
ectiv
reduc
oc
whether
possibl
maintain
alveolar
ventil
low
vt
method
crossov
studi
two
vt
level
versu
mlkg
ibw
includ
aliard
patient
ventil
hour
would
chest
comput
tomographi
ct
scan
mlkg
arm
replac
heat
moistur
exchang
fi
lter
heat
humidifi
er
respiratori
rate
increas
keep
minut
ventil
constant
protocol
two
part
one
bedsid
ct
room
vt
appli
random
order
bedsid
protocol
vt
arm
appli
minut
data
lung
mechan
ga
exchang
taken
baselin
minut
ct
scan
protocol
vt
arm
appli
minut
dynam
ct
imagessecond
second
taken
vt
fi
xed
transvers
region
lower
third
lung
afterward
ct
imag
analyz
softwar
maluna
repeat
oc
determin
nonaer
tissu
variat
inspir
expir
express
percentag
lung
tissu
weight
analyz
nine
patient
six
male
median
age
year
apach
ii
score
sofa
score
patient
pulmonari
origin
ard
fi
rst
day
ventil
baselin
patient
pao
fio
ratio
complianc
mlcmh
peep
cmh
vt
arm
mlkg
vt
ml
respect
p
respiratori
rate
breath
per
minut
p
pao
level
mmhg
p
peep
fio
kept
constant
paco
signifi
cantli
increas
vt
repeat
oc
delta
nonaer
tissu
consist
decreas
figur
introduct
acut
lung
injuri
ali
acut
respiratori
distress
syndrom
ard
associ
signifi
cant
morbid
mortal
mechan
ventil
cornerston
support
therapi
howev
optim
strategi
ventil
adjunct
therapi
still
evolv
evid
support
use
volumelimit
pressurelimit
lungprotect
ventil
practic
variabl
clinic
manag
still
concern
mainli
sicker
patient
hospit
outcom
found
consist
outcom
associ
hypothes
sever
hypoxemia
admiss
optim
ventil
may
predict
hospit
outcom
ard
patient
categoris
base
primari
etiolog
pulmonari
ard
ard
p
extra
pulmonari
ard
ard
exp
aim
therefor
ascertain
relationship
hospit
outcom
sever
hypoxemia
patient
earli
ard
day
follow
admiss
categoris
base
etiolog
method
use
prospect
cohort
studi
design
enrol
consecut
patient
primari
diagnosi
ard
day
admiss
admit
period
adult
gener
icu
patient
enrol
clinic
intervent
trial
exclud
studi
protocolbas
manag
mechan
ventil
use
achiev
optim
ventil
two
author
independ
design
patient
ard
p
ard
exp
third
review
confl
ict
four
case
patient
subcategoris
sever
hypoxaemia
base
pao
fio
ratio
pf
ratio
interv
clinic
intervent
discret
treat
clinician
hospit
mortal
patient
includ
studi
n
ard
patient
classifi
ed
ard
p
higher
hospit
mortal
compar
ard
exp
diff
erenc
statist
signifi
cant
p
nonsurvivor
ard
p
signifi
cantli
lower
pf
ratio
day
ard
diagnosi
compar
survivor
vs
kpa
p
relationship
observ
ard
exp
associ
mortal
hypoxaemia
earli
ard
p
persist
even
serv
level
hypoxaemia
kpa
kpa
kpa
p
p
p
respect
ard
exp
eff
ect
hypoxaemia
mortal
observ
conclus
fi
nding
indic
hypoxaemia
burden
assess
pf
ratio
interv
despit
optim
ventilatori
support
day
icu
admiss
predict
increas
risk
death
ard
p
ard
exp
intervent
trial
need
account
infl
uenc
etiolog
hypoxaemia
burden
outcom
prior
conclud
neg
intervent
patholog
organ
dysfunct
occur
patient
sir
sepsi
believ
relat
vascular
endotheli
damag
investig
role
vascular
endotheli
damag
occurr
acut
lung
injuri
sever
tbi
patient
sir
method
subject
sever
tbi
patient
sir
pf
ratio
calcul
arteri
blood
ga
analysi
data
obtain
seven
consecut
day
time
admiss
peripher
blood
sampl
collect
four
time
measur
serum
level
level
granulocyt
elastas
ge
marker
vascular
endotheli
damag
pf
ratio
decreas
time
day
onward
howev
survivor
maintain
pf
ratio
patient
fatal
outcom
ratio
continu
declin
subject
develop
acut
lung
injuri
day
day
onward
show
signifi
cant
decreas
ratio
valu
less
symptom
adult
respiratori
distress
syndrom
level
ge
increas
admiss
decreas
survivor
patient
die
level
continu
rise
signifi
cant
increas
week
correl
blood
level
level
ge
strong
level
ge
level
also
strong
ge
level
weaker
contrast
correl
pf
ratio
blood
level
ge
moder
neg
therefor
invers
correl
note
pf
ratio
paramet
conclus
determin
chang
humor
mediat
demonstr
vascular
endotheli
damag
involv
occurr
patholog
state
acut
lung
injuri
occur
sever
tbi
patient
sir
introduct
adapt
support
ventil
asv
microprocessorcontrol
mode
mechan
ventil
ventil
adapt
tidal
volum
vt
size
base
oti
least
work
breath
formula
recent
studi
patient
aliard
asv
appli
vt
mlkg
ideal
bodi
weight
ibw
unclear
whether
openlung
approach
use
studi
lung
recruit
improv
lung
complianc
consequ
may
allow
ventil
appli
larg
vt
asv
method
ten
consecut
patient
aliard
ventil
accord
local
protocol
dictat
frequent
recruit
maneuv
observ
ventil
switch
pressur
control
ventil
pc
asv
thereaft
patient
subject
addit
standard
recruit
procedur
primari
endpoint
vt
switch
ventil
standard
recruit
result
four
patient
suff
ere
ali
six
patient
ard
seven
patient
extrapulmonari
caus
aliard
vt
increas
mlkg
ibw
mlkg
ibw
p
switch
pc
asv
addit
recruit
switch
ventil
aff
ect
vt
size
mlkg
ibw
p
seven
patient
asv
appli
vt
mlkg
ibw
one
patient
vt
even
increas
mlkg
ibw
conclus
patient
aliard
may
ventil
larg
vt
subject
asv
result
contrast
fi
nding
previou
studi
asv
patient
aliard
probabl
frequent
use
recruit
maneuv
confer
criteria
measur
plasma
rage
level
twice
fi
rst
day
intub
everi
day
fi
rst
month
week
icu
discharg
death
n
also
measur
rage
level
balf
obtain
mean
standard
techniqu
clinic
indic
n
sampl
time
record
data
ventil
set
ga
exchang
organ
function
blood
cell
count
result
day
plasma
rage
level
normal
valu
pgml
high
median
pgml
iqr
pgml
lower
time
sampl
consid
plasma
rage
level
signifi
cantli
higher
patient
blood
platelet
count
x
plasma
creatinin
level
mgdl
sofa
score
p
p
p
respect
plasma
rage
increas
also
number
organ
failur
p
moreov
circul
rage
signifi
cantli
higher
patient
pao
fio
peep
cmh
p
p
respect
rage
present
balf
median
pgml
iqr
pgml
interestingli
plasma
balf
rage
level
correl
p
balf
rage
signifi
cantli
higher
patient
pao
fio
mmhg
administ
tidal
volum
ideal
bodi
weight
ratio
mlkg
p
p
respect
patient
cultureposit
balf
higher
balf
rage
level
comparison
cultureneg
balf
p
aliard
patient
circul
rage
high
day
decreas
time
may
relat
system
lung
injuri
sever
balf
rage
obtain
patient
may
associ
lung
dysfunct
infect
introduct
anim
model
ventilatorinduc
lung
injuri
vili
mild
hypothermia
found
protect
reduc
pulmonari
infl
ammat
possibl
reduc
mechan
strain
appli
lower
respiratori
rate
howev
model
hamper
sever
alkalosi
ex
vivo
design
physiolog
model
vili
investig
whether
hypothermia
protect
vili
reduc
respiratori
rate
reduc
infl
ammat
method
rat
vili
induc
use
peak
inspiratori
pressur
pip
cmh
zero
peep
control
ventil
pip
cmh
peep
cmh
hypothermia
induc
extern
cool
control
maintain
normoph
strict
normocapnia
kpa
achiev
adjust
respiratori
rate
accord
blood
gase
drawn
everi
minut
hour
critic
care
volum
suppl
http
ventil
bronchoalveolar
lavag
bal
done
statist
includ
kruskalw
mannwhitney
u
test
result
physiolog
model
vili
establish
normoph
group
hypothermia
decreas
pulmonari
neutrophil
infl
ux
tend
decreas
pulmonari
protein
leak
figur
normocapnia
group
hypothermia
allow
lower
respiratori
rate
compar
normoph
vs
breathsminut
figur
howev
reduc
paramet
lung
injuri
conclus
hypothermia
protect
physiolog
model
vili
reduct
infl
ammat
reduc
repetit
strain
respiratori
cycl
introduct
therapeut
hypothermia
appli
reduc
hypoxiainduc
organ
injuri
past
decad
use
hypothermia
increas
critic
ill
patient
mechan
ventil
mv
data
eff
ect
hypothermia
ga
exchang
lung
mechan
patient
limit
retrospect
studi
describ
eff
ect
induc
hypothermia
rewarm
respiratori
paramet
patient
cardiac
arrest
method
patient
glasgow
coma
scale
resuscit
cardiac
arrest
hypothermia
appli
enrol
patient
pao
fio
ratio
mv
posit
endexpiratori
pressur
peep
cmh
exclud
ventil
set
arteri
blood
gass
retriev
electron
patient
databas
hypothermia
everi
grade
increas
rewarm
statist
includ
z
pair
test
result
cohort
patient
patient
exclud
leav
patient
analysi
hypothermia
arteri
pco
decreas
end
tidal
et
co
low
unchang
minut
volum
ventil
figur
hypothermia
increas
pf
ratio
unchang
peep
p
fl
uid
balanc
posit
patient
l
rewarm
arteri
pco
unchang
etco
increas
pf
ratio
rewarm
unchang
compar
start
hypothermia
lower
peep
level
appli
cmh
vs
cmh
p
conclus
induc
hypothermia
improv
ventil
oxygen
critic
ill
patient
hypothermia
may
consid
patient
acut
lung
injuri
low
minut
ventil
result
sever
hypercapnia
extracorpor
life
support
servic
region
referr
center
median
stay
acl
maneuv
ecl
start
minut
case
cardiogen
shock
undergo
ecl
two
four
patient
discharg
icu
conclus
complet
compet
acquisit
ecl
manag
make
system
safe
feasibl
techniqu
possibl
guarante
safe
treatment
must
involv
diff
erent
specialist
properli
train
nurs
found
import
welltim
start
ecl
introduct
sever
acut
respiratori
distress
syndrom
ard
patient
transport
extrem
highrisk
procedur
report
experi
transfer
patient
centr
extracorpor
membran
oxygen
ecmo
method
telephon
referr
bed
avail
confi
rmation
patient
match
entri
criteria
ecmo
evalu
transport
centr
skill
crew
consist
two
expert
plu
one
train
physician
one
expert
plu
one
train
icu
nurs
one
ecmo
specialist
reach
referr
hospit
reevalu
elig
cannul
ecl
circuit
set
ecl
start
accomplish
ground
transport
perform
special
equip
ambul
endow
enlarg
oxygen
fuel
energi
suppli
ambul
load
item
requir
cannul
ecmo
circuit
set
addit
oxygen
nitric
oxid
tank
entri
criteria
potenti
revers
respiratori
failur
murray
score
respiratori
acidosi
ph
intracrani
bleed
absolut
contraind
heparin
crew
evalu
transfer
ecmo
ard
patient
male
age
year
bmi
apach
ii
score
sofa
score
oxygen
index
averag
distanc
km
two
patient
improv
trial
transfer
without
ecmo
patient
underw
venoven
ecmo
cannul
femor
vein
one
femoraljugular
vein
one
dl
cannula
jugular
vein
ecmo
set
mean
sd
bf
gf
gf
fio
data
record
minut
hour
ecl
began
vvecmo
grant
better
clearanc
pco
vs
mmhg
p
thu
improv
ph
vs
p
mean
pulmonari
arteri
pressur
vs
mmhg
p
allow
reduct
respiratori
rate
vs
p
minut
ventil
vs
lmin
p
mean
airway
pressur
vs
cmh
p
arteri
po
mean
blood
pressur
heart
rate
show
signifi
cant
variat
ecmo
began
vasoconstrictor
therapi
administ
fi
patient
quickli
taper
neither
clinic
technic
major
complic
report
conclus
ecmo
employ
referr
center
enabl
longdist
highrisk
ground
transport
controversi
exist
possibl
benefi
cial
eff
ect
hyperton
salin
hs
pulmonari
infl
ammatori
respons
particularli
neutrophil
immunomodul
studi
design
investig
possibl
benefi
ts
hs
treatment
pig
submit
experiment
acut
lung
injuri
method
twelv
anesthet
tracheotom
pig
kg
mechan
ventil
pressur
adjust
mlkg
tidal
volum
fio
submit
intratrach
instil
mlkg
hydrochlor
acid
hcl
n
random
ali
group
n
ali
hs
group
n
anim
latter
group
receiv
mlkg
intraven
hyperton
salin
minut
injuri
hemodynam
paramet
pulmonari
complianc
c
stat
peak
pressur
p
peak
plateau
pressur
p
plat
tidal
volum
v
analyz
baselin
tbl
minut
hcl
instil
tali
hourli
thereaft
hour
bronchoalveolar
lavag
perform
end
observ
period
fl
ow
cytometri
analysi
neutrophil
burst
activ
postmortem
histopatholog
right
diaphragmat
lung
also
perform
anim
result
tali
anim
group
present
signifi
cant
increas
p
peak
p
plat
decreas
c
stat
time
point
compar
tbl
v
preserv
group
time
signifi
cant
diff
erenc
group
ali
ali
hs
respect
central
venou
pressur
pulmonari
arteri
occlus
pressur
pulmonari
vascular
resist
index
tali
ali
group
signifi
cant
diff
erenc
relat
tbl
found
mean
arteri
pressur
mean
pulmonari
arteri
pressur
tali
pulmonari
vascular
resist
index
tali
ali
hs
group
signifi
cant
diff
erenc
relat
tbl
mean
arteri
pressur
mean
pulmonari
arteri
pressur
tali
cardiac
index
pulmonari
vascular
resist
index
diff
erenc
found
group
regard
histopatholog
fl
ow
cytometri
analys
conclus
hs
produc
signifi
cant
benefi
studi
paramet
regard
lung
propos
model
ali
introduct
convent
mechan
ventil
mv
may
caus
addit
lung
injuri
aliard
due
overdistent
aerat
lung
region
high
vt
cyclic
lung
reopen
low
peep
level
hyperproduct
infl
ammatori
mediat
one
side
eff
ect
case
factor
could
delay
prevent
resolut
respiratori
failur
howev
clear
whether
convent
mechan
ventil
damag
intact
lung
aim
studi
evalu
eff
ect
convent
protect
mechan
ventil
intact
lung
patient
sever
trauma
method
prospect
random
control
trial
trauma
patient
mechan
ventil
extrapulmonari
indic
protocol
approv
local
ethic
committe
seventyeight
patient
random
convent
vt
mlkg
ibw
peep
cmh
n
protect
vt
mlkg
ibw
peep
cmh
n
mechan
ventil
level
plasma
bal
fl
uid
measur
day
mv
frequenc
ali
aecc
criteria
vap
evalu
endpoint
studi
length
mv
lo
icu
outcom
day
result
fi
rst
day
ali
reveal
patient
convent
patient
protect
mv
group
p
ci
ard
occur
four
patient
convent
mv
group
li
one
protect
mv
group
p
level
bal
fl
uid
signifi
cantli
higher
convent
mv
group
day
maxim
increas
day
p
diff
erenc
found
level
plasma
sampl
vap
occur
patient
convent
nine
patient
protect
mv
group
p
ci
length
mv
vs
p
ci
lo
icu
vs
p
ci
mortal
signifi
cantli
diff
erent
group
conclus
convent
mv
hour
patient
sever
trauma
intact
lung
caus
lung
injuri
increas
durat
mv
lo
icu
introduct
administr
mgkg
methylprednisolon
shown
prevent
control
mechan
ventil
cmv
diaphragm
dysfunct
rat
partli
inhibit
calpain
system
current
experi
determin
whether
lower
dose
corticosteroid
also
provid
protect
ventilatorinduc
diaphragm
dysfunct
method
rat
assign
control
group
hour
cmv
receiv
singl
inject
salin
mgkg
low
mp
mgkg
high
mp
methylprednisolon
result
diaphragm
forc
product
decreas
cmv
signifi
cantli
low
mp
group
similar
control
high
mp
group
atrophi
type
iia
fi
ber
present
low
mp
group
atrophi
type
iixb
fi
ber
sever
low
mp
group
cmv
group
atrophi
observ
high
mp
group
diaphragm
calpain
activ
increas
cmv
p
vs
c
low
mp
group
p
vs
c
similar
control
high
mp
group
express
calpastatin
critic
care
volum
suppl
http
decreas
cmv
low
mp
group
p
vs
c
level
preserv
control
level
high
mp
group
analysi
mediat
cleavag
ii
spectrin
reveal
cmv
induc
signifi
cant
rise
activ
compar
c
p
activ
similarli
increas
group
respect
p
vs
c
increas
signifi
cantli
less
compar
cmv
signifi
cant
neg
correl
found
calpain
activ
diaphragm
forc
r
p
well
csa
type
iixb
fi
ber
r
p
signifi
cant
posit
correl
observ
calpastatin
diaphragm
forc
r
p
calpastatin
csa
type
iixb
fi
ber
r
p
conclus
abil
corticosteroid
protect
cmvinduc
diaphragmat
contractil
dysfunct
atrophi
dose
depend
high
dose
corticosteroid
provid
protect
introduct
control
mechan
ventil
cmv
result
diaphragmat
dysfunct
oxid
stress
import
contributor
ventilatorinduc
diaphragm
dysfunct
sinc
hour
cmv
lead
increas
protein
oxid
increas
lipid
peroxid
hypothes
administr
antioxid
nacetylcystein
nac
would
restor
redox
balanc
diaphragm
prevent
deleteri
eff
ect
cmv
method
anesthet
rat
submit
hour
either
spontan
breath
receiv
mgkg
nac
sbnac
salin
sbsal
cmv
receiv
mgkg
nac
mvnac
salin
mvsal
hour
diaphragm
forc
signifi
cantli
lower
mvsal
compar
group
administr
nac
complet
abolish
decreas
forc
produc
mvnac
group
compar
sb
group
protein
oxid
signifi
cantli
increas
mvsal
p
restor
mvnac
diaphragm
activ
signifi
cantli
increas
mvsal
compar
sbsal
p
activ
also
increas
mvnac
group
p
signifi
cantli
lesser
extent
compar
mvsal
calpain
activ
signifi
cantli
increas
cmv
p
vs
sbsal
similar
sb
group
mvnac
group
signifi
cant
neg
correl
found
calpain
activ
diaphragm
tetan
forc
r
p
conclus
data
show
administr
nac
abl
preserv
diaphragm
deleteri
eff
ect
cmv
nac
inhibit
increas
oxid
stress
proteolysi
reduc
decreas
forc
gener
capac
diaphragm
vitro
muscl
contract
forc
measur
isol
entir
rat
diaphragm
introduct
inact
diaphragmat
muscl
mechan
ventil
lead
atrophi
contractil
dysfunct
vitro
forc
measur
perform
singl
diaphragmat
muscl
strip
intent
fi
nd
mechan
electr
stimul
infl
uenc
condit
diaphragm
whole
organ
determin
statu
diaphragm
muscl
contract
forc
measur
entir
rat
diaphragm
method
use
earlier
describ
bioreactor
cultiv
measur
devic
whole
rat
diaphragm
bioreactor
consist
pressur
chamber
suppli
chamber
separ
fl
exibl
soft
membran
membran
sampl
diaphragm
place
applic
certain
ga
volum
ml
pressur
chamber
diaphragm
defl
ect
variou
level
pretens
diaphragm
electr
stimul
defl
ection
level
time
ms
duti
cycl
ms
stimul
time
ms
puls
width
hz
frequenc
pressur
chang
caus
muscl
contract
record
insid
pressur
chamber
muscl
contract
forc
calcul
initi
forc
measur
diaphragm
expos
hour
one
four
diff
erent
treatment
nonstimul
storag
control
cyclic
mechan
defl
ection
electr
stimul
everi
minut
combin
cyclic
defl
ection
electr
stimul
hour
anoth
forc
measur
perform
supernat
collect
hour
investig
activ
result
depend
level
defl
ection
diaphragm
muscl
contract
forc
increas
n
volum
ml
n
volum
ml
larger
pretens
diaphragm
result
larger
muscl
contract
forc
treatment
muscl
contract
forc
decreas
group
muscl
contract
forc
smallest
passiv
control
group
n
larger
similar
electr
stimul
n
combin
n
group
largest
mechan
defl
ect
group
n
activ
increas
hour
treatment
conclus
conclud
possibl
perform
forc
measur
whole
rat
diaphragm
vitro
model
addit
diaphragm
kept
aliv
hour
appli
diff
erent
stimul
critic
care
volum
suppl
http
introduct
neural
adjust
ventilatori
assist
nava
new
mode
assist
mechan
ventil
use
signal
obtain
electromyographi
activ
diaphragm
eadi
control
mechan
ventil
deliv
assist
proport
patient
respiratori
drive
studi
evalu
monitor
edi
convent
mode
respons
switch
pressur
support
assist
chang
nava
mode
predict
wean
ventil
method
sixteen
adult
patient
ventil
servoi
maquet
pressur
control
bivent
random
place
special
nasoorogastr
tube
edi
cathet
watch
edi
signal
psv
set
obtain
vtkg
mlkg
activ
inspir
studi
peak
airway
pressur
p
aw
breath
pattern
regist
edi
minimum
edi
maximum
determin
peep
peak
pressur
respect
vt
respiratori
rate
fio
blood
gase
serial
observ
synchroni
edi
signal
ventil
breath
pressur
control
bivent
patient
start
spontan
breath
signal
move
pressur
support
low
edi
minimum
associ
overdistend
diaphragm
requir
decreas
peep
contrari
high
edi
minimum
associ
higher
tonic
activ
dictat
rais
peep
nava
pressur
deliv
proport
edi
nava
level
continu
readjust
proport
predict
inspiratori
eff
ort
edi
signal
highest
assist
level
found
lower
vtkg
mlkg
vs
p
higher
breath
frequenc
vs
p
peak
eadi
vs
p
nava
psv
asynchroni
mechan
ventil
increas
cost
care
length
day
mechan
ventil
morbid
associ
increas
icu
stay
edi
monitor
help
understand
mode
ventil
great
tool
decid
time
switch
nava
predict
earli
wean
systemat
increas
nava
level
reduc
respiratori
drive
unload
respiratori
muscl
er
method
determin
assist
level
result
sustain
unload
low
vt
stabl
respiratori
function
implement
hour
nava
give
us
opportun
augment
patient
drive
breath
enough
recov
quickli
introduct
sepsi
muscl
inact
may
lead
neuromuscular
dysfunct
neural
adjust
ventilatori
assist
nava
convert
diaphragm
electr
activ
eadi
airway
pressur
paw
preserv
respiratori
muscl
activ
hypothesis
respiratori
neuromuscular
function
would
better
preserv
nava
compar
volum
cycl
ventil
vcv
earli
sepsi
method
twentyeight
pig
kg
median
quartil
random
n
per
group
fecal
periton
nonsept
control
ventil
hour
either
nava
vcv
nonparalyz
vt
mlkg
rate
adjust
suppress
eadi
fluid
norepinephrin
ne
use
base
protocol
keep
mean
arteri
pressur
map
mmhg
sepsi
hour
transcutan
supramaxim
stimul
cervic
phrenic
nerv
tpn
expiratori
occlus
manoeuvr
eom
perform
latenc
amplitud
diaphragm
compound
muscl
activ
potenti
cmap
measur
tpn
maxim
defl
ection
paw
esophag
transdiaphragm
pressur
measur
repetit
tpn
hz
stimuli
eom
result
hemodynam
paramet
diff
erent
among
group
sepsi
remain
stabl
control
map
chang
septic
nava
decreas
septic
vcv
anim
mmhg
sepsi
mmhg
hour
p
manova
tg
interact
heart
rate
increas
p
stroke
volum
decreas
p
septic
group
fluid
balanc
diff
erent
among
septic
group
three
septic
nava
six
septic
vcv
anim
receiv
ne
cmap
latenc
amplitud
well
diff
erent
among
group
repetit
tpn
eom
sepsi
hour
p
ns
conclus
respiratori
neuromuscular
function
aff
ect
mode
ventil
fi
rst
hour
abdomin
sepsi
earli
eff
ect
sepsi
neuromuscular
function
refl
ect
respiratori
muscl
strength
nava
may
reduc
need
hemodynam
support
earli
sepsi
introduct
studi
aim
evalu
eff
ect
high
versu
low
tidal
volum
vt
volum
control
vc
ventil
neural
adjust
ventilatori
assist
nava
spinal
cord
injur
sci
patient
hypothes
vc
higher
vt
would
signifi
cantli
unload
deactiv
diaphragm
wherea
nava
would
method
seven
intub
sci
patient
age
year
studi
use
vc
vt
increas
progress
exceed
cmh
l
vt
high
volum
lower
mlkg
intoler
low
volum
nava
progress
adjust
target
similar
peak
pressur
final
subject
receiv
minut
high
vc
low
vc
high
nava
low
nava
random
order
result
despit
compar
increas
peak
airway
pressur
pmo
vt
increas
vc
unalt
nava
inspiratori
total
breath
durat
lower
respiratori
rate
higher
nava
compar
vc
assist
level
vc
result
signifi
cant
diaphragm
unload
deactiv
wherea
maintain
high
low
nava
complet
diaphragm
deactiv
breath
observ
vc
fi
patient
introduct
novel
methodolog
propos
adapt
decisionmak
strategi
fuzzybas
expert
system
autopilotbt
special
featur
approach
knowledg
clinic
expert
extract
setup
simul
daili
icu
routin
autom
process
serv
obtain
requir
inform
creat
new
fuzzi
set
fuzzi
control
autopilotbt
employ
newli
deriv
fuzzi
rule
thu
knowledg
base
easili
modifi
ed
result
mechan
ventil
therapi
may
adapt
individu
prefer
clinician
method
methodolog
consist
acquisit
decisionmak
strategi
singl
group
anesthesiologist
either
done
questionnair
pcbase
program
simul
doctor
everi
day
situat
diagnosi
ii
defi
nition
fuzzi
membership
function
base
acquir
knowledg
fuzzifi
cation
input
iii
construct
fuzzi
infer
rule
defuzzifi
cation
calcul
chang
ventil
set
control
action
approach
allow
implement
cliniciandepend
decisionmak
refl
ect
individu
prefer
thu
guidelin
ebm
use
well
icu
specifi
cs
realiz
exampl
diff
erent
level
accept
hypercapnia
patient
acut
respiratori
distress
syndrom
ard
result
exemplarili
figur
show
healthi
ard
lung
diff
erenc
two
fuzzi
set
paco
control
given
two
clinician
diff
erent
expertis
mechan
ventil
newli
design
fuzzi
set
autopilotbt
react
accord
clinician
prefer
still
minim
time
patient
ventil
within
specifi
ed
limit
conclus
system
automat
implement
knowhow
medic
expert
ventil
manag
clinician
will
interact
queri
system
result
strategi
mainli
infl
uenc
expertis
experi
demand
clinician
thu
autopilotbt
potenti
select
establish
guidelin
adapt
system
modifi
ed
ventil
therapi
introduct
respiratori
muscl
weak
import
risk
factor
prolong
mechan
ventil
may
part
critic
ill
relat
polyneuropathi
myopathi
anim
data
also
strongli
point
atrophi
weak
diaphragm
due
mechan
ventil
call
ventilatorinduc
diaphragmat
dysfunct
recent
measur
transdiaphragmat
pressur
follow
magnet
stimul
twpdi
bamp
introduc
icu
evalu
diaphragm
function
aim
evalu
reproduc
twitch
twpdi
bamp
critic
ill
mechan
ventil
patient
also
aim
describ
relationship
twpdi
durat
mechan
ventil
method
prospect
observ
studi
medic
icu
univers
hospit
twpdi
bamp
measur
critic
ill
mechan
ventil
patient
briefl
phrenic
nerv
stimul
bilater
anterior
approach
posterior
border
sternocleidomastoid
muscl
level
cricoid
use
two
fi
gureofeight
mm
magnet
coil
magstim
dyfe
wale
bistim
magstim
dyfe
wale
custombuilt
occlus
valv
use
creat
isometr
condit
stimul
oesophag
abdomin
pressur
chang
measur
use
balloon
cathet
uk
medic
sheffi
eld
uk
insert
nose
local
anaesthesia
result
nineteen
measur
made
total
patient
variou
interv
start
mechan
ventil
seven
patient
measur
made
least
two
occas
minim
interv
hour
betweenoccas
coeffi
cient
variat
twpdi
compar
data
healthi
volunt
increas
durat
mechan
ventil
associ
logarithm
declin
twpdi
r
p
associ
also
found
cumul
time
pressur
control
ventil
r
p
pressur
support
ventil
p
r
consid
separ
well
cumul
dose
propofol
r
p
piritramid
r
p
conclus
increas
durat
mechan
ventil
associ
logarithm
declin
diaphragmat
forc
fi
nding
compat
concept
ventilatorinduc
diaphragmat
dysfunct
observ
declin
may
also
due
cumul
dose
sedativesanalges
cofactor
sepsi
introduct
aim
investig
studi
paramet
haemodynam
ga
exchang
volhaem
statu
patient
sever
thermal
injuri
trial
cover
injur
patient
age
year
skin
burn
po
fio
patient
random
two
group
fi
rst
group
n
po
fio
h
burn
second
group
n
po
fio
day
burn
injur
person
subject
evalu
cardiac
index
ci
intrathorac
blood
volum
index
itbi
extravascular
lung
water
index
pulmonari
vascular
permeabl
index
pvpi
singl
transpulmonari
thermodilut
piccoplu
pulsion
medic
system
germani
calcul
oxygen
deliveri
colloid
osmot
pressur
plasma
grade
pulmonari
damag
evalu
murrey
sever
dispragia
sofa
correl
analysi
perform
use
pearson
spearman
criteria
r
p
diff
erenc
signifi
cant
p
result
hypoxaemia
po
fio
injur
fi
rst
group
develop
background
reduct
ci
itbi
r
p
elwi
level
normal
second
group
reduct
po
fio
develop
background
burn
sepsi
averag
sofa
point
murrey
caus
increas
elwi
r
p
correl
pvpi
r
p
statist
signifi
cant
correl
elwi
itbi
colloid
osmot
pressur
plasma
r
r
conclus
ga
exchang
disord
patient
fi
rst
group
caus
lack
perfus
misbal
oxygen
deliveri
demand
reduct
oxygen
index
patient
second
group
accompani
elwi
background
alter
intravascular
penetr
sepsi
introduct
prior
noninvas
ventil
niv
associ
increas
mortal
patient
haematolog
malign
acut
respiratori
failur
treat
invas
mechan
ventil
imv
method
assess
whether
niv
failur
independ
prognost
factor
hospit
discharg
gener
cancer
popul
treat
imv
one
hundr
six
patient
solid
tumour
patient
haematolog
malign
elig
retrospect
studi
treat
niv
imv
main
indic
mechan
ventil
sepsi
shock
acut
respiratori
failur
cardiopulmonari
resuscit
neurolog
diseas
respect
patient
extub
discharg
icu
hospit
patient
treat
niv
prior
imv
rate
respect
multivari
analysi
three
variabl
independ
associ
decreas
probabl
discharg
hospit
niv
use
imv
ci
p
leucopenia
ci
p
serum
bilirubin
mgdl
ci
p
conclus
niv
failur
imv
independ
poor
prognost
factor
cancer
patient
treat
imv
data
patient
treat
swell
larynx
depart
otorhinolaryngolog
ludwigmaximiliansunivers
munich
evalu
retrospect
survey
result
caus
laryng
ae
patient
allerg
reaction
case
due
radiotherapi
cancer
patient
took
angiotensinconvert
enzym
inhibitor
acei
one
patient
hereditari
angioedema
hae
patient
unknown
patient
independ
underli
caus
treat
highdos
intraven
steroid
patient
antihistamin
epinephrin
inhal
im
two
patient
aceiinduc
ae
success
treat
icatib
ten
patient
need
intub
tracheotomi
one
patient
emerg
coniotomi
preserv
airway
tracheotomi
patient
suff
ere
cancer
nine
intub
patient
took
acei
extub
icu
day
conclus
accord
experi
patient
laryng
swell
upper
airway
obstruct
react
well
standard
therapi
steroid
epinephrin
antihistamin
indic
ae
histamin
induc
contrast
drug
almost
eff
ect
bradykinininduc
angioedema
ae
induc
acei
preliminari
evid
bradykinin
b
receptor
antagonist
icatib
approv
treatment
hae
type
ii
may
also
eff
ectiv
aceiinduc
edema
fortysix
laryngoscop
test
tradit
vacuum
incandesc
bulb
twelv
fell
lux
six
fell
lux
minimum
failur
correct
batteri
replac
bulb
replac
remain
see
figur
conclus
simpli
check
laryngoscop
presenc
illumin
regular
basi
insuffi
cient
ensur
best
even
adequ
function
poor
function
frequent
relat
bulb
dysfunct
batteri
fatigu
institut
consid
qualiti
control
mainten
program
consid
advanc
laryngoscop
light
exampl
led
halogen
bulb
refer
tabl
fi
nd
signifi
cant
diff
erenc
respiratori
hemodynam
data
group
mr
induc
cardiovascular
instabl
mean
cardiac
output
vs
lmin
mra
vs
nomra
respect
conclus
rm
cpap
perform
pdt
could
perform
safe
prevent
alveolar
derecruit
due
pdt
neurosurg
patient
requir
ventil
icu
tracheostomi
frequent
form
facilit
airway
protect
wean
mechan
ventil
howev
issu
form
tracheostomi
remain
contenti
order
better
inform
decisionmak
process
audit
practic
within
institut
method
retrospect
studi
conduct
icu
chart
neurosurg
patient
admit
tertiari
referr
icu
calendar
year
review
patient
requir
mechan
ventilatori
support
die
within
day
admiss
exclud
demograph
data
diagnosi
durat
mechan
ventil
icu
day
stay
tracheostomi
form
icu
length
stay
record
data
analys
accordingli
result
total
patient
includ
male
femal
mean
age
year
sixtythre
patient
abl
separ
mechan
ventil
within
day
commenc
ventil
via
cuff
ed
oral
endotrach
tube
remain
patient
went
undergo
tracheostomi
format
determin
attend
intensivist
group
median
time
tracheostomi
format
day
median
time
tracheostomi
format
separ
mechan
ventil
day
patient
critic
care
volum
suppl
http
could
extub
within
day
ventilatori
support
nine
success
separ
mechan
ventil
without
need
tracheostomi
signifi
cant
diff
erenc
age
diagnosi
two
group
conclus
data
suggest
failur
neurosurg
patient
separ
mechan
ventil
within
day
predict
eventu
requir
tracheostomi
format
light
intend
expand
sampl
size
period
subject
data
multivari
regress
refer
introduct
percutan
tracheostomi
common
procedur
mani
trauma
icu
concern
safeti
perform
percutan
tracheostomi
patient
cervic
spine
clearanc
cervic
spine
injuri
limit
adopt
surgeon
total
number
tracheotomi
studi
period
pt
ot
group
similar
age
sex
iss
distribut
ot
group
done
patient
cervic
spine
clearanc
cervic
spine
injuri
immedi
complic
report
ot
group
pt
group
case
done
preoper
cervic
spine
clearanc
posit
cervic
spine
injuri
pt
group
underw
procedur
without
bronchoscopi
assist
case
two
case
pt
group
report
postop
bleed
tracheostomi
site
requir
intervent
case
pt
done
without
bronchoscopi
assist
preoper
cervic
spine
clearanc
immedi
complic
report
conclus
result
studi
suggest
pt
safe
trauma
patient
without
preoper
cervic
spine
clearanc
cervic
injuri
compar
ot
group
pt
case
done
without
bronchoscopi
assist
fi
nding
suggest
need
studi
clarifi
role
bronchoscopi
assist
pt
introduct
mechan
ventil
mv
patient
prone
develop
ventilatorassoci
pneumonia
one
major
risk
factor
microaspir
supraglott
secret
past
endotrach
tube
cuff
usual
polyvinyl
pv
novel
polyurethan
pue
cuff
design
minim
leakag
therefor
compar
seal
capac
two
tube
mv
patient
method
twentynin
consecut
mv
patient
mean
age
sd
male
randomli
alloc
receiv
either
pv
hilo
evac
mallinckrodt
pue
sealguard
evac
mallinckrodt
cuff
ed
endotrach
tube
size
men
women
rule
exclud
patient
emerg
intub
unstabl
haemodynam
sever
respiratori
failur
patient
histori
tracheallaryng
diseas
patient
cuff
pressur
maintain
cmh
ventil
paramet
set
plateau
pressur
cmh
patient
fast
place
strict
semirecumb
posit
radioact
tracheal
aspir
assess
sequenti
hourli
sampl
hour
hour
hour
inject
mbq
tcdtpa
dilut
ml
nacl
cuff
via
aspir
channel
tube
addit
kinet
respiratori
tract
contamin
follow
simultan
pulmonari
imag
use
scintil
camera
data
blindli
analys
nuclear
physician
studi
approv
hospit
ethic
committe
inform
consent
obtain
rel
result
sixteen
pue
pv
cuff
ed
tube
compar
studi
perform
day
intub
day
icu
admiss
mean
sd
ventil
paramet
follow
volum
control
pressur
support
one
tube
fio
peep
cmh
leakag
observ
patient
similar
rate
aspir
pue
pv
group
p
ns
leakag
frequent
observ
femal
male
patient
p
trend
decreas
frequenc
aspir
patient
larger
tube
size
vs
p
conclus
pue
pv
cuff
ed
endotrach
tube
poorli
eff
ectiv
prevent
microaspir
mv
patient
tube
size
andor
gender
may
import
cuff
composit
prevent
aspir
mv
introduct
decad
assum
cuff
ed
endotrach
tube
prevent
aspir
howev
current
use
cuff
ed
tube
prevent
develop
postintub
pulmonari
complic
caus
microaspir
new
tapershap
cuff
ed
tube
taperguard
tg
recent
introduc
aim
studi
compar
tube
tradit
tube
hilo
hl
aspir
pig
model
method
fourteen
pig
kg
studi
pig
randomli
intub
either
taperguard
taper
cuff
hilo
barrel
cuff
tube
tube
size
either
depend
weight
cuff
pressur
maintain
cm
water
intub
mlkg
acid
blue
dye
ph
place
top
cuff
anim
ventil
hour
anim
sacrifi
ced
tracheobronchi
tree
lung
examin
aspir
character
follow
dye
leak
ulcerationeros
hemorrhag
pneumonia
bronchitisbronchiol
pig
one
exclud
due
accident
cuff
defl
ation
tube
size
evenli
distribut
amongst
group
cuff
pressur
equal
tg
hl
p
seen
tabl
incid
microaspir
signifi
cantli
less
tg
blue
dye
bronchiti
group
follow
extub
howev
true
incid
laryng
edema
postop
patient
clear
assess
relationship
upper
airway
obstruct
valu
cuff
leak
pressur
postop
patient
method
one
hundr
fi
ftyeight
postop
patient
elect
emerg
includ
ventil
wean
accomplish
measur
airway
pressur
sound
cuff
leakag
audibl
cuff
pressur
monitor
case
cuff
leak
pressur
measur
awak
sedat
state
cuff
leak
pressur
valu
median
mmhg
elect
case
median
emerg
case
ns
six
patient
extub
high
leak
pressur
valu
mmhg
one
hundr
fortythre
patient
extub
nine
diagnos
laryng
edema
laryngoscopi
seven
need
reintub
one
reason
massiv
sputa
three
granuloma
format
three
diagnos
sever
laryng
edema
patient
develop
sever
laryng
edema
higher
leak
pressur
mmhg
patient
pressur
mmhg
sensit
specifi
citi
test
use
threshold
valu
mmhg
sever
laryng
edema
respect
occurr
sever
laryng
edema
associ
age
gender
periop
weight
gain
durat
translaryng
intub
inner
diamet
endotrach
tube
serum
albumin
concentr
howev
cuff
leak
pressur
valu
mmhg
associ
gender
femal
p
inner
diamet
endotrach
tube
p
multivari
regress
patient
cuff
leak
pressur
awak
state
sed
tonu
larynx
consid
relat
cuff
leak
pressur
use
measur
cuff
leak
pressur
sedat
state
patient
high
valu
awak
state
conclus
cuff
leak
pressur
valu
mmhg
time
use
rule
sever
laryng
edema
may
use
measur
pressur
sedat
state
valu
awak
state
high
rapid
shallow
breath
index
rsbi
shown
paramet
predict
success
wean
rsbi
less
predictor
success
wean
investig
whether
rsbi
could
use
paramet
patient
popul
method
june
march
patient
mechan
ventil
sixb
icu
studi
patient
invas
mechan
ventil
longer
hour
miss
inform
die
whilst
ventil
includ
studi
rsbi
measur
patient
two
diff
erent
time
point
wean
fi
rstli
point
reduct
pressur
support
point
extub
rsbi
measur
use
ventil
maquet
servoi
reduc
pressur
support
level
zero
adjust
peep
cmh
signifi
canc
level
consid
signifi
cant
nonparametr
kruskallw
test
use
analys
collect
data
result
one
hundr
nineteen
patient
ventil
time
period
patient
meet
inclus
criteria
includ
time
point
reduct
pressur
support
rsbi
show
signifi
cant
diff
erenc
p
group
readi
wean
group
readi
wean
group
success
reduct
ps
n
rsbi
group
without
success
reduct
ps
n
rsbi
point
extub
rsbi
signifi
cant
predict
success
extub
p
group
success
extub
n
rsbi
group
unsuccess
extub
n
rsbi
conclus
moment
extub
rsbi
show
signifi
cant
low
valu
success
group
also
time
point
reduct
pressur
support
level
increas
pressur
support
vibrocompress
use
respiratori
therapi
w
naue
guntzel
silva
r
condessa
r
oliveira
vieira
method
place
supin
posit
bed
head
angl
elev
patient
random
group
vibrocompress
minut
chest
group
vibrocompress
plu
increas
cmh
ip
psv
minut
chest
clinic
variabl
apach
ii
score
regist
paramet
analyz
begin
end
protocol
variat
peak
pressur
variat
tidal
volum
variat
dynam
complianc
amount
variat
mucu
secret
aspir
end
also
measur
result
show
mean
sd
result
group
n
n
similar
clinic
characterist
apach
ii
score
variat
variabl
respect
cmh
p
ml
p
cmh
p
g
p
conclus
found
diff
erenc
group
except
peak
pressur
greater
result
could
probabl
due
decreas
airway
resist
refer
introduct
failur
wean
mechan
ventil
mv
frequent
associ
high
mortal
index
predict
success
help
clinic
howev
predict
capac
low
princip
patient
cardiac
diseas
goal
studi
evalu
wean
predictor
index
patient
cardiac
diseas
wean
mv
method
includ
patient
without
cardiac
diseas
mv
least
hour
submit
spontan
breath
trial
sbt
minut
extub
accord
clinic
decis
follow
hour
evalu
concern
age
sex
clinic
characterist
length
hospit
icu
stay
mv
fi
rst
minut
sbt
analyz
arteri
blood
gase
hemodynam
respiratori
paramet
respiratori
rate
f
tidal
volum
vt
rapid
shallow
breath
index
fvt
maxim
inspiratori
expiratori
pressur
comparison
done
group
patient
success
x
failur
defi
ning
failur
return
mv
fi
rst
hour
result
four
hundr
thirteen
patient
studi
cardiac
diseas
without
overal
mortal
rate
return
mv
occur
import
diff
erenc
compar
patient
cardiac
diseas
control
group
lower
mortal
rate
x
p
shorter
length
icu
stay
x
day
compar
patient
fail
wean
process
without
heart
diseas
x
p
compar
fvt
minut
patient
success
fail
wean
process
x
p
lower
increas
fvt
x
p
test
conclus
group
patient
great
number
fail
wean
process
show
expect
higher
mortal
rate
paramet
relat
failur
literatur
higher
age
longer
length
icu
stay
mortal
fvt
studi
last
paramet
sensit
princip
minut
higher
increas
fvt
test
demonstr
patient
cardiac
diseas
fail
other
wean
process
well
effi
cienci
test
predict
success
wean
introduct
due
improv
nearli
fi
eld
acut
care
past
decad
burden
longterm
depend
mechan
ventil
mv
increas
incessantli
aim
studi
implement
test
standardis
wean
protocol
patient
suff
ere
longterm
mechan
ventil
method
approv
local
ethic
committe
inform
consent
patient
enrol
prospect
cohort
studi
year
mean
time
ventil
inclus
day
reason
longterm
mv
cerebr
cardiovascular
pulmonari
neuromuscular
diseas
wean
protocol
start
x
minut
spontan
breath
intermiss
mechan
ventil
day
increas
stepwis
hour
spontan
breath
day
improv
wean
step
day
three
step
backward
patient
switch
individu
wean
approach
wean
protocol
carri
previous
train
icu
staff
well
special
physiotherapist
result
total
n
patient
could
wean
ventil
fi
rst
eff
ort
patient
wean
protocol
wherea
need
individu
approach
mean
time
wean
day
use
protocol
day
due
individu
approach
wean
procedur
fail
patient
discharg
hospit
homecar
ventil
program
total
patient
die
mechan
ventil
icu
stay
patient
need
second
wean
eff
ort
n
wean
protocol
transfer
homecar
ventil
die
conclus
use
standardis
wean
protocol
threequart
prolong
mechan
ventil
patient
could
wean
ventil
mean
day
need
individu
strategi
take
day
complet
releas
ventil
therefor
suggest
kind
wean
protocol
use
introduct
studi
compar
reliabl
effi
caci
three
diff
erent
noninvas
cpap
system
low
fl
ow
lf
high
fl
ow
hf
cpap
valv
b
lung
model
healthi
subject
method
lung
model
pneumat
simul
fi
rst
set
respiratori
rate
minut
ml
tidal
volum
rr
ml
tidal
volum
human
studi
healthi
subject
ask
make
expiratori
paus
fi
breath
tidal
volum
short
sequenc
tachypnea
diff
erenc
set
eff
ectiv
peep
fio
use
index
reliabl
minimum
airway
pressur
peep
level
airway
pressur
swing
around
peep
use
index
effi
caci
lung
simul
protocol
pressuretim
product
measur
correl
effi
caci
index
result
lung
model
hf
show
tendenc
toward
stabl
peep
p
b
signifi
cant
fall
fio
valu
observ
p
airway
pressur
swing
around
peep
greater
lf
b
compar
hf
p
lower
b
p
pressuretim
product
better
describ
airway
pressur
swing
around
peep
r
rather
minimum
airway
pressur
peep
level
r
human
studi
lower
diff
erenc
set
eff
ectiv
fio
regist
hf
p
system
show
overal
higher
minimum
airway
pressur
peep
level
compar
b
p
hf
cmh
show
smaller
airway
pressur
swing
around
peep
rel
lf
cmh
p
b
cmh
p
whole
respiratori
sequenc
increas
endexpiratori
pressur
observ
increas
greater
b
valv
hf
lf
p
conclus
accord
observ
hf
seem
reliabl
devic
condit
high
fl
ow
demand
b
reach
fio
valu
lower
expect
dynam
hyperpressur
higher
b
probabl
due
relationship
expiratori
fl
ow
resist
ere
expiratori
valv
b
even
handi
lightweight
less
reliabl
term
fl
ow
suppli
peep
stabil
introduct
noninvas
mechan
ventil
niv
use
hypox
postop
cardiac
patient
studi
necessari
clarifi
respiratori
hemodynam
eff
ect
therefor
object
studi
eff
ect
oxygen
index
pao
fio
hemodynam
variabl
group
patient
method
random
trial
postop
cardiac
patient
pulmonari
arteri
cathet
show
pao
fio
fio
hour
extub
includ
intervent
group
use
niv
bilevel
posit
airway
pressur
inspiratori
pressur
gener
tidal
volum
mlkg
expiratori
pressur
cmh
fio
hour
control
group
use
oxygen
venturi
mask
order
keep
good
oxygen
group
measur
done
basal
situat
fio
fi
rst
hour
begin
treatment
fio
hour
end
intervent
fio
variabl
studi
includ
ph
pao
paco
pao
fio
ratio
heart
rate
hr
mean
arteri
pressur
map
pulmonari
capillari
wedg
pressur
pcwp
central
venou
pressur
cvp
mean
pulmonari
arteri
pressur
mpap
cardiac
output
co
result
fortytwo
patient
includ
studi
period
mean
age
year
basal
variabl
similar
two
group
increas
pao
fio
ratio
niv
group
fi
rst
hour
p
ci
hour
stop
treatment
p
ci
compar
control
group
signifi
cant
chang
hemodynam
paramet
ph
paco
niv
compar
control
group
conclus
chang
hemodynam
variabl
niv
period
howev
result
suggest
niv
improv
oxygen
even
hour
stop
treatment
nippv
use
success
hypercapn
hypoxaem
acut
respiratori
failur
howev
outcom
nippv
burn
patient
less
well
document
purpos
studi
report
experi
nippv
seri
burninjur
patient
method
record
burn
patient
juli
septemb
nippv
use
intens
burn
care
unit
review
criteria
select
patient
nippv
includ
combin
follow
factor
patient
acut
respiratori
failur
haemodynam
stabl
consciou
cooper
treatment
need
endotrach
intub
result
thirtyon
patient
treat
nippv
nineteen
femal
mean
age
year
mean
total
bodi
surfac
area
tbsa
nippv
use
treat
hypoxia
patient
hypercapnia
four
patient
six
patient
mean
pao
fio
ratio
nippv
nippv
use
treat
ard
patient
pneumonia
eight
patient
atelectasi
six
patient
cardiogen
oedema
fi
patient
mean
pao
fio
ratio
nippv
intub
success
avoid
patient
patient
progress
selfventil
statu
follow
nippv
conclus
use
nippv
burninjur
patient
yet
unclear
littl
work
document
experi
use
nippv
lead
avoid
need
endotrach
intub
mechan
ventil
purpos
prospect
studi
describ
hemodynam
cardiac
variat
trial
noninvas
ventil
niv
process
wean
ventilatori
support
continu
hemodynam
monitor
perform
puls
contour
method
mostcar
vytech
health
laboratoir
pharmaceutiqu
vygon
ecouen
franc
devic
could
use
identifi
earli
warn
cardiovascular
dysfunct
may
contribut
unsuccess
wean
method
fourteen
patient
admit
icu
januari
juli
includ
studi
six
intub
respiratori
failur
due
cardiogen
pulmonari
edema
cpe
year
four
male
two
femal
f
eight
intub
chronic
obstruct
pulmonari
diseas
copd
year
four
four
f
niv
trial
perform
face
mask
pressur
support
ps
cmh
posit
endexpiratori
pressur
peep
cmh
cardiovascular
variabl
ga
exchang
data
measur
three
defi
ned
point
time
hour
extub
continu
niv
trial
mean
valu
calcul
express
end
niv
trial
patient
spontan
breath
variat
cardiac
index
ci
mlminutem
cpe
vs
mlminutem
copd
mlminutem
cpe
vs
mlminutem
copd
cpe
vs
mlminutem
copd
variat
ci
depend
variat
stroke
volum
sv
heart
rate
hr
chang
trial
calcul
oxygen
deliveri
correl
ci
ga
exchang
mlminut
cpe
vs
mlminut
copd
mlminut
cpe
vs
mlminut
copd
mlminut
cpe
vs
mlminut
copd
variat
ci
observ
within
among
two
group
never
signifi
cant
conclus
group
patient
success
achiev
spontan
ventil
opinion
continu
hemodynam
monitor
may
provid
help
beattobeat
inform
might
use
combin
ga
exchang
oxygen
satur
monitor
wean
process
predictor
cardiovascular
instabl
respiratori
failur
moreov
continu
hemodynam
monitor
enabl
one
awar
variat
system
oxygen
deliveri
data
could
use
valu
critic
ill
patient
wean
process
introduct
obes
rate
increas
gener
popul
also
preval
icu
patient
sometim
admit
icu
hypercapn
respiratori
failur
cor
pulmonal
gener
admit
pneumonia
excess
daytim
sleepi
heart
failur
copd
asthma
attack
pulmonari
embol
hypercapn
respiratori
failur
notic
period
hand
optim
noninvas
mechan
ventil
strategi
known
icu
treatment
aim
studi
assess
diff
erenc
niv
strategi
outcom
obes
nonobes
patient
acut
hypercapn
respiratori
failur
method
retrospect
cohort
studi
patient
studi
ventil
face
mask
patient
divid
two
group
obes
bmi
kgm
nonobes
bmi
kgm
whether
necessari
pressur
volum
mode
ventil
time
reduc
paco
mmhg
signifi
cantli
diff
erent
obes
nonobes
patient
investig
result
mean
age
patient
year
mean
admiss
apach
ii
score
femal
icu
admiss
reason
obes
patient
signifi
cantli
frequent
pulmonari
edema
less
frequent
pulmonari
infect
p
respect
nonobes
patient
signifi
cant
diff
erenc
across
group
ventil
mode
inspiratori
pressur
level
obes
patient
requir
higher
endexpiratori
pressur
level
time
reduc
paco
level
mmhg
nonobes
group
length
niv
icu
stay
intub
mortal
rate
similar
across
group
conclus
result
suggest
improv
hypercapnia
obes
patient
may
requir
higher
peep
level
longer
time
nonobes
one
acut
hypercapn
respiratori
failur
attack
simpl
predict
score
system
prolong
mechan
ventil
sever
sepsi
septic
shock
n
saito
sakamoto
k
mashiko
chiba
hokus
hospit
nippon
medic
school
chiba
japan
critic
care
suppl
doi
introduct
prolong
mechan
ventil
mv
associ
high
morbid
mortal
septic
patient
howev
limit
data
avail
predict
prolong
mv
conduct
observ
cohort
studi
aim
develop
prolong
mv
predict
score
system
sever
sepsi
septic
shock
method
retrospect
analyz
consecut
patient
sever
sepsi
septic
shock
ventil
hour
januari
octob
clinic
featur
physiolog
paramet
examin
day
use
predictor
mv
patient
divid
two
group
group
requir
mv
day
group
requir
mv
day
mean
sd
age
sofa
score
year
respect
requir
prolong
mv
univari
analysi
indic
length
icu
hospit
stay
hospit
mortal
rate
transfus
incid
ard
ventilatorassoci
pneumonia
vap
nosocomi
infect
ni
drugresist
bacteria
ratio
steroid
therapi
muscl
relax
use
mean
pao
fio
ratio
fi
rst
day
admiss
signifi
cantli
diff
erent
two
group
independ
predictor
prolong
mv
ard
p
ci
vap
p
ci
transfus
p
ci
use
result
abl
develop
prolong
mv
predict
score
system
simplifi
ed
clinic
risk
assess
tool
develop
introduct
sever
score
power
tool
qualiti
control
icu
introduc
new
sever
score
system
icu
aim
report
describ
databas
present
result
fi
rst
month
method
analys
need
databas
sever
score
chose
onadmiss
score
euroscor
cardiac
surgic
patient
mortal
predict
model
ii
time
zero
patient
data
collect
via
highli
simplifi
ed
form
onto
spreadsheet
demograph
entri
ward
clerk
onadmiss
sever
score
resid
medic
staff
risk
death
calcul
data
clean
senior
attend
medic
staff
individu
patient
risk
death
present
logit
combin
risk
death
whole
cohort
calcul
arithmet
mean
individu
logit
estim
time
complet
step
data
acquisit
calcul
total
time
spent
per
patient
result
admiss
mean
sd
age
year
male
median
rang
length
stay
hour
fiftyfour
per
cent
patient
ventil
median
rang
hour
predict
mortal
cardiothorac
noncardiothorac
patient
combin
observ
mortal
euroscorepredict
mortal
cardiothorac
patient
observ
mortal
four
patient
mpmpredict
mortal
noncardiothorac
patient
observ
mortal
patient
estim
time
complet
sever
score
form
second
enter
new
patient
databas
second
calcul
risk
death
check
data
integr
second
total
minut
per
patient
conclus
data
collectionanalysi
essenti
qualiti
manag
icu
proprietari
system
expens
tradit
score
system
apach
ii
poorli
calibr
case
mix
overcom
problem
devis
simpl
inexpens
highli
valuabl
icu
databas
key
featur
well
calibr
onadmiss
sever
score
highli
simplifi
ed
form
basic
spreadsheet
collabor
staff
involv
senior
medic
staff
perform
fi
nal
data
check
project
provid
abund
highqual
data
total
input
minut
per
patient
triall
databas
larg
icu
china
would
welcom
input
icu
would
like
copi
method
valid
computeris
system
calcul
sequenti
organ
failur
assess
score
c
bourdeaux
sequenti
organ
failur
assess
sofa
score
introduc
aim
quantifi
sever
ill
base
organ
dysfunct
serial
time
previou
studi
suggest
reliabl
accuraci
sofa
score
intens
care
physician
good
may
room
improv
manual
calcul
score
time
consum
develop
comput
program
deriv
sofa
score
electron
patient
record
innovian
system
draeger
germani
date
autom
method
sofa
score
calcul
valid
valid
autom
sofa
score
collect
method
order
assess
accuraci
reliabl
also
measur
time
manual
collect
sofa
score
order
assess
resourc
save
potenti
comput
system
method
fifti
patient
record
select
databas
stratifi
ed
random
sampl
order
repres
patient
popul
teach
hospit
adult
icu
two
icu
physician
calcul
total
sofa
score
individu
organ
score
patient
record
gold
standard
sofa
score
gener
discuss
two
physician
aid
third
adjud
icu
physician
sofa
score
gener
comput
compar
gold
standard
assess
accuraci
reason
inaccur
score
record
result
sofa
score
vari
sampl
mean
sofa
score
gold
standard
standard
deviat
agreement
diff
erent
rate
good
comput
score
better
agreement
gold
standard
score
pearson
correl
coeffi
cient
compar
individu
physician
score
pearson
correl
coeffi
cient
comput
calcul
sofa
score
correctli
case
physician
calcul
sofa
score
correctli
case
averag
time
calcul
sofa
score
minut
signifi
cantli
diff
erent
physician
result
show
comput
system
highli
accur
calcul
sofa
score
electron
patient
record
accur
physician
time
save
consider
refer
found
patient
older
year
sofa
score
higher
least
day
unlik
surviv
suggest
could
provid
basi
decid
whether
withhold
withdraw
life
support
tri
control
hypothesi
patient
popul
method
review
data
patient
older
year
lo
higher
day
admit
icu
calcul
daili
sofa
score
patient
initi
sofa
score
higher
igsii
lo
mortal
compar
patient
sofa
score
higher
least
day
sofa
group
select
patient
sofa
group
patient
admit
icu
one
hundr
forti
older
year
remain
day
icu
eleven
patient
sofa
score
higher
day
sofa
group
lo
vs
day
mortal
vs
signifi
cantli
higher
p
mortal
good
agreement
predict
igsii
mortal
far
less
predict
colleagu
conclus
sofa
score
higher
least
day
patient
older
year
seem
useless
defi
ne
futil
patient
popul
applic
less
patient
admit
mortal
rate
sofa
group
increas
remain
far
valu
permit
withdraw
withhold
intens
care
weak
use
sequenti
sofa
score
predict
outcom
therapeut
option
infl
uenc
valu
sofa
score
introduct
prolong
icu
stay
associ
high
morbid
mortal
cost
predict
prolong
stay
provid
inform
physician
famili
help
resourc
alloc
even
though
avail
sever
score
system
ie
apach
ii
apach
iii
mpm
sap
ii
mod
score
wide
accept
evalu
outcom
icu
popul
model
might
inaccur
appli
subpopul
might
predict
prolong
length
stay
conclus
three
score
use
prognost
factor
mortal
icu
therapi
ed
usual
lower
patient
sever
infect
icu
icuvalid
apach
ii
sofa
score
similar
prognost
valu
edspecifi
c
med
score
recent
raum
colleagu
gener
valid
new
trauma
score
emerg
trauma
score
emtra
base
age
prehospit
gc
prothrombin
time
base
excess
paramet
subdivid
four
class
score
point
score
class
sum
obtain
emtra
rang
present
preliminari
result
studi
aim
valid
new
score
system
compar
commonli
use
ill
score
method
one
hundr
fi
fti
trauma
patient
admit
region
referr
trauma
center
careggi
teach
hospit
florenc
itali
studi
predict
valu
emtra
score
compar
injuri
sever
score
iss
revis
trauma
score
rt
trauma
injuri
introduct
sever
sepsi
import
caus
morbid
mortal
follow
major
surgeri
factor
associ
increas
risk
sepsi
follow
surgeri
includ
emerg
surgeri
patient
comorbid
allogen
blood
transfus
degre
surgic
insult
physiolog
trackandtrigg
system
wide
use
identifi
deterior
patient
modifi
ed
earli
warn
system
mew
one
system
studi
regard
predict
develop
sepsi
surgeri
although
high
mew
score
associ
increas
hospit
mortal
sensit
mew
physiolog
track
trigger
score
predict
death
admiss
intens
care
low
method
carri
prospect
cohort
studi
patient
undergo
elect
major
surgeri
larg
univers
teach
hospit
patient
follow
day
incid
sepsi
septic
shock
document
mew
score
record
daili
patient
admiss
critic
care
document
along
critic
care
length
stay
result
twentyseven
patient
develop
sepsi
nine
develop
septic
shock
factor
associ
develop
sepsi
intraop
blood
transfus
p
durat
oper
p
postop
mew
score
greater
p
use
multivari
logist
regress
analysi
mew
score
greater
surgeri
factor
remain
signifi
cantli
associ
sepsi
odd
ratio
p
although
high
mew
score
associ
sepsi
surgeri
fi
patient
develop
sepsi
abnorm
mew
score
prior
mean
day
sepsi
diagnos
postcco
group
patient
admit
icu
treat
hematolog
ward
nine
receiv
niv
figur
defi
ned
six
criteria
activ
cco
team
radiolog
sign
pneumonia
organ
increas
n
type
mi
type
mi
p
type
mi
increas
refl
ect
decreas
patient
formerli
classifi
ed
instabl
angina
note
increas
mi
diagnosi
mainli
refl
ect
increas
type
mi
exampl
acut
heart
failur
tachycardia
hypertens
crisi
number
patient
noncardiac
chest
pain
signifi
cantli
chang
use
new
cutoff
point
auc
admiss
ctnt
level
ctnt
fourth
gener
ctnth
p
admiss
sensit
specifi
citi
ctnth
detect
acut
mi
use
ctnt
fourth
gener
conclus
use
lower
cutoff
point
defi
nition
mi
suggest
current
recommend
rate
chest
pain
patient
acut
mi
doubl
increas
rate
patient
categor
acut
mi
mainli
refl
ect
mi
type
ed
triag
decis
lower
cutoff
level
ctnt
level
includ
patient
histori
physic
examin
ecg
cardiac
imag
introduct
aim
studi
determin
correl
b
line
score
blood
ga
analysi
bga
paramet
patient
acut
cardiogen
pulmonari
edema
acp
presenc
b
line
artifact
lung
us
correl
increas
extravascular
lung
water
patient
acut
decompens
heart
failur
resolut
b
line
use
monitor
resolut
pulmonari
congest
simpl
ninepoint
comet
score
propos
quantifi
b
line
monitor
acp
treatment
method
twentyon
patient
acp
submit
lung
us
bga
present
hour
admiss
lung
us
done
nine
thorac
area
score
one
point
b
line
present
score
given
presenc
multipl
coalesc
comet
fi
eld
white
lung
bga
valu
use
calcul
po
fio
pf
aa
gradient
result
total
scan
perform
simultan
bga
ninetyeight
percent
patient
present
white
lung
sever
hypox
po
mmhg
pf
figur
illustr
strong
linear
correl
reduct
comet
score
improv
pf
r
p
decreas
comet
score
point
correspond
minimum
increas
point
pf
p
correl
comet
score
aa
gradient
less
strike
signifi
cant
r
p
perhap
patient
underli
lung
diseas
exclud
pilot
studi
conclus
strong
neg
correl
lung
comet
score
ga
exchang
patient
acp
patient
serial
thorac
us
may
reduc
need
repeat
invas
bga
monitor
help
tailor
therapi
refer
convent
treatment
distal
radial
fractur
close
reduct
cast
immobil
convent
hematoma
block
use
reduc
fractur
done
blindli
radiograph
techniqu
essenti
eff
ectiv
monitor
reduct
radiationfre
ultrasonographi
howev
provid
realtim
dynam
multipleplan
imag
small
simpletous
transduc
oper
one
hand
therefor
want
see
whether
realtim
dynam
multipleplan
figur
abstract
correl
reduct
comet
score
improv
pf
observ
capabl
ultrasonographi
would
allow
ed
physician
perform
direct
vision
hematoma
block
close
reduct
without
multipl
attempt
either
frequent
requir
convent
techniqu
use
method
sonograph
guid
hematoma
block
close
reduct
perform
three
patient
emerg
depart
acut
distal
radial
fractur
effi
caci
method
evalu
compar
convent
techniqu
ultrasound
imag
help
give
hematoma
block
direct
vision
delin
fractur
accur
convent
radiograph
paramet
measur
ultrasound
imag
show
substanti
restor
anatom
align
reduct
direct
vision
hematoma
block
help
reduc
number
attempt
less
pain
achiev
patient
satisfact
conclus
sonographi
accur
simpl
timesav
less
pain
radiationfre
tool
reduc
badli
displac
angul
forearm
fractur
emerg
depart
diffi
cult
multipl
attempt
reduct
may
requir
repeat
trip
radiolog
depart
adequ
reduct
achiev
therefor
ultrasoundguid
hematoma
block
reduct
diffi
cult
forearm
fractur
reduc
number
needl
attempt
allow
physician
assess
adequaci
reduct
patient
bedsid
introduct
patient
acut
cardiogen
pulmonari
edema
requir
rapid
assess
therapi
prevent
progress
respiratori
failur
cardiovascular
collaps
lisbon
citi
emerg
medic
team
respond
situat
life
patient
risk
whose
goal
begin
treatment
indic
assur
transport
hospit
best
condit
possibl
studi
intervent
one
team
patient
acut
pulmonari
edema
design
studi
fi
nd
use
usg
pattern
diagnosi
assess
dyspnea
also
compar
util
chest
radiogram
supin
posit
thorax
ct
bedsid
usg
techniqu
method
selcuk
univers
meram
medic
faculti
year
patient
acut
dyspnea
includ
studi
patient
chest
trauma
patient
nontraumat
caus
design
studi
prospect
tri
determin
patholog
posit
neg
slide
lung
sign
sl
usg
examin
also
investig
reliabl
diff
erenti
diagnosi
acut
dyspnea
result
first
perform
chest
radiogram
patient
supin
posit
perform
ct
scan
result
interpret
detach
radiologist
perform
bedsid
thorac
usg
fi
nd
sl
physician
er
conced
ct
result
golden
standard
compar
result
chest
radiogram
usg
fi
nding
spss
program
test
use
statist
analysi
p
accord
fi
nding
sl
usg
examin
sensit
specifi
citi
posit
predict
valu
neg
predict
valu
conclus
throughout
year
usg
examin
defi
ned
inappropri
lung
examin
studi
reach
conclus
necess
bedsid
sonograph
examin
allow
impetu
diagnosi
everi
respiratori
failur
sonograph
pattern
mistak
inevit
nevertheless
believ
profound
studi
like
keep
come
clinician
begin
use
usg
examin
sl
diagnost
valu
rise
becom
routin
element
er
introduct
mani
air
medic
transport
program
use
puls
oximet
endtid
carbon
dioxid
monitor
devic
indirect
measur
respiratori
cardiac
statu
thu
method
replac
cardiac
auscult
fl
ight
may
need
identifi
sudden
critic
chang
abil
compar
leftsid
rightsid
breath
sound
may
essenti
confi
rm
appropri
placement
endotrach
tube
well
diagnos
pneumothorax
abil
auscult
air
medic
transport
compromis
high
ambient
nois
level
aim
studi
assess
capabl
tradit
amplifi
ed
stethoscop
expect
reduc
background
ambient
nois
assess
heart
breath
sound
medic
transport
falcon
plane
method
prospect
doubleblind
random
studi
perform
test
one
model
tradit
stethoscop
cardiolog
iii
one
model
amplifi
ed
stethoscop
littman
sound
level
amplifi
ed
six
eight
increment
amplifi
ed
stethoscop
practition
board
experienc
air
medic
transport
normal
audiolog
test
studi
heart
lung
auscult
real
medic
evacu
board
falcon
medic
confi
gure
dassault
aviat
qualiti
critic
care
volum
suppl
http
auscult
describ
use
numer
rate
scale
rang
correspond
hear
noth
hear
perfectli
comparison
accomplish
use
test
pair
valu
result
age
patient
year
male
bodi
mass
index
cardiac
auscult
valu
rate
scale
respect
tradit
amplifi
ed
stethoscop
p
lung
sound
qualiti
auscult
estim
tradit
stethoscop
amplifi
ed
stethoscop
p
conclus
conclud
fl
ight
practition
falcon
abl
hear
cardiac
sound
amplifi
ed
tradit
stethoscop
wherea
signifi
cant
diff
erenc
concern
breath
sound
auscult
fi
nding
suggest
investig
falcon
nois
human
breath
sound
might
share
common
substanti
overlap
frequenc
spectrum
amplifi
cation
one
necessarili
amplifi
assess
hypothesi
studi
need
evalu
sound
frequenc
spectrum
medic
confi
gure
falcon
perform
studi
perform
two
respir
employ
advanc
turbin
deliveri
system
ltv
tbird
assess
abil
ventil
deliv
normal
lung
model
set
fraction
inspir
oxygen
fio
diff
erent
simul
cabin
altitud
method
use
decompress
chamber
mimic
hypobar
environ
rang
simul
cabin
altitud
meter
feet
model
normal
lung
use
concern
tbird
cabin
altitud
input
ventil
test
fio
set
vt
set
ml
note
eff
ectiv
fio
assess
ventil
paramagnet
analysi
measur
fio
realli
deliv
dedic
instrument
french
physiolog
laboratori
aviat
space
medicin
air
forc
comparison
preset
assess
fio
actual
measur
fio
accomplish
use
test
altitud
result
figur
show
data
fio
set
conclus
one
hand
ventil
show
moder
variat
fio
set
deliv
hand
variat
fio
deliv
assess
high
suggest
ineffi
caciti
ventil
paramagnet
analysi
hypobar
condit
conclus
team
evacu
red
code
yellow
one
similar
time
tamp
shorter
consid
global
yellow
green
code
oppos
nt
global
green
lo
also
shorter
group
oppos
nt
train
seem
infl
uenc
global
exercis
manag
less
aff
ect
red
code
impact
yellow
green
evacu
strategi
introduct
exacerb
asthma
appear
air
transport
sever
patient
respond
convent
therapi
requir
ventil
support
evalu
perform
two
transport
ventil
built
turbin
technolog
tbird
ltv
use
aeromed
evacu
acut
sever
asthma
assess
abil
ventil
deliv
acut
sever
asthma
model
tidal
volum
vt
set
diff
erent
simul
altitud
chang
ambient
air
pressur
method
use
decompress
chamber
mimic
hypobar
environ
rang
simul
cabin
altitud
meter
feet
ventil
test
realist
paramet
vt
set
ml
ml
acut
sever
asthma
lung
model
protocol
includ
three
measur
simul
altitud
comparison
preset
actual
measur
valu
accomplish
use
test
altitud
result
figur
summar
data
altitud
tbird
show
decreas
volum
deliv
comparison
actual
deliv
vt
set
vt
demonstr
signifi
cant
diff
erenc
start
vt
set
ml
vt
set
ml
neg
variat
compar
tidal
volum
set
respect
decreas
barometr
pressur
ltv
show
mostli
increas
volum
deliv
comparison
actual
deliv
vt
set
vt
demonstr
signifi
cant
diff
erenc
vt
set
ml
v
test
ml
deliv
tidal
volum
remain
within
set
vt
tbird
progress
deliv
lower
volum
barometr
pressur
decreas
wherea
ltv
show
moder
increas
volum
deliv
acut
sever
asthma
lung
model
increas
altitud
maintain
deliv
volum
within
set
vt
test
interrat
intrarat
agreement
respect
concern
interrat
agreement
nine
triag
nurs
sort
patient
assign
classifi
cation
compar
refer
assign
analyz
cohen
kappa
coeffi
cient
intrarat
agreement
test
ask
triag
nurs
sort
patient
two
diff
erent
time
earli
morn
late
night
compar
classifi
cation
null
hypothesi
diff
erenc
determin
whether
diff
erenc
nurs
depend
result
statist
analysi
intrarat
agreement
reveal
mean
diff
erenc
classifi
cation
signifi
cantli
depend
nurs
p
result
allow
pool
data
test
determin
whether
mean
diff
erent
zero
use
sign
test
found
classifi
cation
diff
erent
classifi
cation
p
concern
interrat
agreement
use
cohen
kappa
coeffi
cient
reveal
almost
perfect
agreement
classifi
cation
nurs
refer
need
specifi
c
triag
tool
emerg
depart
led
us
develop
new
frenchlanguag
triag
scale
present
studi
demonstr
scale
valid
triag
tool
good
interrat
intrarat
agreement
result
allow
futur
studi
evalu
effi
cienci
introduct
uk
audit
suggest
suboptim
involv
consult
care
acut
medicin
acut
medicin
sinc
evolv
specialti
improv
medic
inpati
care
fi
rst
hour
mani
hospit
incorpor
acut
short
stay
unit
medic
admiss
direct
unit
reduc
length
hospit
inpati
stay
method
conduct
review
case
note
consecut
medic
admiss
emerg
short
stay
ward
ess
data
collect
includ
diagnos
admiss
discharg
length
stay
ess
discharg
destin
review
initi
medic
clerk
assess
made
regard
suitabl
admiss
ess
standard
local
criteria
result
data
patient
age
collect
eightynin
per
cent
admit
medic
admiss
unit
commonli
analys
triag
reliabl
among
nurs
student
italian
univers
cours
new
triag
emerg
method
tem
show
good
reliabl
previou
studi
studi
compar
triag
reliabl
nurs
student
knowledg
italian
studi
topic
method
observ
studi
conduct
univers
parma
use
triag
scenario
databas
use
previou
studi
fifti
student
attend
third
year
nurs
cours
select
assign
triag
level
paper
scenario
without
triag
protocol
cours
month
cours
triag
prevent
commun
particip
assign
triag
code
diff
erent
room
presenc
two
investig
triag
scenario
given
randomli
particip
measur
interreli
use
weight
kappa
statist
complet
disagr
nurs
group
assign
scenario
triag
code
diff
ere
two
prioriti
level
complet
agreement
fi
nurs
assign
triag
code
cours
patient
includ
triag
scenario
women
mean
age
year
sd
age
year
frequent
present
triag
minor
trauma
hospit
admiss
nonintens
ward
three
icu
mean
age
student
sd
particip
attend
triag
train
declar
scarc
triag
knowledg
interrat
reliabl
k
ci
k
ci
cours
without
triag
protocol
cours
respect
complet
disagr
occur
scenario
evalu
cours
complet
agreement
alway
zero
conclus
data
suggest
tem
improv
triag
reliabl
among
nurs
student
seem
easi
understand
use
intern
guidelin
trauma
care
still
recommend
tradit
advanc
trauma
life
support
investig
primari
survey
plain
radiograph
chest
cervic
spine
pelvi
fast
ultrasound
howev
increas
amount
data
suggest
plain
xray
excess
low
sensit
cervic
xray
may
miss
spine
injuri
chest
xray
may
miss
mani
mani
traumat
pneumothorax
signifi
cant
percentag
pelvic
fractur
may
detect
pelvi
xray
ct
scan
extend
emerg
ultrasound
eu
much
higher
sensit
compar
plain
xray
moreov
eu
even
less
time
consum
therefor
sinc
adopt
eu
andor
total
bodi
ct
scan
fi
rstline
diagnost
tool
major
trauma
mt
victim
benchmark
analysi
italian
trauma
center
tc
hospit
rank
fi
rst
patient
mortal
longterm
disabl
result
associ
shortest
diagnost
time
aim
studi
assess
whether
result
associ
real
chang
diagnost
process
method
order
evalu
diagnost
approach
mt
retrospect
analyz
mt
case
iss
admit
tc
time
span
investig
perform
emerg
depart
ed
enter
electron
shift
perform
data
investig
request
within
hour
admiss
analyz
result
novemb
octob
mt
patient
admit
ed
eu
perform
patient
total
bodi
ct
scan
patient
submit
ct
either
die
soon
admiss
rush
oper
room
basi
eu
result
thirtyeight
patient
chest
xray
taken
ed
pelvic
xray
three
cervic
spine
xray
conclus
although
mani
intern
guidelin
trauma
care
still
recommend
tradit
plain
radiograph
investig
tc
well
mani
european
institut
high
volum
trauma
patient
adopt
diff
erent
strategi
base
extend
use
eu
ct
scan
may
improv
accuraci
diagnosi
stabil
patient
reduc
time
oper
room
highli
instabl
one
suggest
chang
recommend
guidelin
consid
result
patient
blunt
trauma
patient
mean
age
sd
year
examin
fi
eld
fast
enrol
studi
particip
also
examin
fast
ed
mean
injuri
sever
score
sd
fortyseven
patient
ultim
diagnos
pericardi
intraperiton
fl
uid
field
fast
detect
case
sensit
fi
eld
fast
signifi
cantli
lower
fast
ed
p
wherea
specifi
citi
fast
two
set
signifi
cantli
diff
erent
emerg
surgeri
perform
nine
patient
posit
fi
eld
fast
aim
investig
analyz
diagnost
prognost
signifi
canc
serum
proapoptosi
antiapoptosi
marker
patient
sever
trauma
injuri
method
thirtythre
patient
sever
trauma
injuri
enrol
investig
exclud
patient
sever
brain
injuri
middl
age
initi
triss
scale
apach
ii
patient
demonstr
sign
system
infl
ammatori
respons
patient
infecti
pulmonari
complic
reveal
patient
infecti
complic
develop
venou
blood
serum
edta
sampl
investig
everi
day
week
freez
investig
antiapoptot
marker
solubl
fasl
solubl
cuzn
superoxid
dismutas
proapoptot
marker
protein
protein
highsensit
crp
elisa
bender
medsystem
observ
increas
proapoptot
marker
patient
infecti
complic
fi
rst
day
icu
antiapoptot
marker
cuzn
superoxid
dismutas
lower
regard
refer
point
patient
demonstr
maximum
fasl
protein
protein
near
rel
fi
rst
day
second
day
patient
without
infect
complic
identifi
ed
decreas
level
proapoptot
marker
increas
level
antiapoptot
marker
sod
solubl
fasl
solubl
introduct
inadequ
delay
imag
unconsci
patient
traumat
brain
injuri
unconsci
polytrauma
patient
may
lead
catastroph
consequ
need
comprehens
imag
need
balanc
patient
condit
resourc
avail
excess
radiat
exposur
introduc
region
evidencebas
guidelin
southwest
region
uk
aim
guidelin
standardis
practic
minimis
delay
miss
diagnosi
seriou
injuri
facilit
treatment
associ
injuri
head
injuri
obviat
need
repeat
imag
method
note
unconsci
polytrauma
patient
transfer
emerg
depart
hospit
patient
transfer
institut
ongo
neurosurg
care
retrospect
review
period
adher
imag
protocol
assess
need
radiolog
investig
within
hour
also
document
result
total
patient
identifi
ed
fulfi
lled
criteria
introduc
guidelin
patient
transfer
hospit
remaind
admit
onsit
emerg
depart
eightythre
per
cent
elig
patient
adher
protocol
two
patient
requir
radiolog
investig
hour
follow
admiss
isol
head
injuri
requir
imag
exclud
cervic
injuri
follow
inadequ
imag
follow
protocol
one
patient
requir
repeat
imag
exclud
mesenter
injuri
conclus
region
adopt
imag
guidelin
aim
obtain
earli
comprehens
imag
headinjur
polytrauma
patient
result
high
complianc
low
rate
reimag
introduct
blunt
cerebrovascular
injuri
bcvi
common
previous
report
promptli
recogn
treat
may
devast
sequela
injuri
diagnos
onset
stroke
patient
receiv
earli
antiplatelet
anticoagul
therapi
substanti
reduct
bcvirel
neurolog
event
demonstr
method
studi
set
level
trauma
center
catchment
popul
million
peopl
admit
major
trauma
yearli
assess
incid
asymptomat
bcvi
sever
injur
patient
plan
prospect
cohort
studi
accord
studi
design
sever
injur
patient
present
least
one
follow
criteria
submit
screen
ct
angiographi
within
hour
admiss
diff
use
axon
injuri
fractur
cervic
vertebra
skull
base
lefort
ii
iii
sever
facial
fractur
result
fi
rst
month
studi
major
trauma
patient
iss
least
one
list
risk
factor
submit
screen
ct
angiographi
bcvi
patient
sedat
artifi
cialli
ventil
none
symptomat
stroke
three
patient
highrisk
group
asymptomat
bcvi
pseudoaneurysm
one
traumat
stenosi
one
dissect
one
carotid
arteri
immedi
treat
antiplatelet
therapi
clopidogrel
aspirin
experienc
episod
cerebr
infarct
cerebr
haemorrhag
conclus
limit
data
literatur
traumat
bcvi
avail
data
well
preliminari
result
prospect
studi
show
bcvi
common
previous
recogn
aggress
screen
earlier
therapi
may
signifi
cantli
reduc
complic
improv
patient
outcom
introduct
aim
studi
determin
effi
caci
sodium
bicarbon
intracrani
pressur
icp
reduct
adult
patient
sever
traumat
brain
injuri
tbi
intracrani
hypertens
method
studi
examin
episod
icp
mmhg
seven
patient
sever
tbi
eightyfi
millilit
sodium
bicarbon
infus
minut
osmotherapi
indic
standard
care
icp
mean
arteri
pressur
map
cerebr
perfus
pressur
cpp
record
baselin
continu
hour
serum
ph
pco
na
cl
measur
baselin
minut
minut
hourli
hour
serum
osmol
measur
baselin
hour
three
patient
care
ident
institut
protocol
manag
rais
icp
result
complet
infus
mean
icp
reduc
baselin
mmhg
mmhg
mean
icp
remain
mmhg
hour
figur
cpp
increas
infus
due
eff
ect
icp
map
chang
mean
ph
elev
minut
remain
elev
durat
studi
period
serum
na
increas
mosml
mosml
minut
pco
chang
osmol
elev
conclus
eightyfi
millilit
sodium
bicarbon
infus
minut
eff
ectiv
reduc
sustain
icp
mmhg
within
accept
treatment
target
icp
mmhg
least
hour
introduct
waterelectrolyt
imbal
endocrin
disord
make
problem
maintain
patient
sever
traumat
brain
injuri
tbi
diffi
cult
plasma
sodium
level
mmoll
associ
mortal
purpos
investig
fi
nd
relationship
hypernatraemia
rate
unfavor
outcom
children
tbi
method
total
children
year
age
tbi
admiss
gc
score
divid
retrospect
three
group
group
includ
children
without
hypernatraemia
n
group
b
children
hypernatraemia
n
group
c
n
children
hypernatraemia
polyuria
group
c
consid
group
patient
central
diabet
insipidu
cdi
hypernatraemia
defi
ned
twice
elev
plasma
sodium
level
mmoll
within
hour
polyuria
defi
ned
increas
hourli
diuresi
mlkghour
less
hour
mean
sodium
level
admiss
mmoll
hypernatraemia
detect
patient
mean
durat
period
hypernatraemia
group
b
day
day
mean
sodium
level
period
hypernatraemia
mmoll
max
mmoll
durat
period
hypernatraemia
group
c
day
max
mmoll
averag
mmoll
polyuria
diagnos
case
highest
diuresi
group
mmolkghour
mean
mlkghour
chang
consid
manifest
cdi
patient
group
c
receiv
desmopressin
ddavp
hour
mean
hour
dose
mgday
four
children
group
b
increas
hourli
diuresi
mlkghour
consid
onset
cdi
thu
also
prescrib
ddavp
unfavor
outcom
go
score
assess
observ
group
b
c
comparison
unsuccess
outcom
group
b
c
increas
unfavor
outcom
rate
patient
group
c
hypernatraemia
polyuria
children
group
bfour
children
risk
factor
comparison
patient
group
b
c
p
conclus
result
demonstr
hypernatraemia
increas
rate
unfavor
outcom
children
tbi
thirtyday
outcom
wors
cdi
patient
presum
use
ddavp
prevent
dehydr
cdi
advanc
introduct
secondari
ischem
insult
sever
traumat
brain
injuri
tbi
correl
poor
outcom
transcrani
doppler
sonographi
tcd
permit
noninvas
measur
cerebr
blood
fl
ow
purpos
studi
determin
use
tcd
patient
sever
tbi
method
tcd
perform
patient
sever
tbi
defi
ned
glasgow
coma
scale
less
admiss
patient
mechan
ventil
tcd
perform
hospit
day
hypoperfus
defi
ned
two
three
follow
mean
veloc
middl
cerebr
arteri
less
cm
second
diastol
veloc
middl
cerebr
arteri
less
cm
second
pulsatil
index
greater
vasospasm
defi
ned
follow
mean
veloc
middl
cerebr
arteri
greater
cmsecond
andor
landegaard
index
greater
result
thirtyfour
patient
normal
measur
thirteen
discharg
home
discharg
longterm
care
facil
fi
die
two
patient
comatos
famili
request
withdraw
care
three
die
brain
death
eighteen
patient
hypoperfus
progress
brain
death
twentyon
patient
vasospasm
four
patient
discharg
home
longterm
care
facil
six
die
vasospasm
detect
hospit
day
three
patient
hospit
day
seven
patient
hospit
day
four
patient
hospit
day
seven
patient
nimodipin
administ
six
patient
six
discharg
longterm
care
facil
howev
one
patient
nimodipin
caus
hemodynam
instabl
discontinu
patient
nimodipin
given
six
patient
expir
brain
death
twelv
patient
subarachnoid
hemorrhag
comput
tomographi
vasospasm
conclus
patient
normal
measur
expect
surviv
patient
hypoperfus
poor
prognosi
patient
vasospasm
use
nimodipin
consid
howev
studi
need
determin
safeti
effi
caci
tcd
may
use
determin
earli
prognosi
studi
also
need
determin
whether
tcd
improv
outcom
patient
sever
tbi
yet
confi
rmed
suppos
hbo
could
make
oxygen
stay
longer
injur
tissu
poor
circul
perfus
blood
injur
area
mechan
may
help
explain
longer
eff
ect
hbo
hbo
treatment
purpos
studi
method
patient
suff
ere
subacut
traumat
brain
injuri
would
treat
hbo
enrol
studi
divid
two
group
frontal
lobe
lesion
nonfront
lobe
lesion
group
n
depend
iconographi
check
xct
mr
region
cerebr
oxygen
satur
rso
measur
somanet
invo
monitor
minut
treatment
hbo
minut
compress
minut
breath
oxygen
fio
mask
minut
rest
minut
decompress
meanwhil
arteri
blood
sampl
measur
blood
ga
analysi
cytokin
paramet
rso
show
signifi
cant
diff
erenc
follow
hbo
treatment
two
group
p
howev
inconceiv
result
blood
ga
analysi
partial
pressur
oxygen
pao
signifi
cantli
decreas
hbo
treatment
p
although
chang
take
eff
ect
clinic
manifest
otherwis
measur
cytokin
tnf
hbo
diff
erenc
p
group
conclus
hbo
eff
ect
brain
oxygen
satur
hbo
treatment
pao
signifi
cantli
decreas
follow
hbo
mechan
need
studi
introduct
studi
evalu
relationship
csf
level
brain
biomark
glial
fi
brillari
acid
protein
gfap
ubiquitin
ctermin
hydrolas
ii
spectrin
breakdown
partial
pressur
brain
tissu
oxygen
ptio
brain
temperatur
licox
system
fi
rst
hour
day
follow
sever
tbi
method
studi
sever
tbi
patient
csf
drainag
invas
monitor
partial
brain
tissu
oxygen
tension
pbto
brain
temperatur
use
licox
integra
neurosci
plainsboro
nj
usa
probe
csf
gfap
level
measur
quantit
elisa
assay
admiss
everi
hour
thereaft
maximum
day
use
doubl
lumen
bolt
ptio
temperatur
measur
licox
studi
focus
record
fi
rst
hour
follow
injuri
patient
well
preliminari
data
four
patient
day
total
durat
monitor
hour
fi
rst
hour
biomark
level
decreas
level
pbro
increas
three
biomark
correl
pbro
p
p
p
respect
fi
rst
hour
statist
signifi
cant
chang
level
brain
biomark
gfap
well
level
ptio
respect
p
p
p
p
howev
correl
biomark
brain
tissu
oxygen
sustain
improv
p
signifi
cant
correl
biomark
level
brain
temperatur
found
complic
monitor
conclus
fi
nding
show
cf
level
gfap
relat
brain
tissu
oxygen
acut
possibl
subacut
day
post
injuri
phase
sever
tbi
futur
studi
directli
address
relationship
chang
tissu
oxygen
biochem
marker
injuri
follow
sever
tbi
csf
level
biomark
brain
tissu
oxygen
could
yield
insight
pathophysiolog
event
follow
sever
tbi
aid
clinic
assess
sever
tbi
patient
introduct
traumat
brain
injuri
tbi
structur
lesion
heterogen
spatial
heterogen
consequ
insult
hypoxiahypotens
hh
andor
tbi
never
studi
object
studi
compar
eff
ect
standard
insult
hh
tbi
brain
energi
metabol
two
diff
erent
region
frontal
cortex
thalamu
method
twentyeight
spraguedawley
rat
random
four
group
sham
tbi
impact
acceler
alon
g
weight
drop
hh
blood
deplet
mean
arteri
pressur
mmhg
fio
minut
tbihh
tbi
follow
hh
minut
delay
cerebr
perfus
pressur
cpp
continu
invas
measur
brain
microdialysi
ptio
probe
insert
stereotax
right
thalamu
frontal
cortex
result
except
hh
phase
cpp
alway
greater
mmhg
hour
follow
hh
period
signifi
cant
increas
cerebr
lactatepyruv
ratio
figur
glycerol
glutam
observ
increas
higher
cortex
thalamu
group
subject
hh
p
tbihh
group
increas
glycerol
cortex
signifi
cantli
higher
compar
hh
group
p
well
thalam
cortic
glutam
minut
follow
hh
phase
reinject
reoxygen
increas
ptio
observ
cortex
thalamu
diff
erent
profi
le
lower
increas
cortex
figur
conclus
diff
erent
profi
le
cerebr
respons
hh
tbi
observ
higher
sensit
cortex
thalamu
postischem
hyperemia
seem
alter
traumat
cortex
conserv
thalamu
nontraumat
brain
introduct
decompress
craniectomi
indic
treatment
sever
intracrani
hypertens
howev
procedur
invas
potenti
associ
complic
present
preliminari
result
studi
compar
earli
late
decompress
craniectomi
sever
traumat
brain
injuri
method
patient
studi
admit
icu
tertiari
referr
center
careggi
teach
hospit
florenc
itali
year
total
data
braininjur
patient
underw
decompress
craniectomi
retrospect
examin
includ
two
group
base
decompress
craniectomi
execut
earli
decompress
craniectomi
group
decompress
craniectomi
perform
within
hour
brain
injuri
group
n
late
decompress
craniectomi
later
hour
group
b
n
patient
demograph
score
clinic
data
length
stay
fi
nal
outcom
collect
institut
databas
traumat
lesion
compar
admiss
use
marshal
score
hour
decompress
craniectomi
execut
ct
scan
glasgow
outcom
scale
go
month
also
collect
result
demograph
clinic
characterist
group
shown
figur
data
express
mean
sd
patient
underw
decompress
craniectomi
within
hour
injuri
group
signifi
cant
worst
marshal
score
compar
group
b
vs
respect
p
also
show
signifi
cant
enlarg
contus
compar
group
b
vs
p
icu
hospit
length
stay
mortal
signifi
cantli
diff
erent
group
go
evalu
month
show
good
recoveri
surviv
patient
group
group
group
b
conclus
data
limit
retrospect
natur
studi
encourag
earli
decompress
treatment
sever
intracrani
hypertens
decompress
craniectomi
consid
case
lack
respons
medic
even
intens
approach
introduct
purpos
studi
verifi
reliabl
optic
nerv
ultrasound
onu
detect
intracrani
hypertens
ih
ih
frequent
potenti
fatal
complic
sever
head
injuri
actual
intraventricular
cathet
repres
gold
standard
icp
measur
unfortun
present
seriou
complic
rel
contraind
like
thrombocytopenia
coagulopathi
comput
tomographi
transcrani
doppler
tcd
repres
noninvas
method
evalu
icp
present
drawback
onu
recent
suggest
noninvas
tool
diagnos
ih
reliabl
show
patient
sever
head
injuri
intracrani
hemorrhag
method
studi
conduct
patient
admit
neurointens
care
unit
moderatesever
head
injuri
period
januari
june
group
ten
healthi
subject
enrol
control
group
group
estim
icp
eicp
calcul
tcd
use
equat
propos
czosnyka
colleagu
measur
twice
day
consecut
day
sonograph
session
optic
nerv
sheath
diamet
onsd
measur
sagitt
transvers
plane
mm
behind
papilla
eye
signifi
cant
diff
erenc
found
group
regard
age
sex
onsd
distribut
shown
figur
onsd
eicp
icp
valu
signifi
cantli
higher
group
group
linear
regress
analysi
identifi
ed
signifi
cant
relationship
critic
care
volum
suppl
http
onsd
icp
r
calcul
receiv
oper
characterist
curv
onsd
valu
mm
result
optim
cutoff
point
sensit
specifi
citi
conclus
onsd
measur
correl
invas
noninvas
tcd
measur
icp
use
noninvas
bedsid
tool
diagnos
ih
safe
easi
perform
rapidli
give
reproduc
inform
patient
icp
introduct
traumat
brain
injuri
tbi
multiphas
diseas
follow
ing
initi
impact
secondari
injuri
includ
oxid
stress
infl
ammat
thought
contribut
signifi
cantli
death
disabl
ongo
damag
penumbra
brain
lead
demis
neuron
popul
ultim
decreas
brain
function
identifi
cation
variou
neural
marker
neuron
specifi
c
enolas
nse
variou
time
point
follow
tbi
may
help
us
better
understand
magnitud
secondari
injuri
follow
tbi
may
help
predict
outcom
patient
method
earli
serial
cerebrospin
fl
uid
csf
sampl
collect
patient
sever
tbi
gc
requir
placement
therapeut
ventriculostomi
follow
ventriculostomi
placement
csf
sampl
obtain
everi
hour
fi
rst
hour
postinjuri
everi
hour
postinjuri
day
level
nse
measur
use
elisa
method
result
follow
sampl
analysi
patient
found
tbi
patient
good
neurolog
outcom
level
nse
csf
rose
earli
ngml
within
hour
follow
initi
injuri
nse
level
rapidli
decreas
normal
level
ngml
approxim
hour
follow
injuri
level
persist
day
day
fi
nal
sampl
collect
patient
poor
outcom
lack
abil
return
preinjuri
activ
death
show
signifi
cantli
higher
level
nse
persist
day
post
injuri
late
level
rang
ngml
conclus
tbi
patient
good
outcom
increas
nse
level
csf
note
earli
time
point
hour
abat
approxim
hour
injuri
tbi
patient
poor
clinic
outcom
csf
level
nse
signifi
cantli
elev
later
time
point
fi
rst
day
post
injuri
introduct
aim
studi
determin
whether
serum
level
biomark
hyperphosphoryl
neurofi
lament
nfh
protein
nse
correl
sever
brain
injuri
outcom
children
traumat
brain
injuri
tbi
glasgow
outcom
scale
go
calcul
month
patient
gener
practition
unfavour
outcom
defi
ned
dd
go
correl
dd
go
measur
abil
dd
predict
go
month
survivor
assess
use
logist
regress
sensit
specifi
citi
dichotomis
dd
predict
unfavour
outcom
month
also
calcul
result
data
avail
patient
highli
correl
linear
relationship
evid
dd
go
spearman
correl
coeffi
cient
p
unfavour
outcom
measur
dd
show
sensit
ci
specifi
citi
predict
unfavour
outcom
month
defi
ned
go
dd
show
strong
associ
go
month
survivor
discharg
fulli
depend
patient
time
higher
odd
unfavour
outcom
adjust
known
tbi
prognost
factor
attenu
strength
associ
howev
dd
remain
statist
signifi
cant
strong
predictor
outcom
conclus
dd
strongli
associ
go
could
potenti
use
replac
miss
data
provid
surrog
outcom
measur
tbi
trial
valid
predict
score
may
also
aid
clinician
abil
discuss
patient
prognosi
hospit
discharg
refer
btcpa
ptcpa
treat
strategi
includ
emerg
depart
thoracotomi
edt
method
studi
populationbas
case
seri
observ
studi
taken
three
approach
patient
privat
aggress
treatment
strategi
resuscit
minut
aggress
infus
use
sheath
introduc
subclavian
vein
edt
inhospit
system
support
aggress
resuscit
logist
issu
close
locat
ed
room
cathet
intervent
ct
direct
entranc
exclus
lift
common
instrument
interchang
ed
includ
bed
prehospit
em
citi
cpa
patient
transfer
minut
nearest
select
hospit
receiv
treat
cpa
patient
bagvalvemask
resuscit
bvm
equip
valv
limit
fl
owrat
peak
airway
pressur
decreas
hyperventil
gastric
insuffl
ation
studi
devic
use
hospit
staff
without
train
evalu
possibl
chang
standard
bvm
sb
hospit
ward
posit
pressur
ventil
rare
need
train
sporad
particip
physician
nurs
randomis
use
standard
bvm
sb
ventil
resuscit
train
manikin
minut
mechan
sb
shortli
describ
sb
group
handson
train
provid
particip
ask
ventil
patient
would
patient
puls
breath
tidal
volum
regist
comput
connect
manikin
median
minut
ventil
interquartil
rang
iqr
litr
per
minut
sb
control
group
respect
figur
hyperventil
lminut
occur
control
group
p
conclus
use
sb
without
previou
handson
train
possibl
major
nurs
medic
staff
decreas
hyperventil
comparison
standard
bvm
current
studi
therefor
investig
effi
caci
ecc
dental
chair
comparison
ecc
fl
oor
method
two
dentist
two
nurs
experi
ecc
particip
studi
year
old
cm
height
kg
weight
studi
educ
cpr
perform
ecc
minut
resuscit
manikin
two
diff
erent
situat
fl
oor
dental
chair
separ
day
repeat
ecc
procedur
fl
oor
dental
chair
depth
compress
percentag
adequ
compress
evalu
addit
particip
comment
prefer
situat
questionnair
set
ecc
result
four
dental
personnel
perform
ecc
fi
time
fl
oor
fi
time
dental
chair
comment
prefer
set
fi
time
effi
caci
ecc
evalu
averag
depth
percentag
ecc
adequ
depth
mm
fl
oor
mm
dental
chair
percentag
ecc
adequ
depth
higher
fl
oor
set
dental
chair
set
although
reach
statist
signifi
canc
p
questionnair
three
prefer
dental
chair
set
two
diff
erenc
set
prefer
fl
oor
set
conclus
ecc
fl
oor
perform
eff
ectiv
easi
start
cpr
immedi
move
patient
onto
fl
oor
introduct
today
emerg
medic
servic
em
system
develop
countri
howev
known
whether
peopl
will
perform
cpr
whether
prepar
perform
cpr
telephon
cpr
advic
studi
examin
japanes
citizen
interest
import
immedi
cpr
defi
brillat
understand
import
method
patient
outofhospit
cardiac
arrest
due
nontraumat
etiolog
treat
center
past
year
enrol
cardiac
arrest
scene
exclud
patient
record
emerg
depart
review
japan
ambul
servic
dispatch
servic
emerg
lifesav
technician
elst
belong
fi
depart
elst
perform
advanc
cpr
cpa
patient
job
also
educ
call
taker
central
oper
center
medic
control
import
recognit
cpa
advic
immedi
bystand
cpr
result
total
patient
enrol
telephon
cpr
advic
perform
bystand
patient
bystand
actual
perform
cpr
five
percent
case
underw
voluntarili
bystand
cpr
telephon
advic
underw
bystand
cpr
accord
telephon
advic
undergo
cpr
telephon
cpr
advic
patient
bystand
cpr
reach
rosc
surviv
hour
discharg
patient
without
bystand
cpr
respect
restrict
wit
patient
bystand
cpr
reach
rosc
surviv
hour
discharg
without
bystand
cpr
reach
rosc
surviv
hour
discharg
respect
conclus
peopl
will
perform
cpr
bystand
prepar
perform
cpr
telephon
cpr
advic
help
howev
bystand
cpr
alway
adequ
result
distinct
eff
ect
cpr
surviv
rate
educ
citizen
beforehand
guid
bystand
proper
quick
advic
telephon
introduct
purpos
studi
analyz
eff
ect
type
natur
cpr
prognosi
outofhospit
cardiac
arrest
ohca
method
analyz
ohca
wit
citizen
handl
dispatch
system
ishikawa
japan
april
march
bystand
cpr
classifi
ed
four
group
accord
type
cc
cc
mmv
natur
one
initi
telephoneassist
instruct
presenc
bystand
cpr
signifi
cantli
augment
surviv
rate
howev
signifi
cant
diff
erenc
among
four
group
cpr
multivari
logist
regress
analysi
identifi
ed
three
time
factor
includ
interv
collapsetocal
calltofi
rst
cpr
calltoarriv
patient
independ
factor
associ
surviv
see
figur
conclus
signifi
canc
correct
time
factor
rather
type
cpr
consid
futur
guidelin
revis
conclus
altern
airway
devic
recommend
erc
lt
may
enabl
airway
control
rapidli
eff
ectiv
addit
use
lt
reduc
nofl
owtim
better
outcom
may
possibl
lt
may
good
altern
airway
devic
provid
maintain
patent
airway
resuscit
introduct
besid
gold
standard
endotrach
tube
supraglott
airway
devic
altern
emerg
airway
manag
goal
studi
identifi
airway
devic
provid
success
ventil
even
month
train
manikin
conclus
one
year
train
time
success
ventil
devic
lower
second
accept
compar
gold
standard
endotrach
tube
due
rise
gastric
infl
ation
rate
high
amount
insuffi
cient
tidal
volum
shorter
interv
train
mayb
necessari
introduct
purpos
studi
clarifi
infl
uenc
age
attitud
toward
initi
three
link
chain
surviv
method
gave
questionnair
attend
compulsori
program
basic
life
support
bl
drive
techniqu
begin
author
drive
school
questionnair
includ
background
studi
willing
four
hypothet
scenario
relat
initi
three
link
earli
emerg
call
cardiopulmonari
resuscit
cpr
one
initi
telephoneassist
chest
compress
use
a
respond
divid
young
year
n
middleag
year
n
older
person
year
n
group
result
signifi
cant
diff
erenc
gender
occup
residenti
area
experi
bl
train
knowledg
a
use
three
group
proport
respond
will
perform
desir
bl
action
lowest
older
person
group
tabl
multipl
logist
regress
analysi
confi
rmed
age
one
independ
factor
relat
neg
attitud
scenario
gender
occup
resid
area
experi
bl
train
knowledg
a
use
independ
factor
relat
neg
attitud
scenario
conclus
age
popul
neg
chain
surviv
will
follow
telephoneassist
direct
chest
compress
bl
train
modifi
ed
gain
confi
denc
awar
signifi
canc
benefi
earli
call
ecg
trace
record
ventricular
fi
brillat
vf
use
autom
extern
defi
brillat
a
contain
use
inform
predict
shock
outcom
focu
vf
waveform
morpholog
amplitud
spectral
properti
vf
may
predict
likelihood
success
defi
brillat
almost
previou
studi
amplitud
spectral
properti
ecg
trace
singularli
use
howev
approach
led
method
lack
suffi
cient
predict
power
method
five
hundr
patient
outofhospit
cardiac
arrest
arriv
emerg
room
examin
rhythm
identifi
ed
vf
confi
rmed
two
train
investig
ecg
data
store
modul
digit
form
period
minut
analyz
retrospect
ecg
trace
contain
cpr
artefact
remov
digit
fi
ltere
time
collaps
dispatch
scene
arriv
cpr
initi
defi
brillat
determin
dispatch
record
record
arrest
event
interview
bystand
hospit
record
preshock
vf
waveform
morpholog
studi
diff
erent
paramet
vf
ecg
signal
extract
introduc
pattern
classifi
cation
machin
combin
amplitud
spectral
featur
simultan
use
pattern
classifi
cation
machin
combin
amplitud
spectral
featur
vf
ecg
signal
show
improv
predict
power
compar
method
conclus
techniqu
could
help
determin
patient
receiv
shock
fi
rst
receiv
period
cpr
prior
shock
therebi
increas
probabl
surviv
potenti
impact
research
high
direct
gener
new
methodolog
abl
increas
probabl
surviv
cardiac
crisi
refer
introduct
recent
studi
report
increas
asystol
pulseless
electr
activ
pea
fi
rst
monitor
cardiac
arrest
rhythm
arriv
emerg
medic
servic
asystol
patient
presum
undergo
ischaemia
longer
time
may
benefi
treatment
reduc
hypox
brain
injuri
therapeut
hypothermia
th
expand
prehospit
care
initi
soon
possibl
rapid
cold
crystalloid
infus
frequent
method
howev
sever
haemodynam
instabl
contraind
aim
studi
assess
advers
eff
ect
prehospit
volum
expans
patient
initi
nonshock
rhythm
use
set
restrict
cardiovascular
monitor
method
patient
deem
elig
advanc
cardiac
life
support
acl
includ
long
arrest
wit
cardiopulmonari
resuscit
cpr
initi
within
minut
collaps
patient
random
treatment
control
group
trial
design
determin
safeti
eff
ectiv
earli
cool
initi
site
arrest
surviv
time
target
temperatur
document
result
data
present
mean
sd
median
interquartil
rang
mean
age
year
intervent
group
year
control
group
averag
cool
therapi
start
minut
group
minut
control
group
temperatur
hospit
admiss
signifi
cant
lower
group
time
target
tympan
temperatur
refl
ect
brain
temperatur
signifi
cant
faster
group
minut
vs
minut
p
advers
event
occur
patient
none
relat
cool
therapi
intervent
group
fi
patient
surviv
three
patient
cpc
control
group
four
patient
surviv
one
patient
cpc
conclus
use
intranas
cool
method
cool
much
faster
earlier
treat
patient
neurolog
intact
surviv
discharg
rate
higher
treat
patient
transnas
cool
induct
therapeut
hypothermia
prehospit
resuscit
feasibl
highli
eff
ectiv
lower
brain
temperatur
rapidli
method
er
possibl
immedi
introduct
realiz
mild
hypothermia
fi
eld
sought
investig
whether
hospitalwid
approach
th
ca
would
reduc
delay
result
improv
outcom
method
conduct
retrospect
analysi
th
intervent
follow
implement
hospitalwid
approach
th
reevalu
hospitalwid
approach
includ
educ
programm
th
guidelin
resuscit
room
ed
cool
pack
store
icu
could
taken
immedi
postca
patient
result
carosc
cahosp
delay
similar
group
hospitalwid
approach
signifi
cantli
reduc
time
initi
th
time
achiev
target
temperatur
see
tabl
small
sampl
size
may
prohibit
demonstr
outcom
diff
erenc
object
studi
demonstr
diff
erenc
chest
compress
eff
ectiv
bed
height
provid
suggest
optim
achiev
bed
height
eff
ectiv
chest
compress
demonstr
fatigu
chest
compress
provid
suggest
upper
time
limit
eff
ectiv
chest
compress
method
exclus
criterion
trial
previou
basic
life
support
train
past
year
refus
consent
particip
modifi
ed
laerdal
manikin
connect
dragor
ventil
measur
intrathorac
pressur
gener
manikin
place
hospit
trolley
cpr
perform
candid
three
diff
erent
bed
height
mid
thigh
anterior
superior
iliac
spine
xiphistern
area
chest
compress
continu
asynchron
ventil
allow
continu
second
record
taken
result
one
hundr
one
subject
took
part
diff
erenc
intrathorac
pressur
gener
diff
erent
bed
height
compar
use
anova
varianc
test
multipl
group
statist
critic
care
volum
suppl
http
signifi
cant
p
figur
also
found
eff
ectiv
cpr
decreas
period
figur
introduct
therapeut
hypothermia
defi
ned
control
cool
bodi
temperatur
therapeut
purpos
present
use
mildmoder
hypothermia
patient
neurolog
damag
increas
icu
regard
recent
studi
suggest
abl
improv
neurolog
outcom
patient
anox
cerebr
damag
follow
sudden
cardiac
death
sca
aim
studi
assess
role
therapeut
hypothermia
neurolog
outcom
patient
experienc
sca
ensu
return
spontan
circul
rosc
method
nineti
adult
patient
age
refer
icu
sca
due
cardiac
diseas
follow
rosc
randomli
alloc
follow
treatment
group
patient
group
treat
immedi
admiss
therapeut
hypothermia
plu
standard
treatment
patient
group
receiv
standard
treatment
patient
entri
present
gc
neurolog
outcom
assess
discharg
month
mean
go
scale
dead
veget
sever
disabl
moder
disabl
good
recoveri
consid
score
unfavour
outcom
score
favour
outcom
conduct
retrospect
studi
look
infect
rate
patient
treat
therapeut
hypothermia
th
follow
cardiac
arrest
admit
icu
bristol
royal
infi
rmari
sinc
may
th
recommend
patient
present
persist
coma
follow
cardiac
arrest
one
complic
th
risk
infect
hypothermia
suppress
immun
system
inhibit
releas
proinfl
ammatori
cytokin
suppress
chemotact
migrat
leukocyt
phagocytosi
patient
traumat
brain
injuri
th
hour
associ
higher
risk
infect
period
hypothermia
less
hour
patient
follow
cardiac
arrest
infect
common
report
patient
method
data
collect
retrospect
inform
icu
length
stay
whether
protect
cathet
pc
specimen
taken
whether
posit
cultur
whether
treat
antibiot
extract
data
icu
length
stay
also
obtain
infect
defi
ned
colonyform
unit
cfu
grown
either
pc
specimen
peripher
blood
cultur
identifi
ed
patient
treat
th
post
cardiac
arrest
nineteen
proven
infect
either
pc
peripher
blood
cultur
pc
specimen
taken
patient
patient
pc
specimen
taken
proven
infect
also
found
increas
icu
length
stay
associ
increas
infect
rate
patient
length
stay
greater
day
patient
length
stay
greater
day
shown
icu
patient
treat
th
follow
cardiac
arrest
proven
infect
pc
sampl
much
higher
rate
infect
patient
posit
cultur
suggest
risk
infect
patient
treat
therapeut
hypothermia
post
cardiac
arrest
higher
patient
cool
post
traumat
brain
injuri
introduct
present
review
process
use
develop
therapeut
hypothermia
program
outcom
fi
rst
year
despit
fact
therapeut
hypothermia
shown
improv
surviv
neurolog
outcom
cardiac
arrest
underus
slowli
introduc
mani
institut
one
reason
wide
use
may
diffi
culti
implement
program
method
multidisciplinari
team
assembl
explor
opportun
therapeut
hypothermia
patient
cardiac
arrest
pertin
literatur
review
guidelin
electron
order
draft
team
investig
avail
option
cool
chose
method
noninvas
requir
larg
fi
nancial
invest
institut
nurs
sent
intern
program
learn
hypothermia
becom
advoc
educ
educ
done
caregiv
prehospit
set
emerg
depart
cardiac
catheter
laboratori
adult
icu
advertis
commun
hospit
done
newspap
radio
televis
team
continu
meet
regularli
assess
modifi
program
base
experi
result
prior
start
program
therapeut
hypothermia
essenti
util
institut
twentyon
patient
cool
cardiac
arrest
resuscit
institut
fi
rst
year
miss
opportun
fifteen
surviv
good
neurolog
outcom
postcardiac
arrest
surviv
rate
without
hypothermia
literatur
rang
less
challeng
includ
alter
histor
practic
pattern
integr
sector
healthcar
deliveri
system
histor
drift
apart
interact
extrainstitut
regul
govern
prehospit
care
conclus
therapeut
hypothermia
program
institut
success
improv
patient
outcom
cardiac
arrest
element
contribut
success
program
includ
teamwork
multidisciplinari
natur
team
promot
awar
program
buyin
nurs
champion
program
icu
posit
patient
outcom
low
fi
nancial
invest
institut
introduct
measur
bodi
temperatur
use
tympan
method
ttm
repres
standard
noninvas
method
best
approxim
core
temperatur
ctm
howev
publish
evid
increasingli
cast
doubt
agreement
ttm
ctm
aim
studi
assess
agreement
two
method
temperatur
measur
critic
ill
patient
method
recruit
consecut
critic
ill
patient
requir
indwel
thermistortip
arteri
cathet
haemodynam
monitor
patient
simultan
collect
core
temperatur
obtain
arteri
cathet
tympan
temperatur
left
right
ear
supin
posit
tympan
temperatur
record
use
ear
set
ttme
core
set
tympan
temperatur
ttmc
accord
manufactur
instruct
kendal
tyco
healthcar
usa
local
ethic
committe
approv
waiv
studi
conduct
servic
improv
audit
blandaltman
analysi
use
measur
agreement
two
set
measur
result
patient
made
pair
measur
comparison
ttm
right
left
ear
result
high
variabl
record
temperatur
percentag
error
view
observ
larg
variabl
mean
ttm
two
ear
use
subsequ
comparison
core
temperatur
comparison
core
measur
tympan
measur
use
ear
set
ttme
show
small
posit
mean
bia
limit
agreement
loa
percentag
error
howev
ctm
ttm
compar
use
core
temperatur
set
thermomet
bia
loa
increas
creat
larger
bia
unadjust
ttm
conclus
tympan
temperatur
measur
show
larg
random
variabl
compar
core
temperatur
suggest
bilater
averag
tympan
measur
may
necessari
seri
use
core
set
increas
error
increas
bia
two
method
fi
nding
rais
possibl
diagnosi
fever
need
investig
may
aff
ect
choic
temperatur
measur
site
devic
set
use
predict
neurolog
prognos
comput
tomographi
resuscit
introduct
technolog
improv
ventil
design
may
confound
diagnosi
brain
death
describ
seri
patient
clinic
perceiv
breath
spontan
even
though
satisfi
ed
criteria
brain
death
misdiagnosi
cerebr
function
patient
delay
diagnosi
brain
death
subsequ
organ
donat
resourc
util
patientfamili
suff
ere
staff
moral
neg
impact
occur
method
ventil
trigger
mode
record
patient
patient
identifi
ed
author
high
likelihood
brain
death
receiv
pressur
support
ventil
patient
without
cranial
nerv
function
underw
formal
apnea
test
result
seven
patient
identifi
ed
cessat
cranial
nerv
function
thought
spontan
breath
activ
patient
pressur
support
ventil
fl
ow
trigger
formal
apnea
test
perform
tabl
conclus
improv
trigger
ventil
may
confound
diagnosi
brain
death
consid
unmet
need
transplant
neg
impact
recogn
death
famili
staff
resourc
util
patient
potenti
recipi
organ
mandat
simpl
solut
elimin
problem
propos
introduct
studi
patient
present
coma
limit
littl
known
prognosi
case
aim
studi
investig
acut
longterm
prognosi
episod
nontraumat
coma
method
adult
admit
consecut
emerg
depart
stockholm
sweden
februari
may
glasgow
coma
scale
gc
score
enrol
prospect
avail
data
use
explor
caus
impair
conscious
admiss
patient
surviv
hospit
follow
year
regard
surviv
fi
nal
studi
popul
patient
follow
eight
diff
erent
coma
etiolog
poison
n
stroke
n
epilepsi
n
circulatori
failur
n
infect
n
metabol
disord
n
respiratori
insuffi
cienci
n
intracrani
malign
n
hospit
mortal
rate
among
patient
vari
epilepsi
circulatori
failur
accumul
total
mortal
rate
vari
poison
malign
level
conscious
admiss
also
infl
uenc
prognosi
gc
score
conclus
prognosi
patient
present
nontraumat
coma
seriou
depend
larg
level
conscious
admiss
etiolog
coma
ad
suspect
coma
etiolog
routin
coma
grade
emerg
may
accur
predict
prognosi
introduct
recent
nearinfrar
timeresolv
spectroscopi
tr
quit
eff
ectiv
quantit
monitor
tissu
oxygen
er
actual
measur
photon
migrat
tissu
photon
mean
path
length
easili
obtain
center
graviti
tempor
profi
le
develop
studi
investig
whether
chang
cerebr
oxygen
satur
tso
obtain
tr
jugular
venou
oxygen
satur
sjvo
predict
cognit
declin
cardiac
surgeri
method
institut
approv
inform
consent
studi
patient
year
undergo
cardiac
surgeri
cardiopulmonari
bypass
cpb
tso
continu
monitor
use
hamamatsu
photon
kk
hamamatsu
japan
measur
sjvo
fr
oximetri
cathet
insert
retrograd
cannul
right
intern
jugular
vein
valu
tso
sjvo
compar
point
cpb
minut
onset
cpb
aorta
clamp
aorta
clamp
rewarm
aorta
declamp
end
rewarm
end
cpb
cognit
declin
evalu
mini
mental
state
examin
day
oper
statist
analysi
perform
repeatedmeasur
anova
follow
fisher
plsd
p
consid
statist
signifi
cant
result
four
case
show
postop
cognit
declin
mean
valu
tso
sjvo
oper
patient
without
postop
cognit
declin
n
respect
statist
signifi
canc
valu
howev
mean
valu
tso
sjvo
oper
patient
postop
cognit
declin
n
tso
sjvo
show
signifi
cant
diff
erenc
two
valu
p
rewarm
period
valu
signifi
cantli
higher
tso
vs
p
system
hypertens
smoke
show
strong
associ
ruptur
intracrani
aneurysm
arteri
previou
segment
higher
incid
aneurysm
onehalf
patient
complic
procedur
embol
cerebr
aneurysm
reveal
low
lethal
method
object
work
assess
use
monitor
region
brain
oxygen
satur
rso
identifi
cation
intraop
episod
cerebr
ischemia
surgic
clip
brain
aneurysm
moreov
aim
verifi
whether
kind
monitor
aff
ect
incid
postop
neurolog
defi
cit
method
monitor
patient
undergo
cerebr
aneurysm
clip
use
somanet
invo
cerebr
oximet
alarm
threshold
rso
defi
ned
minimum
drop
baselin
trigger
intervent
aim
increas
rso
valu
result
eleven
case
postop
deterior
neurolog
statu
note
six
revers
addit
intraop
event
numer
surgic
clip
displac
temporari
clip
aneurysm
ruptur
trap
occur
case
oper
side
rapid
last
increas
rso
valu
note
nearli
onehalf
case
impli
artifact
caus
neurosurg
procedur
nonoper
side
seven
case
rso
valu
dip
alarm
threshold
note
case
intervent
led
increas
normal
rso
valu
rel
short
time
sinc
valu
regist
frontal
lobe
nonoper
side
consid
repres
entir
brain
balanc
cerebr
oxygen
suppli
consumpt
seen
intraop
preserv
comparison
two
group
patient
without
neurolog
defi
cit
develop
postop
period
reveal
dispar
cerebr
oximetri
valu
nonoper
side
rang
monitor
physiolog
paramet
case
involv
addit
intraop
event
deterior
neurolog
statu
note
remain
case
one
occurr
regist
conclus
monitor
region
brain
oxygen
satur
oper
side
method
hamper
larg
percentag
fals
result
thu
monitor
tool
littl
prognost
valu
assum
frontal
lobe
nonoper
side
repres
entir
brain
regard
rso
measur
mainten
oxygen
suppli
demand
balanc
safeguard
brain
ischem
lesion
suppli
area
oper
arteri
stiff
ness
assess
sonograph
measur
carotid
femor
puls
wave
veloc
pwv
sonograph
measur
along
bnp
measur
obtain
upon
admiss
repeat
measur
perform
day
follow
acut
phase
sah
patient
mechan
ventil
condit
measur
result
patient
sever
sah
show
depress
lv
function
increas
aortic
stiff
ness
hunthess
fisher
scale
associ
lvef
r
p
r
p
respect
pwv
valu
r
p
r
p
respect
introduct
anemia
frequent
encount
critic
ill
patient
advers
aff
ect
cerebr
oxygen
deliveri
metabol
function
howev
limit
evid
support
use
pack
red
blood
cell
prbc
transfus
optim
brain
homeostasi
subarachnoid
hemorrhag
object
studi
investig
eff
ect
prbc
transfus
cerebr
oxygen
metabol
patient
subarachnoid
hemorrhag
method
prospect
observ
studi
neurolog
icu
univers
hospit
nineteen
prbc
transfus
studi
consecut
patient
subarachnoid
hemorrhag
underw
multimod
monitor
intracrani
pressur
brain
tissu
oxygen
cerebr
microdialysi
data
collect
baselin
hour
transfus
relationship
hb
chang
lactatepyruv
ratio
lpr
brain
tissu
oxygen
pbto
test
univari
multivari
analys
coil
group
hhh
therapi
csf
drainag
lumber
punctur
start
liber
patient
respect
due
least
two
follow
fi
nding
clinician
decis
headach
agit
elev
leukocyt
level
without
infect
new
motor
defi
cit
worsen
gc
sever
case
admiss
clip
coil
group
similar
although
mortal
morbid
rate
higher
coil
group
statist
diff
erenc
group
tabl
go
glasgow
outcom
score
h
h
hunt
hess
critic
care
volum
suppl
http
conclus
studi
demonstr
although
mortal
morbid
rate
dci
incid
lower
surgic
group
statist
signifi
canc
conclus
accord
outcom
conclud
group
obtain
greater
protect
vasospasm
incid
comparison
group
show
diff
erenc
mortal
p
valu
signifi
cant
vasospasm
still
signifi
cant
mortal
introduct
vasospasm
main
caus
death
cognit
defi
cit
patient
subarachnoid
hemorrhag
ruptur
aneurysm
asah
trial
shown
statin
acut
phase
asah
reduc
incid
morbid
mortal
cerebr
vasospasm
method
realiz
prospect
random
nonblind
studi
use
mg
svt
night
fi
rst
hour
begin
bleed
control
group
use
svt
day
januari
decemb
inform
consent
obtain
patient
ct
scan
perform
control
anoth
ct
scan
patient
alter
neurolog
signal
presenc
chang
suggest
vasospasm
correl
clinic
ct
scan
patient
taken
cerebr
arteriographi
examin
follow
angioplasti
procedur
necessari
liver
renal
function
ldl
cholesterol
evalu
weekli
ck
total
evalu
everi
day
exclus
criteria
liver
renal
diseas
pregnant
elev
serum
transaminas
three
time
valu
normal
creatinin
rhabdomyolysi
ck
total
ul
exclud
two
patient
bleed
hour
signifi
cant
chang
level
ck
total
renal
liver
function
includ
patient
svt
group
nine
control
group
mortal
eight
patient
six
patient
control
group
two
svt
group
vasospasm
confi
rmed
critic
care
volum
suppl
http
cerebr
arteriographi
examin
four
patient
control
group
one
patient
svt
group
patient
die
fisher
scale
iv
conclus
svt
dose
mg
eff
ectiv
reduc
mortal
compar
group
use
svt
also
decreas
incid
cerebr
vasospasm
despit
higher
apach
ii
score
group
use
svt
conclus
conclud
group
patient
sah
predominantli
femal
apach
ii
group
group
ii
regard
criteria
use
assess
patient
sah
observ
criterion
show
statist
signifi
canc
predict
death
serum
sodium
p
criteria
evalu
statist
signifi
canc
predict
prognosi
patient
refer
introduct
object
studi
investig
relationship
cardiac
output
respons
fl
uid
challeng
chang
brain
tissu
oxygen
pressur
pbto
patient
sever
brain
injuri
method
prospect
observ
studi
conduct
neurolog
icu
univers
hospit
seventyeight
fl
uid
challeng
administ
consecut
comatos
patient
underw
multimod
monitor
cardiac
output
intracrani
pressur
icp
pbto
relationship
cardiac
output
pbto
analyz
logist
regress
util
gee
exchang
correl
structur
fl
uid
bolus
analyz
result
increas
cardiac
output
median
absolut
vs
mmhg
percentag
vs
chang
pbto
greater
cardiac
output
respond
nonrespond
within
minut
end
fl
uid
bolu
infus
multivari
model
cardiac
output
respons
independ
associ
pbto
respons
adjust
odd
ratio
ci
p
adjust
mean
arteri
pressur
critic
care
volum
suppl
http
intracrani
pressur
endtid
co
stroke
volum
variat
show
good
abil
predict
cardiac
output
respons
area
roc
curv
best
cutoff
valu
see
figur
conclus
bolu
fl
uid
resuscit
result
augment
cardiac
output
improv
cerebr
oxygen
sever
brain
injuri
introduct
icm
softwar
encapsul
year
experi
brain
monitor
collect
data
varieti
bedsid
monitor
produc
time
trend
paramet
defi
ned
use
confi
gurabl
mathemat
formula
date
use
nearli
clinic
research
centr
worldwid
present
applic
continu
monitor
cerebr
autoregul
use
nearinfrar
spectroscopi
nir
method
data
multipl
bedsid
monitor
process
icm
real
time
use
larg
select
signal
process
method
includ
variou
time
frequenc
domain
analysi
function
well
fulli
customis
digit
fi
lter
fi
nal
result
display
varieti
way
includ
simpl
time
trend
well
time
window
base
histogram
cross
histogram
correl
forth
allow
complex
inform
bedsid
monitor
summar
concis
fashion
present
medic
nurs
staff
simpl
way
alert
develop
variou
patholog
process
conclus
icm
softwar
prove
use
tool
enhanc
batteri
avail
mean
monitor
cerebr
vasoreact
potenti
facilit
autoregul
guid
therapi
complex
data
analysi
also
hidden
insid
loadabl
profi
le
thu
allow
investig
take
full
advantag
valid
protocol
includ
advanc
process
formula
dysbal
relationship
outcom
neurologicneurosurg
care
unit
nnicu
period
year
method
prospect
evalu
patient
brain
diseas
develop
serum
sodium
mmoll
hyponatremia
mmoll
hypernatremia
compar
incid
cerebr
complic
glasgow
outcom
scale
upon
discharg
nnicu
mortal
nnicu
two
group
observ
period
serum
sodium
dysbal
occur
patient
major
hyponatremia
patient
hypernatremia
less
frequent
patient
hypernatrem
patient
stay
nnicu
longer
p
onset
hypernatremia
aros
patient
signifi
cantli
lower
glasgow
coma
scale
p
patient
cerebr
complic
p
wors
glasgow
outcom
scale
upon
discharg
nnicu
p
higher
mortal
nnicu
p
higher
incid
pulmonari
edema
p
receiv
antiedemat
therapi
p
diuret
p
hand
hyponatremia
frequent
upon
entri
nnicu
p
aros
later
brain
damag
p
comparison
hypernatremia
conclus
neurointens
care
hypernatremia
prognost
seriou
less
frequent
sodium
dysbal
hyponatremia
cerebr
contus
patient
brain
oedema
patient
subdur
hematoma
two
patient
glasgow
coma
score
rang
patient
mechan
ventil
diabet
hypertens
hypernatremia
document
patient
total
tbi
patient
total
inhospit
mortal
normal
sodium
level
inhospit
cours
patient
hypernatrem
adjust
baselin
risk
incid
hypernatremia
cours
icu
stay
signifi
cantli
relat
increas
mortal
hazard
ratio
p
howev
posit
correl
serum
sodium
level
durat
icu
stay
spearman
correl
coeffi
cient
p
conclus
hypernatremia
patient
sever
tbi
associ
increas
risk
death
longer
icu
stay
associ
independ
outcom
predictor
includ
age
glasgow
coma
score
strategi
prevent
hypernatremia
neurocrit
icu
encourag
refer
addit
chemic
prophylaxi
initi
soon
determin
safe
limit
data
exist
describ
use
chemic
prophylaxi
time
relat
ivcf
placement
patient
popul
aim
describ
use
time
relat
ivcf
placement
method
trauma
patient
retriev
prophylact
ivcf
insert
year
age
iss
enrol
descript
studi
patient
identifi
ed
use
local
trauma
registri
data
collect
registri
patient
chart
result
one
hundr
three
patient
prophylact
ivcf
describ
mean
age
year
male
mean
iss
total
injuri
total
injuri
maximum
ai
score
type
injuri
associ
maxim
ai
head
pelvic
thorac
spinal
cord
injuri
shock
present
admiss
patient
requir
icu
admiss
requir
intub
patient
requir
prbc
fi
rst
hour
retriev
ivcf
insert
prophylact
mean
day
rang
day
hospit
admiss
chemic
prophylaxi
initi
day
ivcf
patient
dalteparin
enoxaparin
initi
agent
choic
heparin
chosen
case
time
hospit
admiss
start
chemic
prophylaxi
rang
day
conclus
chemic
prophylaxi
initi
major
trauma
patient
ivcf
albeit
still
receiv
administ
lowmolecularweight
heparin
select
although
rapidli
insert
admiss
consider
delay
insert
ivcf
initi
chemic
prophylaxi
studi
icu
lower
limb
dvt
incid
compress
ultrasonographi
cu
perform
three
train
ultrasonograph
twice
week
discharg
sm
mr
administr
regist
daili
drug
consid
present
figur
mrtreat
patient
exclud
statist
analysi
diff
erenc
sm
administr
dvt
group
vs
dvtposit
group
assay
chisquar
test
result
period
studi
patient
enrol
lower
limb
dvt
diagnos
patient
dvt
incid
mr
administ
patient
associ
dvt
incid
p
statist
analysi
result
perform
patient
shown
figur
none
consid
sm
result
associ
dvt
incid
sedat
whole
number
sm
administ
conclus
studi
confi
rm
prior
fi
nding
mr
role
dvt
risk
factor
nevertheless
sm
administr
patient
treat
mr
associ
increas
dvt
risk
introduct
despit
evid
periop
hypercoagul
cancer
patient
consist
data
evalu
extent
durat
specifi
c
contribut
platelet
procoagulatori
protein
vitro
test
studi
compar
effi
caci
haemoviscoelastographi
versu
thromboelastographi
monitor
coagul
imbal
method
two
hundr
fortyon
patient
undergo
surgeri
abdomin
cancer
examin
effi
caci
varieti
coagul
test
complet
coagul
screen
thromboelastographi
teg
haemoviscoelastographi
hvg
perform
end
surgeri
calcul
elast
shear
modulu
standard
gt
hvg
gh
refl
ect
total
clot
strength
procoagulatori
protein
compon
respect
diff
erenc
estim
platelet
compon
gp
periop
increas
standard
correspond
increas
gt
p
contribut
calcul
gp
gt
conclud
serial
standard
thromboelastographi
hvg
viscoelast
test
may
reveal
independ
contribut
platelet
procoagulatori
protein
clot
strength
use
multipl
linear
regress
coagul
teg
hvg
variabl
use
model
postop
hypercoagul
result
show
compon
teg
fail
identifi
hypercoagul
r
p
compon
hvg
test
refl
ect
postop
coagulopathi
conclus
hypercoagul
refl
ect
complet
standard
coagul
monitor
teg
seem
predominantli
caus
increas
platelet
reactiv
hvg
provid
fast
easytoperform
bedsid
test
quantifi
vitro
coagul
may
use
determin
coagul
statu
cancer
patient
periop
aim
studi
incid
etiolog
assess
sever
thrombocytopenia
surgic
icu
sicu
patient
admit
central
armi
hospit
algier
algeria
method
conduct
retrospect
studi
admit
patient
year
enrol
studi
patient
chart
review
diff
erent
hemogram
record
admiss
discharg
one
hundr
fi
ftythre
thrombocytopenia
case
defi
ned
platelet
count
plt
x
report
result
among
patient
survivor
die
develop
thrombocytopenia
male
femal
onset
thrombocytopenia
major
patient
hour
icu
admiss
sever
plt
x
x
etiopatholog
multifactori
diffi
cult
obtain
precis
figur
abstract
statist
analysi
case
hemodynam
unstabl
multitrauma
patient
without
ard
fat
embol
necessit
volum
blood
product
administr
intravascular
devic
sepsi
present
case
dissemin
intravascular
coagulopathi
fi
thrombocytopenia
case
relat
drug
administr
late
onset
day
report
mortal
p
compar
overal
mortal
relat
sever
underli
diseas
associ
comorbid
conclus
thrombocytopenia
frequent
among
chirurg
patient
especi
multitrauma
patient
cardiovascular
instabl
aggress
volum
blood
product
administr
need
introduct
thrombocytopenia
common
occurr
critic
ill
popul
aim
determin
incid
sever
prognosi
thrombocytopenia
icu
method
retrospect
laboratori
result
review
consecut
admiss
victoria
infi
rmari
icu
undertaken
demograph
apach
ii
score
outcom
data
retriev
ward
watcher
system
icu
compar
survivor
nonsurvivor
platelet
level
admiss
icu
trough
level
icu
look
correl
length
stay
durat
mechan
ventil
data
analys
use
student
test
pearson
correl
coeffi
cient
chisquar
test
appropri
result
complet
data
avail
patient
popul
demograph
follow
male
mean
age
year
median
apach
ii
iqr
crude
icu
mortal
mean
length
stay
day
incid
thrombocytopenia
platelet
count
x
l
admiss
icu
increas
consid
entir
icu
stay
compar
survivor
nonsurvivor
nonsurvivor
lower
trough
platelet
count
x
l
vs
x
l
p
patient
platelet
count
less
x
l
highest
mortal
vs
p
platelet
data
use
construct
roc
curv
demonstr
area
curv
p
platelet
count
correl
neg
apach
ii
r
p
correl
signifi
cantli
length
stay
durat
mechan
ventil
conclus
thrombocytopenia
occur
icu
patient
correl
signifi
cantli
sever
ill
measur
apach
ii
decreas
platelet
count
correl
increas
mortal
highest
mortal
trough
icu
platelet
count
less
x
l
roc
characterist
also
demonstr
platelet
count
use
predictor
mortal
introduct
heparininduc
thrombocytopenia
hit
lifethreaten
limbthreaten
immunemedi
prothrombot
diseas
result
interact
heparin
platelet
factor
due
mani
caus
thrombocytopenia
critic
ill
patient
diagnosi
hit
diffi
cult
requir
high
clinic
suspicion
confi
rmatori
test
elisa
test
commonli
perform
method
detect
antibodi
howev
elisa
result
gener
take
one
day
report
particl
immunofi
ltration
assay
pifa
test
advantag
done
rapidli
result
gener
avail
within
hour
method
start
juli
patient
micu
screen
daili
thrombocytopenia
defi
ned
either
platelet
count
decreas
least
baselin
absolut
platelet
count
less
patient
thrombocytopenia
underw
pifa
gti
elisa
test
antibodi
pifa
qualit
test
report
result
posit
neg
gti
elisa
test
report
optic
densiti
od
od
greater
consid
posit
patient
follow
hospit
introduct
heparininduc
thrombocytopenia
hit
lifethreaten
limbthreaten
immunemedi
prothrombot
complic
caus
heparin
drug
aim
studi
evalu
incid
hit
mix
icu
popul
method
patient
admit
icu
region
referr
center
careggi
teach
hospit
florenc
itali
underw
unfraction
heparin
ufh
lowmolecularweight
heparin
lmwh
administr
prospect
observ
octob
exclus
criteria
haematolog
malign
platelet
count
anticoagul
treatment
anticoagul
administr
start
patient
show
fall
platelet
count
nadir
clinic
evalu
score
case
least
investig
laboratori
antigen
assay
elisa
posit
test
underw
function
confi
rmation
test
heparininduc
platelet
activ
hipa
test
result
preliminari
result
refer
period
start
august
patient
admit
icu
enrol
studi
clinic
evalu
perform
patient
valu
least
eight
ufh
remain
lmwh
potenti
etiolog
thrombocytopenia
consid
patient
septic
three
extracorpor
membran
oxygen
two
admit
icu
due
cardiogen
shock
elisa
test
result
posit
three
suspect
hit
case
none
three
case
result
posit
hipa
test
hit
exclud
medium
suspect
hit
case
wherea
diff
er
patient
posit
neg
elisa
test
conclus
hit
incid
icu
extrem
rare
case
shown
studi
hit
suspect
patient
hit
incid
icu
patient
show
numer
potenti
etiolog
thrombocytopenia
popul
sepsi
common
refer
introduct
mani
procedur
cardiac
surgeri
requir
extracorpor
circul
ec
ec
blood
pump
venou
line
oxygen
cool
infus
back
via
arteri
line
procedur
known
compromis
coagul
system
especi
prolong
hypothermia
aim
present
studi
investig
eff
ect
ec
hypothermia
coagul
system
porcin
model
effi
caci
substitut
therapi
prothrombin
complex
concentr
pcc
regard
normal
coagul
decreas
hemorrhag
evalu
method
total
male
anesthet
pig
includ
studi
ec
perform
anim
hollowfi
ber
oxygen
prime
solut
contain
salin
he
heparin
five
anim
without
ec
serv
control
coagul
system
character
thromboelastographi
teg
thrombin
gener
coagul
factor
level
platelet
number
function
aggreg
goretex
patch
insert
carotid
arteri
bleed
occur
stitch
channel
eff
ect
intraven
substitut
therapi
pcc
beriplex
pn
ukg
n
compar
placebo
n
bleed
stitch
channel
investig
result
ec
hypothermia
compromis
coagul
system
coagul
factor
level
decreas
teg
thrombin
gener
becam
patholog
platelet
count
aggreg
decreas
blood
loss
stitch
channel
goretex
patch
doubl
ec
group
compar
anim
without
ec
substitut
therapi
pcc
blood
loss
decreas
signifi
cantli
ml
ec
placebo
ml
ec
pcc
group
p
wilcoxon
test
figur
pcc
normal
impair
coagul
conclus
hypothermia
ec
led
compromis
coagul
system
result
increas
hemorrhag
defi
cit
coagul
could
overcom
substitut
therapi
pcc
elev
blood
loss
stitch
channel
decreas
signifi
cantli
treatment
pcc
conclud
pcc
benefi
cial
patient
undergo
cardiovascular
surgeri
ecinduc
coagulopathi
introduct
dilut
coagulopathi
follow
massiv
bleed
result
clot
factor
dilut
impair
fi
brin
polymer
infus
colloid
plasma
expand
although
fi
brinogen
clinic
use
treat
dilut
coagulopathi
eff
ect
fi
brinogen
dosag
normal
coagul
function
unclear
studi
investig
eff
ect
six
diff
erent
fi
brinogen
dosag
rang
mgkg
paramet
overal
blood
loss
pig
model
dilut
coagulopathi
method
fortytwo
pig
underw
hemodilut
standard
bone
injuri
perform
complet
hemodilut
anim
random
receiv
mgkg
fi
brinogen
fgtw
lfb
franc
ml
salin
four
hour
fi
brinogen
administr
standard
liver
injuri
perform
anim
observ
hour
death
blood
loss
measur
tissu
sampl
collect
end
studi
hemodynam
coagul
paramet
measur
baselin
bl
hemodilut
minut
hour
drug
infus
hour
liver
injuri
right
anim
death
statist
signifi
canc
set
p
result
fibrinogen
dosag
mgkg
higher
complet
revers
dilut
coagulopathi
maximum
clot
fi
rmness
mcf
decreas
hemodilut
vs
mm
bl
p
return
bl
level
fi
brinogen
administr
mm
blood
loss
bone
liver
injuri
signifi
cantli
decreas
increas
fi
brinogen
dosag
sham
mgkg
mgkg
mlkg
bw
mgkg
thrombot
event
occur
conclus
swine
model
hemodilut
bone
liver
injuri
fi
brinogen
administr
mgkg
normal
mcf
decreas
blood
loss
infus
time
dosag
recommend
human
induc
hypercoagul
introduct
postpartum
haemorrhag
pph
lead
caus
matern
death
present
guidelin
pph
manag
focu
uteroton
treatment
potenti
effi
caci
antifi
brinolyt
drug
poorli
explor
indic
method
approv
ethic
committe
randomli
assign
women
pph
ml
vagin
deliveri
receiv
intraven
tranexam
acid
txa
g
within
hour
follow
ghour
hour
txa
group
antifi
brinolyt
treatment
control
group
monitor
manag
perform
accord
guidelin
addit
procoagul
treatment
coagul
concentr
fresh
frozen
plasma
platelet
use
pph
becam
intract
ml
minut
embol
surgeri
perform
consid
clinic
necessari
blood
loss
matern
morbid
safeti
collect
four
time
point
inclus
minut
hour
hour
studi
plan
base
hypothesi
txa
would
induc
blood
loss
reduct
risk
risk
requir
inclus
patient
group
statist
analysi
use
sa
system
result
one
hundr
fortyfour
patient
includ
txa
group
control
group
manag
data
similar
two
group
txa
group
compar
control
figur
abstract
blood
loss
goretex
patch
ec
group
blood
loss
lower
p
lower
p
bleed
durat
shorter
vs
minut
p
matern
morbid
reduc
hemoglobin
drop
gdl
n
vs
p
blood
transfus
requir
n
vs
p
ns
overal
number
transfus
pack
red
blood
cell
n
vs
p
number
sever
pph
charbit
criteria
n
vs
p
invas
procedur
need
four
women
txa
group
seven
women
control
group
p
ns
transient
visual
digest
side
eff
ect
observ
frequent
txa
group
control
group
vs
p
conclus
result
show
fi
rst
time
txa
administ
earli
manag
pph
reduc
blood
loss
matern
morbid
minor
transient
side
eff
ect
txa
readili
avail
cheap
hemostat
agent
strongli
suggest
investig
adjuv
treatment
pph
fi
rst
public
appear
use
recombin
factor
viia
rfviia
uncontrol
haemorrhag
sinc
widespread
intern
use
rfviia
set
consensu
guidelin
publish
much
variat
administr
method
review
blood
bank
databas
six
acut
hospit
southwest
england
januari
februari
undertaken
reveal
prescript
rfviia
case
note
analys
administr
blood
product
hour
either
side
rfviia
administr
extract
blood
bank
databas
result
eightytwo
patient
identifi
ed
receiv
licenc
rfviia
full
data
avail
patient
unequ
use
hospit
plymouth
use
compar
taunton
total
patient
male
mean
age
year
mean
apach
ii
score
patient
die
hour
mean
dosag
administ
number
annual
prescript
show
bimod
pattern
peak
distribut
usag
predominantli
gener
vascular
surgic
patient
trauma
obstetr
cardiac
surgeri
next
frequent
specialti
rfviia
given
mean
unit
pack
red
cell
unit
fresh
frozen
plasma
pool
platelet
follow
rfviia
transfus
blood
product
markedli
less
three
patient
receiv
repeat
dose
rfviia
prothrombin
time
decreas
mean
second
second
follow
rfviia
thirtysix
per
cent
patient
platelet
administr
acidot
ph
sixtyeight
per
cent
patient
haematocrit
patient
hypotherm
conclus
label
prescrib
rfviia
vari
wide
across
southwest
region
use
adjunct
therapi
uncontrol
haemorrhag
often
unsuccess
analysi
prescrib
rfviia
set
refl
ect
practic
larger
australian
seri
term
indic
dosag
howev
mortal
day
lower
seri
still
heterogen
prescrib
rfviia
use
conform
european
guidelin
introduct
bleed
cardiac
surgeri
common
state
associ
advers
eff
ect
factor
viia
recombin
factor
abl
restor
blood
coagul
without
signifi
cant
advers
eff
ect
aim
evalu
whether
earli
use
factor
viia
reduc
bleed
rate
transfus
method
studi
patient
submit
cardiac
surgeri
present
bleed
heparin
revers
fi
rst
replac
clot
factor
patient
submit
valv
procedur
coronari
arteri
bypass
surgeri
cabg
valv
cabg
aortic
ascend
surgeri
cardiac
transplant
receiv
factor
viia
earli
intraop
room
receiv
drug
icu
result
group
patient
present
statist
signifi
cant
reduct
blood
transfus
receiv
factor
viia
p
group
patient
undergo
earli
use
present
lower
rate
reoper
due
bleed
p
receiv
less
unit
red
blood
cell
p
fresh
frozen
plasma
p
cryoprecipit
platelet
p
also
detect
low
incid
infect
group
receiv
factor
intraop
room
conclus
earli
use
factor
viia
patient
bleed
cardiac
surgeri
associ
lower
rate
reoper
lower
rate
transfus
lower
incid
infect
suggest
drug
use
last
therapeut
tool
may
indic
earlier
manag
bleed
refer
introduct
venou
thromboembol
common
complic
cancer
patient
may
due
hypercoagul
state
malign
surgic
treatment
method
patient
undergo
plan
cur
open
surgeri
abdomin
cancer
receiv
mednord
ukrain
co
analyz
analysi
hvg
viscoelast
test
measur
clot
format
includ
inform
cellular
well
plasmat
coagul
system
examin
effi
caci
varieti
coagul
test
complet
coagul
screen
activ
clot
time
thromboelastographi
teg
haemoviscoelastographi
hvg
perform
surgeri
end
surgeri
postop
day
analyz
reaction
time
maxim
amplitud
calcul
elast
shear
modulu
standard
gt
hvg
gh
refl
ect
total
clot
strength
procoagulatori
protein
compon
respect
diff
erenc
estim
platelet
compon
gp
periop
increas
standard
correspond
increas
gt
p
contribut
calcul
gp
gt
conclud
serial
standard
thromboelastographi
hvg
viscoelast
test
may
reveal
independ
contribut
platelet
procoagulatori
protein
clot
strength
use
multipl
linear
regress
coagul
teg
hvg
variabl
use
model
postop
hypercoagul
howev
three
compon
routin
coagul
assay
includ
bleed
time
prothrombin
time
platelet
count
could
model
show
prolong
postop
hypercoagul
p
conclud
compon
hvg
test
refl
ect
postop
coagulopathi
result
suggest
may
use
determin
coagul
statu
cancer
patient
periop
introduct
number
studi
observ
decreas
surviv
associ
transfus
leukocytemedi
immunosuppress
may
contribut
postop
infecti
complic
evid
benefi
use
leukocyt
reduc
transfus
unclear
among
septic
shock
patient
japan
leukocytedeplet
blood
product
use
sinc
assess
eff
ect
transfus
effi
caci
use
leukocytedeplet
blood
product
new
onset
septic
shock
mortal
among
patient
septic
shock
method
total
septic
shock
patient
singl
univers
gener
icu
enrol
studi
target
hemoglobin
hb
concentr
gdl
ht
consid
allogen
red
cell
transfus
maintain
central
venou
satur
earli
phase
sever
sepsi
hb
kept
rang
gdl
stabl
phase
except
patient
particular
diseas
acut
coronari
syndrom
forth
fresh
frozen
plasma
use
keep
ptinr
platelet
transfus
done
due
patient
condit
exampl
postop
forth
result
eightysix
patient
receiv
transfus
group
age
apach
ii
receiv
blood
product
group
nt
age
apach
ii
frequent
site
infect
lung
peritoneum
mediastinum
gastrointestin
tract
ns
group
overal
mortal
group
vs
group
nt
vs
p
onset
new
septic
shock
group
vs
group
nt
vs
p
survivor
receiv
japanes
unit
total
blood
product
unit
patient
die
respect
american
unit
almost
equival
japanes
unit
p
group
patient
receiv
leukocytereduc
blood
product
lrb
receiv
ordinari
product
cont
overal
mortal
lrb
vs
cont
vs
p
conclus
total
amount
blood
product
receiv
highli
associ
increas
mortal
obviou
advers
eff
ect
transfus
onset
new
septic
shock
associ
overal
mortal
use
leukocyt
deplet
blood
identifi
ed
patient
septic
shock
prospect
studi
compar
outcom
restrict
liber
strategi
cardiac
surgeri
studi
doubleblind
random
studi
determin
whether
restrict
strategi
red
cell
transfus
liber
strategi
produc
equival
result
patient
submit
cardiac
surgeri
method
novemb
enrol
patient
undergo
elect
cardiac
surgeri
randomli
assign
patient
restrict
strategi
transfus
red
cell
transfus
hematocrit
concentr
drop
patient
liber
strategi
transfus
given
hematocrit
fell
transfus
strategi
follow
oper
room
icu
stay
compar
rate
complic
death
caus
hospit
stay
clinic
outcom
patient
day
adult
patient
written
inform
consent
alloc
would
submit
elect
primari
surgeri
redon
adult
cardiac
surgic
patient
coronari
arteri
bypass
graft
valv
procedur
combin
procedur
result
overal
hospit
mortal
similar
two
group
vs
p
rate
complic
similar
two
group
deleteri
eff
ect
red
blood
cell
rbc
transfus
well
known
restrict
transfus
practic
safe
patient
without
activ
haemorrhag
object
determin
transfus
practic
critic
ill
patient
without
evid
ongo
bleed
establish
conform
publish
guidelin
method
adult
icu
patient
receiv
rbc
transfus
septemb
august
includ
analysi
data
collect
demograph
apach
ii
score
icu
hospit
length
stay
lo
icu
hospit
mortal
presenc
ischaem
heart
diseas
ihd
preposttransfus
haemoglobin
concentr
gdl
hb
subgroup
analys
perform
patient
ihd
age
year
apach
ii
analys
patient
ihd
benefi
liber
transfus
confi
rmed
wherea
latter
two
subgroup
shown
mortal
benefi
restrict
transfus
result
total
patient
admit
icu
studi
period
two
hundr
fi
patient
receiv
rbc
activ
bleed
exclud
analysi
import
restrict
transfus
limit
morbid
mortal
make
effi
cient
use
rbc
studi
demonstr
import
regular
audit
use
inform
local
guidelin
introduct
transfus
red
blood
cell
use
object
improv
oxygen
deliveri
tissu
critic
ill
patient
howev
appropri
hemoglobin
hb
level
still
controversi
septic
shock
patient
object
studi
evalu
eff
ect
red
blood
cell
transfus
central
venou
satur
svco
lactat
level
patient
septic
shock
two
diff
erent
level
hb
method
patient
less
hour
septic
shock
hb
level
gdl
random
maintain
hb
gdl
group
group
hour
transfus
hb
lactat
svco
determin
result
express
median
percentil
percentag
analyz
chisquar
mannwhitney
test
p
consid
signifi
cant
result
fortysix
patient
includ
total
transfus
group
group
without
diff
erenc
demograph
hemodynam
data
group
hb
level
gdl
gdl
group
p
gdl
gdl
group
p
reduct
median
lactat
transfus
found
patient
alter
lactat
level
reduct
found
regardless
basal
level
hemoglobin
p
p
group
respect
demonstr
patient
svco
p
p
group
respect
hand
patient
normal
level
perfus
paramet
present
worsen
variabl
either
group
group
conclus
red
blood
cell
transfus
improv
tissu
perfus
patient
sign
hypoperfus
regardless
basal
level
hb
transfus
seem
worsen
tissu
perfus
patient
without
sign
hypoperfus
even
group
hb
level
gdl
refer
introduct
uncontrol
haemorrhag
lead
caus
earli
mortal
trauma
administr
blood
product
pack
red
cell
fresh
frozen
plasma
prbc
ffp
ratio
associ
improv
mortal
major
haemorrhag
adult
trauma
howev
littl
evid
avail
manag
major
haemorrhag
context
paediatr
trauma
method
retrospect
analys
local
paediatr
trauma
databas
children
follow
trauma
call
activ
arriv
emerg
depart
royal
london
hospit
major
urban
trauma
centr
london
studi
period
month
may
august
period
major
haemorrhag
polici
within
centr
paediatr
trauma
collect
data
demograph
profi
le
injuri
sever
score
blood
product
transfus
fi
rst
hour
outcom
defi
ned
massiv
transfus
requir
pack
red
cell
mlkg
fi
rst
hour
mlkg
fi
rst
hour
result
two
hundr
twentyseven
children
present
emerg
depart
period
follow
major
trauma
call
activ
median
age
present
year
thirteen
children
major
haemorrhag
median
iss
iqr
one
male
three
penetr
trauma
one
made
theatr
die
four
emerg
damag
control
surgeri
abnorm
result
seen
three
patient
one
abnorm
result
inr
aptt
low
hb
thrombocytopaenia
eight
patient
receiv
addit
blood
product
fresh
frozen
plasma
platelet
cryoprecipit
howev
patient
receiv
ratio
blood
product
prbc
ffp
practis
adult
trauma
two
patient
admiss
blood
done
worsen
coagul
paramet
seen
two
patient
measur
post
transfus
remain
patient
routin
monitor
blood
paramet
post
transfus
eight
patient
die
seven
die
emerg
depart
conclus
major
haemorrhag
associ
high
mortal
sever
injur
children
recommend
rigor
monitor
laboratori
paramet
guid
appropri
administr
blood
product
need
institut
major
haemorrhag
polici
paediatr
trauma
consider
pointofcar
test
blood
paramet
method
twentyon
pig
anesthet
instrument
random
three
group
control
he
gel
anim
he
gel
group
submit
acut
isovolem
anemia
target
hematocrit
volum
replac
perform
he
gel
ratio
withdrawn
blood
return
anim
minut
end
aia
tnf
measur
perform
blood
sampl
collect
femor
vein
follow
time
point
baselin
instrument
inst
immedi
aia
aia
minut
aia
minut
aia
minut
blood
infus
minut
blood
infus
cytokin
measur
serum
commerci
avail
elisa
specifi
c
monoclon
antibodi
twoway
analys
varianc
anova
tukey
test
use
assess
signifi
canc
p
result
tnf
vari
signifi
cantli
among
group
diff
erent
time
point
aia
control
gel
p
control
he
p
gel
p
control
gel
p
control
gel
p
relat
gel
group
verifi
ed
statist
signifi
cant
time
point
compar
control
p
level
studi
gel
present
statist
signifi
cant
gel
compar
control
p
serum
level
geltreat
anim
statist
signifi
cantli
elev
control
gel
p
control
gel
p
conclus
fluid
replac
infl
uenc
cytokin
measur
acut
isovolem
anemia
express
serum
tnf
increas
especi
gel
group
introduct
communityacquir
sepsi
earli
stage
common
haemodynam
alter
remain
unclear
aim
studi
character
cardiovascular
alter
patient
prof
monocentr
observ
studi
character
patient
sepsi
emerg
depart
method
system
vascular
resist
svr
cardiac
output
co
measur
noninvas
use
taskforc
monitor
cnsystem
graz
austria
admiss
hour
hour
index
valu
calcul
svri
ci
lminutem
procalcitonin
pct
ngml
measur
serum
result
sampl
patient
includ
patient
receiv
haemodynam
examin
mean
age
year
male
patient
divid
pct
age
gender
previou
medic
histori
compar
group
heart
rate
vs
p
ns
mean
arteri
pressur
vs
mmhg
p
mean
svri
patient
pct
vs
p
time
admiss
diff
erenc
found
hour
vs
p
ns
hour
vs
p
ns
contrari
patient
pct
increas
hour
signifi
cant
p
diff
erenc
admiss
could
observ
ci
patient
pct
vs
mean
valu
admiss
vs
hour
vs
hour
vs
p
ns
see
figur
conclus
patient
communityacquir
sepsi
emerg
depart
elev
svri
time
admiss
patient
high
pct
signifi
cantli
lower
svri
patient
low
pct
cardiac
index
time
admiss
lower
limit
normal
rang
patient
fi
nding
strong
contrast
classic
pattern
sepsi
icu
svri
keenli
reduc
ci
elev
implic
patient
sepsi
emerg
depart
may
benefi
applic
fl
uid
posit
inotrop
substanc
vasopressor
introduct
multicentr
prospect
observ
studi
conduct
four
intens
therapi
unit
itu
india
june
june
determin
incid
outcom
sever
sepsi
among
adult
patient
method
patient
admit
itu
screen
daili
sir
organ
dysfunct
sever
sepsi
defi
ned
accp
sccm
patient
sever
sepsi
studi
result
total
itu
admiss
studi
sir
organ
dysfunct
found
patient
due
sepsi
incid
sever
sepsi
admiss
mean
age
studi
popul
year
sd
male
median
apach
ii
score
iqr
predomin
medic
admiss
itu
mortal
admiss
sever
sepsi
hospit
mortal
mortal
sever
sepsi
respect
standard
mortal
ratio
sever
sepsi
patient
median
durat
stay
itu
sever
sepsi
cohort
surviv
day
iqr
number
episod
infect
primari
reason
admiss
itu
cultur
posit
found
lung
predomin
sourc
sepsi
gramneg
organ
respons
case
gramposit
rest
parasit
viral
fungal
infect
conclus
sever
sepsi
common
indian
itu
itu
mortal
higher
compar
western
literatur
gramposit
infect
less
common
although
incid
parasit
viral
infect
higher
west
method
randomis
prospect
trial
paediatr
patient
admit
interdisciplinari
picu
tertiari
univers
hospit
assign
either
control
intervent
group
latter
receiv
inlin
fi
ltration
infus
fi
lter
pall
braun
intrapur
lipidintrapur
neonat
lipid
throughout
whole
infus
therapi
prior
studi
infus
regimen
optimis
prevent
precipit
incompat
solut
drug
primari
object
includ
reduct
incid
sepsi
thrombosi
sir
organ
failur
liver
lung
kidney
circul
mortal
result
eight
hundr
seven
children
femal
male
heterogen
background
underli
diagnos
gaussian
distribut
either
control
group
patient
inlin
fi
ltration
group
patient
includ
accord
studi
criteria
signifi
cant
reduct
incid
sir
intervent
group
ci
versu
patient
p
evid
diff
erenc
demonstr
occurr
sepsi
thrombosi
organ
failur
liver
lung
kidney
circul
mortal
control
intervent
group
conclus
occurr
sir
often
complic
treatment
intens
care
medicin
inlin
fi
ltration
eff
ectiv
reduc
incid
sir
er
novel
therapeut
option
introduct
intraven
catheterrel
bloodstream
infect
icrbsi
major
contribut
factor
inhospit
mortal
morbid
extend
inpati
stay
day
expenditur
per
patient
prospect
survey
conduct
unit
patient
central
venou
cathet
ascertain
incid
icrbsi
identifi
organ
determin
occurr
infect
variou
site
femor
intern
jugular
subclavian
line
survey
carri
period
week
data
collect
patient
case
note
includ
site
central
line
insert
length
line
situ
reason
line
remov
posit
blood
cultur
report
result
studi
period
patient
treat
unit
fiftytwo
central
venou
line
insert
patient
femor
n
intern
jugular
n
subclavian
line
n
line
review
daili
remov
indic
clinic
pyrexia
rais
white
cell
count
requir
total
femor
line
n
remov
due
clinic
indic
n
intern
jugular
n
subclavian
line
averag
durat
line
remain
situ
day
femor
day
intern
jugular
day
subclavian
line
blood
cultur
taken
time
line
remov
yield
posit
result
eight
femor
seven
intern
jugular
one
subclavian
line
survey
indic
incid
icrbsi
unit
coagulaseneg
staphylococci
cn
e
coli
pseudomona
mssa
mrsa
conclus
distribut
microorgan
caus
bacteraemia
broadli
similar
unit
teach
hospit
uk
cn
commonest
organ
isol
howev
e
coli
pseudomona
next
common
organ
unlik
unit
staphylococcu
aureu
second
preval
organ
incid
bacteraemia
femor
line
catheterday
lower
intern
jugular
line
catheterday
possibl
due
higher
index
suspicion
case
femor
line
earlier
remov
figur
studi
highlight
fact
femor
line
often
safest
option
unstabl
patient
head
injuri
eff
ectiv
manag
strict
adher
guidelin
reduc
icrbsi
central
venou
cathet
cvc
indispens
icu
catheterrel
bloodstream
infect
crbsi
lead
caus
healthcareassoci
infect
one
import
complic
cvc
nowaday
two
wellknown
way
diagnos
crbsi
standard
method
withdraw
cathet
conserv
method
without
withdraw
cathet
object
compar
inhospit
mortal
two
method
patient
crbsi
shortterm
cathet
icu
method
studi
conduct
mix
icu
tertiari
hospit
review
episod
crbsi
occur
icu
januari
decemb
standard
method
defi
ned
patient
cvc
least
one
posit
blood
cultur
obtain
peripher
vein
posit
semiquantit
cfu
cathet
segment
cultur
wherebi
organ
speci
antibiogram
isol
cathet
segment
peripher
blood
conserv
method
defi
ned
patient
cvc
least
one
posit
blood
cultur
obtain
peripher
vein
one
follow
diff
erenti
time
period
cvc
cultur
versu
peripher
cultur
posit
hour
simultan
quantit
blood
cultur
ratio
cvc
versu
peripher
result
studi
period
episod
bloodstream
infect
identifi
ed
catheterassoci
bloodstream
infect
crbsi
standard
method
conserv
method
consid
crbsi
patient
mean
age
standard
variat
sd
year
mechan
ventil
vasopressor
total
parent
nutrit
hemodialysi
doubl
lumen
mean
time
sd
place
day
inhospit
mortal
standard
method
versu
conserv
method
show
diff
erenc
vs
p
conclus
studi
show
diff
erenc
inhospit
mortal
standard
method
versu
conserv
method
patient
icu
crbsi
introduct
previou
guidelin
center
diseas
control
prevent
cdc
recent
publish
guidelin
societi
healthcar
epidemiolog
americainfecti
diseas
societi
america
sheaidsa
recommend
avoid
femor
access
reduc
risk
catheterrel
bacteremia
crb
howev
guidelin
recommend
cathet
site
regard
presenc
tracheostomi
found
data
incid
crb
compar
central
jugular
site
tracheostomi
femor
site
object
studi
determin
whether
jugular
site
tracheostomi
may
higher
risk
crb
femor
site
method
prospect
observ
studi
may
april
carri
medicalsurg
icu
univers
hospit
canari
island
tenerif
spain
includ
patient
undergo
central
jugular
catheter
tracheostomi
femor
venou
catheter
period
studi
use
cathet
femor
access
cathet
central
intern
jugular
access
tracheostomi
signifi
cant
diff
erenc
patient
central
jugular
tracheostomi
femor
access
age
sex
apach
ii
score
diagnosi
group
use
mechan
ventil
use
antimicrobi
use
total
parenter
nutrit
use
pulmonari
arteri
cathet
durat
cathet
diagnos
crb
femor
cathet
day
catheter
crb
central
intern
jugular
cathet
tracheostomi
day
catheter
incid
crb
higher
central
intern
jugular
tracheostomi
femor
site
vs
per
catheterday
risk
ratio
confi
denc
interv
p
conclus
femor
site
could
consid
safe
venou
access
central
intern
jugular
patient
tracheostomi
minim
risk
crb
central
venou
cathet
cvc
use
icu
compar
studi
antisept
impregn
standard
cathet
therefor
great
valu
method
altern
type
cvc
use
patient
record
patient
sex
age
apach
ii
score
gc
site
punctur
reason
withdraw
cathet
type
cathet
use
tip
cathet
cultur
group
divid
group
patient
punctur
use
standard
cvc
group
ii
patient
punctur
use
impregn
cvc
result
sixtytwo
patient
includ
male
studi
period
standard
cvc
impregn
cvc
averag
length
stay
higher
impregn
cvc
day
compar
standard
cvc
day
exclud
death
group
length
stay
cathet
group
day
compar
day
group
ii
ad
period
catheter
group
amount
day
day
group
ii
total
durat
group
ii
higher
group
regard
reason
withdraw
cvc
predomin
suspect
infect
time
standard
cvc
time
impregn
cvc
cultur
cathet
tip
posit
standard
cv
eight
cvc
impregn
group
patient
gc
averag
apach
ii
score
group
compar
group
ii
predomin
site
punctur
subclavian
vein
see
figur
conclus
accord
studi
observ
length
stay
use
impregn
cvc
higher
day
rate
colon
higher
standard
cvc
patient
requir
cvc
long
period
benefi
ted
use
impregn
cvc
introduct
chirurg
strategi
infect
control
complic
intraabdomin
infect
respons
alon
reduct
mortal
second
look
strategi
tertiari
periton
reduc
mortal
morbid
patient
vacuumassist
closur
therapi
potenti
decreas
concentr
proinfl
ammatori
cytokin
bacteri
count
manag
thirdspac
fl
uid
improv
input
output
monitor
method
author
present
revis
patient
tertiari
periton
admit
icu
chirurg
infect
control
patient
septic
shock
admiss
twelv
percent
admit
open
abdomen
vacuumassist
closur
therapi
use
paramet
evalu
hospit
mortal
icu
stay
day
time
mechan
ventil
day
patient
submit
vacuumassist
closur
therapi
similar
patient
abdomin
wall
close
regard
risk
factor
periton
infect
corticotherapi
oncolog
diseas
renal
insuffi
cienci
hepat
insuffi
cienci
desnutrit
hypoalbuminemia
high
apach
ii
score
patient
submit
vacuumassist
closur
therapi
higher
icu
stay
time
mechan
ventil
lower
hospit
mortal
conclus
vacuumassist
closur
therapi
superior
primari
abdomin
wall
closur
patient
tertiari
periton
sequenti
organ
failur
assess
sofa
score
wide
use
method
describ
organ
dysfunctionfailur
critic
ill
patient
although
major
studi
use
sofa
score
outcom
research
littl
known
correl
left
ventricular
lv
function
patient
sever
sepsi
septic
shock
purpos
studi
evalu
correl
sofa
score
lv
function
tissu
doppler
imag
patient
popul
method
sixti
patient
age
men
n
admit
icu
sever
sepsi
septic
shock
prospect
enrol
transthorac
echocardiographi
perform
within
hour
admiss
icu
measur
lv
end
diastol
volum
index
lvedvi
lv
end
systol
volum
index
lvesvi
lv
eject
fraction
lvef
mitral
deceler
time
e
veloc
dct
myocardi
tissu
doppler
strain
imag
profi
le
basal
mid
apic
portion
lv
septal
wall
lv
apic
fourchamb
view
icu
admiss
day
sofa
score
calcul
signifi
cantli
correl
paramet
subject
linear
regress
analysi
p
consid
signifi
cant
mean
heart
rate
bpm
mean
lv
volum
mean
lvef
mean
dct
within
normal
limit
lvedvi
mlm
lvesvi
mlm
lvef
dct
ms
mean
peak
systol
strain
measur
basal
mid
apic
mean
sofa
score
linear
regress
analysi
show
correl
sofa
score
lvef
r
p
dct
r
p
mean
septal
strain
r
p
midsept
strain
r
p
apic
septal
strain
r
p
conclus
result
suggest
higher
sofa
score
lower
lvef
lower
lv
systol
strain
higher
lv
fi
lling
pressur
patient
sever
sepsi
septic
shock
assess
left
ventricular
longitudin
contract
tissu
doppler
strain
imag
may
serv
use
tool
evalu
multipl
organ
failur
patient
popul
introduct
myocardi
dysfunct
reportedli
common
complic
sepsi
requir
specifi
c
manag
although
frequent
report
literatur
clinic
spectrum
frequenc
organ
failur
fulli
appreci
sought
determin
frequenc
myocardi
dysfunct
sever
sepsi
septic
shock
describ
clinic
spectrum
entiti
transthorac
echocardiographi
method
prospect
singlecent
studi
captur
patient
admit
icu
sever
sepsi
septic
shock
may
januari
patient
enrol
underw
comprehens
transthorac
echocardiographi
admiss
exclus
criteria
includ
year
age
pregnanc
document
ischem
valvular
congenit
heart
diseas
patient
lv
systol
dysfunct
defi
ned
lvef
receiv
repeat
echocardiograph
studi
day
upon
dismiss
icu
result
one
hundr
six
patient
enrol
mean
age
femal
mean
sofa
score
central
venou
oxygen
satur
less
patient
twentynin
patient
global
lv
systol
dysfunct
mild
nine
moder
six
sever
patient
rv
dysfunct
mild
nine
moder
six
sever
patient
biventricular
involv
patient
diastol
fi
lling
abnorm
patient
lv
systol
dysfunct
initi
examin
receiv
followup
echocardiogram
patient
n
improv
paramet
thirtyday
mortal
mortal
myocardi
dysfunct
predict
mortal
conclus
result
confi
rm
myocardi
dysfunct
frequent
broad
patient
sever
sepsi
septic
shock
right
ventricular
involv
diastol
abnorm
consid
part
clinic
spectrum
entiti
poor
correl
myocardi
dysfunct
mortal
revers
regardless
present
focu
left
ventricular
eject
fraction
diagnos
myocardi
dysfunct
sepsi
sinc
small
portion
patient
isol
lv
systol
dysfunct
sepsi
microcirculatori
blood
fl
ow
impair
intraven
nitroglycerin
ntg
seem
eff
ect
sublingu
microcircul
introduct
elev
serum
level
cardiacspecifi
c
troponin
ctni
claim
associ
degre
sepsisrel
cardiac
dysfunct
diseas
outcom
critic
ill
test
associ
specifi
c
group
icu
patient
posttraumat
sepsi
method
prospect
observ
studi
conduct
icu
level
iequival
trauma
center
septemb
august
exclus
criteria
adopt
serum
ctni
concentr
collect
peak
sepsisrel
cardiovascular
dysfunct
defi
ned
highest
pressur
adjust
heart
rate
par
mod
score
dose
inotrop
data
gather
demograph
sever
infl
ammatori
respons
sir
criteria
organ
dysfunct
mod
score
presenc
superimpos
acut
coronari
event
potenti
reason
ctni
elev
diseas
outcom
intergroup
comparison
made
student
testnonparametr
altern
prognost
util
ctni
examin
construct
roc
curv
level
categor
basi
defi
ned
cutoff
valu
probabl
associ
categori
organ
dysfunct
sever
well
outcom
examin
fisher
exact
test
result
total
polytrauma
patient
enrol
confi
denc
interv
par
mod
sir
respect
blunt
cardiac
injuri
diagnos
patient
admiss
three
patient
develop
acut
coronari
event
icu
stay
patient
potenti
reason
ctni
elev
signifi
cantli
higher
ctni
concentr
found
critic
ill
myocardi
contus
acut
coronari
event
howev
presenc
blunt
cardiac
injuri
measur
outcom
eff
ect
troponin
level
signifi
cantli
higher
nonsurvivor
p
good
prognost
perform
ctni
found
auroc
cutoff
valu
ngml
subsequ
comparison
categor
valu
par
mod
show
strong
posit
associ
elev
ctni
concentr
ngml
signifi
cantli
increas
risk
death
rr
ci
p
conclus
group
patient
posttraumat
sepsi
elev
serum
ctni
level
prove
good
marker
sever
organ
includ
cardiovascular
dysfunct
also
show
reason
prognost
valu
regard
diseas
outcom
measur
use
simpson
rule
earli
peak
diastol
relax
veloc
septal
mitral
annulu
e
cmsecond
measur
use
tissu
doppler
imag
apach
ii
score
calcul
admiss
apach
ii
score
two
group
form
low
apach
ii
score
la
defi
ned
patient
high
apach
ii
score
patient
patient
echocardiograph
examin
perform
age
vs
year
p
ns
male
sex
vs
p
ns
mean
arteri
pressur
vs
mmhg
p
ns
compar
wherea
patient
higher
heart
rate
vs
p
admiss
patient
signifi
cantli
lower
ef
patient
la
vs
p
diff
erenc
could
observ
hour
vs
p
ns
hour
vs
p
ns
see
figur
patient
show
lower
initi
e
patient
la
vs
p
hour
vs
p
three
day
admiss
e
valu
patient
la
compar
vs
p
ns
conclus
patient
communityacquir
sepsi
apach
ii
score
point
signifi
cantli
depress
systol
diastol
function
could
observ
hour
systol
function
hour
diastol
function
patient
apach
ii
score
point
similar
could
possibl
due
alter
afterload
follow
mmhg
drop
mean
arteri
pressur
map
baselin
sheep
randomli
assign
receiv
intraven
infus
either
pov
avp
vehicl
nacl
n
pov
avp
titrat
keep
map
baselin
mmhg
sheep
awak
mechan
ventil
fl
uid
resuscit
maintain
hematocrit
baselin
data
express
mean
sem
hour
fluid
repres
averag
time
account
individu
surviv
time
result
treatment
strategi
signifi
cantli
reduc
fl
uid
input
avp
mlkghour
pov
mlkghour
posit
net
fl
uid
balanc
avp
mlkghour
pov
mlkghour
thorac
avp
mlkghour
pov
mlkghour
abdomin
fl
uid
avp
mlkghour
pov
mlkghour
well
extravascular
lung
water
avp
mlkg
pov
ml
kg
increas
plasma
oncot
pressur
avp
mmhg
pov
mmhg
vs
control
anim
mlkghour
mlkg
hour
mlkghour
mlkghour
mlkg
mmhg
respect
notabl
pov
superior
avp
variabl
p
myocardi
contractil
higher
pov
group
vs
avp
control
anim
suggest
higher
left
ventricular
stroke
work
index
vs
gmm
respect
p
lower
similar
global
enddiastol
volum
pulmonari
dysfunct
decreas
pao
fio
ratio
attenu
pov
mmhg
compar
avp
mmhg
p
control
anim
mmhg
p
wherea
one
avp
three
control
anim
sacrifi
ced
prematur
povtreat
anim
surviv
studi
period
conclus
mrsa
pneumoniainduc
ovin
septic
shock
select
v
receptor
agonist
pov
superior
mix
v
v
agonist
avp
reduc
vascular
leakag
cardiopulmonari
dysfunct
administ
fi
rstline
vasopressor
introduct
improv
surviv
acut
myocardi
infarct
trauma
stroke
realiz
continu
qualiti
improv
cqi
initi
includ
earli
identifi
cation
implement
timesensit
therapi
earliest
stage
diseas
present
addit
challeng
manag
sever
sepsi
septic
shock
remain
regard
implement
earli
sepsi
resuscit
bundl
rb
order
maxim
outcom
benefi
examin
impact
hospitalwid
cqi
initi
septic
rb
complianc
outcom
investig
mortal
benefi
ts
beyond
recommend
period
method
prospect
cohort
studi
patient
met
defi
nition
sever
sepsi
septic
shock
period
current
sepsi
rb
map
cvp
svo
goal
met
within
hour
hour
upon
present
sever
sepsi
septic
shock
patient
enrol
examin
time
period
would
rb
still
eff
ectiv
use
time
cutoff
complier
hour
noncompli
hour
compar
patient
rb
complet
less
equal
hour
complier
hour
patient
never
complet
rb
within
hour
noncompli
hour
complier
hour
signifi
cant
lower
hospit
mortal
rel
reduct
compar
noncompli
hour
hospit
mortal
p
adjust
diff
erenc
baselin
ill
sever
complier
hour
greater
reduct
predict
mortal
vs
p
complianc
start
fi
nish
conclus
cqi
initi
sever
sepsi
septic
shock
particular
emphasi
rb
signifi
cantli
improv
bundl
complianc
decreas
hospit
mortal
previous
shown
complianc
rb
within
hour
improv
outcom
howev
time
bundl
complet
extend
hour
mortal
benefi
ts
still
signifi
cant
introduct
investig
eff
ect
myocardi
preserv
earli
goaldirect
therapi
egdt
sever
sepsissept
shock
patient
icu
method
prospect
random
control
studi
total
sever
sepsissept
shock
patient
icu
randomli
assign
two
group
egdt
group
n
control
group
n
concentr
serum
cardiac
troponin
ctni
high
sensit
creactiv
protein
hscrp
apach
ii
score
patient
obtain
day
fl
uid
resuscit
therapi
level
ctni
egdt
control
group
day
exceed
normal
ctni
patient
two
group
vs
normal
ctni
patient
two
group
vs
p
dramat
decreas
exceed
normal
ctni
patient
egdt
group
ctni
return
normal
egdt
day
exceed
normal
ctni
patient
two
group
vs
p
howev
littl
diff
erenc
normal
ctni
patient
two
group
p
level
hscrp
chang
like
ctni
p
posit
correl
ctni
hscrp
time
p
apach
ii
score
obvious
decreas
egdt
group
p
meanwhil
egdt
group
obvious
higher
surviv
rate
longer
surviv
time
control
group
vs
vs
p
conclus
egdt
eff
ect
myocardi
preserv
improv
surviv
rate
sever
sepsissept
shock
patient
icu
introduct
sepsi
mortal
rate
brazil
high
mani
studi
alreadi
shown
implement
educ
program
base
surviv
sepsi
campaign
ssc
bundl
success
reduc
sepsi
mortal
object
studi
evalu
impact
sscbase
program
patient
outcom
brazil
method
sever
sepsi
septic
shock
patient
includ
voluntari
particip
hospit
sent
data
least
year
intervent
base
strategi
aim
improv
complianc
bundl
regular
report
contain
complianc
mortal
data
sent
hospit
order
base
local
strategi
improv
care
result
present
semest
hospit
inclus
campaign
year
regardless
month
occur
time
frame
studi
result
complianc
ssc
increas
fi
rst
fourth
semest
follow
lactat
p
blood
cultur
p
antibiot
p
achiev
mean
arteri
pressur
mmhg
p
cvp
achiev
p
svo
achiev
p
complet
whole
bundl
p
absolut
reduct
rel
reduct
hospit
mortal
found
third
semest
campaign
p
howev
fourth
semest
mortal
increas
conclus
implement
ssc
brazil
associ
increas
bundl
adher
howev
impact
mortal
rate
seem
sustain
probabl
due
diffi
culti
associ
keep
educ
program
import
develop
strategi
aim
increas
motiv
brazilian
hospit
introduct
noradrenalin
dopamin
standard
catecholamin
use
treatment
septic
shock
loss
respons
common
problem
led
patient
loss
larg
continu
dose
noradrenalin
term
catecholamin
refractori
septic
shock
recent
vasopressin
analog
name
terlipressin
use
treatment
catastroph
condit
method
prospect
control
studi
includ
patient
catecholamineresist
septic
shock
noradrenalin
dose
exceed
divid
two
group
patient
treat
convent
accord
surviv
sepsi
campaign
serv
control
group
patient
treat
convent
noradrenalin
dose
exceed
minut
terlipressin
dose
mg
intraven
bolu
everi
hour
studi
time
hour
start
result
terlipressin
therapi
associ
increas
system
vascular
resist
cm
hour
repres
normal
arterilor
tone
expect
allow
better
organ
bed
perfus
reduct
stroke
volum
cardiac
output
mlbeat
ml
beat
lminut
lminut
respect
yet
associ
abnorm
organ
perfus
mark
improv
urin
output
mlhour
mlhour
improv
global
perfus
mark
decreas
lactic
acidosi
meql
meql
p
signifi
cant
reduct
oxygen
deliveri
mlminut
mlminut
hour
p
eff
ect
length
icu
stay
group
day
terlipressin
group
day
control
group
p
terlipressin
support
show
nonsignifi
cantli
less
mortal
vs
control
group
regard
organ
function
terlipressin
could
improv
sofa
score
p
conclus
terlipressin
rather
safe
inexpens
easi
administ
altern
treatment
septic
shock
studi
need
decid
ideal
time
initi
therapi
earli
vs
late
adjuv
initi
treatment
refer
patient
specifi
c
comorbid
chronic
liver
diseas
studi
evalu
whether
adher
resuscit
sepsi
bundl
improv
outcom
cirrhot
patient
septic
shock
admit
icu
method
prospect
observ
cohort
studi
includ
patient
document
cirrhosi
septic
shock
admit
multidisciplinari
icu
univers
hospit
januari
june
patient
complianc
four
resuscit
intervent
recommend
ssc
guidelin
bundl
mortal
measur
result
bundl
complet
patient
patient
meld
sofa
score
higher
p
observ
patient
without
complianc
bundl
vs
mortal
p
patient
without
bundl
complianc
respect
cox
regress
analysi
adjust
meld
sofa
score
indic
none
singl
sepsi
intervent
well
bundl
independ
associ
surviv
conclus
adher
resuscit
intervent
recommend
ssc
evidencebas
guidelin
improv
surviv
rate
cirrhot
patient
septic
shock
admit
icu
recent
interest
complic
daa
follow
review
gentri
colleagu
suggest
signifi
cantli
increas
incid
sbe
death
baselin
bleed
precaut
one
largest
singlecentr
user
daa
worldwid
thu
keen
report
experi
method
score
system
report
tool
support
databas
develop
track
outcom
daatreat
sever
sepsi
patient
hospit
maintain
clinic
pharmacist
captur
data
rel
contraind
advers
event
patient
outcom
classifi
cation
data
obtain
electron
patient
record
daa
administr
outsid
agre
criteria
record
bleed
incid
review
consult
intensivist
confi
rm
categoris
seriou
minor
conclus
result
similar
ukwid
audit
apc
usag
mortal
patient
higher
vs
patient
probabl
sicker
median
fi
organ
failur
vs
three
base
apach
actual
outcom
appear
wors
predict
patient
receiv
apc
use
icnarc
method
score
howev
outcom
hemoperfus
use
lp
adsorb
lp
adsorb
alteco
medic
ab
lund
sweden
patient
blood
taken
adsorpt
serum
separ
store
determin
lp
concentr
lal
test
lipopolysaccharidebind
protein
lbp
rii
elisa
kit
hycult
biotechnolog
netherland
proinfl
ammatori
antiinfl
ammatori
cytokin
elisa
kit
bender
medsystem
result
case
saw
reliabl
reduct
lp
level
serum
time
investig
cytokin
level
obtain
similar
result
level
reduc
accordingli
time
level
serum
chang
practic
howev
approxim
case
concentr
increas
serum
observ
accordingli
also
research
shown
case
applic
sorbent
lbp
decreas
insignifi
cantli
rii
level
slightli
increas
major
patient
consider
decreas
two
time
investig
patient
concentr
patient
serum
reliabl
chang
adsorpt
somat
statu
patient
stabil
lp
adsorpt
introduct
assum
patholog
activ
neutrophil
monocyt
associ
sepsi
acut
lung
injuryard
multipl
organ
failur
remov
cell
circul
could
reduc
leukocytedepend
tissu
injuri
cartridg
contain
polymyxin
b
pmx
immobil
fi
ber
toraymyxin
toray
industri
tokyo
japan
develop
select
adsorpt
circul
endotoxin
patient
gramneg
bacteri
infect
treatment
proven
highli
eff
ectiv
studi
examin
eff
ect
direct
hemoperfus
fi
lter
immobil
pmx
directhemoperfus
dhp
leukocyt
function
plasma
level
cytokin
patient
septic
shock
method
evalu
eff
ect
pmxdhp
circul
leukocyt
patient
septic
shock
assess
chang
neutrophil
monocyt
surfac
antigen
express
pmxdhp
anoth
experi
heparin
blood
patient
sepsi
pass
pmx
fi
lter
laboratori
circuit
chang
cell
count
surfac
antigen
express
neutrophil
monocyt
assess
perfus
neutrophil
isol
capac
cell
damag
cultur
endotheli
monolay
also
determin
found
pmxdhp
led
increas
express
along
decreas
express
circul
neutrophil
septic
patient
plasma
level
cytokin
includ
highmobl
group
elev
patient
septic
shock
compar
healthi
control
cytokin
level
alter
pmxdhp
ex
vivo
perfus
heparin
blood
patient
sepsi
pmx
fi
lter
laboratori
circuit
caus
signifi
cant
decreas
neutrophil
monocyt
count
activ
neutrophil
high
express
low
express
show
preferenti
adhes
pmx
fi
lter
neutrophil
isol
blood
ex
vivo
pmx
perfus
caus
less
damag
endotheli
cell
monolay
cell
shamtreat
blood
introduct
direct
rapid
remov
pathogen
noxiou
metabolit
patient
straightforward
cure
imagin
dialysi
plasma
fi
ltrationexchang
current
broadli
applic
method
perform
direct
remov
diseasecaus
factor
patient
describ
use
stabl
nanomagnet
rapidli
select
remov
heavi
metal
ion
overdos
steroid
drug
protein
human
blood
nanomagnetbas
purifi
cation
method
avoid
foul
fi
lter
membran
benefi
ts
high
extern
surfac
area
correspondingli
fast
diff
usion
method
nanomagnet
equip
heavi
metal
complex
digoxin
antibodi
fragment
entir
human
antibodi
ad
seri
blood
sampl
nanomagnet
scan
blood
brownian
motion
captur
target
afterward
small
magnet
place
sampl
tube
wall
accumul
nanomagnet
pole
region
extern
magnet
purifi
ed
supernat
easili
decant
concentr
lead
digoxin
blood
sampl
determin
standard
clinic
method
blood
integr
observ
rotat
thromboelastographi
monitor
serum
potassium
lactat
dehydrogenas
bilirubin
haptoglobin
level
measur
biolog
relev
remov
eff
ect
activ
assess
camptothecinstimul
neutrophil
result
signifi
cant
decreas
lead
digoxin
level
measur
blood
purifi
cation
procedur
extract
use
nanomagnet
clear
doseeff
ect
depend
could
accur
titrat
treatment
nanomagnet
signifi
cantli
aff
ect
integr
blood
level
remain
clinic
norm
rang
assay
show
reduc
antiapoptot
eff
ect
remov
underlin
biolog
relev
achiev
remov
effi
cienci
conclus
demonstr
extract
lead
digoxin
whole
blood
exampl
rapid
treatment
heavi
metal
poison
drug
overdos
sever
infl
ammat
present
direct
blood
extract
could
combin
exist
therapeut
strategi
may
major
implic
treatment
sever
intox
sepsi
specifi
c
fi
ltere
cytokin
toxin
metabol
disord
thyreotoxicosi
autoimmun
diseas
refer
method
fiftyfi
septic
patient
enrol
studi
everi
patient
four
cpfa
treatment
linda
bellcomirandola
itali
hour
q
b
mlminut
q
ultrafi
ltration
mlkghour
q
plasma
q
b
basal
fi
rst
cycl
second
cycl
third
cycl
fourth
cycl
evalu
haemodynam
paramet
norepinephrin
dosag
pao
fio
ratio
plasma
procalcitonin
pct
anova
test
use
compar
chang
time
studi
p
consid
statist
signifi
cant
result
patient
enrol
studi
submit
cpfa
treatment
hour
tabl
present
main
result
studi
iv
quartil
shown
tabl
diff
erent
group
group
patient
trend
toward
higher
number
organ
dysfunct
p
septic
shock
episod
p
regard
treatment
adequaci
complianc
indic
entir
bundl
relat
surviv
howev
achiev
cpv
target
associ
higher
earli
mortal
group
group
p
conclus
observ
studi
factor
relat
diseas
sever
rather
evidencebas
treatment
complianc
associ
shortterm
death
among
sever
septic
patient
sepsi
mortal
rate
higher
brazilian
public
hospit
clear
diff
erenc
risk
factor
aim
identifi
risk
factor
could
explain
mortal
rate
diff
erent
public
privat
hospit
method
sever
sepsi
septic
shock
patient
year
old
admit
two
privat
icu
group
one
public
icu
group
prospect
includ
demograph
clinic
outcom
featur
includ
complianc
surviv
sepsi
campaign
bundl
collect
electron
crf
durat
organ
dysfunct
defi
ned
time
elaps
instal
dysfunct
diagnosi
healthcar
provid
result
express
percentag
median
interquartil
p
consid
signifi
cant
introduct
critic
ill
cancer
patient
increas
risk
acut
kidney
injuri
aki
studi
patient
scarc
singl
center
conduct
special
icu
aim
studi
evalu
characterist
outcom
prospect
cohort
icu
cancer
patient
aki
method
prospect
multicent
cohort
studi
conduct
icu
hospit
brazil
period
univari
multivari
logist
regress
use
identifi
factor
associ
hospit
mortal
result
icu
admiss
aki
receiv
dialysi
kidney
injuri
develop
frequent
patient
hematolog
malign
patient
solid
tumor
vs
p
ischemiashock
sepsi
main
contribut
factor
kidney
injuri
multifactori
patient
icu
mortal
hospit
mortal
despit
lack
statist
signifi
canc
hospit
mortal
higher
patient
receiv
rrt
later
icu
stay
comparison
receiv
rrt
fi
rst
day
icu
dialyz
p
endoflif
decis
withhold
withstand
therapi
taken
patient
gener
renalspecifi
c
severityofil
score
inaccur
predict
outcom
patient
multivari
analysi
length
hospit
stay
prior
icu
acut
organ
dysfunct
need
mechan
ventil
poor
perform
statu
associ
increas
mortal
moreov
cancerrel
characterist
associ
outcom
conclus
present
multicent
studi
confi
rmed
aki
critic
ill
patient
cancer
frequent
usual
multifactori
still
associ
high
mortal
rate
hand
current
studi
also
suggest
icu
admiss
rrt
consid
select
patient
mortal
patient
mostli
depend
sever
acut
ill
perform
statu
rather
cancerrel
characterist
conclus
result
suggest
signifi
cant
increas
icu
mortal
follow
group
year
old
smoker
patient
poor
exercis
toler
patient
ihd
pv
patient
copd
patient
drink
alcohol
excess
ald
result
use
basi
upon
permit
refus
intens
care
admiss
use
inform
staff
patient
like
outcom
intens
care
introduct
creactiv
protein
crp
acutephas
protein
blood
level
increas
rapidli
respons
infect
trauma
ischemia
burn
infl
ammatori
condit
serum
albumin
decreas
critic
ill
patient
similar
condit
use
blood
test
risk
marker
predictor
organ
failur
death
studi
previous
wish
investig
applic
popul
admiss
crp
correl
posit
length
stay
r
p
apach
ii
score
r
p
signifi
cantli
correl
durat
mechan
ventil
r
p
admiss
albumin
correl
neg
length
stay
r
p
durat
mechan
ventil
r
p
apach
ii
score
r
p
conclus
crp
serum
albumin
admiss
predictor
intens
care
mortal
crp
serum
albumin
also
correl
signifi
cantli
sever
marker
length
stay
durat
mechan
ventil
also
apach
ii
score
statin
may
reduc
mortal
critic
ill
patient
aim
investig
associ
statin
therapi
admiss
outcom
intens
care
icu
method
prospect
casenot
review
consecut
admiss
glasgow
royal
infi
rmari
icu
undertaken
period
detail
statin
prescript
cardiovascular
comorbid
smoke
statu
sought
patient
case
note
hand
use
detail
current
previou
admiss
clinic
letter
result
investig
correspond
patient
gener
practition
use
agre
criteria
demograph
acut
physiolog
chronic
health
evalu
ii
apach
ii
score
outcom
data
retriev
ward
watcher
system
icu
result
complet
data
avail
patient
one
hundr
eleven
statin
therapi
admiss
intens
care
data
express
mean
confi
denc
interv
median
interquartil
rang
aim
studi
establish
children
view
outcom
regard
method
cohort
children
age
year
preexist
learn
diffi
culti
complet
pedsql
pediatr
qualiti
life
inventori
posttraumat
stress
screener
facetofac
interview
month
discharg
picu
group
also
complet
questionnair
post
telephon
month
result
children
total
pedsql
score
signifi
cantli
lower
healthi
children
month
picu
mean
healthi
mean
p
month
compar
month
mean
score
picu
group
physic
function
subscal
improv
signifi
cantli
p
still
normal
popul
level
healthi
mean
p
total
pedsql
score
month
associ
pim
score
length
stay
signifi
cantli
neg
associ
posttraumat
stress
symptom
r
p
withingroup
analys
reveal
elect
admit
children
report
higher
emot
function
healthi
children
month
picu
elect
mean
vs
healthi
mean
p
conclus
selfreport
version
pedsql
prove
feasibl
respons
tool
assess
hrqol
group
picu
survivor
howev
order
assess
aspect
outcom
major
children
admit
picu
younger
andor
signifi
cant
cognit
impair
administr
parentproxi
version
questionnair
would
necessari
health
method
potenti
particip
patient
admit
hour
medicalsurg
icu
patient
proxi
ask
give
inform
consent
complet
questionnair
measur
hrqol
eight
subscal
use
proxi
valid
particip
ask
complet
base
situat
week
icu
admiss
score
compar
norm
data
n
independ
test
result
fiftyon
questionnair
complet
complet
proxi
hrqol
icu
admiss
signifi
cantli
lower
domain
compar
gener
popul
p
figur
line
fi
nding
one
dutch
survey
conclus
hrqol
admitt
icu
lower
compar
hrqol
normal
healthi
popul
like
contribut
diminish
hrqol
icu
discharg
measur
infl
uenc
critic
ill
icu
stay
hrqol
icu
stay
import
measur
hrqol
icu
admiss
introduct
creation
innov
retent
strategi
major
focu
nurs
administr
shortag
nurs
recur
turnov
staff
becom
problem
retent
strategi
eff
ectiv
need
target
specifi
calli
particular
condit
nurs
staff
introduct
thiopent
tp
use
sever
brain
trauma
control
high
intracrani
pressur
episod
deleteri
side
eff
ect
describ
question
abil
reach
object
secur
effi
cientli
analyz
impact
tp
use
cerebr
hemodynam
caregiv
behavior
toward
recommend
use
highrat
record
inform
system
method
set
hour
data
record
rate
hz
studi
observ
deleteri
episod
detect
use
inform
system
valid
two
expert
detect
low
cerebr
perfus
pressur
cpp
high
intracrani
hicp
andor
low
mean
arteri
pressur
lmap
episod
use
commonli
admit
threshold
icp
mmhg
cpp
mmhg
medic
order
intend
reach
recommend
object
analyz
result
fortyeight
period
stratifi
ed
accord
tp
dose
analyz
patient
cumul
durat
tp
minut
minut
without
tp
mean
dose
tp
administr
mghour
mgkghour
hicp
incid
per
hour
tp
vs
without
tp
ns
hicp
durat
longer
tp
vs
minut
p
lmap
incid
without
tp
vs
per
hour
monitor
durat
lmap
episod
without
tp
vs
minut
ns
incid
order
intend
restor
cerebr
hemodynam
equival
situat
tp
vs
tp
vs
per
hour
ns
one
hundr
eightyeight
medic
order
analyz
use
catecholamin
frequent
tp
n
vs
n
p
conclus
use
tp
compli
recommend
prolong
hicp
result
signifi
cant
increas
cerebr
hypoperfus
episod
show
evid
adapt
use
physician
dose
lower
dose
prescrib
earlier
literatur
use
catecholamin
frequent
tp
infus
could
result
better
control
deleteri
side
eff
ect
tp
better
complianc
recommend
effi
cient
physician
order
analysi
introduct
mistak
error
may
occur
care
process
particularli
icu
character
larg
number
drug
administ
singl
patient
one
import
infl
uenc
factor
intramur
morbid
mortal
inde
harm
unpredict
reaction
drug
socal
advers
drug
event
ade
far
largest
proport
ade
dose
relat
object
studi
measur
frequenc
sever
ade
icu
determin
infl
uenc
sever
ill
nurs
workload
preval
method
crosssect
studi
icu
tertiari
referr
hospit
base
retrospect
chart
review
tool
develop
measur
incid
characterist
ade
base
global
trigger
tool
measur
advers
drug
event
ade
identifi
ed
sever
evalu
use
categori
base
system
classifi
medic
error
nation
coordin
council
medic
error
report
prevent
sever
ill
calcul
use
sepsisrel
organ
failur
assess
score
nurs
workload
classic
therapeut
intervent
score
review
nurs
day
patient
reveal
ade
occur
total
nurs
day
commonli
identifi
ed
ade
hypoglycemia
mgdl
n
follow
hypokalemia
n
ninetysix
percent
ade
classifi
ed
categori
e
wherea
ade
classifi
ed
categori
f
mean
sever
ill
nurs
workload
score
signifi
cant
higher
nurs
day
ade
occur
p
p
respect
conclus
ade
common
icu
lack
golden
standard
report
collect
ade
make
diffi
cult
compar
studi
assess
real
valu
studi
howev
date
strongli
clearli
indic
infl
uenc
sever
ill
nurs
workload
preval
ade
introduct
appropri
use
icu
resourc
mandatori
patient
admit
unit
abl
provid
higher
lower
level
care
requir
wast
overus
resourc
advoc
start
approach
identifi
possibl
mismatch
level
care
actual
deliv
assum
correspond
clinic
requir
level
care
deliver
unit
method
icu
bed
classifi
ed
level
care
deliver
high
ventil
monitor
minut
nurs
time
low
monitor
minut
nurs
time
level
care
actual
deliv
classifi
ed
high
invas
noninvas
ventil
two
vasoact
drug
least
two
follow
one
vasoact
drug
dialysi
respiratori
support
low
singl
vasoact
drug
dialysi
respiratori
support
ordinari
none
mismatch
level
bed
avail
level
care
deliv
evalu
admiss
icuday
patient
icu
icuday
judg
inappropri
even
without
mismatch
ordinari
patient
present
patient
critic
care
typic
receiv
highrisk
medic
error
report
integr
identifi
common
error
medic
risk
reduct
method
medic
report
form
develop
run
alongsid
offi
cial
hospit
incid
report
system
week
form
distribut
throughout
critic
care
facil
member
multidisciplinari
team
ask
anonym
complet
form
everi
time
medic
error
near
miss
occur
week
submit
form
analys
project
team
total
report
submit
largest
number
incid
report
due
prescrib
error
follow
administr
document
electron
prescrib
problem
storag
monitor
introduct
commun
healthcar
profession
key
step
patient
safeti
failur
account
root
caus
sentinel
event
bedsid
round
import
teamwork
commun
improv
explicit
approach
processori
inform
tool
organ
direct
interprofession
round
method
part
qualiti
improv
project
conduct
observ
document
daili
goal
dg
best
practic
bp
stepdown
unit
tool
previous
ad
patient
fl
owsheet
introduct
structur
round
process
team
educ
hypothesi
import
tool
use
round
without
input
team
member
round
observ
two
separ
period
observ
would
take
note
whether
dg
bp
document
whether
discuss
took
place
document
diff
erenc
proport
two
period
analyz
fisher
exact
test
p
consid
signifi
cant
observ
bedsid
interact
period
document
remain
unchang
dg
pre
vs
post
p
bp
pre
vs
post
howev
second
period
improv
document
team
discuss
dg
pre
vs
post
p
bp
pre
vs
post
p
conclus
intervent
aid
increas
document
discuss
impli
increas
commun
among
interprofession
team
patient
still
document
bedsid
round
patient
inform
collect
therefor
studi
limit
provid
inform
clinic
outcom
research
focu
best
implement
tool
qualit
assess
content
daili
goal
demonstr
eff
ect
patientcent
outcom
introduct
use
highfi
deliti
simul
lead
realist
clinic
situat
sometim
diffi
cult
manag
psycholog
aim
studi
evalu
psycholog
stress
induc
simulationbas
train
associ
skill
anesthesiologist
resid
method
cohort
resid
studi
psycholog
stress
simul
session
quantifi
ed
autoevalu
scale
numer
scale
salivari
amylas
sampl
nontechn
skill
quantifi
ed
analys
videotap
score
anaesthetist
nontechn
skill
median
stress
numer
scale
simul
session
rang
p
figur
stress
scale
session
signifi
cantli
lower
resid
alreadi
underw
simulationbas
train
p
resid
stress
scale
simul
session
salivari
amylas
session
signifi
cantli
higher
p
correspond
increas
signifi
cant
relationship
psycholog
stress
paramet
nontechn
skill
conclus
psycholog
stress
simul
session
especi
simul
appear
high
anesthesiologist
resid
particularli
perform
simul
session
fi
rst
time
fact
consid
organis
simulationbas
teach
refer
respiratori
therapist
central
role
manag
critic
ill
patient
object
studi
evalu
impact
educ
program
aim
improv
qualiti
care
respiratori
therapi
method
beforeaft
studi
design
assess
complianc
respiratori
therapi
indic
chosen
due
relev
patient
care
avail
object
measur
patient
admit
icu
regardless
mechan
ventil
complianc
assess
month
implement
educ
program
educ
process
compris
meet
group
train
written
manual
individu
feedback
noncompli
situat
month
implement
process
complianc
assess
perform
result
decid
studi
level
adher
mexican
physician
measur
propos
checklist
method
conduct
prospect
observ
studi
adult
icu
academ
hospit
northeastern
mexico
patient
sort
one
two
studi
group
group
critic
care
physician
charg
icu
manag
group
noncrit
care
physician
charg
measur
adher
physician
fast
hug
checklist
item
arbitrarili
defi
ned
good
complianc
fulfi
lled
item
result
one
hundr
fortyseven
patient
admit
icu
studi
period
complet
data
evalu
patient
group
group
patient
group
patient
higher
age
sofa
apach
score
admiss
analyz
subgroup
patient
initi
apach
score
usual
one
like
benefi
fast
hug
measur
result
describ
tabl
notic
group
patient
sever
sepsi
group
patient
ischem
heart
diseas
clearli
explain
diff
erenc
mechan
ventil
length
icu
stay
result
cohort
examin
result
similar
demograph
clinic
data
shown
figur
microorgan
isol
chang
signifi
cantli
two
period
figur
summar
diff
erenc
tracheal
aspirateblood
cultur
isol
among
two
period
conclus
confi
rm
singleb
room
locat
prevent
nosocomi
infect
diff
usion
limit
studi
previou
sniffi
ng
posit
wide
promot
teach
airway
posit
prior
intub
attempt
whether
analog
result
novic
place
head
neck
appropri
evalu
altern
analog
win
chin
simpl
anatom
instruct
may
perform
better
method
random
control
studi
compar
diff
erent
instruct
enabl
novic
adequ
posit
simul
mannequin
head
neck
studi
volunt
includ
medic
student
resid
surgeri
intern
medicin
subject
independ
posit
mannequin
base
upon
understand
four
randomlyassign
written
instruct
sniffi
ng
posit
win
chin
analog
anatom
instruct
instruct
control
digit
photograph
follow
instruct
analyz
two
airway
expert
adequaci
overal
posit
three
compon
airway
posit
result
volunt
posit
adequ
often
follow
win
chin
analog
compar
instruct
anatom
instruct
control
sniffi
ng
posit
analog
posit
follow
sniffi
ng
posit
instruct
diff
erent
instruct
p
win
chin
anatom
instruct
better
instruct
p
p
respect
win
chin
analog
result
adequ
airway
posit
signifi
cantli
often
sniffi
ng
posit
control
maintain
atlantooccipit
extens
compar
provid
anatom
instruct
overal
win
chin
superior
teach
analog
could
replac
sniffi
ng
posit
analog
averag
apach
ii
score
averag
sofa
score
four
admiss
elect
due
sever
comorbid
extrem
weight
anticip
airway
diffi
culti
seven
patient
need
go
back
theatr
one
time
reexploratori
surgeri
due
postop
complic
three
patient
remain
intub
day
two
requir
tracheostomi
three
patient
die
two
intraabdomin
haemorrhag
one
sepsi
conclus
highrisk
cohort
patient
requir
icu
admiss
need
patient
return
theatr
reexploratori
surgeri
associ
longer
icu
stay
multipl
complic
demand
critic
care
servic
like
increas
bariatr
surgeri
continu
grow
specialti
nh
need
increas
invest
icu
accordingli
five
result
period
quantiti
cost
drug
increas
follow
nonsteadi
nonparallel
pattern
four
atc
code
account
quantiti
cost
atc
code
b
blood
haematopoiet
organ
amount
quantiti
cost
follow
atc
code
j
system
antiinfect
cost
atc
code
n
nervou
system
cost
atc
code
c
cardiovascular
system
cost
prescript
sc
amount
drug
quantiti
drug
cost
rate
increas
quantiti
cost
seven
time
larger
icp
sc
figur
overleaf
peak
valu
cost
quantiti
relat
limit
number
patient
conclus
increas
quantiti
cost
drug
prescript
icu
matter
concern
rather
unexpectedli
total
cost
cost
increas
gener
mainli
icp
care
followup
necessari
tri
infl
uenc
evolut
institut
polici
coopt
profession
categori
involv
process
introduct
one
consequ
pressur
inpati
hospit
bed
number
delay
discharg
critic
ill
patient
ward
although
delay
discharg
report
number
countri
clinic
econom
consequ
delay
studi
method
examin
data
mix
london
icu
bed
use
medtrack
softwar
tool
mash
ltd
addit
realtim
map
icu
bed
utilis
patient
fl
ow
defi
ned
delay
discharg
begin
hour
actual
medicalnurs
decis
discharg
describ
set
criteria
priori
assess
eff
ect
delay
patient
discharg
search
benefi
cial
harm
eff
ect
also
analys
econom
consequ
discharg
delay
use
medtrack
captur
critic
care
minimum
dataset
avail
tariff
analysi
period
hour
delay
discharg
result
postponementdelay
oper
patient
requir
level
intens
care
oper
patient
requir
level
intens
care
one
hundr
fourteen
tertiari
referr
refus
bed
blockag
seventytwo
patient
discharg
hour
mean
delay
hour
identifi
patient
requir
unplan
admiss
critic
care
actual
admiss
due
delay
discharg
patient
acquir
hospitalacquir
organ
await
discharg
seven
infect
familypati
interview
suggest
neg
eff
ect
nois
exposur
resuscit
andor
death
icu
patient
set
perceiv
benefi
receiv
critic
care
nurs
prolong
period
potenti
benefi
refl
ect
reduct
readmiss
critic
ill
patient
critic
care
estim
cost
delay
discharg
conclus
delay
discharg
patient
ward
follow
episod
critic
ill
common
increas
problem
delay
benign
consid
prioritis
bed
utilis
acut
hospit
introduct
pain
relev
factor
prolong
hospit
stay
thorac
surgeri
associ
stress
known
alter
ratio
th
helper
cell
immedi
postop
period
thorac
epidur
block
teb
central
receptor
stimul
via
intraven
clonidin
applic
stimul
opioid
receptor
decreas
either
pain
andor
stress
might
therefor
infl
uenc
immun
imbal
primari
endpoint
current
studi
periop
balanc
lung
surgeri
secondari
endpoint
aim
incid
pain
pneumonia
method
approv
ethic
committe
inform
consent
total
patient
random
receiv
doubleblind
either
remifentanil
intraven
remifentanil
clonidin
intraven
ropivacain
epidur
pain
intens
assess
numer
rate
scale
nr
ratio
measur
use
cytometr
bead
array
pneumonia
diagnos
accord
hospitalacquir
pneumonia
criteria
american
thorac
societi
ratio
adjust
baselin
diff
ere
group
time
p
end
surgeri
signifi
cant
diff
erenc
remifentanil
remifentanil
clonidin
group
p
signifi
cantli
lower
ratio
ropivacain
group
compar
remifentanil
p
remifentanil
clonidin
group
p
nr
score
immedi
surgeri
lower
ropivacain
group
compar
remifentanil
group
remifentanil
clonidin
group
achiev
borderlin
statist
signifi
canc
none
patient
develop
pneumonia
conclus
intraop
teb
decreas
ratio
provid
better
pain
therapi
immedi
surgeri
introduct
protocol
periop
usag
beta
blocker
use
major
clinic
usa
common
practic
discontinu
beta
blocker
periop
period
maxim
reduc
dose
main
purpos
paper
investig
incid
advers
eff
ect
beta
blocker
largescal
trauma
orthoped
surgeri
spinal
anesthesia
method
open
prospect
studi
evalu
advers
eff
ect
beta
blocker
asa
ii
iii
research
subject
receiv
beta
blocker
hour
preoper
n
mean
age
adjac
metabol
syndrom
result
compar
number
patient
asa
group
mean
age
receiv
beta
blocker
patient
group
receiv
midazolam
premed
minut
arriv
oper
room
spinal
anesthesia
bupivacain
patient
surveil
conduct
continu
ekg
blood
pressur
puls
noninvas
spo
monitor
systol
diastol
pressur
puls
record
everi
minut
result
statist
test
sd
test
result
shown
figur
group
receiv
beta
blocker
show
higher
percentag
patient
hypertens
arriv
oper
room
hypotens
start
spinal
anesthesia
occurr
bradycardia
hr
increas
statist
signifi
canc
p
use
atropin
p
occurr
arrhythmia
show
statist
increas
group
p
well
nausea
p
conclus
due
advers
eff
ect
beta
blocker
discontinu
spinal
anesthesia
surgic
procedur
signifi
cant
circul
volum
loss
introduct
surgicalrel
neuroendocrin
stress
respons
extend
postop
period
induc
insulin
resist
hyperglycaemia
remifentanil
continu
infus
reduc
pain
anxieti
may
reduc
postop
insulin
resist
result
better
glycaem
control
aim
studi
assess
trend
glycaemia
homa
score
postop
patient
remifentanildriven
postop
analgosed
method
enrol
patient
consecut
admit
surgic
icu
major
abdomin
intervent
period
juli
group
r
patient
underw
analgosed
continu
remifentanil
infus
recommend
dose
glycaemia
homa
score
evalu
admiss
time
hour
control
patient
underw
morphinebas
continu
analgosed
group
conclus
remifentanilbas
analgosed
associ
lower
glycaemia
homa
score
patient
follow
major
abdomin
surgeri
particularli
hour
icu
admiss
homa
score
show
morphinetr
patient
insulin
resist
although
normoglycaem
better
control
neuroendocrin
stress
respons
patient
analgosed
remifentanil
might
explain
result
introduct
ultralowdos
opioid
antagonist
enhanc
opioid
analgesia
prevent
toler
rodent
nocicept
pain
assay
method
random
doubleblind
control
trial
design
investig
whether
addit
ml
ultralowdos
naltrexon
liter
steril
water
morphin
mgkg
chang
total
opioid
requir
side
eff
ect
result
two
hundr
sixtyseven
patient
year
old
moder
extrem
trauma
enter
studi
pain
control
measur
evalu
everi
minut
fi
rst
hour
everi
minut
second
third
hour
fi
nalli
fourth
hour
effi
caci
measur
numer
pain
rate
scale
follow
side
eff
ect
evalu
sedat
nausea
vomit
pruritu
found
opioid
requir
diff
er
signifi
cantli
group
morphin
naltrexon
group
averag
requir
mg
morphin
hour
morphin
group
conclus
morphin
naltrexon
group
lower
incid
nausea
morphin
placebo
group
howev
incid
vomit
pruritu
sedat
two
group
similar
combin
ultralowdos
naltrexon
morphin
moder
introduct
pulmonari
hypertens
ph
lifethreaten
diseas
commonli
seen
icu
septic
patient
associ
poor
outcom
new
better
therapi
requir
sinc
respons
variou
agent
prostaglandin
phosphodiesteras
inhibitor
usual
partial
mortal
rate
remain
high
inhal
drug
seem
attract
treatment
option
sinc
deliv
directli
pulmonari
resist
vessel
new
devic
anesthet
conserv
devic
anaconda
acd
permit
direct
administr
volatil
anaesthet
sevofl
uran
breath
circuit
convent
icu
ventil
safe
eff
ectiv
way
recent
introduc
aim
present
studi
evalu
effi
caci
safeti
sevofl
uran
administr
via
acd
porcin
model
acut
ph
sepsi
method
ph
induc
anaesthet
mechan
ventil
swine
kg
intraven
infus
mgkg
lp
escherichia
coli
period
minut
lp
anim
random
two
group
group
sevofl
uran
infus
via
acd
accord
manufactur
recommend
order
obtain
endtid
concentr
wherea
group
b
receiv
sevofl
uran
serv
control
haemodynam
paramet
system
pulmonari
record
phase
lp
phase
everi
minut
next
hour
phase
result
lp
found
produc
ph
phase
reduc
arteri
blood
pressur
group
sevofl
uran
infus
systol
pap
diastol
papd
pulmonari
pressur
exhibit
stepbystep
reduct
becam
statist
signifi
cant
phase
thereaft
relat
phase
valu
contrari
group
b
anim
sevofl
uranetr
pulmonari
pressur
remain
high
level
throughout
studi
period
system
arteri
pressur
exhibit
endotoxinrel
reduct
group
found
aff
ect
sevofl
uran
treatment
conclus
sevofl
uran
administr
via
acd
found
reduc
pulmonari
pressur
porcin
model
endotoxininduc
acut
ph
without
detriment
eff
ect
system
circul
may
repres
signifi
cant
advanc
treatment
acut
ph
howev
potenti
clinic
implic
method
merit
studi
introduct
methylnaltrexon
peripher
receptor
antagonist
shown
induc
laxat
patient
receiv
opioid
licenc
use
palli
care
similar
benefi
propos
critic
care
patient
impair
gut
motil
constip
common
issu
critic
care
set
contribut
factor
includ
trauma
surgeri
use
opiat
analges
eff
ect
methylnaltrexon
studi
seven
patient
convent
treatment
constip
stimul
osmot
lax
faecal
soften
suppositori
fail
produc
eff
ect
method
period
critic
ill
patient
opiateinduc
constip
oic
day
durat
pro
pectiv
studi
patient
treat
convent
method
admiss
critic
care
includ
regular
senna
sodium
docus
supplement
glycerin
suppositori
picolax
resist
constip
methylnaltrexon
administ
seven
patient
subcutan
altern
day
laxat
occur
remaind
patient
studi
continu
convent
therapi
result
six
seven
patient
respond
methylnaltrexon
laxat
occur
hour
one
patient
respond
due
faecal
impact
subsequ
experienc
laxat
manual
disimpact
side
eff
ect
nausea
vomit
increas
opiat
requir
patient
treat
convent
mean
eventu
produc
laxat
day
conclus
previou
studi
shown
earlier
return
gut
motil
improv
patient
progress
facilit
earlier
respiratori
wean
prevent
debilit
result
reduc
length
stay
methylnaltrexon
safe
effi
caciou
drug
treatment
oic
critic
care
patient
convent
treatment
prove
unsuccess
side
eff
ect
opiat
requir
remain
unchang
investig
elucid
costeff
ectiv
methylnaltrexon
use
oic
critic
ill
patient
warrant
introduct
evid
suggest
prolong
sedat
associ
prolong
ventil
mortal
evid
suggest
sed
analges
prone
caus
oversed
other
possibl
due
disturb
pharmacokinet
properti
context
acut
organ
failur
aim
describ
current
sedat
analges
practic
uk
icu
determin
whether
recent
evid
chang
practic
recent
year
method
perform
webbas
survey
use
tool
develop
via
systemat
stepwis
process
follow
recognis
practic
questionnair
design
step
includ
question
develop
questionnair
format
test
publish
websit
conclus
propofol
propos
altern
benzodiazepin
sever
aw
could
increas
rate
complic
especi
seizur
respiratori
infect
could
lead
increas
intub
rate
length
stay
apach
score
could
predictor
risk
complic
intub
introduct
object
studi
identifi
proport
patient
experienc
agit
andor
pain
physiotherapi
session
intens
care
icu
preval
caus
distress
critic
ill
patient
poorli
describ
identifi
ed
stressor
includ
physiotherapi
standard
sedationanalgesia
manag
physiotherapi
exist
recent
evid
support
routin
icu
manag
lighter
level
sedat
potenti
increas
import
intervent
avoid
distress
intervent
physiotherapi
method
prospect
observ
studi
undertaken
fortynin
patient
admit
icu
requir
mechan
ventil
physiotherapi
recruit
studi
singl
session
physiotherapi
observ
independ
assessor
agit
measur
use
richmond
agit
sedat
scale
rass
pain
use
behaviour
pain
scale
bp
rass
bp
collect
immedi
pre
physiotherapi
intervent
physiotherapi
minut
post
physiotherapi
result
sixteen
particip
experienc
agit
rass
score
particip
experienc
pain
bp
score
figur
show
number
particip
experienc
agit
pain
relat
rass
level
prior
physiotherapi
interest
independ
assessor
observ
littl
commun
regard
manag
sedat
pain
stage
physiotherapi
nurs
physiotherapi
staff
regardless
rass
level
pre
physiotherapi
major
particip
experienc
pain
contrast
onethird
particip
experienc
agit
preval
lighter
sedat
level
routin
use
rass
bp
commun
nurs
staff
undertaken
physiotherapi
ensur
optim
level
sedat
adequ
level
analgesia
achiev
introduct
contrari
ward
manag
usual
chronic
acut
pain
algolog
gerontolog
surgeri
recoveri
room
forth
comparison
fi
popular
selfreport
pain
tool
vertic
horizont
visual
analog
scale
vasv
vash
oral
numer
rate
scale
nrso
visual
enlarg
nr
nrsv
verbal
descriptor
scale
vd
never
evalu
icu
set
method
consecut
patient
admit
medicalsurg
icu
year
includ
alert
rass
abl
follow
simpl
command
exclus
criteria
previou
selfreport
pain
assess
without
presenc
investig
pain
assess
use
fi
scale
random
order
either
baselin
administr
analges
nocicept
procedur
absenc
pain
baselin
evalu
paramet
psychometr
properti
scale
feasibl
valid
respons
prefer
nonparametr
test
use
statist
analysi
statview
data
express
median
result
basal
level
expect
valu
follow
enter
administr
pharmacolog
level
alreadi
reach
minut
serum
peak
minut
halfabsorpt
time
minut
second
maximum
serum
level
observ
pgml
disappear
rate
indic
halfelimin
time
hour
minut
serum
melatonin
level
decreas
signifi
cantli
midnight
pharmacolog
level
maintain
hour
follow
administr
excess
sleepi
report
patient
group
conclus
critic
ill
patient
exhibit
reduc
melatonin
secret
report
literatur
despit
critic
ill
oral
bioavail
satisfactori
serum
level
oral
administr
show
basic
unchang
intestin
absorpt
disappear
rate
slower
report
elsewher
healthi
volunt
introduct
aim
studi
describ
clinic
progress
need
mechan
ventil
mv
complic
mortal
patient
delirium
tremen
dt
admit
icu
method
patient
diagnosi
dt
admit
medic
icu
tertiari
hospit
januari
decemb
includ
record
admiss
diagnosi
patholog
associ
dt
apach
ii
score
treatment
need
mv
durat
complic
length
stay
icu
total
hospit
stay
mortal
surviv
year
result
case
dt
median
age
year
male
reason
hospit
admiss
dt
seizur
sepsi
brain
injuri
reason
admiss
icu
dt
dt
seizur
dt
brain
injuri
dt
sepsi
dt
median
apach
ii
score
rang
seventyfour
percent
patient
control
need
mv
midazolam
infus
haloperidol
twentyeight
per
cent
patient
requir
mv
dt
associ
patholog
admiss
figur
total
patient
admit
dt
associ
patholog
four
need
mv
median
time
mv
day
rang
complic
present
ventilationassoci
pneumonia
infecti
condit
total
hospit
length
stay
day
sd
day
icu
sd
regist
hospit
mortal
rate
surviv
year
continu
visit
emerg
consult
year
episod
relat
alcohol
withdraw
complic
associ
chronic
alcohol
abus
conclus
even
though
patient
dt
frequent
admit
icu
patholog
time
benign
cours
low
hospit
mortal
high
rate
surviv
year
patient
regular
user
health
system
occurr
complic
need
mv
patient
low
present
group
dt
diagnos
introduct
delirium
icu
patient
increas
time
mechan
venti
lation
independ
risk
factor
death
caus
cognit
impair
survivor
two
commonli
use
valid
assess
method
diagnos
delirium
intens
care
confus
assess
method
icu
cam
intens
care
delirium
checklist
score
isdc
wish
determin
preval
delirium
unit
whether
diff
erenc
result
method
assess
whether
good
agreement
could
achiev
two
train
assessor
method
perform
prospect
preval
studi
singl
tertiari
icu
patient
assess
day
stay
test
provid
richmond
agit
sedat
score
rass
patient
independ
assess
two
train
assessor
cam
isdc
randomis
order
interview
score
use
set
assess
carri
within
hour
exclus
includ
readmiss
speak
english
deaf
regist
psychiatr
patient
cam
complet
assessor
isdc
requir
observ
answer
bedsid
nurs
perform
assess
test
patient
mean
sd
age
apach
ii
total
sofa
day
admiss
respect
delirium
found
patient
use
cam
use
isdc
interrat
agreement
cam
isdc
se
p
se
p
respect
signifi
cant
underscor
rass
bedsid
nurs
train
assessor
found
diff
erenc
alway
lower
score
document
bedsid
nurs
conclus
good
interrat
agreement
diagnosi
delirium
two
train
assessor
preval
found
lower
previous
report
vari
consider
method
use
diff
erenc
result
two
score
may
due
lack
discern
part
bedsid
nurs
isdc
assess
process
introduct
delirium
aff
ect
acut
hospit
patient
icu
patient
prolong
length
stay
increas
mortal
optim
manag
delirium
requir
calm
environ
sleep
hygien
correct
underli
factor
exampl
infect
challeng
icu
drug
therapi
commonli
haloperidol
clonidin
benzodiazepin
propofol
often
use
quetiapin
atyp
antipsychot
use
acut
delirium
outsid
icu
extrapyramid
side
eff
ect
short
halflif
mildli
sedat
impress
potenti
treatment
delirium
method
tertiari
icu
admiss
annual
review
note
patient
admit
februari
novemb
delirium
treat
quetiapin
patient
exclud
take
quetiapin
prior
admiss
follow
data
record
richmond
agit
sedat
score
critic
care
volum
suppl
http
rass
durat
delirium
agent
use
patient
demograph
advers
event
result
five
patient
met
inclus
criteria
tabl
male
age
year
prolong
delirium
prior
commenc
quetiapin
combin
four
drug
clonidin
haloperidol
lorazepam
propofol
control
delirium
day
follow
commenc
quetiapin
rass
score
drug
ceas
advers
eff
ect
note
conclus
quetiapin
success
control
prolong
icu
delirium
allow
wean
medic
patient
may
use
delirium
therapi
studi
requir
demonstr
effi
caci
safeti
refer
vs
respect
icu
length
stay
tend
longer
syncollgroup
versu
day
p
conclus
patient
sever
sepsi
fl
uid
therapi
synthet
colloid
gelatin
thirdgener
he
consider
increas
incid
arf
need
rrt
compar
crystalloid
result
confi
rm
recent
metaanalysi
rct
demonstr
increas
incid
arf
synthet
colloid
introduct
dehydr
import
problem
among
patient
admit
emerg
depart
ed
howev
yet
consensu
ideal
fl
uid
patient
studi
plan
evalu
ideal
crystalloid
patient
admit
ed
symptom
dehydr
method
conduct
random
control
trial
includ
dehydr
patient
three
group
patient
includ
random
one
solut
lactat
ringer
nacl
turkey
solut
infus
rate
mlkg
hour
hour
venou
blood
sampl
ph
na
k
cl
hco
level
evalu
hour
result
detect
decreas
serum
ph
hco
level
second
hour
nacl
group
howev
group
increas
serum
ph
hco
level
observ
lactat
ringer
group
introduct
evalu
earli
continu
venoven
hemodiafi
ltration
cvvhdf
patient
refractori
septic
shock
multiorgan
failur
upon
mortal
morbid
icu
method
forti
patient
prospect
studi
randomli
treat
either
convent
treatment
patient
group
ii
earli
cvvhdf
less
hour
maxim
hemodynam
support
addit
convent
treatment
patient
group
metabol
acidosi
serum
lactat
serum
procalcitonin
level
pct
day
cvvhdf
monitor
evalu
outcom
apach
ii
score
system
use
day
cvvhdf
result
compar
group
ii
patient
group
lower
mortal
vs
insignifi
cant
p
valu
p
group
patient
show
nonsignifi
cant
vs
group
ii
respect
p
regard
apach
ii
score
group
also
show
statist
nonsignifi
cant
lower
fi
gure
group
ii
admiss
apach
ii
score
vs
group
ii
respect
p
day
apach
ii
score
vs
group
ii
respect
p
group
patient
show
lower
pct
admiss
day
group
ii
patient
admiss
pct
level
vs
group
ii
respect
p
day
pct
level
vs
group
ii
respect
p
indic
improv
show
statist
signifi
cant
diff
erenc
survivor
nonsurvivor
group
regard
serum
lactat
level
day
p
indic
fever
renal
profi
le
wbc
count
metabol
acidosi
serum
lactat
level
admiss
platelet
count
statist
insignifi
cant
admiss
p
respect
day
p
respect
signifi
cant
statist
diff
erenc
survivor
nonsurvivor
group
consid
number
organ
failur
less
equal
three
organ
involv
comparison
three
organ
involv
p
introduct
inhal
hydrogen
sulfi
de
h
intraven
h
donor
protect
kidney
ischemiareperfus
ir
injuri
data
origin
unresuscit
rodent
model
therefor
investig
eff
ect
h
donor
na
clinic
relev
porcin
model
aortic
occlusioninduc
renal
ir
injuri
method
anesthetis
ventil
pig
receiv
na
n
vehicl
n
hour
hour
minut
intraaort
balloon
occlusioninduc
kidney
ischemia
reperfus
noradrenalin
titrat
keep
blood
pressur
baselin
level
na
prior
aortic
occlus
hour
reperfus
measur
renal
blood
fl
ow
function
creatinin
clearanc
blood
level
fraction
na
excret
blood
cytokin
nitrat
renal
tissu
dna
damag
comet
assay
express
western
blot
activ
emsa
histolog
damag
glomerular
tubularis
assess
immedi
post
mortem
result
na
pretreat
associ
progress
fall
core
temperatur
signifi
cantli
lower
noradrenalin
infus
rate
need
achiev
hemodynam
target
renal
blood
fl
ow
fraction
na
excret
compar
na
attenu
fall
creatinin
clearanc
rise
creatinin
blood
level
respect
coincid
signifi
cantli
lower
nitrat
blood
level
kidney
glomerular
tissu
dna
damag
markedli
attenu
wherea
activ
signifi
cantli
higher
na
streat
anim
conclus
clinic
relev
porcin
model
mimick
aortic
crossclampinginduc
kidney
ir
injuri
na
attenu
tissu
injuri
organ
dysfunct
result
reduc
system
infl
ammat
oxid
stress
higher
activ
unchang
fraction
na
excret
probabl
due
drop
temperatur
direct
eff
ect
h
tubular
na
absorpt
respect
introduct
sepsi
identifi
ed
common
caus
renal
injuri
icu
although
pathophysiolog
well
understood
larg
clinic
studi
avail
show
improv
renal
function
patient
sepsi
may
relat
lack
earli
diagnost
test
indic
onset
renal
injuri
aim
current
studi
search
potenti
new
earli
marker
renal
injuri
acut
endotoxemia
investig
whether
renal
injuri
amelior
induct
lipopolysaccharid
lp
toler
method
five
healthi
male
receiv
intraven
bolu
inject
ngkgday
escherichia
coli
lp
consecut
day
use
surfaceenhanc
laser
desorptionion
timeoffl
ight
mass
spectrometri
selditof
ms
approach
allow
rapid
highthroughput
profi
ling
multipl
urin
sampl
detect
low
molecular
weight
biomark
result
repeat
lp
administr
induc
diminish
glomerular
fi
ltration
rate
p
day
increas
serum
creatinin
p
day
associ
appear
peak
intens
urinari
protein
profi
le
includ
increas
level
p
hour
fi
rst
lp
administr
four
peak
intens
day
correl
serum
creatinin
level
day
mz
p
respect
develop
lp
toler
renal
function
restor
refl
ect
decreas
serum
creatinin
level
baselin
p
respect
day
attenu
peak
intens
urinari
protein
profi
le
p
peak
intens
conclus
renal
injuri
occur
repeat
endotoxemia
predict
new
urinari
marker
use
proteom
research
four
marker
correl
extent
renal
injuri
may
repres
potenti
new
biomark
renal
injuri
need
identifi
cation
infl
ammationinduc
renal
injuri
subsid
lp
toler
develop
consecut
day
lp
administr
develop
techniqu
detect
mdz
glucuronid
commerci
sourc
prevent
assay
develop
pharmacolog
activ
renal
excret
postul
ultrafi
ltrate
ufr
would
rich
describ
method
purifi
ufr
method
ethic
approv
grant
purifi
ufr
extract
column
wash
elut
hplcm
separ
perform
mol
wt
ms
desicc
redissolv
four
time
maximis
puriti
electrospray
esi
mass
spectrometri
ms
characteris
puriti
calcul
use
nmr
calibr
plot
mdz
dzp
intern
standard
hplcm
perform
result
ident
confi
rmed
use
msm
figur
two
milligram
purifi
ed
ml
ufr
pure
nmr
extinct
coeffi
cient
ident
mdz
calibr
plot
result
correl
assay
appli
clinic
practic
report
sera
ufr
level
introduct
complex
care
hematooncolog
icu
sometim
requir
use
crrt
hematooncolog
patient
specifi
cation
retrospect
follow
result
eff
ort
patient
acut
renal
failur
due
venoocclus
diseas
vod
allogen
hematopoiet
stem
cell
transplant
vod
one
sever
earli
complic
type
patient
mortal
high
method
januari
octob
perform
procedur
one
procedur
hour
patient
vod
acut
renal
oligoanur
failur
standard
icu
perform
cvvh
post
dilut
freseniu
multifi
ltrate
machin
key
drug
treatment
vod
defi
brotid
patient
sever
thrombocytopen
use
anticoagul
cvvh
set
dose
defi
brotid
rang
mgkgday
accord
sever
thrombocytopenia
eventu
hemorrhag
symptom
blood
count
acidbas
balanc
biochemistri
monitor
least
twice
daili
thrombocytopenia
correct
donor
platelet
platelet
level
sustain
x
l
introduct
cvvh
patient
dramat
help
overcom
sever
part
vod
defi
brotid
help
restor
critic
care
volum
suppl
http
right
function
vascular
endothelium
none
patient
die
vod
caus
death
surprisingli
median
patenc
cvvh
tube
set
hour
despit
anticoagul
tube
set
defi
brotid
effi
cient
prevent
coagul
tube
set
seriou
hemorrhag
event
observ
fl
uent
mainten
fl
uid
balanc
remov
wast
product
metabol
mainten
acidbas
balanc
import
patient
critic
point
advanc
vod
conclus
cvvh
integr
part
intens
care
hematooncolog
use
therapeut
modal
patient
vod
acut
renal
failur
signifi
cantli
improv
result
therapeut
eff
ort
comparison
effi
caci
safeti
two
region
citrat
anticoagul
protocol
use
acid
citrat
dextros
introduct
continu
renal
replac
therapi
crrt
treatment
choic
acut
renal
failur
critic
ill
patient
studi
compar
effi
caci
safeti
region
citrat
anticoagul
rca
acid
citrat
dextros
acda
prismocitr
gambro
use
prismocitr
elimin
need
separ
infus
pump
acda
doubl
replac
fl
uid
anticoagul
remov
sourc
error
calcul
fl
uid
balanc
combin
trisodium
citrat
citric
acid
prismocitr
avoid
metabol
alkalosi
associ
acda
method
prospect
sequenti
cohort
studi
patient
admit
surgic
icu
requir
crrt
arf
recruit
group
use
acda
recruit
octob
septemb
n
group
b
use
prismocitr
recruit
octob
septemb
n
evalu
incid
metabol
alkalosi
biochem
chang
azotemia
control
fi
lter
lifespan
complic
incid
metabol
alkalosi
group
b
treatment
day
onward
signifi
cantli
lower
group
group
median
ph
compar
group
b
ph
p
control
electrolyt
azotemia
signifi
cantli
diff
erent
mean
fi
lter
durat
hour
ci
group
hour
ci
group
b
p
longitudin
analysi
reveal
statist
signifi
cant
result
reduc
metabol
alkalosi
group
b
standard
bicarbon
p
base
excess
p
repeat
treatment
session
also
show
statist
signifi
cant
reduct
metabol
alkalosi
use
prismocitr
rather
acda
p
conclus
rca
prismocitr
reduc
incid
metabol
alkalosi
associ
acda
regim
safe
feasibl
improv
patient
safeti
increas
complic
rate
unit
convert
prismocitr
rca
injuri
tbi
common
hypothesis
use
therapi
would
signifi
cantli
augment
creatinin
clearanc
crcl
popul
method
headinjur
patient
requir
hyperosmolar
therapi
use
salin
solut
andor
norepinephrin
infus
mainten
cpp
mmhg
recruit
studi
addit
manag
consist
local
practic
line
brain
trauma
foundat
guidelin
crcl
physiolog
variabl
fl
uid
balanc
medic
record
daili
activ
manag
cpp
crcl
collect
prior
discharg
cpp
therapi
elev
repeat
ward
augment
renal
clearanc
arc
defi
ned
crcl
male
femal
result
twenti
consecut
patient
enrol
averag
icu
length
stay
day
ci
time
studi
entri
averag
day
ci
patient
receiv
norepinephrin
n
n
receiv
hyperton
salin
therapi
last
averag
day
ci
arc
demonstr
patient
point
activ
manag
cpp
mean
maximum
crcl
ml
cpp
therapi
ci
return
mean
crcl
ci
p
measur
ward
mean
crcl
icu
receiv
cpp
therapi
ci
p
mean
time
reach
peak
crcl
activ
treatment
day
ci
norepinephrin
use
salin
load
mean
arteri
pressur
central
venou
pressur
predict
crcl
day
measur
conclus
arc
common
headinjur
patient
receiv
activ
manag
cpp
persist
even
ceas
therapi
signifi
cant
implic
appropri
dose
renal
excret
drug
set
introduct
kidney
organ
human
bodi
design
sens
regul
intravascular
volum
king
kidney
instant
monitor
orvim
paderno
dugnano
itali
new
devic
allow
continu
measur
urinari
electrolyt
realtim
bodi
respons
chang
intrathorac
intraabdomin
pressur
lung
injuri
method
sixteen
pig
weight
kg
anaesthet
tracheotom
catheter
mechan
ventil
pig
ventil
approxim
hour
tv
mlkg
rr
breathsminut
f
peep
tv
increas
pig
divid
two
group
eight
pig
lower
tv
eight
pig
higher
tv
variabl
dead
space
ad
maintain
normocapnia
pig
mechan
ventil
new
tv
hour
king
measur
urinari
output
urinari
concentr
sodium
potassium
everi
minut
nacl
exclus
infus
averag
urinari
concentr
electrolyt
express
total
concentr
introduct
ngal
level
dramat
increas
urin
plasma
patient
acut
kidney
injuri
aki
studi
test
clinic
util
ngal
critic
ill
patient
mani
confound
condit
includ
sepsi
addit
new
fulli
autom
ngal
assay
valid
select
clinic
sampl
patient
method
plasma
urinari
ngal
monitor
daili
altern
day
consecut
patient
admit
intens
care
aki
classifi
ed
accord
rifl
criteria
three
patient
exclud
incomplet
data
ngal
determin
elisa
kit
bioporto
diagnost
diff
erenc
maxim
ngal
level
patient
analyz
nonparametr
kruskalw
test
data
report
median
interquartil
rang
ngml
fulli
autom
immunoturbidimetr
ngal
test
ngal
test
bioporto
diagnost
test
ngal
test
valid
mean
linear
studi
dilut
calibr
materi
determin
antigen
excess
zone
method
comparison
elisa
kit
urin
plasma
sampl
ngal
level
ngml
measur
elisa
result
sixtytwo
patient
aki
classifi
ed
risk
r
injuri
failur
f
urinari
ngal
signifi
cantli
p
higher
patient
aki
r
f
patient
without
aki
plasma
ngal
level
signifi
cantli
p
higher
patient
aki
r
f
patient
without
aki
linear
studi
ngal
test
demonstr
measur
rang
ngml
deleteri
eff
ect
antigen
excess
seen
level
ngml
good
agreement
elisa
ngal
test
result
pearson
coeffi
cient
correl
urin
plasma
sampl
conclus
conclud
ngal
dramat
increas
urin
plasma
unselect
critic
ill
patient
aki
degre
injuri
refl
ect
observ
level
despit
sever
confound
condit
ngal
determin
may
therefor
use
diagnosi
renal
injuri
monitor
manag
patient
admit
intens
care
valid
ngal
test
demonstr
perform
compli
expect
fulli
autom
clinic
laboratori
assay
thu
valuabl
tool
manag
critic
ill
patient
introduct
intraabdomin
hypertens
iah
associ
signifi
cant
mortal
surgic
trauma
patient
howev
iah
occur
medic
patient
well
thu
main
object
studi
assess
whether
iah
fi
rst
period
admiss
independ
predictor
mortal
method
conduct
prospect
observ
studi
patient
admit
medic
icu
enrol
studi
underw
intraabdomin
pressur
iap
measur
via
bladder
primari
outcom
associ
iah
mortal
rate
result
seventyseven
elig
patient
enrol
studi
incid
iah
mean
age
year
term
mortal
associ
presenc
iah
mortal
outcom
howev
regard
icu
mortal
nonsurvivor
signifi
cantli
higher
mean
iap
within
hour
admiss
survivor
vs
p
conclus
neither
mean
iap
presenc
iah
within
fi
rst
hour
admiss
independ
predictor
mortal
nonetheless
studi
demonstr
diff
erenc
iap
survivor
nonsurvivor
term
icu
mortal
medic
icu
introduct
intraabdomin
hypertens
iah
abdomin
compart
syndrom
ac
becom
seriou
caus
morbid
mortal
critic
surgic
medic
patient
especi
past
year
increas
iap
level
becam
one
routin
physiolog
paramet
measur
element
critic
patient
indic
prognosi
studi
aim
observ
iap
increas
apb
decreas
clinic
manifest
icu
patient
method
eightynin
icu
patient
includ
studi
iap
level
measur
infus
ml
salin
urinari
bladder
symphisi
pubi
plane
affi
liat
zero
point
patient
divid
group
accord
iap
apb
level
clinic
followup
requir
medic
care
surviv
investig
result
within
patient
diagnos
iah
diagnos
low
apb
patient
iah
low
apb
patient
fi
rst
day
studi
statist
signifi
cant
sgot
sgpt
po
urea
creatinin
level
found
also
determin
increas
posit
inotrop
support
ventilatori
support
need
increas
sepsi
multipl
organ
failur
incid
patient
mortal
rate
strongli
relat
iah
low
apb
level
conclus
critic
ill
patient
iap
measur
simpl
valuabl
method
must
perform
iah
low
apb
level
indic
high
morbid
mortal
rate
therefor
iap
measur
may
becom
routin
element
followup
surviv
rate
determin
critic
ill
patient
introduct
acut
liver
failur
alf
rare
diseas
spectrum
present
mild
coagulopathi
alter
consciou
level
multipl
organ
failur
intracrani
hypertens
ich
new
group
acut
liver
failur
studi
europ
alsi
wish
initi
collabor
centr
clinic
expertis
manag
alf
aim
establish
paneuropean
databas
clinic
demograph
data
alf
initi
clinic
studi
method
describ
experi
centr
seven
countri
period
march
alf
defi
ned
inr
encephalopathi
absenc
chronic
liver
diseas
result
present
median
iq
rang
result
eightyfi
patient
treat
acetaminophen
domin
aetiolog
uk
repres
centr
present
inr
hepat
encephalopathi
grade
observ
requir
pressor
grade
iiiiv
coma
seen
cours
develop
ich
seventyon
per
cent
requir
ventil
renal
replac
therapi
pressor
nineti
per
cent
requir
manag
critic
care
environ
overal
surviv
case
fulfi
lled
poor
prognost
criteria
ppc
transplant
surviv
hospit
discharg
remain
four
surviv
seven
die
thirtytwo
fulfi
ppc
surviv
patient
die
older
predomin
aetiolog
hypox
hepat
one
organ
support
less
associ
surviv
medic
manag
alon
two
organ
support
requir
patient
surviv
medic
manag
remaind
requir
transplant
die
conclus
alf
high
preval
progress
multipl
organ
failur
requir
multidisciplinari
approach
critic
care
transplant
surgeri
hepatolog
achiev
optim
outcom
develop
ich
grade
iiiiv
despit
outcom
good
introduct
follow
liver
transplant
hepat
arteri
stenosi
portal
vein
obstruct
occur
patient
frequent
children
adult
today
standard
care
doppler
ultrasound
liver
enzym
assess
daili
accordingli
detect
sever
hypoperfus
may
delay
aim
present
studi
explor
whether
microdialysi
cathet
implant
left
right
liver
lobe
measur
glucos
lactat
pyruv
glycerol
everi
hour
detect
vascular
complic
reject
method
seventythre
patient
undergo
liver
transplant
includ
nine
patient
children
two
microdialysi
cathet
insert
liver
one
subcutan
tissu
split
needl
techniqu
kept
long
cathet
function
maxim
week
metabol
paramet
glucos
pyruv
glycerol
lactat
collect
everi
hour
measur
bedsid
result
median
age
patient
year
month
year
median
time
cathet
insert
liver
day
rang
day
six
patient
hepat
arteri
stenosi
occlus
fi
lactat
increas
valu
mm
lactatepyruv
ratio
sever
hundr
concomit
decreas
glucos
increas
glycerol
one
patient
child
lactat
increas
mm
lp
ratio
background
patholog
metabol
valu
patient
underw
immedi
reoper
blood
clot
remov
arteri
reanastomos
child
low
lactat
valu
fl
ow
arteri
less
total
hepat
blood
fl
ow
despit
reanastomosi
thu
except
high
portal
fl
ow
deliv
enough
oxygen
prevent
major
ischemia
despit
low
fl
ow
arteri
thirteen
patient
reject
verifi
ed
biopsi
six
patient
antireject
therapi
given
base
liver
function
test
clinic
judgement
patient
increas
lactat
period
reject
increas
four
patient
mm
remain
four
increas
mm
conclus
use
microdialysi
cathet
measur
metabol
paramet
hepat
arteri
occlus
detect
rapidli
patient
reject
show
small
signifi
cant
increas
lactat
introduct
liver
dysfunct
critic
ill
patient
repres
major
concern
mani
drug
use
icu
associ
hepatotox
hepatotox
present
three
distinct
pattern
cholestat
alkalin
phosphatas
ap
x
uln
ratio
altuln
ap
uln
hepatocellular
alt
x
uln
ratio
mix
ap
x
uln
alt
x
uln
ratio
publish
studi
assess
druginduc
cholestast
pattern
hepatotox
icu
aim
studi
assess
whether
use
pharmacolog
class
previous
associ
cholestasi
associ
increas
risk
pure
mix
cholestasi
icu
method
nest
casecontrol
studi
assess
potenti
associ
use
specifi
ed
pharmacolog
class
cholestasi
case
identifi
ed
cohort
patient
admit
hour
least
one
valu
ap
iul
obtain
hour
follow
admiss
exclud
patient
identifi
ed
caus
cholestasi
well
patient
bone
metastasi
pregnant
women
case
subject
match
control
subject
base
age
gender
length
icu
stay
admiss
year
exposur
antiepilept
penicillin
cephalosporin
carbapenem
macrolid
antibiot
parenter
nutrit
collect
includ
multivari
condit
logist
regress
analysi
known
risk
factor
introduct
energi
requir
critic
ill
septic
shock
patient
treat
icu
particularli
diffi
cult
determin
recent
research
show
energi
expenditur
ee
patient
may
smaller
previous
believ
ee
valu
group
aff
ect
sever
diseas
process
well
administ
treatment
sedat
inact
skelet
respiratori
muscl
fi
ghting
fever
purpos
studi
establish
infl
uenc
septic
shock
ee
sedat
mechan
ventil
patient
treat
icu
use
indirect
calorimetri
assess
ee
patient
compar
result
basal
energi
expenditur
calcul
accord
harrisbenedict
equat
bee
ee
valu
patient
subject
gener
anesthesia
method
two
group
patient
studi
regard
ee
measur
mean
indirect
calorimetri
group
consist
critic
ill
patient
treat
icu
septic
shock
evalu
use
apach
ii
sofa
score
take
account
mortal
ee
measur
continu
fi
rst
hour
treatment
mean
datexohmeda
mcovx
indirect
calorimet
group
ii
compris
patient
asa
ii
whose
energi
expenditur
measur
gener
anesthesia
surgic
treatment
disc
herniat
energi
expenditur
measur
taken
use
datexohmeda
ecaiovx
indirect
calorimet
adapt
work
atmospher
contain
anesthet
gase
conclus
decreas
total
metabol
rate
patient
sever
sepsi
septic
shock
constitut
prognost
indic
heighten
death
risk
group
icutr
patient
exclud
studi
onset
time
occurr
pneumonia
extract
hospit
databas
patient
die
fi
rst
hour
exclud
patient
stay
day
longer
icu
divid
two
group
without
ngt
analyz
separ
result
one
hundr
fi
ftysix
patient
analyz
ct
scan
show
ngt
patient
one
malposit
medium
esophagu
gastric
ga
liquidsolid
total
volum
diff
erent
patient
without
ngt
z
test
ga
vs
ml
p
liquidsolid
vs
p
total
vs
p
twenti
patient
develop
pneumonia
fi
rst
day
fi
ngt
without
chisquar
p
diff
erenc
gastric
residu
patient
other
mannwhitney
ga
vs
ml
p
liquidsolid
vs
ml
p
total
vs
ml
p
seventythre
patient
admit
icu
ngt
develop
pneumonia
diff
erenc
gastric
residu
ngt
other
pneumonia
develop
fi
rst
day
patient
ngt
vs
without
ngt
chisquaredy
p
fi
rst
day
patient
ngt
vs
without
ngt
chisquar
p
diff
erenc
gastric
residu
patient
develop
earli
pneumonia
fi
rst
day
diff
erenc
icu
length
stay
vs
day
p
onset
time
pneumonia
vs
day
p
conclus
result
suggest
gastric
volum
high
admiss
trauma
patient
irrespect
ngt
presenc
studi
pneumonia
incid
relat
neither
high
gastric
volum
ngt
usag
mcwhirter
pennington
state
patient
malnourish
admiss
hospit
malnutrit
increas
morbid
mortal
icu
earli
feed
improv
outcom
length
stay
septic
complic
method
aim
assess
standard
nutrit
practic
measur
calor
achiev
calor
debt
fi
rst
day
admiss
critic
ill
patient
european
societi
parenter
enter
nutrit
guidelin
enter
nutrit
set
standard
april
august
adult
patient
fed
oral
within
day
admiss
icu
includ
calor
target
kcalkgday
impedi
achiev
feed
target
record
result
among
patient
surgic
medic
patient
fed
earli
within
hour
admiss
patient
fed
hour
admiss
twentythre
patient
fed
nasogastr
tube
three
patient
receiv
small
bowel
feed
parenter
nutrit
pn
use
alon
two
patient
supplement
enter
nutrit
en
one
patient
conclus
mean
calor
achiev
day
figur
well
target
follow
recommend
made
improv
nutrit
practic
higher
threshold
residu
gastric
volum
adopt
earlier
aggress
use
prokinet
agent
recommend
strategi
access
small
bowel
feed
earlier
pn
consid
within
hour
en
contraind
supplement
en
calor
target
reach
hour
introduct
nutrit
screen
nutrit
support
import
role
prevent
malnutrit
aff
ect
prognosi
increas
morbid
mortal
patient
aim
assess
patient
consult
follow
nutrit
support
team
period
retrospect
method
demograph
characterist
subject
global
assess
score
sga
patient
type
rout
durat
nutrit
support
complic
assess
result
total
patient
consult
period
two
hundr
two
male
femal
mean
valu
age
year
year
minimum
maximum
sga
score
n
b
n
c
n
n
patient
combin
parenter
enter
n
parenter
n
enter
n
oral
nutrit
support
administ
combin
parenter
enter
nutrit
support
appli
via
nasogastr
tube
peripher
parenter
n
nasogastr
tube
santral
parenter
n
oral
santral
n
oral
peripher
parenter
n
nasojejun
peripher
parenter
n
gastrostomi
peripher
parenter
n
parenter
nutrit
support
appli
via
peripher
rout
n
santral
rout
n
enter
nutrit
commonli
appli
nasogastr
tube
n
gastrostomi
tube
n
nutrit
support
appli
day
day
common
complic
constip
nasogastr
tube
displac
obstruct
diarrhea
thrombophleb
aspir
hyperglycemia
conclus
nutrit
screen
compon
physic
examin
hospit
outpati
feed
critic
ill
patient
appropri
introduct
nutrit
play
signifi
cant
part
overal
treatment
plan
critic
ill
patient
india
vari
practic
includ
use
kitchen
feed
andor
commerci
formula
also
predomin
use
bolu
feed
multidisciplinari
team
critic
care
unit
ccu
includ
senior
dietician
want
review
whether
standard
practic
routin
screen
malnutrit
use
subject
global
assess
earli
use
nutrit
prefer
within
hour
continu
enter
feed
use
commerci
formula
help
achiev
nutrit
goal
method
retrospect
chart
review
conduct
patient
receiv
continu
enter
feed
day
day
icu
stay
inform
calori
prescrib
use
harrisbenedict
equat
deliv
day
day
collect
achiev
nutrit
goal
defi
ned
success
deliveri
prescrib
introduct
earli
enter
nutrit
en
prefer
strategi
feed
critic
ill
howev
alway
possibl
achiev
suffi
cient
calori
protein
en
alon
use
supplement
parenter
nutrit
pn
advoc
strategi
avoid
complic
associ
proteincalori
defi
cit
inadequ
enter
feed
purpos
studi
evalu
eff
ect
practic
nutrit
clinic
outcom
method
intern
observ
studi
conduct
examin
nutrit
practic
icu
elig
patient
mechan
ventil
remain
icu
hour
receiv
earli
en
within
hour
admiss
data
collect
patient
characterist
daili
nutrit
practic
day
patient
outcom
record
day
compar
outcom
patient
receiv
earli
en
alon
earli
en
earli
pn
earli
en
late
pn
hour
admiss
regress
analys
conduct
determin
eff
ect
increas
age
apach
score
day
hospit
prior
icu
admiss
gastrointestin
dysfunct
nutrit
strategi
baselin
variabl
relationship
aliv
discharg
within
day
introduct
liver
function
disturb
concern
parenter
nutrit
aim
post
hoc
analys
two
pool
studi
compar
liver
function
paramet
use
fi
shoilcontain
vs
soybean
oil
lipid
emuls
method
two
prospect
control
random
parallelgroup
doubleblind
multicent
studi
compar
smoflipid
fi
shoilcontain
lipid
emuls
smof
soybean
oil
g
mediumchain
triglycerid
g
oliv
oil
g
fi
sh
oil
g
per
l
vs
standard
soybean
oil
emuls
g
soybean
oill
studi
follow
postsurg
adult
patient
day
total
parenter
nutrit
smof
vs
patient
b
adult
patient
receiv
parenter
nutrit
day
smof
vs
patient
patient
data
baselin
studi
end
select
data
pool
diff
erenc
laboratori
data
week
minu
baselin
studi
end
minu
baselin
calcul
analys
varianc
appli
use
diff
erenc
weekstudi
end
valu
baselin
valu
bilirubin
bil
ast
alt
depend
variabl
treatment
group
independ
variabl
covari
use
baselin
valu
bil
ast
alt
mean
daili
dose
fat
per
kg
bodi
weight
result
baselin
valu
signifi
cantli
diff
erent
two
treatment
group
mean
daili
intak
fatkg
bw
week
studi
end
treatment
group
oneweekbaselin
valu
liver
paramet
mean
smof
group
bil
ast
ul
alt
ul
group
bil
ast
ul
alt
ul
signifi
cantli
diff
erent
treatment
group
p
extend
analysi
day
alter
result
conclus
infus
smoflipid
compar
soybean
oil
standard
lipid
emuls
exert
signifi
cant
decreas
valu
bil
ast
also
signifi
cantli
attenu
rise
seen
alt
result
indic
smoflipid
promis
prevent
parenter
nutritioninduc
liver
disturb
suppos
diagnost
signifi
canc
ratio
proinfl
ammatori
antiinfl
ammatori
cytokin
periton
caviti
system
blood
fl
ow
patient
abdomin
sepsi
tri
correct
disbal
glutamin
intraven
enter
supplement
method
prospect
control
random
investig
patient
abdomin
sepsi
exclud
pancreat
group
n
standard
therapi
group
n
intraven
infus
glutamin
dipeptiven
freseniu
kabi
germani
group
n
intraven
infus
glutamin
enter
supplement
glutamin
intestamin
freseniu
kabi
patient
group
ident
accord
sever
diseas
apach
ii
standard
intens
care
volum
surgeri
care
investig
proinfl
ammatori
cytokin
antiinfl
ammatori
cytokin
solubl
stnfri
stnfrii
antagonist
receptor
blood
serum
periton
caviti
initi
day
intens
care
elisa
bd
bioscienc
pharmingen
san
diego
ca
usa
easia
biosourc
nivel
belgium
probabl
surviv
day
standard
therapi
group
group
glutamin
intraven
group
glutamin
intraven
enter
fi
x
decreas
durat
respiratori
support
group
durat
acut
intestin
injuri
signifi
cantli
diff
erent
standard
group
hour
vs
hour
group
glutamin
intraven
supplement
hour
group
intraven
enter
glutamin
supplement
investig
preval
concentr
proinfl
ammatori
cytokin
periton
caviti
blood
serum
accord
molar
coeffi
cient
control
group
molar
coeffi
cient
posit
correl
sofa
scale
group
glutamin
intraven
molar
coeffi
cient
decreas
preval
antiinfl
ammatori
cytokin
serum
day
periton
day
group
glutamin
intraven
enter
investig
signifi
canc
diff
erenc
decreas
cytokin
level
blood
serum
periton
caviti
conclus
intraven
enter
supplement
glutamin
improv
cytokin
balanc
blood
periton
compart
introduct
glycem
control
mandatori
critic
ill
hypoglycemia
hyperglycemia
associ
increas
mortal
compar
prospect
observ
studi
three
new
pointofcar
devic
hexokinas
refer
method
evalu
whether
result
would
modifi
insulin
titrat
method
arteri
blood
glucos
simultan
measur
blood
ga
analys
rapidlab
three
glucos
meter
accuchek
performa
precis
xceedpro
nova
statstrip
hexokinas
refer
method
valu
duplic
averag
valu
comput
blandaltman
pass
bablok
kanji
modifi
ed
kanji
approach
perform
bias
express
glucos
result
pointofcar
method
minu
refer
method
evalu
theoret
impact
insulin
titrat
compar
glucos
meter
result
hexokinas
refer
method
dynam
slide
scale
target
glycemia
mgdl
result
total
match
analys
done
patient
mean
fl
ash
sofa
score
rang
refer
glucos
mgdl
number
discrep
dose
insulin
respect
uhour
uhour
uhour
none
greater
uhour
regard
pointofcar
result
total
theoret
insulin
dose
chang
respect
u
u
u
u
measur
devic
order
method
tabl
present
standard
comparison
introduct
chronic
critic
ill
character
sever
metabol
disord
caus
loss
physiolog
hypothalam
pituitari
function
onset
socal
wast
syndrom
mani
studi
confi
rmed
studi
assess
correl
neuroendocrin
pattern
chronic
icu
patient
mortal
method
patient
enrol
male
fi
femal
mean
age
year
apach
ii
score
exclud
femal
premenopaus
state
patient
previou
endocrin
problem
therapi
dopamin
high
dose
cortison
amiodaron
patient
evalu
seventh
day
stay
icu
consid
chronic
phase
critic
ill
mean
valu
four
nocturn
hormon
measur
lh
fsh
estrogen
testosteron
dhea
androstenedion
androstenediol
progesteron
tsh
gh
prolactin
cortisol
furthermor
observ
hormon
pattern
peopl
die
icu
found
statist
evid
correl
high
level
estrogen
relat
aromatas
increas
function
percentag
death
group
patient
estrogen
pgml
six
die
estrogen
normal
low
none
die
figur
survivor
nonsurvivor
diff
er
mechan
injuri
apach
score
vs
medium
serum
estradiol
level
pg
ml
survivor
pgml
nonsurvivor
conclus
date
role
hormon
critic
ill
pathophysiolog
increas
estrogen
level
still
uncertain
studi
requir
introduct
patient
sever
burn
injuri
experi
rapid
elev
multipl
circul
proinfl
ammatori
cytokin
level
correl
injuri
sever
outcom
accumul
cytokin
anim
model
observ
remot
organ
howev
data
lack
regard
earli
serial
heart
cytokin
level
follow
burn
injuri
therapeut
eff
ect
estrogen
level
use
anim
model
studi
acut
eff
ect
fullthick
thirddegre
burn
cardiac
level
addit
analyz
eff
ect
estrogen
level
cytochrom
c
signifi
apoptosi
level
signifi
infl
ammat
hypothes
acut
estrogen
treatment
decreas
infl
ammat
heart
block
induct
apoptosi
method
studi
male
rat
receiv
thirddegre
total
bodi
surfac
area
burn
fifteen
minut
follow
burn
injuri
anim
receiv
subcutan
inject
either
placebo
mgkg
heart
harvest
hour
injuri
heart
cytokin
level
measur
use
elisa
method
addit
assess
cytosol
level
cytochrom
c
time
point
use
western
blot
analysi
burn
rat
signifi
cantli
decreas
cardiac
level
compar
placebo
group
addit
determin
estradiol
treatment
restor
cytosol
level
increas
time
point
also
estrogen
decreas
cytosol
accumul
cytochrom
c
reduct
time
point
conclus
follow
sever
burn
injuri
estrogen
decreas
cardiac
infl
ammat
level
proapoptot
cytochrom
c
addit
estrogen
signal
promot
cell
surviv
indic
increas
level
importantli
estrogen
treatment
follow
burn
injuri
nearli
ablat
deleteri
burninduc
increas
heart
level
similar
unburn
control
anim
elev
cardiac
level
previous
link
poor
outcom
introduct
glucocorticoid
known
antiinsulin
action
glucos
metabol
lead
increas
lactat
product
altern
glucocorticoidinduc
apoptosi
wellrecogn
phenomenon
initi
mitochondri
dysfunct
increas
lactat
product
follow
loss
mitochondri
membran
potenti
apoptosi
mechan
may
lead
clinic
relev
hyperlactatemia
follow
glucocorticoid
administr
cardiac
surgeri
requir
cardiopulmonari
bypass
method
adult
patient
undergo
cardiac
surgeri
cardiopulmonari
bypass
octob
novemb
larg
academ
teach
hospit
rotterdam
netherland
includ
studi
dexamethason
mg
given
periop
discret
anesthetist
lactat
level
measur
within
hour
postop
associ
dexamethason
treatment
serum
lactat
level
possibl
confound
evalu
use
anova
linear
regress
result
total
patient
year
older
underw
cardiopulmonari
bypass
cardiac
surgeri
abovement
period
three
patient
undergo
heart
lung
transplant
thu
receiv
methylprednisolon
exclud
two
patient
receiv
hydrocortison
allerg
reaction
also
exclud
data
incomplet
one
patient
leav
total
patient
analysi
mean
lactat
level
mmoll
patient
receiv
steroid
mmoll
patient
receiv
dexamethason
p
figur
adjust
potenti
confound
age
glucos
level
durat
cardiopulmonari
bypass
preoper
nyha
heart
failur
classifi
cation
diff
erenc
remain
signifi
cant
p
conclus
administr
dexamethason
cardiac
surgeri
requir
cardiopulmonari
bypass
associ
signifi
cant
hyperlactatemia
introduct
previous
observ
critic
ill
patient
vitd
defi
cient
statu
restor
increas
normal
recommend
intraven
vitd
dose
antimicrobi
peptid
express
macrophag
upon
stimul
solubl
patternrecognit
receptor
marker
macrophag
activ
predictor
mortal
sir
aim
studi
unravel
impact
defi
cienci
normal
innat
immun
paramet
crp
critic
ill
method
randomli
alloc
patient
upon
icu
admiss
receiv
either
placebo
n
treatment
intraven
load
dose
intraven
n
top
normal
vitd
dose
iu
patient
chronic
bone
kidney
diseas
glucocorticoid
treatment
age
younger
year
anticip
icu
length
stay
less
day
exclud
admiss
patient
compar
healthi
agematch
gendermatch
bmimatch
control
n
result
administr
regimen
result
rapid
sustain
increas
serum
level
p
vs
placebo
oh
level
rose
transient
p
day
p
day
vs
placebo
oh
level
lower
healthi
control
sampl
summer
treatment
signifi
cant
eff
ect
crp
admiss
level
compar
healthi
control
treatment
tend
transient
increas
level
chang
baselin
p
day
vs
placebo
serum
level
tend
higher
baselin
critic
care
volum
suppl
http
p
vs
healthi
control
rose
signifi
cantli
time
p
day
day
vs
day
infl
uenc
treatment
preliminari
result
random
placebocontrol
pilot
studi
indic
contrast
high
intraven
iu
vitd
supplement
intraven
treatment
result
immedi
persist
increas
serum
aff
ect
oh
level
plasma
alter
studi
prolong
critic
ill
patient
hint
amelior
product
provid
statu
restor
serum
crp
level
evolv
icu
stay
signifi
cantli
alter
supplement
result
pilot
studi
warrant
research
potenti
modul
innat
immun
process
critic
ill
introduct
critic
ill
character
lean
tissu
wast
wherea
adipos
tissu
preserv
obes
critic
ill
patient
may
lower
risk
death
nonobes
patient
recent
observ
may
suggest
protect
role
adipos
tissu
ill
role
previous
investig
hypothes
adipos
tissu
could
function
wast
bin
potenti
toxic
metabolit
glucos
critic
ill
method
studi
adipos
tissu
biopsi
critic
ill
patient
specifi
calli
morpholog
potenti
take
metabol
glucos
compar
biopsi
match
control
result
adipos
tissu
biopsi
critic
ill
patient
reveal
higher
number
smaller
size
adipocyt
compar
match
control
coincid
increas
preadipocyt
marker
level
also
adipos
biopsi
critic
ill
patient
display
posit
macrophag
stain
gene
protein
express
insulinindepend
glut
tissu
glucos
content
increas
glucokinas
express
upregul
wherea
glycogen
level
low
acetylcoacarboxylas
protein
level
activ
fattyacid
synthas
increas
substanti
increas
activ
ampk
may
play
crucial
role
conclus
larger
number
small
adipocyt
respons
critic
ill
appear
increas
abil
take
metabol
glucos
fatti
acid
chang
may
render
adipos
tissu
biolog
activ
function
wast
bin
toxic
metabolit
critic
ill
could
contribut
surviv
good
commun
patient
rel
humanitarian
profession
medicoleg
benefi
ts
nh
litig
author
requir
clear
inform
document
monitor
satisfactori
review
perform
ascertain
rel
opinion
regard
current
standard
commun
receiv
medic
staff
method
paper
questionnair
made
avail
rel
discuss
member
medic
staff
data
fi
rst
month
discuss
base
averag
admissionsmonth
questionnair
main
recept
desk
staff
also
ere
rel
profession
contact
close
question
singl
answer
chosen
fi
option
includ
one
neutral
option
ask
along
space
free
comment
result
eighteen
questionnair
complet
knowledg
rel
refus
complet
thirteen
discuss
took
place
pm
monday
friday
three
pm
weekday
two
weekend
respond
felt
doctor
explain
role
care
thirteen
discuss
took
place
dedic
interview
room
four
bedsid
one
telephon
seventeen
rate
servic
good
inform
given
clariti
eff
ect
exchang
overal
impress
care
one
questionnair
rate
servic
good
conclus
rel
commun
highli
subject
known
infl
uenc
impress
form
overal
qualiti
care
nation
audit
framework
emphasis
object
quantifi
abl
standard
captur
qualiti
interact
monitor
servic
qualiti
base
subject
rel
impress
howev
respons
rate
potenti
posit
bia
favour
mani
discuss
complex
possibl
questionnair
ere
certain
situat
addit
despit
full
anonym
form
rel
may
concern
written
impact
famili
member
care
known
benefi
ts
process
clinic
care
lead
improv
qualiti
aris
pure
measur
perform
servic
review
one
target
use
benchmark
qualiti
care
area
need
consider
appropri
target
altern
accept
potenti
lower
data
captur
area
introduct
patient
satisfact
data
collat
prioriti
uk
care
qualiti
commiss
adult
intens
care
unit
aicu
patient
often
sedat
prolong
period
famili
satisfact
data
may
use
gaug
qualiti
servic
deliveri
famili
satisfactionicu
fsicu
questionnair
develop
valid
usa
knowledg
fi
rst
group
use
uk
method
fsicu
anonymis
questionnair
adapt
american
terminolog
use
uk
inclus
criteria
aicu
admiss
day
presenc
nextofkin
patient
die
exclud
hand
person
aicu
patient
nextofkin
follow
discharg
nurs
staff
aicu
gener
ward
assist
return
complet
questionnair
key
area
question
use
fsicu
percept
treatment
patient
discomfort
coordin
aicu
servic
skill
compet
aicu
staff
consist
frequenc
commun
standard
famili
facil
emot
support
rel
ask
grade
answer
fi
vepoint
scale
excel
poor
result
data
fi
rst
month
survey
analys
one
hundr
per
cent
patient
rel
fulfi
lled
inclus
criteria
receiv
questionnair
respons
rate
major
respond
satisfi
ed
overal
care
decisionmak
similarli
publish
data
famili
satisfi
ed
nurs
skill
compet
satisfi
ed
least
satisfi
ed
wait
room
atmospher
frequenc
commun
doctor
conclus
fsicu
enabl
us
identifi
target
resourc
key
aspect
servic
deliveri
present
opportun
us
address
misunderstand
misconcept
regard
icu
within
client
base
survey
uniqu
examin
link
icu
commun
inform
process
understand
relationship
method
questionnair
around
variou
issu
conscious
present
attende
confer
europ
data
obtain
respond
age
year
rang
women
eu
countri
analyz
spss
v
result
sixtyseven
percent
n
agre
anh
withdraw
chronic
vs
n
disagre
n
respons
signifi
cant
agreement
express
nonreligi
respond
vs
religi
b
p
nonmed
profession
vs
doctor
b
p
signifi
cant
disagr
express
women
vs
men
b
p
central
south
european
vs
northern
b
p
b
p
respect
higher
age
b
p
eighti
percent
n
wish
stay
aliv
perman
vs
n
wish
stay
aliv
n
respons
seventyeight
percent
consid
perman
vs
wors
death
patient
famili
consid
wors
death
patient
sixtynin
percent
n
disagre
anh
withdraw
chronic
mc
n
agre
n
respons
signifi
cant
disagr
express
central
south
european
vs
northern
b
p
b
p
respect
respond
higher
age
b
p
signifi
cant
agreement
express
nonreligi
respond
vs
religi
b
p
sixtyfour
percent
n
wish
kept
aliv
perman
mc
n
wish
stay
aliv
n
respons
forti
percent
consid
mc
wors
vs
patient
famili
consid
wors
vs
patient
conclus
fi
nding
rais
import
ethic
issu
concern
care
patient
chronic
disord
conscious
light
high
rate
diagnost
error
patient
necess
adapt
standard
care
warrant
introduct
aim
studi
demonstr
improv
staff
patient
experi
endoflif
care
icu
set
death
common
suggest
patient
us
die
icu
given
major
icu
death
involv
withhold
withdraw
treatment
import
endoflif
care
clear
despit
frequenc
studi
suggest
current
qualiti
endoflif
care
suboptim
icu
result
develop
new
framework
address
issu
method
introduc
new
framework
period
circul
questionnair
staff
pre
post
studi
demonstr
improv
endoflif
care
result
framework
found
help
respond
associ
improv
commun
knowledg
endoflif
care
discov
increas
number
staff
felt
patient
along
analgesiased
need
met
experienc
care
conduc
good
qualiti
die
number
staff
felt
confi
dent
manag
withdraw
care
trend
toward
signifi
cant
p
valu
see
figur
detail
conclus
qualiti
endoflif
care
improv
new
framework
howev
research
vital
ensur
patient
receiv
kind
evidencebas
medicin
fi
nal
hour
acut
ill
acknowledg
local
practic
respect
endoflif
decis
accord
law
ethic
principl
inevit
intens
physician
countri
fi
rst
step
requir
social
dialogu
search
local
custom
harmonis
ethic
legal
regul
well
interest
physician
patient
method
perform
fi
rst
hungarian
survey
purpos
learn
local
practic
endoflif
decis
questionnair
sent
electron
regist
member
hungarian
societi
anaesthesiolog
intens
care
respect
anonym
statist
evalu
repli
respons
rate
compar
data
european
countri
result
expect
turn
repli
practic
domest
intens
care
physician
patern
promot
legal
regul
share
similar
charact
intens
care
physician
gener
make
decis
alon
point
without
respect
opinion
patient
point
rel
point
medic
personnel
point
furthermor
prefer
start
therapi
rather
withdraw
ongo
treatment
nevertheless
frequenc
endoflif
decis
icu
patient
similar
european
countri
conclus
hungarian
intens
care
physician
make
endoflif
action
routin
usual
decid
base
opinion
slightli
consid
opinion
nurs
personnel
patient
rel
support
hungarian
legal
regul
make
decis
although
live
advanc
direct
acknowledg
widespread
requir
studi
fi
rst
step
commenc
social
dialogu
taken
evolut
endoflif
decisionmak
procedur
